date generated: 2024-04-01
Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch
Here is the first few lines of the input profile.
x | |
---|---|
PRG2 | 4.351472 |
IGHV3-15 | -4.056375 |
DTL | 3.852456 |
CRHBP | -3.827404 |
BX284613.2 | 3.449226 |
HPGD | 3.437028 |
Here are some metrics about the input data profile:
Profile metrics | |
---|---|
num_genesets | 10461 |
num_genes_in_profile | 9017 |
duplicated_genes_present | 0 |
num_profile_genes_in_sets | 7965 |
num_profile_genes_not_in_sets | 1052 |
Here is a plot of the input profiles. Note the dynamic ranges.
Here is the contour plot of the profile including all detected genes.
Here are some metrics about the gene sets used:
GMT file of genesets: c5.go.v2023.2.Hs.symbols.gmtGene sets metrics | |
---|---|
num_genesets | 10461 |
num_genesets_excluded | 5628 |
num_genesets_included | 4833 |
Significance is calculated by -log10(p-value). All points shown are FDR<0.05.
Significance is calculated by -log10(p-value). Top N sets shown irrespective of FDR.
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 5 | 0.000593 | 0.887 | 0.0241 |
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 5 | 0.002930 | -0.768 | 0.0680 |
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 5 | 0.003490 | -0.754 | 0.0732 |
GOCC BRCA1 C COMPLEX | 6 | 0.001410 | 0.753 | 0.0431 |
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 0.000812 | 0.731 | 0.0301 |
GOBP FAT PAD DEVELOPMENT | 5 | 0.004770 | -0.729 | 0.0872 |
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 0.001210 | 0.706 | 0.0398 |
GOCC CMG COMPLEX | 7 | 0.001220 | 0.706 | 0.0398 |
GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 6 | 0.002750 | -0.706 | 0.0659 |
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 0.002780 | -0.705 | 0.0660 |
GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 6 | 0.002810 | -0.704 | 0.0662 |
GOBP DETOXIFICATION OF INORGANIC COMPOUND | 6 | 0.003210 | 0.695 | 0.0708 |
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 8 | 0.000674 | -0.694 | 0.0266 |
GOMF COPPER CHAPERONE ACTIVITY | 6 | 0.003670 | 0.685 | 0.0754 |
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 0.008160 | -0.683 | 0.1180 |
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 0.008790 | -0.677 | 0.1210 |
GOMF MAP KINASE PHOSPHATASE ACTIVITY | 5 | 0.009040 | -0.674 | 0.1230 |
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 5 | 0.009040 | -0.674 | 0.1230 |
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 5 | 0.009040 | -0.674 | 0.1230 |
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 5 | 0.009120 | 0.673 | 0.1230 |
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 7 | 0.002740 | 0.654 | 0.0657 |
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 5 | 0.011700 | -0.651 | 0.1410 |
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 9 | 0.000724 | 0.651 | 0.0279 |
GOBP PROXIMAL DISTAL PATTERN FORMATION | 7 | 0.002910 | -0.650 | 0.0680 |
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 0.000105 | 0.647 | 0.0065 |
GOBP TETRAPYRROLE CATABOLIC PROCESS | 5 | 0.012500 | 0.645 | 0.1460 |
GOMF THIOESTERASE BINDING | 5 | 0.013000 | -0.641 | 0.1500 |
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 5 | 0.013200 | 0.640 | 0.1500 |
GOBP RESPONSE TO WATER | 6 | 0.006670 | -0.640 | 0.1050 |
GOBP NEURON FATE SPECIFICATION | 5 | 0.014100 | 0.634 | 0.1570 |
GOCC DNA REPLICATION PREINITIATION COMPLEX | 8 | 0.001900 | 0.634 | 0.0528 |
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 0.014600 | -0.631 | 0.1610 |
GOBP STARTLE RESPONSE | 6 | 0.007680 | -0.628 | 0.1140 |
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 10 | 0.000600 | -0.627 | 0.0242 |
GOMF DNA REPLICATION ORIGIN BINDING | 12 | 0.000179 | 0.625 | 0.0100 |
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 6 | 0.008430 | 0.621 | 0.1190 |
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 0.008510 | -0.620 | 0.1190 |
GOCC MCM COMPLEX | 7 | 0.004530 | 0.620 | 0.0848 |
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 5 | 0.016800 | 0.617 | 0.1750 |
GOCC U4 SNRNP | 10 | 0.000739 | 0.616 | 0.0281 |
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 5 | 0.017200 | -0.615 | 0.1770 |
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 6 | 0.009450 | -0.612 | 0.1260 |
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 6 | 0.009640 | -0.610 | 0.1280 |
GOCC KNL1 SPC105 COMPLEX | 5 | 0.018200 | 0.610 | 0.1830 |
GOCC ORIGIN RECOGNITION COMPLEX | 7 | 0.005300 | 0.609 | 0.0940 |
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 7 | 0.005380 | -0.608 | 0.0947 |
GOBP RESPONSE TO HYDROSTATIC PRESSURE | 5 | 0.018700 | -0.607 | 0.1850 |
GOMF INTERLEUKIN 1 RECEPTOR BINDING | 5 | 0.019100 | -0.605 | 0.1860 |
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 0.019500 | 0.603 | 0.1890 |
GOBP MEIOTIC CHROMOSOME CONDENSATION | 5 | 0.019900 | 0.601 | 0.1920 |
set | setSize | pANOVA | s.dist | p.adjustANOVA |
---|---|---|---|---|
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE | 5 | 5.93e-04 | 8.87e-01 | 2.41e-02 |
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION | 5 | 2.93e-03 | -7.68e-01 | 6.80e-02 |
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH | 5 | 3.49e-03 | -7.54e-01 | 7.32e-02 |
GOCC BRCA1 C COMPLEX | 6 | 1.41e-03 | 7.53e-01 | 4.31e-02 |
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX | 7 | 8.12e-04 | 7.31e-01 | 3.01e-02 |
GOBP FAT PAD DEVELOPMENT | 5 | 4.77e-03 | -7.29e-01 | 8.72e-02 |
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 1.21e-03 | 7.06e-01 | 3.98e-02 |
GOCC CMG COMPLEX | 7 | 1.22e-03 | 7.06e-01 | 3.98e-02 |
GOBP REGULATION OF NEUTROPHIL DEGRANULATION | 6 | 2.75e-03 | -7.06e-01 | 6.59e-02 |
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS | 6 | 2.78e-03 | -7.05e-01 | 6.60e-02 |
GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 6 | 2.81e-03 | -7.04e-01 | 6.62e-02 |
GOBP DETOXIFICATION OF INORGANIC COMPOUND | 6 | 3.21e-03 | 6.95e-01 | 7.08e-02 |
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE | 8 | 6.74e-04 | -6.94e-01 | 2.66e-02 |
GOMF COPPER CHAPERONE ACTIVITY | 6 | 3.67e-03 | 6.85e-01 | 7.54e-02 |
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX | 5 | 8.16e-03 | -6.83e-01 | 1.18e-01 |
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY | 5 | 8.79e-03 | -6.77e-01 | 1.21e-01 |
GOMF MAP KINASE PHOSPHATASE ACTIVITY | 5 | 9.04e-03 | -6.74e-01 | 1.23e-01 |
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 5 | 9.04e-03 | -6.74e-01 | 1.23e-01 |
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY | 5 | 9.04e-03 | -6.74e-01 | 1.23e-01 |
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING | 5 | 9.12e-03 | 6.73e-01 | 1.23e-01 |
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING | 7 | 2.74e-03 | 6.54e-01 | 6.57e-02 |
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE | 5 | 1.17e-02 | -6.51e-01 | 1.41e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION | 9 | 7.24e-04 | 6.51e-01 | 2.79e-02 |
GOBP PROXIMAL DISTAL PATTERN FORMATION | 7 | 2.91e-03 | -6.50e-01 | 6.80e-02 |
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX | 12 | 1.05e-04 | 6.47e-01 | 6.50e-03 |
GOBP TETRAPYRROLE CATABOLIC PROCESS | 5 | 1.25e-02 | 6.45e-01 | 1.46e-01 |
GOMF THIOESTERASE BINDING | 5 | 1.30e-02 | -6.41e-01 | 1.50e-01 |
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 5 | 1.32e-02 | 6.40e-01 | 1.50e-01 |
GOBP RESPONSE TO WATER | 6 | 6.67e-03 | -6.40e-01 | 1.05e-01 |
GOBP NEURON FATE SPECIFICATION | 5 | 1.41e-02 | 6.34e-01 | 1.57e-01 |
GOCC DNA REPLICATION PREINITIATION COMPLEX | 8 | 1.90e-03 | 6.34e-01 | 5.28e-02 |
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY | 5 | 1.46e-02 | -6.31e-01 | 1.61e-01 |
GOBP STARTLE RESPONSE | 6 | 7.68e-03 | -6.28e-01 | 1.14e-01 |
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION | 10 | 6.00e-04 | -6.27e-01 | 2.42e-02 |
GOMF DNA REPLICATION ORIGIN BINDING | 12 | 1.79e-04 | 6.25e-01 | 1.00e-02 |
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION | 6 | 8.43e-03 | 6.21e-01 | 1.19e-01 |
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE | 6 | 8.51e-03 | -6.20e-01 | 1.19e-01 |
GOCC MCM COMPLEX | 7 | 4.53e-03 | 6.20e-01 | 8.48e-02 |
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 5 | 1.68e-02 | 6.17e-01 | 1.75e-01 |
GOCC U4 SNRNP | 10 | 7.39e-04 | 6.16e-01 | 2.81e-02 |
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 5 | 1.72e-02 | -6.15e-01 | 1.77e-01 |
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY | 6 | 9.45e-03 | -6.12e-01 | 1.26e-01 |
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT | 6 | 9.64e-03 | -6.10e-01 | 1.28e-01 |
GOCC KNL1 SPC105 COMPLEX | 5 | 1.82e-02 | 6.10e-01 | 1.83e-01 |
GOCC ORIGIN RECOGNITION COMPLEX | 7 | 5.30e-03 | 6.09e-01 | 9.40e-02 |
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 7 | 5.38e-03 | -6.08e-01 | 9.47e-02 |
GOBP RESPONSE TO HYDROSTATIC PRESSURE | 5 | 1.87e-02 | -6.07e-01 | 1.85e-01 |
GOMF INTERLEUKIN 1 RECEPTOR BINDING | 5 | 1.91e-02 | -6.05e-01 | 1.86e-01 |
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX | 5 | 1.95e-02 | 6.03e-01 | 1.89e-01 |
GOBP MEIOTIC CHROMOSOME CONDENSATION | 5 | 1.99e-02 | 6.01e-01 | 1.92e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 5 | 2.01e-02 | 6.00e-01 | 1.93e-01 |
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 7 | 6.03e-03 | -5.99e-01 | 9.85e-02 |
GOMF RNA POLYMERASE III ACTIVITY | 9 | 2.02e-03 | 5.94e-01 | 5.40e-02 |
GOBP OXALOACETATE METABOLIC PROCESS | 6 | 1.20e-02 | 5.92e-01 | 1.43e-01 |
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY | 7 | 6.73e-03 | 5.92e-01 | 1.05e-01 |
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX | 6 | 1.28e-02 | -5.87e-01 | 1.48e-01 |
GOBP REGULATION OF VASCULAR WOUND HEALING | 5 | 2.32e-02 | -5.86e-01 | 2.10e-01 |
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 7 | 7.27e-03 | 5.86e-01 | 1.10e-01 |
GOCC IMMUNOGLOBULIN COMPLEX CIRCULATING | 8 | 4.13e-03 | -5.86e-01 | 8.05e-02 |
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION | 8 | 4.16e-03 | 5.85e-01 | 8.06e-02 |
GOCC IGG IMMUNOGLOBULIN COMPLEX | 10 | 1.36e-03 | -5.85e-01 | 4.28e-02 |
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 9 | 2.38e-03 | 5.85e-01 | 6.02e-02 |
GOMF DOLICHYL DIPHOSPHOOLIGOSACCHARIDE PROTEIN GLYCOTRANSFERASE ACTIVITY | 5 | 2.36e-02 | 5.85e-01 | 2.11e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION | 7 | 7.46e-03 | 5.84e-01 | 1.12e-01 |
GOCC CONDENSIN COMPLEX | 7 | 7.46e-03 | 5.84e-01 | 1.12e-01 |
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS | 5 | 2.41e-02 | 5.83e-01 | 2.14e-01 |
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 5 | 2.42e-02 | -5.82e-01 | 2.14e-01 |
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION | 7 | 7.75e-03 | -5.81e-01 | 1.14e-01 |
GOBP T HELPER 17 CELL LINEAGE COMMITMENT | 6 | 1.37e-02 | -5.81e-01 | 1.55e-01 |
GOCC PROTEASOME CORE COMPLEX | 18 | 2.06e-05 | 5.80e-01 | 1.68e-03 |
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY | 6 | 1.40e-02 | 5.79e-01 | 1.56e-01 |
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION | 11 | 8.87e-04 | 5.79e-01 | 3.24e-02 |
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT | 6 | 1.45e-02 | -5.77e-01 | 1.60e-01 |
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 5 | 2.57e-02 | -5.76e-01 | 2.21e-01 |
GOBP REGULATION OF MIRNA CATABOLIC PROCESS | 6 | 1.47e-02 | -5.75e-01 | 1.62e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 9 | 2.86e-03 | 5.74e-01 | 6.69e-02 |
GOCC PICLN SM PROTEIN COMPLEX | 6 | 1.52e-02 | 5.72e-01 | 1.66e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX | 5 | 2.68e-02 | 5.72e-01 | 2.26e-01 |
GOMF TAP BINDING | 7 | 9.26e-03 | 5.68e-01 | 1.24e-01 |
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION | 5 | 2.79e-02 | -5.68e-01 | 2.30e-01 |
GOBP REGULATION OF NEUTROPHIL ACTIVATION | 9 | 3.24e-03 | -5.67e-01 | 7.08e-02 |
GOBP EMBRYONIC FORELIMB MORPHOGENESIS | 8 | 5.60e-03 | -5.66e-01 | 9.62e-02 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 2.99e-02 | 5.61e-01 | 2.36e-01 |
GOCC CHAPERONIN CONTAINING T COMPLEX | 8 | 6.17e-03 | 5.59e-01 | 9.97e-02 |
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 5 | 3.04e-02 | -5.59e-01 | 2.38e-01 |
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS | 5 | 3.05e-02 | 5.59e-01 | 2.38e-01 |
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS | 5 | 3.05e-02 | 5.59e-01 | 2.38e-01 |
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT | 32 | 4.57e-08 | 5.59e-01 | 6.49e-06 |
GOBP RESPONSE TO INTERLEUKIN 18 | 5 | 3.06e-02 | -5.59e-01 | 2.38e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION | 5 | 3.11e-02 | 5.57e-01 | 2.40e-01 |
GOCC PLATELET DENSE TUBULAR NETWORK | 7 | 1.11e-02 | 5.55e-01 | 1.38e-01 |
GOBP CORONARY VASCULATURE MORPHOGENESIS | 5 | 3.18e-02 | -5.54e-01 | 2.42e-01 |
GOCC LSM2 8 COMPLEX | 7 | 1.11e-02 | 5.54e-01 | 1.38e-01 |
GOBP RESPONSE TO ERYTHROPOIETIN | 5 | 3.24e-02 | 5.52e-01 | 2.45e-01 |
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE | 6 | 1.96e-02 | 5.50e-01 | 1.90e-01 |
GOMF HISTONE H4 DEMETHYLASE ACTIVITY | 5 | 3.31e-02 | -5.50e-01 | 2.46e-01 |
GOCC U6 SNRNP | 8 | 7.09e-03 | 5.50e-01 | 1.09e-01 |
GOBP WATER TRANSPORT | 6 | 1.97e-02 | -5.50e-01 | 1.91e-01 |
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY | 7 | 1.18e-02 | 5.49e-01 | 1.42e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 5 | 3.34e-02 | 5.49e-01 | 2.47e-01 |
GOBP CDP CHOLINE PATHWAY | 5 | 3.36e-02 | -5.49e-01 | 2.47e-01 |
GOMF RNA POLYMERASE I ACTIVITY | 9 | 4.51e-03 | 5.47e-01 | 8.48e-02 |
GOCC METHYLOSOME | 11 | 1.69e-03 | 5.47e-01 | 4.89e-02 |
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY | 6 | 2.04e-02 | 5.47e-01 | 1.95e-01 |
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY | 5 | 3.48e-02 | -5.45e-01 | 2.52e-01 |
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 3.50e-02 | 5.44e-01 | 2.53e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET | 5 | 3.53e-02 | -5.44e-01 | 2.54e-01 |
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION | 13 | 6.91e-04 | 5.44e-01 | 2.70e-02 |
GOMF THREONINE TYPE PEPTIDASE ACTIVITY | 9 | 4.79e-03 | 5.43e-01 | 8.73e-02 |
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 3.58e-02 | 5.42e-01 | 2.55e-01 |
GOBP CHONDROCYTE DEVELOPMENT | 10 | 3.05e-03 | -5.41e-01 | 6.92e-02 |
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE | 6 | 2.18e-02 | -5.41e-01 | 2.03e-01 |
GOMF NADPH BINDING | 10 | 3.10e-03 | 5.40e-01 | 6.94e-02 |
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION | 13 | 7.85e-04 | 5.38e-01 | 2.96e-02 |
GOBP UTERUS DEVELOPMENT | 8 | 8.50e-03 | -5.37e-01 | 1.19e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION | 7 | 1.38e-02 | 5.37e-01 | 1.55e-01 |
GOMF FOLIC ACID BINDING | 5 | 3.75e-02 | 5.37e-01 | 2.62e-01 |
GOCC CDC73 PAF1 COMPLEX | 6 | 2.29e-02 | 5.36e-01 | 2.09e-01 |
GOBP GOLGI TO LYSOSOME TRANSPORT | 8 | 8.89e-03 | -5.34e-01 | 1.22e-01 |
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX | 10 | 3.47e-03 | 5.34e-01 | 7.32e-02 |
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 5 | 3.90e-02 | -5.33e-01 | 2.65e-01 |
GOMF MALATE DEHYDROGENASE ACTIVITY | 5 | 3.90e-02 | 5.33e-01 | 2.65e-01 |
GOCC NADH DEHYDROGENASE COMPLEX | 47 | 2.63e-10 | 5.33e-01 | 7.60e-08 |
GOBP LEUKOCYTE AGGREGATION | 8 | 9.13e-03 | -5.32e-01 | 1.23e-01 |
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY | 43 | 1.63e-09 | 5.32e-01 | 3.47e-07 |
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 9 | 5.76e-03 | -5.32e-01 | 9.68e-02 |
GOCC COPI COATED VESICLE MEMBRANE | 16 | 2.46e-04 | 5.30e-01 | 1.27e-02 |
GOMF PHOSPHOLIPASE C ACTIVITY | 7 | 1.53e-02 | -5.29e-01 | 1.66e-01 |
GOBP T HELPER 17 CELL DIFFERENTIATION | 13 | 1.03e-03 | -5.26e-01 | 3.57e-02 |
GOBP RETINA LAYER FORMATION | 8 | 1.00e-02 | -5.26e-01 | 1.32e-01 |
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY | 6 | 2.59e-02 | 5.25e-01 | 2.23e-01 |
GOBP PROTEIN MATURATION BY PROTEIN FOLDING | 5 | 4.24e-02 | 5.24e-01 | 2.75e-01 |
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY | 6 | 2.69e-02 | 5.22e-01 | 2.26e-01 |
GOCC PROTEIN LIPID COMPLEX | 10 | 4.41e-03 | 5.20e-01 | 8.35e-02 |
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY | 15 | 5.08e-04 | 5.19e-01 | 2.15e-02 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS | 11 | 2.97e-03 | 5.17e-01 | 6.85e-02 |
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 4.52e-02 | 5.17e-01 | 2.83e-01 |
GOBP EXCRETION | 5 | 4.54e-02 | -5.17e-01 | 2.83e-01 |
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX | 8 | 1.15e-02 | 5.16e-01 | 1.41e-01 |
GOBP GERM CELL PROLIFERATION | 6 | 2.89e-02 | 5.15e-01 | 2.34e-01 |
GOBP SENSORY PERCEPTION OF SMELL | 5 | 4.65e-02 | 5.14e-01 | 2.83e-01 |
GOBP PROTEIN RETENTION IN GOLGI APPARATUS | 5 | 4.67e-02 | -5.14e-01 | 2.83e-01 |
GOBP 3 UTR MEDIATED MRNA STABILIZATION | 16 | 3.75e-04 | -5.14e-01 | 1.75e-02 |
GOBP RESPONSE TO LECTIN | 13 | 1.36e-03 | -5.13e-01 | 4.28e-02 |
GOBP STRESS INDUCED PREMATURE SENESCENCE | 5 | 4.70e-02 | -5.13e-01 | 2.84e-01 |
GOMF C ACETYLTRANSFERASE ACTIVITY | 6 | 2.97e-02 | 5.13e-01 | 2.35e-01 |
GOMF DNA CLAMP LOADER ACTIVITY | 5 | 4.73e-02 | 5.12e-01 | 2.85e-01 |
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM | 5 | 4.75e-02 | -5.12e-01 | 2.85e-01 |
GOMF C METHYLTRANSFERASE ACTIVITY | 5 | 4.80e-02 | 5.11e-01 | 2.87e-01 |
GOBP ENDOPLASMIC RETICULUM LOCALIZATION | 6 | 3.04e-02 | -5.10e-01 | 2.38e-01 |
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE | 6 | 3.06e-02 | -5.10e-01 | 2.38e-01 |
GOBP MITOTIC DNA REPLICATION | 10 | 5.29e-03 | 5.09e-01 | 9.40e-02 |
GOCC COPI COATED VESICLE | 21 | 5.45e-05 | 5.09e-01 | 3.83e-03 |
GOBP LUNG CELL DIFFERENTIATION | 11 | 3.49e-03 | -5.09e-01 | 7.32e-02 |
GOMF FMN BINDING | 6 | 3.11e-02 | 5.08e-01 | 2.40e-01 |
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION | 8 | 1.29e-02 | 5.08e-01 | 1.49e-01 |
GOBP L SERINE METABOLIC PROCESS | 5 | 4.92e-02 | 5.08e-01 | 2.90e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 12 | 2.33e-03 | -5.08e-01 | 5.92e-02 |
GOBP EPITHELIAL CELL MORPHOGENESIS | 10 | 5.62e-03 | -5.06e-01 | 9.62e-02 |
GOBP ENDOCRINE HORMONE SECRETION | 13 | 1.60e-03 | -5.06e-01 | 4.68e-02 |
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY | 5 | 5.03e-02 | 5.06e-01 | 2.93e-01 |
GOCC COPI VESICLE COAT | 12 | 2.47e-03 | 5.05e-01 | 6.15e-02 |
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION | 10 | 5.82e-03 | -5.04e-01 | 9.68e-02 |
GOBP REGULATION OF CHROMOSOME CONDENSATION | 10 | 5.83e-03 | 5.04e-01 | 9.68e-02 |
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 11 | 3.90e-03 | 5.03e-01 | 7.81e-02 |
GOBP TETRAHYDROFOLATE INTERCONVERSION | 9 | 9.05e-03 | 5.03e-01 | 1.23e-01 |
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS | 6 | 3.35e-02 | 5.01e-01 | 2.47e-01 |
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 5 | 5.25e-02 | 5.01e-01 | 2.99e-01 |
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING | 7 | 2.25e-02 | 4.98e-01 | 2.07e-01 |
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY | 5 | 5.43e-02 | -4.97e-01 | 3.03e-01 |
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY | 5 | 5.43e-02 | -4.97e-01 | 3.03e-01 |
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING | 5 | 5.45e-02 | -4.97e-01 | 3.03e-01 |
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS | 7 | 2.30e-02 | 4.96e-01 | 2.09e-01 |
GOBP PRENYLATION | 7 | 2.30e-02 | -4.96e-01 | 2.09e-01 |
GOBP REGULATION OF GERM CELL PROLIFERATION | 5 | 5.50e-02 | 4.96e-01 | 3.05e-01 |
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY | 7 | 2.33e-02 | -4.95e-01 | 2.10e-01 |
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY | 7 | 2.33e-02 | -4.95e-01 | 2.10e-01 |
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT | 6 | 3.70e-02 | 4.92e-01 | 2.60e-01 |
GOBP EPIDERMIS MORPHOGENESIS | 5 | 5.71e-02 | -4.91e-01 | 3.12e-01 |
GOCC SIGNAL PEPTIDASE COMPLEX | 5 | 5.71e-02 | 4.91e-01 | 3.12e-01 |
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION | 9 | 1.08e-02 | 4.91e-01 | 1.37e-01 |
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX | 9 | 1.08e-02 | 4.91e-01 | 1.37e-01 |
GOBP CELLULAR RESPONSE TO COLD | 7 | 2.49e-02 | -4.90e-01 | 2.17e-01 |
GOMF NADP RETINOL DEHYDROGENASE ACTIVITY | 6 | 3.84e-02 | 4.88e-01 | 2.64e-01 |
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 10 | 7.61e-03 | 4.88e-01 | 1.13e-01 |
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY | 9 | 1.14e-02 | 4.87e-01 | 1.40e-01 |
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 7 | 2.57e-02 | -4.87e-01 | 2.21e-01 |
GOBP BONE MARROW DEVELOPMENT | 6 | 3.90e-02 | -4.87e-01 | 2.65e-01 |
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION | 5 | 5.98e-02 | 4.86e-01 | 3.20e-01 |
GOBP POSITIVE REGULATION OF CENTRIOLE ELONGATION | 5 | 5.99e-02 | -4.86e-01 | 3.20e-01 |
GOBP ISOCITRATE METABOLIC PROCESS | 6 | 3.96e-02 | 4.85e-01 | 2.67e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE | 14 | 1.67e-03 | 4.85e-01 | 4.86e-02 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 7 | 2.63e-02 | 4.85e-01 | 2.25e-01 |
GOMF ESTROGEN RESPONSE ELEMENT BINDING | 7 | 2.64e-02 | -4.85e-01 | 2.25e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR | 49 | 4.74e-09 | 4.84e-01 | 8.79e-07 |
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 5 | 6.13e-02 | -4.83e-01 | 3.25e-01 |
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION | 5 | 6.15e-02 | -4.83e-01 | 3.25e-01 |
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX | 5 | 6.16e-02 | 4.83e-01 | 3.25e-01 |
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT | 5 | 6.23e-02 | -4.81e-01 | 3.26e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION | 6 | 4.14e-02 | -4.81e-01 | 2.72e-01 |
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 14 | 1.86e-03 | -4.81e-01 | 5.22e-02 |
GOMF ACTIVIN BINDING | 5 | 6.33e-02 | -4.80e-01 | 3.29e-01 |
GOCC INNER KINETOCHORE | 11 | 6.03e-03 | 4.78e-01 | 9.85e-02 |
GOBP TELOMERASE RNA LOCALIZATION | 18 | 4.49e-04 | 4.78e-01 | 2.00e-02 |
GOCC COMMITMENT COMPLEX | 5 | 6.44e-02 | 4.78e-01 | 3.32e-01 |
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 7 | 2.93e-02 | -4.76e-01 | 2.34e-01 |
GOMF QUINONE BINDING | 11 | 6.32e-03 | 4.76e-01 | 1.01e-01 |
GOBP CYCLOOXYGENASE PATHWAY | 5 | 6.57e-02 | 4.75e-01 | 3.36e-01 |
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS | 5 | 6.58e-02 | 4.75e-01 | 3.37e-01 |
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY | 14 | 2.11e-03 | -4.75e-01 | 5.57e-02 |
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 7 | 3.06e-02 | -4.72e-01 | 2.38e-01 |
GOCC U7 SNRNP | 6 | 4.58e-02 | 4.71e-01 | 2.83e-01 |
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY | 5 | 6.84e-02 | -4.71e-01 | 3.45e-01 |
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY | 6 | 4.61e-02 | -4.70e-01 | 2.83e-01 |
GOCC MITOTIC COHESIN COMPLEX | 6 | 4.64e-02 | 4.70e-01 | 2.83e-01 |
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS | 10 | 1.02e-02 | -4.69e-01 | 1.33e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB | 7 | 3.15e-02 | 4.69e-01 | 2.41e-01 |
GOMF S METHYLTRANSFERASE ACTIVITY | 5 | 6.92e-02 | -4.69e-01 | 3.47e-01 |
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 6 | 4.66e-02 | -4.69e-01 | 2.83e-01 |
GOBP REGULATION OF KIDNEY DEVELOPMENT | 6 | 4.67e-02 | 4.69e-01 | 2.83e-01 |
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY | 5 | 6.96e-02 | 4.69e-01 | 3.48e-01 |
GOBP AROMATIC AMINO ACID METABOLIC PROCESS | 10 | 1.04e-02 | 4.68e-01 | 1.34e-01 |
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY | 5 | 6.99e-02 | 4.68e-01 | 3.49e-01 |
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 62 | 2.05e-10 | 4.67e-01 | 6.18e-08 |
GOBP NEGATIVE REGULATION OF GLYCOLYTIC PROCESS | 9 | 1.54e-02 | -4.66e-01 | 1.67e-01 |
GOBP OSTEOCLAST PROLIFERATION | 5 | 7.14e-02 | -4.66e-01 | 3.52e-01 |
GOMF EPHRIN RECEPTOR BINDING | 14 | 2.59e-03 | -4.65e-01 | 6.31e-02 |
GOCC MICOS COMPLEX | 7 | 3.33e-02 | 4.65e-01 | 2.46e-01 |
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY | 6 | 4.88e-02 | 4.65e-01 | 2.88e-01 |
GOBP AORTIC VALVE MORPHOGENESIS | 8 | 2.30e-02 | -4.64e-01 | 2.09e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB | 10 | 1.11e-02 | 4.64e-01 | 1.38e-01 |
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY | 11 | 7.73e-03 | 4.64e-01 | 1.14e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 3.36e-02 | 4.64e-01 | 2.47e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 5 | 7.28e-02 | -4.63e-01 | 3.56e-01 |
GOBP DNA REPLICATION INITIATION | 23 | 1.24e-04 | 4.63e-01 | 7.38e-03 |
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING | 11 | 7.92e-03 | -4.62e-01 | 1.16e-01 |
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION | 5 | 7.41e-02 | -4.61e-01 | 3.59e-01 |
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS | 69 | 3.73e-11 | 4.61e-01 | 1.42e-08 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 49 | 2.50e-08 | 4.61e-01 | 3.77e-06 |
GOCC BRAHMA COMPLEX | 12 | 5.76e-03 | 4.60e-01 | 9.68e-02 |
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 15 | 2.04e-03 | -4.60e-01 | 5.44e-02 |
GOBP PHOTOTRANSDUCTION | 7 | 3.52e-02 | 4.60e-01 | 2.54e-01 |
GOMF HEXOSAMINIDASE ACTIVITY | 7 | 3.57e-02 | -4.59e-01 | 2.55e-01 |
GOBP NEUTROPHIL DEGRANULATION | 11 | 8.47e-03 | -4.59e-01 | 1.19e-01 |
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS | 8 | 2.50e-02 | -4.58e-01 | 2.18e-01 |
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 5 | 7.64e-02 | 4.58e-01 | 3.63e-01 |
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 7 | 3.61e-02 | -4.57e-01 | 2.56e-01 |
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY | 5 | 7.67e-02 | 4.57e-01 | 3.63e-01 |
GOMF AMINOACYL TRNA EDITING ACTIVITY | 5 | 7.67e-02 | 4.57e-01 | 3.63e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 12 | 6.12e-03 | 4.57e-01 | 9.93e-02 |
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS | 5 | 7.69e-02 | 4.57e-01 | 3.64e-01 |
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION | 9 | 1.79e-02 | -4.56e-01 | 1.81e-01 |
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING | 5 | 7.76e-02 | -4.56e-01 | 3.65e-01 |
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT | 9 | 1.81e-02 | -4.55e-01 | 1.82e-01 |
GOMF NUCLEAR RECEPTOR ACTIVITY | 20 | 4.31e-04 | -4.55e-01 | 1.94e-02 |
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 15 | 2.31e-03 | -4.55e-01 | 5.90e-02 |
GOBP NEURON RECOGNITION | 12 | 6.43e-03 | -4.54e-01 | 1.02e-01 |
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE | 5 | 7.85e-02 | 4.54e-01 | 3.67e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY | 6 | 5.40e-02 | -4.54e-01 | 3.02e-01 |
GOBP HOMOCYSTEINE METABOLIC PROCESS | 7 | 3.75e-02 | 4.54e-01 | 2.62e-01 |
GOCC SMN SM PROTEIN COMPLEX | 11 | 9.12e-03 | 4.54e-01 | 1.23e-01 |
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY | 5 | 7.87e-02 | -4.54e-01 | 3.67e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS | 10 | 1.29e-02 | -4.54e-01 | 1.50e-01 |
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM | 11 | 9.23e-03 | 4.53e-01 | 1.24e-01 |
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION | 9 | 1.85e-02 | 4.53e-01 | 1.84e-01 |
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY | 6 | 5.49e-02 | 4.53e-01 | 3.05e-01 |
GOBP SNORNA LOCALIZATION | 6 | 5.50e-02 | 4.52e-01 | 3.05e-01 |
GOBP TRNA 5 END PROCESSING | 12 | 6.82e-03 | 4.51e-01 | 1.06e-01 |
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 12 | 6.82e-03 | -4.51e-01 | 1.06e-01 |
GOBP U4 SNRNA 3 END PROCESSING | 7 | 3.88e-02 | 4.51e-01 | 2.65e-01 |
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY | 8 | 2.73e-02 | -4.51e-01 | 2.27e-01 |
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY | 56 | 5.57e-09 | 4.51e-01 | 1.01e-06 |
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION | 7 | 3.92e-02 | 4.50e-01 | 2.66e-01 |
GOBP PLASMA CELL DIFFERENTIATION | 5 | 8.16e-02 | -4.50e-01 | 3.74e-01 |
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION | 6 | 5.70e-02 | -4.49e-01 | 3.12e-01 |
GOMF HISTONE H3K27ME2 H3K27ME3 DEMETHYLASE ACTIVITY | 5 | 8.27e-02 | -4.48e-01 | 3.77e-01 |
GOCC MHC CLASS I PROTEIN COMPLEX | 7 | 4.04e-02 | 4.48e-01 | 2.69e-01 |
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS | 7 | 4.04e-02 | 4.47e-01 | 2.69e-01 |
GOCC LSM1 7 PAT1 COMPLEX | 5 | 8.34e-02 | 4.47e-01 | 3.79e-01 |
GOBP RNA 5 END PROCESSING | 16 | 1.97e-03 | 4.47e-01 | 5.34e-02 |
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 11 | 1.04e-02 | -4.46e-01 | 1.34e-01 |
GOBP CELL JUNCTION DISASSEMBLY | 11 | 1.04e-02 | -4.46e-01 | 1.34e-01 |
GOBP REGULATION OF PINOCYTOSIS | 7 | 4.10e-02 | -4.46e-01 | 2.71e-01 |
GOMF PRE MRNA INTRONIC BINDING | 9 | 2.07e-02 | -4.45e-01 | 1.96e-01 |
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE | 9 | 2.08e-02 | 4.45e-01 | 1.96e-01 |
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 7 | 4.16e-02 | -4.45e-01 | 2.72e-01 |
GOBP S ADENOSYLMETHIONINE CYCLE | 7 | 4.17e-02 | 4.45e-01 | 2.72e-01 |
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY | 5 | 8.54e-02 | 4.44e-01 | 3.81e-01 |
GOBP GLYCINE METABOLIC PROCESS | 7 | 4.18e-02 | 4.44e-01 | 2.73e-01 |
GOBP INTERMEDIATE FILAMENT ORGANIZATION | 8 | 2.96e-02 | -4.44e-01 | 2.35e-01 |
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS | 8 | 2.98e-02 | 4.44e-01 | 2.35e-01 |
GOMF METALLOCHAPERONE ACTIVITY | 11 | 1.09e-02 | 4.44e-01 | 1.37e-01 |
GOBP IMP METABOLIC PROCESS | 10 | 1.54e-02 | 4.43e-01 | 1.67e-01 |
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS | 5 | 8.66e-02 | 4.43e-01 | 3.84e-01 |
GOBP REGULATION OF HEXOKINASE ACTIVITY | 5 | 8.68e-02 | -4.42e-01 | 3.85e-01 |
GOCC TRNA METHYLTRANSFERASE COMPLEX | 5 | 8.69e-02 | 4.42e-01 | 3.85e-01 |
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION | 5 | 8.72e-02 | -4.42e-01 | 3.86e-01 |
GOBP TRANSLATIONAL READTHROUGH | 7 | 4.35e-02 | -4.41e-01 | 2.78e-01 |
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY | 5 | 8.81e-02 | -4.41e-01 | 3.86e-01 |
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION | 6 | 6.19e-02 | -4.40e-01 | 3.26e-01 |
GOBP REGULATION OF VITAMIN METABOLIC PROCESS | 5 | 8.84e-02 | 4.40e-01 | 3.86e-01 |
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 5 | 8.84e-02 | 4.40e-01 | 3.86e-01 |
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION | 31 | 2.34e-05 | 4.39e-01 | 1.84e-03 |
GOCC RNA POLYMERASE I COMPLEX | 10 | 1.62e-02 | 4.39e-01 | 1.71e-01 |
GOMF LONG CHAIN FATTY ACID TRANSPORTER ACTIVITY | 7 | 4.45e-02 | 4.39e-01 | 2.82e-01 |
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT | 7 | 4.47e-02 | 4.38e-01 | 2.82e-01 |
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY | 15 | 3.33e-03 | 4.38e-01 | 7.18e-02 |
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION | 6 | 6.34e-02 | -4.38e-01 | 3.29e-01 |
GOBP DIGESTIVE TRACT MORPHOGENESIS | 9 | 2.30e-02 | -4.38e-01 | 2.09e-01 |
GOMF DNA INSERTION OR DELETION BINDING | 6 | 6.35e-02 | 4.38e-01 | 3.29e-01 |
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 6 | 6.38e-02 | 4.37e-01 | 3.31e-01 |
GOBP DEFENSE RESPONSE TO TUMOR CELL | 6 | 6.40e-02 | -4.37e-01 | 3.31e-01 |
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS | 5 | 9.09e-02 | 4.37e-01 | 3.92e-01 |
GOBP POLYKETIDE METABOLIC PROCESS | 5 | 9.09e-02 | 4.37e-01 | 3.92e-01 |
GOBP BRANCHING MORPHOGENESIS OF A NERVE | 6 | 6.42e-02 | -4.36e-01 | 3.32e-01 |
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION | 8 | 3.26e-02 | 4.36e-01 | 2.45e-01 |
GOBP NEUROBLAST DIVISION | 8 | 3.31e-02 | 4.35e-01 | 2.46e-01 |
GOCC LATERAL ELEMENT | 5 | 9.22e-02 | 4.35e-01 | 3.95e-01 |
GOBP REGULATION OF RNA BINDING | 6 | 6.53e-02 | -4.35e-01 | 3.35e-01 |
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 9 | 2.40e-02 | 4.35e-01 | 2.13e-01 |
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 8 | 3.36e-02 | -4.34e-01 | 2.47e-01 |
GOBP POSITIVE REGULATION OF RESPIRATORY BURST | 6 | 6.57e-02 | -4.34e-01 | 3.36e-01 |
GOBP PROTEIN CONTAINING COMPLEX REMODELING | 7 | 4.72e-02 | 4.33e-01 | 2.85e-01 |
GOCC PERICHROMATIN FIBRILS | 5 | 9.37e-02 | -4.33e-01 | 3.98e-01 |
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 6 | 6.64e-02 | -4.33e-01 | 3.39e-01 |
GOBP RESPONSE TO POTASSIUM ION | 8 | 3.42e-02 | -4.32e-01 | 2.50e-01 |
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS | 10 | 1.83e-02 | 4.31e-01 | 1.84e-01 |
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 5 | 9.58e-02 | -4.30e-01 | 4.01e-01 |
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 8 | 3.54e-02 | 4.30e-01 | 2.54e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION | 8 | 3.55e-02 | 4.29e-01 | 2.55e-01 |
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS | 7 | 4.93e-02 | 4.29e-01 | 2.90e-01 |
GOMF UNMETHYLATED CPG BINDING | 8 | 3.57e-02 | -4.29e-01 | 2.55e-01 |
GOCC EPSILON DNA POLYMERASE COMPLEX | 5 | 9.68e-02 | 4.29e-01 | 4.03e-01 |
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 7 | 4.97e-02 | -4.28e-01 | 2.91e-01 |
GOBP REGULATION OF ATP METABOLIC PROCESS | 11 | 1.42e-02 | 4.27e-01 | 1.58e-01 |
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE | 6 | 7.03e-02 | -4.27e-01 | 3.50e-01 |
GOBP RESPONSE TO GLUCAGON | 7 | 5.08e-02 | -4.26e-01 | 2.95e-01 |
GOBP POSITIVE REGULATION OF DNA REPLICATION | 21 | 7.28e-04 | 4.26e-01 | 2.79e-02 |
GOCC ORGANELLAR RIBOSOME | 86 | 9.28e-12 | 4.26e-01 | 3.95e-09 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 6 | 7.10e-02 | -4.26e-01 | 3.51e-01 |
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX | 5 | 9.97e-02 | 4.25e-01 | 4.09e-01 |
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE | 5 | 1.00e-01 | -4.25e-01 | 4.09e-01 |
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY | 9 | 2.76e-02 | -4.24e-01 | 2.29e-01 |
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY | 5 | 1.01e-01 | -4.24e-01 | 4.10e-01 |
GOCC U1 SNRNP | 18 | 1.91e-03 | 4.23e-01 | 5.28e-02 |
GOBP LUNG EPITHELIUM DEVELOPMENT | 16 | 3.46e-03 | -4.22e-01 | 7.32e-02 |
GOBP IMP BIOSYNTHETIC PROCESS | 8 | 3.88e-02 | 4.22e-01 | 2.65e-01 |
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY | 5 | 1.03e-01 | -4.22e-01 | 4.13e-01 |
GOBP 2FE 2S CLUSTER ASSEMBLY | 9 | 2.86e-02 | 4.21e-01 | 2.32e-01 |
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS | 8 | 3.91e-02 | 4.21e-01 | 2.66e-01 |
GOMF U2 SNRNA BINDING | 6 | 7.43e-02 | -4.21e-01 | 3.59e-01 |
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER | 6 | 7.44e-02 | 4.21e-01 | 3.59e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 13 | 8.68e-03 | -4.21e-01 | 1.21e-01 |
GOBP LEUCINE CATABOLIC PROCESS | 5 | 1.04e-01 | 4.20e-01 | 4.15e-01 |
GOBP NEGATIVE REGULATION OF NEUTROPHIL ACTIVATION | 5 | 1.04e-01 | -4.20e-01 | 4.15e-01 |
GOBP METHIONINE METABOLIC PROCESS | 12 | 1.19e-02 | 4.20e-01 | 1.42e-01 |
GOBP AMINO ACID SALVAGE | 5 | 1.05e-01 | 4.19e-01 | 4.17e-01 |
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE | 5 | 1.05e-01 | 4.19e-01 | 4.17e-01 |
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 9 | 2.98e-02 | 4.18e-01 | 2.36e-01 |
GOBP PROTEIN RETENTION IN ER LUMEN | 6 | 7.62e-02 | 4.18e-01 | 3.63e-01 |
GOBP ACTIN FILAMENT SEVERING | 12 | 1.22e-02 | -4.18e-01 | 1.44e-01 |
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY | 5 | 1.06e-01 | -4.18e-01 | 4.20e-01 |
GOBP ACTIN CROSSLINK FORMATION | 5 | 1.06e-01 | -4.18e-01 | 4.20e-01 |
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY | 5 | 1.06e-01 | -4.18e-01 | 4.20e-01 |
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE | 11 | 1.65e-02 | -4.17e-01 | 1.73e-01 |
GOCC DEATH INDUCING SIGNALING COMPLEX | 7 | 5.59e-02 | 4.17e-01 | 3.08e-01 |
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION | 6 | 7.68e-02 | -4.17e-01 | 3.63e-01 |
GOBP CHRONIC INFLAMMATORY RESPONSE | 6 | 7.72e-02 | -4.17e-01 | 3.64e-01 |
GOBP BASE EXCISION REPAIR GAP FILLING | 10 | 2.28e-02 | 4.16e-01 | 2.08e-01 |
GOBP TRANSFERRIN TRANSPORT | 7 | 5.68e-02 | 4.16e-01 | 3.12e-01 |
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY | 6 | 7.80e-02 | -4.16e-01 | 3.66e-01 |
GOBP UTP BIOSYNTHETIC PROCESS | 6 | 7.87e-02 | 4.15e-01 | 3.67e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY | 11 | 1.77e-02 | 4.13e-01 | 1.79e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 5 | 1.10e-01 | 4.13e-01 | 4.26e-01 |
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 17 | 3.28e-03 | -4.12e-01 | 7.11e-02 |
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX | 10 | 2.41e-02 | 4.12e-01 | 2.14e-01 |
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX | 9 | 3.26e-02 | 4.11e-01 | 2.45e-01 |
GOBP HETEROTYPIC CELL CELL ADHESION | 25 | 3.73e-04 | -4.11e-01 | 1.75e-02 |
GOBP RENAL WATER HOMEOSTASIS | 7 | 5.97e-02 | -4.11e-01 | 3.20e-01 |
GOBP TRANSMISSION OF NERVE IMPULSE | 14 | 7.77e-03 | -4.11e-01 | 1.14e-01 |
GOBP PROTEIN GERANYLGERANYLATION | 5 | 1.12e-01 | -4.11e-01 | 4.29e-01 |
GOCC MYOFILAMENT | 5 | 1.12e-01 | 4.11e-01 | 4.29e-01 |
GOCC STRIATED MUSCLE THIN FILAMENT | 5 | 1.12e-01 | 4.11e-01 | 4.29e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION | 17 | 3.39e-03 | -4.11e-01 | 7.27e-02 |
GOMF RNA POLYMERASE II ACTIVITY | 10 | 2.48e-02 | 4.10e-01 | 2.16e-01 |
GOCC COHESIN COMPLEX | 8 | 4.48e-02 | 4.10e-01 | 2.82e-01 |
GOCC RESPIRASOME | 86 | 5.54e-11 | 4.10e-01 | 2.00e-08 |
GOBP CELLULAR RESPONSE TO ATP | 8 | 4.50e-02 | 4.09e-01 | 2.82e-01 |
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT | 8 | 4.53e-02 | -4.09e-01 | 2.83e-01 |
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION | 25 | 4.07e-04 | -4.09e-01 | 1.85e-02 |
GOBP CELLULAR RESPONSE TO ALDEHYDE | 8 | 4.55e-02 | 4.09e-01 | 2.83e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 8 | 4.55e-02 | 4.08e-01 | 2.83e-01 |
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT | 9 | 3.41e-02 | -4.08e-01 | 2.49e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN | 14 | 8.28e-03 | 4.08e-01 | 1.19e-01 |
GOBP REGULATION OF LIGASE ACTIVITY | 6 | 8.41e-02 | 4.07e-01 | 3.81e-01 |
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX | 5 | 1.15e-01 | 4.07e-01 | 4.36e-01 |
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX | 18 | 2.82e-03 | 4.07e-01 | 6.62e-02 |
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 8.43e-03 | 4.07e-01 | 1.19e-01 |
GOBP MAST CELL CHEMOTAXIS | 6 | 8.45e-02 | 4.07e-01 | 3.81e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN | 17 | 3.74e-03 | 4.06e-01 | 7.61e-02 |
GOBP POSITIVE REGULATION OF MRNA 3 END PROCESSING | 6 | 8.49e-02 | 4.06e-01 | 3.81e-01 |
GOMF ISOCITRATE DEHYDROGENASE NAD P PLUS ACTIVITY | 5 | 1.16e-01 | 4.06e-01 | 4.37e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS | 7 | 6.31e-02 | 4.06e-01 | 3.29e-01 |
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE | 15 | 6.57e-03 | -4.05e-01 | 1.04e-01 |
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE | 5 | 1.17e-01 | -4.05e-01 | 4.39e-01 |
GOCC RIBONUCLEASE P COMPLEX | 9 | 3.54e-02 | 4.05e-01 | 2.54e-01 |
GOBP DENDRITIC CELL APOPTOTIC PROCESS | 6 | 8.58e-02 | -4.05e-01 | 3.83e-01 |
GOBP POSITIVE REGULATION OF PINOCYTOSIS | 6 | 8.58e-02 | -4.05e-01 | 3.83e-01 |
GOMF CALCIUM ACTIVATED CATION CHANNEL ACTIVITY | 6 | 8.66e-02 | -4.04e-01 | 3.84e-01 |
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 1.18e-01 | -4.04e-01 | 4.39e-01 |
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE | 13 | 1.17e-02 | 4.04e-01 | 1.41e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY | 7 | 6.44e-02 | -4.04e-01 | 3.32e-01 |
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS | 6 | 8.71e-02 | -4.03e-01 | 3.85e-01 |
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III | 11 | 2.09e-02 | 4.02e-01 | 1.97e-01 |
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING | 5 | 1.21e-01 | 4.01e-01 | 4.46e-01 |
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS | 7 | 6.65e-02 | -4.01e-01 | 3.39e-01 |
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT | 10 | 2.84e-02 | -4.00e-01 | 2.31e-01 |
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT | 88 | 9.20e-11 | 4.00e-01 | 3.03e-08 |
GOMF PROTEASOME ACTIVATING ACTIVITY | 6 | 8.97e-02 | 4.00e-01 | 3.90e-01 |
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT | 6 | 8.99e-02 | 4.00e-01 | 3.90e-01 |
GOBP MITOCHONDRIAL TRANSLATION | 119 | 5.86e-14 | 4.00e-01 | 3.53e-11 |
GOBP MALATE METABOLIC PROCESS | 6 | 9.01e-02 | 4.00e-01 | 3.90e-01 |
GOMF HISTONE DEUBIQUITINASE ACTIVITY | 5 | 1.22e-01 | 3.99e-01 | 4.47e-01 |
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS | 5 | 1.22e-01 | 3.99e-01 | 4.48e-01 |
GOBP GLYCOSIDE METABOLIC PROCESS | 9 | 3.83e-02 | 3.99e-01 | 2.64e-01 |
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 7 | 6.79e-02 | -3.99e-01 | 3.44e-01 |
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION | 25 | 5.66e-04 | -3.99e-01 | 2.34e-02 |
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY | 7 | 6.80e-02 | -3.98e-01 | 3.44e-01 |
GOBP CELL CYCLE DNA REPLICATION | 30 | 1.62e-04 | 3.98e-01 | 9.43e-03 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 9 | 3.87e-02 | -3.98e-01 | 2.65e-01 |
GOCC NURF COMPLEX | 6 | 9.17e-02 | 3.98e-01 | 3.93e-01 |
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 10 | 2.95e-02 | 3.98e-01 | 2.35e-01 |
GOBP RESPONSE TO PH | 6 | 9.20e-02 | -3.97e-01 | 3.94e-01 |
GOMF ELECTRON TRANSFER ACTIVITY | 90 | 8.09e-11 | 3.97e-01 | 2.79e-08 |
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY | 7 | 6.90e-02 | 3.97e-01 | 3.46e-01 |
GOCC CHROMAFFIN GRANULE | 6 | 9.22e-02 | 3.97e-01 | 3.95e-01 |
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX | 8 | 5.20e-02 | -3.97e-01 | 2.98e-01 |
GOBP MAINTENANCE OF CELL POLARITY | 9 | 3.93e-02 | 3.97e-01 | 2.66e-01 |
GOBP REGULATION OF MEMBRANE REPOLARIZATION | 8 | 5.24e-02 | 3.96e-01 | 2.99e-01 |
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION | 7 | 6.99e-02 | 3.96e-01 | 3.49e-01 |
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III | 6 | 9.34e-02 | 3.96e-01 | 3.97e-01 |
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS | 7 | 7.05e-02 | 3.95e-01 | 3.50e-01 |
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE | 5 | 1.27e-01 | 3.95e-01 | 4.55e-01 |
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY | 6 | 9.44e-02 | 3.94e-01 | 3.99e-01 |
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE | 6 | 9.44e-02 | 3.94e-01 | 3.99e-01 |
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS | 5 | 1.27e-01 | 3.94e-01 | 4.55e-01 |
GOBP ALDITOL METABOLIC PROCESS | 9 | 4.06e-02 | 3.94e-01 | 2.70e-01 |
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE | 6 | 9.46e-02 | 3.94e-01 | 4.00e-01 |
GOBP METHIONINE BIOSYNTHETIC PROCESS | 10 | 3.12e-02 | 3.94e-01 | 2.40e-01 |
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS | 10 | 3.12e-02 | 3.94e-01 | 2.40e-01 |
GOBP OXIDATIVE PHOSPHORYLATION | 121 | 8.98e-14 | 3.93e-01 | 4.64e-11 |
GOBP SULFUR AMINO ACID CATABOLIC PROCESS | 5 | 1.28e-01 | 3.93e-01 | 4.56e-01 |
GOCC ASTER | 6 | 9.61e-02 | -3.92e-01 | 4.02e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 15 | 8.62e-03 | -3.92e-01 | 1.21e-01 |
GOCC TUBULAR ENDOSOME | 5 | 1.29e-01 | 3.92e-01 | 4.57e-01 |
GOCC RNA POLYMERASE III COMPLEX | 15 | 8.67e-03 | 3.92e-01 | 1.21e-01 |
GOBP OUTER MITOCHONDRIAL MEMBRANE ORGANIZATION | 15 | 8.72e-03 | 3.91e-01 | 1.21e-01 |
GOBP HYPOXIA INDUCIBLE FACTOR 1ALPHA SIGNALING PATHWAY | 6 | 9.70e-02 | -3.91e-01 | 4.03e-01 |
GOMF 4 IRON 4 SULFUR CLUSTER BINDING | 33 | 1.01e-04 | 3.91e-01 | 6.32e-03 |
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION | 5 | 1.30e-01 | -3.91e-01 | 4.57e-01 |
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION | 5 | 1.30e-01 | -3.91e-01 | 4.57e-01 |
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY | 8 | 5.57e-02 | 3.91e-01 | 3.08e-01 |
GOBP RNA CAPPING | 29 | 2.74e-04 | 3.91e-01 | 1.38e-02 |
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION | 7 | 7.38e-02 | -3.90e-01 | 3.59e-01 |
GOBP RENAL FILTRATION | 9 | 4.27e-02 | -3.90e-01 | 2.76e-01 |
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY | 14 | 1.15e-02 | 3.90e-01 | 1.41e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR | 9 | 4.27e-02 | 3.90e-01 | 2.76e-01 |
GOBP CYSTEINE METABOLIC PROCESS | 5 | 1.31e-01 | 3.90e-01 | 4.58e-01 |
GOBP BLOOD VESSEL MATURATION | 5 | 1.31e-01 | -3.90e-01 | 4.58e-01 |
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT | 8 | 5.63e-02 | -3.90e-01 | 3.09e-01 |
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 6 | 9.84e-02 | 3.90e-01 | 4.07e-01 |
GOBP CELLULAR RESPONSE TO POTASSIUM ION | 7 | 7.48e-02 | -3.89e-01 | 3.60e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I | 23 | 1.25e-03 | 3.89e-01 | 4.05e-02 |
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX | 14 | 1.19e-02 | 3.89e-01 | 1.42e-01 |
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING | 5 | 1.33e-01 | -3.89e-01 | 4.60e-01 |
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX | 14 | 1.19e-02 | 3.88e-01 | 1.42e-01 |
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS | 5 | 1.33e-01 | 3.88e-01 | 4.60e-01 |
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS | 5 | 1.33e-01 | 3.88e-01 | 4.60e-01 |
GOBP POSITIVE REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 5 | 1.33e-01 | -3.88e-01 | 4.60e-01 |
GOMF AMIDINE LYASE ACTIVITY | 5 | 1.34e-01 | 3.87e-01 | 4.62e-01 |
GOBP ATP BIOSYNTHETIC PROCESS | 84 | 9.57e-10 | 3.87e-01 | 2.10e-07 |
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT | 6 | 1.01e-01 | -3.87e-01 | 4.10e-01 |
GOMF PHOSPHOSERINE RESIDUE BINDING | 10 | 3.47e-02 | 3.86e-01 | 2.52e-01 |
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 22 | 1.76e-03 | -3.86e-01 | 5.04e-02 |
GOBP FLUID TRANSPORT | 10 | 3.50e-02 | -3.85e-01 | 2.53e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 6 | 1.02e-01 | 3.85e-01 | 4.13e-01 |
GOBP ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS | 12 | 2.09e-02 | 3.85e-01 | 1.97e-01 |
GOBP REGULATION OF ISOMERASE ACTIVITY | 5 | 1.36e-01 | -3.85e-01 | 4.65e-01 |
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 6 | 1.03e-01 | -3.85e-01 | 4.13e-01 |
GOMF CO SMAD BINDING | 7 | 7.83e-02 | -3.84e-01 | 3.66e-01 |
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 9 | 4.63e-02 | -3.84e-01 | 2.83e-01 |
GOCC BETA CATENIN TCF COMPLEX | 9 | 4.63e-02 | -3.84e-01 | 2.83e-01 |
GOMF SULFURTRANSFERASE ACTIVITY | 7 | 7.91e-02 | 3.83e-01 | 3.67e-01 |
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION | 9 | 4.65e-02 | -3.83e-01 | 2.83e-01 |
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 15 | 1.03e-02 | -3.83e-01 | 1.34e-01 |
GOBP PEPTIDYL METHIONINE MODIFICATION | 9 | 4.68e-02 | 3.83e-01 | 2.84e-01 |
GOMF TAU PROTEIN KINASE ACTIVITY | 16 | 8.16e-03 | -3.82e-01 | 1.18e-01 |
GOMF 2 IRON 2 SULFUR CLUSTER BINDING | 19 | 3.97e-03 | 3.82e-01 | 7.86e-02 |
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY | 9 | 4.73e-02 | 3.82e-01 | 2.85e-01 |
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY | 5 | 1.39e-01 | -3.82e-01 | 4.69e-01 |
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX | 267 | 1.34e-26 | 3.82e-01 | 9.66e-23 |
GOBP LEUKOTRIENE METABOLIC PROCESS | 11 | 2.88e-02 | -3.81e-01 | 2.33e-01 |
GOMF NUCLEOTIDE RECEPTOR ACTIVITY | 6 | 1.06e-01 | 3.81e-01 | 4.21e-01 |
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE | 15 | 1.08e-02 | 3.81e-01 | 1.37e-01 |
GOMF ACTIVIN RECEPTOR ACTIVITY | 5 | 1.41e-01 | -3.80e-01 | 4.72e-01 |
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE | 5 | 1.42e-01 | 3.80e-01 | 4.72e-01 |
GOBP BILE ACID AND BILE SALT TRANSPORT | 6 | 1.08e-01 | 3.79e-01 | 4.23e-01 |
GOBP HEART FORMATION | 6 | 1.08e-01 | -3.79e-01 | 4.23e-01 |
GOBP CITRATE METABOLIC PROCESS | 5 | 1.42e-01 | 3.79e-01 | 4.72e-01 |
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 11 | 2.95e-02 | -3.79e-01 | 2.35e-01 |
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS | 6 | 1.08e-01 | 3.79e-01 | 4.24e-01 |
GOCC EARLY PHAGOSOME | 9 | 4.92e-02 | -3.79e-01 | 2.90e-01 |
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 136 | 3.17e-14 | 3.78e-01 | 2.09e-11 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5 | 8 | 6.42e-02 | 3.78e-01 | 3.32e-01 |
GOCC IGA IMMUNOGLOBULIN COMPLEX | 6 | 1.09e-01 | -3.78e-01 | 4.24e-01 |
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING | 6 | 1.09e-01 | -3.78e-01 | 4.24e-01 |
GOBP POSITIVE REGULATION OF RNA BINDING | 5 | 1.44e-01 | -3.77e-01 | 4.76e-01 |
GOCC OXIDOREDUCTASE COMPLEX | 104 | 3.46e-11 | 3.77e-01 | 1.39e-08 |
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS | 5 | 1.45e-01 | 3.77e-01 | 4.77e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H | 65 | 1.56e-07 | 3.77e-01 | 2.10e-05 |
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY | 6 | 1.10e-01 | 3.77e-01 | 4.26e-01 |
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION | 5 | 1.45e-01 | -3.77e-01 | 4.77e-01 |
GOBP PROTEIN NITROSYLATION | 7 | 8.46e-02 | -3.77e-01 | 3.81e-01 |
GOBP REGULATION OF ENDOCRINE PROCESS | 9 | 5.07e-02 | -3.76e-01 | 2.95e-01 |
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY | 6 | 1.11e-01 | 3.76e-01 | 4.27e-01 |
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT | 5 | 1.46e-01 | 3.75e-01 | 4.78e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME | 19 | 4.65e-03 | 3.75e-01 | 8.58e-02 |
GOBP SIGNAL PEPTIDE PROCESSING | 12 | 2.45e-02 | 3.75e-01 | 2.15e-01 |
GOCC T CELL RECEPTOR COMPLEX | 6 | 1.12e-01 | -3.75e-01 | 4.29e-01 |
GOCC COLLAGEN TRIMER | 9 | 5.17e-02 | -3.75e-01 | 2.98e-01 |
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION | 20 | 3.74e-03 | -3.75e-01 | 7.61e-02 |
GOMF URIDYLYLTRANSFERASE ACTIVITY | 5 | 1.47e-01 | -3.75e-01 | 4.79e-01 |
GOCC PERICENTRIC HETEROCHROMATIN | 21 | 3.01e-03 | 3.74e-01 | 6.86e-02 |
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE | 5 | 1.48e-01 | 3.74e-01 | 4.80e-01 |
GOMF GLUTAMATE RECEPTOR BINDING | 14 | 1.54e-02 | -3.74e-01 | 1.67e-01 |
GOMF STEROL TRANSFER ACTIVITY | 11 | 3.18e-02 | -3.74e-01 | 2.42e-01 |
GOBP REGULATION OF ENDOSOME ORGANIZATION | 5 | 1.48e-01 | -3.74e-01 | 4.81e-01 |
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 6 | 1.13e-01 | 3.74e-01 | 4.32e-01 |
GOBP ECTODERM DEVELOPMENT | 9 | 5.24e-02 | -3.74e-01 | 2.99e-01 |
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA | 5 | 1.48e-01 | -3.74e-01 | 4.81e-01 |
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 9 | 5.24e-02 | -3.73e-01 | 2.99e-01 |
GOBP ALDEHYDE CATABOLIC PROCESS | 8 | 6.76e-02 | 3.73e-01 | 3.43e-01 |
GOCC PROCENTRIOLE REPLICATION COMPLEX | 5 | 1.49e-01 | 3.73e-01 | 4.82e-01 |
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY | 10 | 4.13e-02 | -3.73e-01 | 2.72e-01 |
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX | 8 | 6.81e-02 | -3.73e-01 | 3.44e-01 |
GOBP TETRAHYDROFOLATE METABOLIC PROCESS | 14 | 1.59e-02 | 3.72e-01 | 1.70e-01 |
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS | 7 | 8.85e-02 | -3.72e-01 | 3.86e-01 |
GOCC PRE SNORNP COMPLEX | 7 | 8.85e-02 | 3.72e-01 | 3.86e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA | 8 | 6.87e-02 | 3.72e-01 | 3.45e-01 |
GOBP CENTRIOLE CENTRIOLE COHESION | 13 | 2.04e-02 | -3.72e-01 | 1.95e-01 |
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX | 9 | 5.41e-02 | -3.71e-01 | 3.03e-01 |
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS | 6 | 1.16e-01 | -3.71e-01 | 4.37e-01 |
GOMF SEMAPHORIN RECEPTOR BINDING | 5 | 1.52e-01 | 3.70e-01 | 4.86e-01 |
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT | 53 | 3.34e-06 | 3.70e-01 | 3.66e-04 |
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 8 | 7.07e-02 | -3.69e-01 | 3.50e-01 |
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS | 12 | 2.69e-02 | -3.69e-01 | 2.26e-01 |
GOMF GUANYLYLTRANSFERASE ACTIVITY | 5 | 1.53e-01 | 3.69e-01 | 4.88e-01 |
GOBP NEURON PROJECTION MAINTENANCE | 5 | 1.53e-01 | -3.69e-01 | 4.88e-01 |
GOBP DTMP METABOLIC PROCESS | 6 | 1.18e-01 | 3.69e-01 | 4.39e-01 |
GOBP PROTEIN TRIMERIZATION | 7 | 9.16e-02 | 3.68e-01 | 3.93e-01 |
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME | 9 | 5.59e-02 | 3.68e-01 | 3.08e-01 |
GOBP RADIAL GLIAL CELL DIFFERENTIATION | 5 | 1.54e-01 | -3.68e-01 | 4.89e-01 |
GOBP ENDOCRINE PROCESS | 21 | 3.53e-03 | -3.68e-01 | 7.38e-02 |
GOBP ONE CARBON METABOLIC PROCESS | 19 | 5.54e-03 | 3.68e-01 | 9.62e-02 |
GOBP NEURON MATURATION | 19 | 5.55e-03 | -3.68e-01 | 9.62e-02 |
GOMF UBIQUINONE BINDING | 5 | 1.55e-01 | 3.68e-01 | 4.89e-01 |
GOCC INTEGRIN COMPLEX | 14 | 1.73e-02 | -3.67e-01 | 1.78e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 7 | 9.23e-02 | -3.67e-01 | 3.95e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 13 | 2.19e-02 | -3.67e-01 | 2.03e-01 |
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION | 6 | 1.19e-01 | 3.67e-01 | 4.41e-01 |
GOBP FACE MORPHOGENESIS | 12 | 2.81e-02 | -3.66e-01 | 2.30e-01 |
GOMF IMMUNOGLOBULIN RECEPTOR BINDING | 11 | 3.56e-02 | -3.66e-01 | 2.55e-01 |
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 8 | 7.32e-02 | 3.66e-01 | 3.57e-01 |
GOCC MULTI PASS TRANSLOCON COMPLEX | 8 | 7.32e-02 | 3.66e-01 | 3.57e-01 |
GOBP TRNA 5 LEADER REMOVAL | 9 | 5.74e-02 | 3.66e-01 | 3.13e-01 |
GOBP REGULATION OF STEROID HORMONE SECRETION | 5 | 1.57e-01 | -3.66e-01 | 4.92e-01 |
GOBP POSITIVE REGULATION OF RRNA PROCESSING | 9 | 5.75e-02 | 3.66e-01 | 3.13e-01 |
GOBP L ARGININE TRANSMEMBRANE TRANSPORT | 5 | 1.57e-01 | -3.65e-01 | 4.93e-01 |
GOMF METAL CLUSTER BINDING | 51 | 6.67e-06 | 3.65e-01 | 6.27e-04 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY | 9 | 5.80e-02 | -3.65e-01 | 3.15e-01 |
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 6 | 1.22e-01 | 3.65e-01 | 4.47e-01 |
GOBP AEROBIC RESPIRATION | 162 | 1.48e-15 | 3.65e-01 | 1.07e-12 |
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION | 6 | 1.22e-01 | -3.65e-01 | 4.47e-01 |
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 6 | 1.22e-01 | 3.64e-01 | 4.48e-01 |
GOBP NEURAL RETINA DEVELOPMENT | 23 | 2.51e-03 | -3.64e-01 | 6.19e-02 |
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III | 7 | 9.55e-02 | -3.64e-01 | 4.01e-01 |
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS | 7 | 9.57e-02 | -3.64e-01 | 4.01e-01 |
GOBP T CELL EXTRAVASATION | 7 | 9.61e-02 | -3.63e-01 | 4.02e-01 |
GOCC BRISC COMPLEX | 6 | 1.24e-01 | 3.63e-01 | 4.50e-01 |
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 11 | 3.71e-02 | -3.63e-01 | 2.60e-01 |
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS | 8 | 7.54e-02 | -3.63e-01 | 3.62e-01 |
GOBP LIPID DROPLET DISASSEMBLY | 5 | 1.60e-01 | -3.63e-01 | 4.98e-01 |
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 40 | 7.29e-05 | -3.63e-01 | 4.86e-03 |
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION | 8 | 7.59e-02 | -3.63e-01 | 3.63e-01 |
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION | 7 | 9.68e-02 | 3.63e-01 | 4.03e-01 |
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 101 | 3.47e-10 | 3.62e-01 | 9.29e-08 |
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS | 32 | 3.98e-04 | -3.62e-01 | 1.82e-02 |
GOBP POLYOL CATABOLIC PROCESS | 5 | 1.61e-01 | 3.62e-01 | 5.00e-01 |
GOBP MITOCHONDRIAL GENE EXPRESSION | 144 | 7.97e-14 | 3.62e-01 | 4.43e-11 |
GOBP PEPTIDYL ARGININE MODIFICATION | 7 | 9.75e-02 | 3.62e-01 | 4.04e-01 |
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 19 | 6.36e-03 | 3.62e-01 | 1.02e-01 |
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 15 | 1.53e-02 | -3.62e-01 | 1.66e-01 |
GOBP MACROPHAGE PROLIFERATION | 5 | 1.62e-01 | 3.61e-01 | 5.00e-01 |
GOMF ALDO KETO REDUCTASE NADP ACTIVITY | 10 | 4.79e-02 | 3.61e-01 | 2.87e-01 |
GOMF NEUROTROPHIN RECEPTOR BINDING | 5 | 1.62e-01 | -3.61e-01 | 5.01e-01 |
GOMF PROTEIN SEQUESTERING ACTIVITY | 16 | 1.25e-02 | -3.61e-01 | 1.46e-01 |
GOBP ATP METABOLIC PROCESS | 100 | 5.01e-10 | 3.61e-01 | 1.26e-07 |
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT | 9 | 6.10e-02 | -3.61e-01 | 3.25e-01 |
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 13 | 2.45e-02 | 3.60e-01 | 2.15e-01 |
GOBP CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE | 7 | 9.88e-02 | -3.60e-01 | 4.07e-01 |
GOBP AMINO ACID BETAINE TRANSPORT | 5 | 1.63e-01 | -3.60e-01 | 5.02e-01 |
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS | 6 | 1.27e-01 | -3.60e-01 | 4.55e-01 |
GOBP FEMALE GENITALIA DEVELOPMENT | 5 | 1.64e-01 | -3.60e-01 | 5.02e-01 |
GOMF RIBONUCLEASE P ACTIVITY | 7 | 9.96e-02 | 3.60e-01 | 4.09e-01 |
GOMF FATTY ACID DERIVATIVE BINDING | 10 | 4.91e-02 | 3.59e-01 | 2.90e-01 |
GOBP CHOLESTEROL STORAGE | 14 | 2.00e-02 | -3.59e-01 | 1.93e-01 |
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION | 9 | 6.20e-02 | 3.59e-01 | 3.26e-01 |
GOCC ESC E Z COMPLEX | 9 | 6.21e-02 | 3.59e-01 | 3.26e-01 |
GOBP VESICLE UNCOATING | 6 | 1.28e-01 | 3.59e-01 | 4.56e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 7 | 1.00e-01 | 3.59e-01 | 4.09e-01 |
GOBP REGULATION OF PODOSOME ASSEMBLY | 9 | 6.24e-02 | -3.59e-01 | 3.26e-01 |
GOMF VINCULIN BINDING | 6 | 1.28e-01 | 3.59e-01 | 4.56e-01 |
GOBP RRNA 3 END PROCESSING | 8 | 7.92e-02 | 3.58e-01 | 3.67e-01 |
GOMF ACTIN MONOMER BINDING | 13 | 2.53e-02 | 3.58e-01 | 2.19e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 12 | 3.17e-02 | -3.58e-01 | 2.42e-01 |
GOBP REGULATION OF RESPIRATORY BURST | 12 | 3.20e-02 | -3.58e-01 | 2.42e-01 |
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS | 17 | 1.08e-02 | 3.57e-01 | 1.37e-01 |
GOBP REGULATION OF LIPID KINASE ACTIVITY | 19 | 7.15e-03 | -3.57e-01 | 1.09e-01 |
GOCC ENDOCYTIC VESICLE LUMEN | 8 | 8.09e-02 | 3.56e-01 | 3.73e-01 |
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 5 | 1.68e-01 | -3.56e-01 | 5.09e-01 |
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 5 | 1.68e-01 | 3.56e-01 | 5.09e-01 |
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 6 | 1.31e-01 | -3.56e-01 | 4.58e-01 |
GOCC CYTOCHROME COMPLEX | 28 | 1.14e-03 | 3.55e-01 | 3.79e-02 |
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION | 5 | 1.69e-01 | -3.55e-01 | 5.10e-01 |
GOBP AORTA MORPHOGENESIS | 8 | 8.19e-02 | -3.55e-01 | 3.74e-01 |
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS | 15 | 1.74e-02 | 3.55e-01 | 1.78e-01 |
GOBP LIPID PHOSPHORYLATION | 5 | 1.70e-01 | -3.55e-01 | 5.11e-01 |
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY | 5 | 1.70e-01 | -3.55e-01 | 5.11e-01 |
GOCC INTERCALATED DISC | 18 | 9.23e-03 | -3.55e-01 | 1.24e-01 |
GOBP MAINTENANCE OF LENS TRANSPARENCY | 5 | 1.70e-01 | 3.54e-01 | 5.11e-01 |
GOCC COSTAMERE | 7 | 1.05e-01 | -3.54e-01 | 4.17e-01 |
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE | 6 | 1.34e-01 | 3.53e-01 | 4.62e-01 |
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL | 5 | 1.71e-01 | 3.53e-01 | 5.13e-01 |
GOBP MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL | 5 | 1.71e-01 | 3.53e-01 | 5.13e-01 |
GOMF CUPROUS ION BINDING | 5 | 1.72e-01 | 3.53e-01 | 5.14e-01 |
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY | 7 | 1.06e-01 | -3.53e-01 | 4.20e-01 |
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 13 | 2.79e-02 | -3.52e-01 | 2.30e-01 |
GOBP REELIN MEDIATED SIGNALING PATHWAY | 5 | 1.73e-01 | -3.52e-01 | 5.15e-01 |
GOBP KERATINOCYTE MIGRATION | 8 | 8.47e-02 | -3.52e-01 | 3.81e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 16 | 1.48e-02 | -3.52e-01 | 1.62e-01 |
GOBP RESPIRATORY ELECTRON TRANSPORT CHAIN | 103 | 7.41e-10 | 3.52e-01 | 1.68e-07 |
GOBP DIGESTIVE SYSTEM DEVELOPMENT | 34 | 3.89e-04 | -3.52e-01 | 1.79e-02 |
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY | 91 | 7.15e-09 | 3.52e-01 | 1.26e-06 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING | 6 | 1.36e-01 | -3.52e-01 | 4.64e-01 |
GOBP ONCOGENE INDUCED CELL SENESCENCE | 6 | 1.36e-01 | -3.52e-01 | 4.65e-01 |
GOMF OMEGA PEPTIDASE ACTIVITY | 6 | 1.36e-01 | 3.51e-01 | 4.65e-01 |
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY | 7 | 1.08e-01 | -3.51e-01 | 4.24e-01 |
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 8 | 8.62e-02 | -3.50e-01 | 3.84e-01 |
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION | 14 | 2.33e-02 | -3.50e-01 | 2.10e-01 |
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE | 17 | 1.25e-02 | 3.50e-01 | 1.46e-01 |
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING | 7 | 1.09e-01 | -3.50e-01 | 4.24e-01 |
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE | 5 | 1.75e-01 | 3.50e-01 | 5.20e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 10 | 5.55e-02 | -3.50e-01 | 3.07e-01 |
GOBP RESPONSE TO LEUCINE | 12 | 3.60e-02 | -3.50e-01 | 2.56e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 9 | 6.94e-02 | -3.50e-01 | 3.47e-01 |
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY | 7 | 1.09e-01 | -3.50e-01 | 4.25e-01 |
GOBP LATE NUCLEOPHAGY | 6 | 1.38e-01 | -3.49e-01 | 4.68e-01 |
GOBP METHYLGLYOXAL METABOLIC PROCESS | 5 | 1.76e-01 | 3.49e-01 | 5.20e-01 |
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.10e-01 | -3.49e-01 | 4.25e-01 |
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS | 6 | 1.38e-01 | 3.49e-01 | 4.68e-01 |
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION | 6 | 1.39e-01 | -3.49e-01 | 4.68e-01 |
GOCC NUCLEAR REPLICATION FORK | 24 | 3.11e-03 | 3.49e-01 | 6.94e-02 |
GOCC PROTEASOME ACCESSORY COMPLEX | 23 | 3.81e-03 | 3.49e-01 | 7.65e-02 |
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX | 6 | 1.39e-01 | 3.49e-01 | 4.69e-01 |
GOMF RIBONUCLEASE P RNA BINDING | 6 | 1.39e-01 | 3.49e-01 | 4.69e-01 |
GOCC NUCLEAR EXOSOME RNASE COMPLEX | 11 | 4.56e-02 | 3.48e-01 | 2.83e-01 |
GOBP NEGATIVE REGULATION OF ANOIKIS | 9 | 7.06e-02 | -3.48e-01 | 3.50e-01 |
GOBP REGULATION OF MONOCYTE CHEMOTAXIS | 9 | 7.06e-02 | -3.48e-01 | 3.50e-01 |
GOBP FORELIMB MORPHOGENESIS | 11 | 4.57e-02 | -3.48e-01 | 2.83e-01 |
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS | 32 | 6.61e-04 | 3.48e-01 | 2.63e-02 |
GOBP RRNA BASE METHYLATION | 7 | 1.11e-01 | 3.48e-01 | 4.27e-01 |
GOBP OOCYTE MATURATION | 13 | 2.99e-02 | 3.48e-01 | 2.36e-01 |
GOBP REGULATION OF MYOBLAST PROLIFERATION | 6 | 1.40e-01 | -3.48e-01 | 4.70e-01 |
GOBP CHROMOSOME CONDENSATION | 24 | 3.25e-03 | 3.47e-01 | 7.08e-02 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE | 9 | 7.13e-02 | 3.47e-01 | 3.52e-01 |
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES | 6 | 1.41e-01 | -3.47e-01 | 4.72e-01 |
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 5 | 1.79e-01 | -3.47e-01 | 5.25e-01 |
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING | 5 | 1.79e-01 | 3.47e-01 | 5.25e-01 |
GOMF U3 SNORNA BINDING | 7 | 1.12e-01 | 3.47e-01 | 4.30e-01 |
GOMF DIACYLGLYCEROL BINDING | 6 | 1.42e-01 | -3.46e-01 | 4.73e-01 |
GOBP NEUROPEPTIDE SIGNALING PATHWAY | 6 | 1.43e-01 | -3.45e-01 | 4.74e-01 |
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY | 11 | 4.75e-02 | -3.45e-01 | 2.85e-01 |
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 7 | 1.14e-01 | -3.45e-01 | 4.34e-01 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C | 12 | 3.88e-02 | 3.45e-01 | 2.65e-01 |
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS | 11 | 4.86e-02 | 3.44e-01 | 2.88e-01 |
GOMF TOLL LIKE RECEPTOR BINDING | 9 | 7.47e-02 | -3.43e-01 | 3.60e-01 |
GOBP REGULATION OF MITOTIC CYTOKINESIS | 6 | 1.46e-01 | -3.43e-01 | 4.78e-01 |
GOMF CARBOXY LYASE ACTIVITY | 21 | 6.51e-03 | 3.43e-01 | 1.03e-01 |
GOBP MITOTIC CHROMOSOME CONDENSATION | 15 | 2.15e-02 | 3.43e-01 | 2.01e-01 |
GOBP ASTROCYTE DEVELOPMENT | 17 | 1.44e-02 | -3.43e-01 | 1.60e-01 |
GOBP VASCULAR WOUND HEALING | 8 | 9.32e-02 | -3.43e-01 | 3.97e-01 |
GOBP HEMOGLOBIN METABOLIC PROCESS | 8 | 9.33e-02 | 3.43e-01 | 3.97e-01 |
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING | 6 | 1.47e-01 | 3.42e-01 | 4.79e-01 |
GOBP EXONUCLEOLYTIC CATABOLISM OF DEADENYLATED MRNA | 12 | 4.04e-02 | 3.42e-01 | 2.69e-01 |
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 13 | 3.29e-02 | 3.42e-01 | 2.46e-01 |
GOBP REGULATION OF FAT CELL PROLIFERATION | 5 | 1.86e-01 | 3.41e-01 | 5.32e-01 |
GOBP OUTFLOW TRACT MORPHOGENESIS | 19 | 1.01e-02 | -3.41e-01 | 1.32e-01 |
GOBP SULFUR AMINO ACID METABOLIC PROCESS | 19 | 1.02e-02 | 3.41e-01 | 1.33e-01 |
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 7 | 1.19e-01 | 3.40e-01 | 4.40e-01 |
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 8 | 9.59e-02 | -3.40e-01 | 4.01e-01 |
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 15 | 2.27e-02 | 3.40e-01 | 2.08e-01 |
GOMF ACYLGLYCEROL LIPASE ACTIVITY | 6 | 1.50e-01 | -3.40e-01 | 4.82e-01 |
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 30 | 1.29e-03 | -3.40e-01 | 4.13e-02 |
GOBP DETECTION OF LIGHT STIMULUS | 11 | 5.12e-02 | 3.40e-01 | 2.96e-01 |
GOCC MICROBODY LUMEN | 27 | 2.28e-03 | 3.39e-01 | 5.88e-02 |
GOBP SNRNA TRANSCRIPTION | 14 | 2.80e-02 | -3.39e-01 | 2.30e-01 |
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY | 5 | 1.89e-01 | -3.39e-01 | 5.35e-01 |
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION | 9 | 7.83e-02 | 3.39e-01 | 3.66e-01 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING | 7 | 1.20e-01 | -3.39e-01 | 4.44e-01 |
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION | 8 | 9.73e-02 | -3.39e-01 | 4.04e-01 |
GOBP CELL FATE DETERMINATION | 8 | 9.74e-02 | -3.39e-01 | 4.04e-01 |
GOBP REGULATION OF RRNA PROCESSING | 13 | 3.47e-02 | 3.38e-01 | 2.52e-01 |
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION | 7 | 1.21e-01 | -3.38e-01 | 4.46e-01 |
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.52e-01 | -3.38e-01 | 4.86e-01 |
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS | 17 | 1.59e-02 | 3.38e-01 | 1.70e-01 |
GOBP T HELPER 17 TYPE IMMUNE RESPONSE | 19 | 1.08e-02 | -3.38e-01 | 1.37e-01 |
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING | 6 | 1.52e-01 | -3.38e-01 | 4.87e-01 |
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS | 12 | 4.30e-02 | -3.38e-01 | 2.77e-01 |
GOMF HYDRO LYASE ACTIVITY | 28 | 2.01e-03 | 3.38e-01 | 5.39e-02 |
GOBP TUBULIN COMPLEX ASSEMBLY | 7 | 1.22e-01 | 3.37e-01 | 4.48e-01 |
GOMF ARP2 3 COMPLEX BINDING | 9 | 7.99e-02 | -3.37e-01 | 3.69e-01 |
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY | 19 | 1.10e-02 | -3.37e-01 | 1.38e-01 |
GOBP COPULATION | 5 | 1.92e-01 | -3.37e-01 | 5.38e-01 |
GOBP POSITIVE REGULATION OF BONE MINERALIZATION | 12 | 4.34e-02 | -3.37e-01 | 2.78e-01 |
GOBP IRON ION TRANSPORT | 24 | 4.35e-03 | 3.36e-01 | 8.28e-02 |
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY | 6 | 1.54e-01 | 3.36e-01 | 4.88e-01 |
GOBP CENTRIOLE ELONGATION | 8 | 9.96e-02 | -3.36e-01 | 4.09e-01 |
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS | 7 | 1.23e-01 | 3.36e-01 | 4.50e-01 |
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY | 6 | 1.54e-01 | -3.36e-01 | 4.89e-01 |
GOBP EMBRYONIC BRAIN DEVELOPMENT | 6 | 1.54e-01 | -3.36e-01 | 4.89e-01 |
GOBP ETHER BIOSYNTHETIC PROCESS | 9 | 8.13e-02 | -3.36e-01 | 3.73e-01 |
GOBP PROTEIN REPAIR | 5 | 1.94e-01 | 3.36e-01 | 5.40e-01 |
GOCC U5 SNRNP | 18 | 1.38e-02 | 3.35e-01 | 1.55e-01 |
GOBP REGULATION OF GENE EXPRESSION BY GENOMIC IMPRINTING | 8 | 1.01e-01 | -3.35e-01 | 4.10e-01 |
GOBP ASYMMETRIC CELL DIVISION | 11 | 5.43e-02 | 3.35e-01 | 3.03e-01 |
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 22 | 6.60e-03 | 3.35e-01 | 1.04e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 14 | 3.05e-02 | -3.34e-01 | 2.38e-01 |
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 1.57e-01 | 3.34e-01 | 4.92e-01 |
GOBP RAP PROTEIN SIGNAL TRANSDUCTION | 11 | 5.55e-02 | -3.34e-01 | 3.07e-01 |
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX | 13 | 3.75e-02 | 3.33e-01 | 2.62e-01 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 11 | 5.58e-02 | -3.33e-01 | 3.08e-01 |
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 21 | 8.32e-03 | 3.33e-01 | 1.19e-01 |
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING | 12 | 4.61e-02 | -3.33e-01 | 2.83e-01 |
GOCC RESPIRATORY CHAIN COMPLEX IV | 18 | 1.46e-02 | 3.33e-01 | 1.61e-01 |
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II | 12 | 4.61e-02 | -3.33e-01 | 2.83e-01 |
GOBP PROTEIN DESUMOYLATION | 7 | 1.28e-01 | -3.32e-01 | 4.56e-01 |
GOCC NEUROMUSCULAR JUNCTION | 31 | 1.39e-03 | -3.32e-01 | 4.31e-02 |
GOBP ACROSOME REACTION | 5 | 1.99e-01 | -3.32e-01 | 5.46e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 8 | 1.04e-01 | 3.32e-01 | 4.15e-01 |
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY | 5 | 1.99e-01 | 3.32e-01 | 5.46e-01 |
GOCC PRESPLICEOSOME | 16 | 2.16e-02 | 3.32e-01 | 2.02e-01 |
GOBP REGULATION OF RIBOSOME BIOGENESIS | 5 | 1.99e-01 | 3.32e-01 | 5.46e-01 |
GOBP L SERINE TRANSPORT | 7 | 1.29e-01 | 3.31e-01 | 4.57e-01 |
GOBP SERINE TRANSPORT | 7 | 1.29e-01 | 3.31e-01 | 4.57e-01 |
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.29e-01 | 3.31e-01 | 4.57e-01 |
GOMF SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.29e-01 | 3.31e-01 | 4.57e-01 |
GOCC RIBONUCLEASE MRP COMPLEX | 6 | 1.60e-01 | 3.31e-01 | 4.98e-01 |
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS | 6 | 1.60e-01 | -3.31e-01 | 4.98e-01 |
GOMF LYSINE ACETYLATED HISTONE BINDING | 21 | 8.74e-03 | -3.31e-01 | 1.21e-01 |
GOCC PROTEASOME COMPLEX | 57 | 1.62e-05 | 3.31e-01 | 1.36e-03 |
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I | 8 | 1.06e-01 | -3.30e-01 | 4.20e-01 |
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY | 7 | 1.30e-01 | -3.30e-01 | 4.57e-01 |
GOBP ANTIBACTERIAL HUMORAL RESPONSE | 14 | 3.25e-02 | -3.30e-01 | 2.45e-01 |
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION | 10 | 7.07e-02 | -3.30e-01 | 3.50e-01 |
GOMF CHANNEL INHIBITOR ACTIVITY | 19 | 1.28e-02 | 3.30e-01 | 1.48e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS | 5 | 2.01e-01 | 3.30e-01 | 5.49e-01 |
GOBP RESPONSE TO TYPE III INTERFERON | 6 | 1.62e-01 | -3.30e-01 | 5.00e-01 |
GOBP PIGMENT BIOSYNTHETIC PROCESS | 29 | 2.12e-03 | 3.30e-01 | 5.57e-02 |
GOBP POSITIVE REGULATION OF OSSIFICATION | 17 | 1.87e-02 | -3.30e-01 | 1.85e-01 |
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS | 11 | 5.85e-02 | 3.30e-01 | 3.16e-01 |
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 7 | 1.31e-01 | -3.30e-01 | 4.58e-01 |
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING | 15 | 2.74e-02 | 3.29e-01 | 2.28e-01 |
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING | 15 | 2.74e-02 | 3.29e-01 | 2.28e-01 |
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY | 7 | 1.32e-01 | -3.29e-01 | 4.59e-01 |
GOCC CHROMAFFIN GRANULE MEMBRANE | 5 | 2.03e-01 | 3.29e-01 | 5.51e-01 |
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION | 5 | 2.03e-01 | -3.29e-01 | 5.51e-01 |
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY | 10 | 7.21e-02 | 3.29e-01 | 3.54e-01 |
GOBP PROLINE TRANSPORT | 5 | 2.03e-01 | -3.29e-01 | 5.51e-01 |
GOMF DEAMINASE ACTIVITY | 15 | 2.78e-02 | 3.28e-01 | 2.30e-01 |
GOBP PROTEIN C LINKED GLYCOSYLATION | 5 | 2.04e-01 | 3.28e-01 | 5.51e-01 |
GOMF OXYSTEROL BINDING | 5 | 2.04e-01 | -3.28e-01 | 5.51e-01 |
GOBP PML BODY ORGANIZATION | 5 | 2.04e-01 | -3.28e-01 | 5.51e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL | 6 | 1.64e-01 | 3.28e-01 | 5.02e-01 |
GOMF AMP BINDING | 9 | 8.83e-02 | -3.28e-01 | 3.86e-01 |
GOCC NUCLEAR PORE NUCLEAR BASKET | 11 | 5.97e-02 | 3.28e-01 | 3.20e-01 |
GOMF PYRIMIDINE NUCLEOTIDE BINDING | 6 | 1.64e-01 | 3.28e-01 | 5.03e-01 |
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 18 | 1.61e-02 | 3.28e-01 | 1.70e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS | 10 | 7.27e-02 | 3.28e-01 | 3.56e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 18 | 1.62e-02 | 3.28e-01 | 1.71e-01 |
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY | 5 | 2.05e-01 | 3.27e-01 | 5.53e-01 |
GOBP DENDRITIC CELL DIFFERENTIATION | 22 | 7.96e-03 | -3.27e-01 | 1.16e-01 |
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 15 | 2.85e-02 | 3.27e-01 | 2.31e-01 |
GOBP PODOSOME ASSEMBLY | 13 | 4.16e-02 | -3.27e-01 | 2.72e-01 |
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION | 8 | 1.10e-01 | 3.27e-01 | 4.26e-01 |
GOBP FATTY ACID ALPHA OXIDATION | 5 | 2.06e-01 | 3.26e-01 | 5.54e-01 |
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING SIGNALING PATHWAY | 10 | 7.39e-02 | -3.26e-01 | 3.59e-01 |
GOBP ASTROCYTE ACTIVATION | 8 | 1.10e-01 | -3.26e-01 | 4.26e-01 |
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM | 5 | 2.07e-01 | -3.26e-01 | 5.54e-01 |
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGA ISOTYPES | 5 | 2.07e-01 | 3.26e-01 | 5.54e-01 |
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 5 | 2.07e-01 | -3.26e-01 | 5.54e-01 |
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 5 | 2.07e-01 | -3.26e-01 | 5.54e-01 |
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM | 22 | 8.18e-03 | -3.26e-01 | 1.18e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 7 | 1.36e-01 | -3.26e-01 | 4.64e-01 |
GOBP NAD METABOLIC PROCESS | 18 | 1.68e-02 | 3.26e-01 | 1.75e-01 |
GOMF WW DOMAIN BINDING | 11 | 6.16e-02 | -3.26e-01 | 3.25e-01 |
GOBP GTP BIOSYNTHETIC PROCESS | 8 | 1.11e-01 | 3.25e-01 | 4.27e-01 |
GOBP REGULATION OF DNA CATABOLIC PROCESS | 7 | 1.36e-01 | 3.25e-01 | 4.65e-01 |
GOBP REPLACEMENT OSSIFICATION | 8 | 1.11e-01 | -3.25e-01 | 4.27e-01 |
GOBP EOSINOPHIL MIGRATION | 6 | 1.68e-01 | -3.25e-01 | 5.09e-01 |
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS | 6 | 1.68e-01 | -3.25e-01 | 5.09e-01 |
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY | 20 | 1.20e-02 | -3.25e-01 | 1.43e-01 |
GOBP MEMBRANE REPOLARIZATION | 11 | 6.25e-02 | 3.24e-01 | 3.27e-01 |
GOBP TETRAPYRROLE METABOLIC PROCESS | 38 | 5.48e-04 | 3.24e-01 | 2.28e-02 |
GOBP REGULATION OF MIRNA TRANSCRIPTION | 35 | 9.14e-04 | -3.24e-01 | 3.27e-02 |
GOBP NEGATIVE REGULATION OF LIPID STORAGE | 12 | 5.24e-02 | -3.23e-01 | 2.99e-01 |
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT | 12 | 5.25e-02 | 3.23e-01 | 2.99e-01 |
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS | 9 | 9.33e-02 | -3.23e-01 | 3.97e-01 |
GOBP ELECTRON TRANSPORT CHAIN | 129 | 2.78e-10 | 3.23e-01 | 7.73e-08 |
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 45 | 1.88e-04 | -3.22e-01 | 1.03e-02 |
GOBP TRICARBOXYLIC ACID CYCLE | 29 | 2.70e-03 | 3.22e-01 | 6.50e-02 |
GOBP POLYADENYLATION DEPENDENT RNA CATABOLIC PROCESS | 7 | 1.41e-01 | 3.21e-01 | 4.72e-01 |
GOBP PROTEIN K63 LINKED DEUBIQUITINATION | 25 | 5.47e-03 | -3.21e-01 | 9.56e-02 |
GOBP ESTABLISHMENT OF SKIN BARRIER | 9 | 9.54e-02 | -3.21e-01 | 4.01e-01 |
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS | 10 | 7.88e-02 | 3.21e-01 | 3.67e-01 |
GOBP APOPTOTIC DNA FRAGMENTATION | 11 | 6.53e-02 | 3.21e-01 | 3.35e-01 |
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 6 | 1.73e-01 | 3.21e-01 | 5.16e-01 |
GOBP RESPONSE TO FLUID SHEAR STRESS | 15 | 3.15e-02 | -3.21e-01 | 2.41e-01 |
GOBP GRANULOCYTE ACTIVATION | 27 | 3.93e-03 | -3.21e-01 | 7.85e-02 |
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS | 26 | 4.74e-03 | 3.20e-01 | 8.70e-02 |
GOBP T HELPER CELL LINEAGE COMMITMENT | 10 | 7.97e-02 | -3.20e-01 | 3.69e-01 |
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION | 7 | 1.43e-01 | -3.20e-01 | 4.74e-01 |
GOMF SUMO LIGASE ACTIVITY | 9 | 9.68e-02 | -3.20e-01 | 4.03e-01 |
GOMF FERRIC IRON BINDING | 5 | 2.16e-01 | 3.20e-01 | 5.68e-01 |
GOBP KERATINOCYTE DEVELOPMENT | 5 | 2.16e-01 | -3.20e-01 | 5.68e-01 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 19 | 1.60e-02 | -3.19e-01 | 1.70e-01 |
GOMF GLUCOSYLTRANSFERASE ACTIVITY | 10 | 8.06e-02 | 3.19e-01 | 3.72e-01 |
GOBP RESPONSE TO INTERFERON ALPHA | 13 | 4.65e-02 | -3.19e-01 | 2.83e-01 |
GOMF EXTRACELLULAR MATRIX BINDING | 13 | 4.66e-02 | -3.19e-01 | 2.83e-01 |
GOMF AP 2 ADAPTOR COMPLEX BINDING | 8 | 1.19e-01 | -3.19e-01 | 4.40e-01 |
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX | 35 | 1.12e-03 | 3.19e-01 | 3.79e-02 |
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION | 25 | 5.94e-03 | -3.18e-01 | 9.77e-02 |
GOMF ENOYL COA HYDRATASE ACTIVITY | 9 | 9.86e-02 | 3.18e-01 | 4.07e-01 |
GOBP REGULATION OF CELLULAR PH REDUCTION | 5 | 2.18e-01 | -3.18e-01 | 5.71e-01 |
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 5.70e-02 | -3.17e-01 | 3.12e-01 |
GOMF DNA METHYLTRANSFERASE ACTIVITY | 5 | 2.19e-01 | -3.17e-01 | 5.72e-01 |
GOCC BRCA1 A COMPLEX | 8 | 1.20e-01 | 3.17e-01 | 4.44e-01 |
GOBP PHAGOCYTOSIS RECOGNITION | 5 | 2.20e-01 | -3.17e-01 | 5.72e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 9 | 9.98e-02 | -3.17e-01 | 4.09e-01 |
GOMF ALDEHYDE LYASE ACTIVITY | 5 | 2.21e-01 | 3.16e-01 | 5.73e-01 |
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 15 | 3.41e-02 | 3.16e-01 | 2.49e-01 |
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT | 9 | 1.01e-01 | -3.16e-01 | 4.10e-01 |
GOBP REGULATION OF FC GAMMA RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 5 | 2.21e-01 | -3.16e-01 | 5.73e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 11 | 6.97e-02 | -3.16e-01 | 3.48e-01 |
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY | 13 | 4.87e-02 | -3.16e-01 | 2.88e-01 |
GOBP NEUTROPHIL MEDIATED IMMUNITY | 18 | 2.04e-02 | -3.16e-01 | 1.95e-01 |
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT | 17 | 2.42e-02 | -3.16e-01 | 2.14e-01 |
GOBP POSITIVE REGULATION OF VASCULOGENESIS | 5 | 2.22e-01 | -3.16e-01 | 5.74e-01 |
GOBP REGULATION OF VASCULOGENESIS | 5 | 2.22e-01 | -3.16e-01 | 5.74e-01 |
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 22 | 1.05e-02 | -3.15e-01 | 1.35e-01 |
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION | 8 | 1.23e-01 | 3.15e-01 | 4.48e-01 |
GOBP LEUCINE TRANSPORT | 5 | 2.22e-01 | -3.15e-01 | 5.74e-01 |
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY | 6 | 1.81e-01 | -3.15e-01 | 5.28e-01 |
GOBP WHITE FAT CELL DIFFERENTIATION | 7 | 1.49e-01 | -3.15e-01 | 4.82e-01 |
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 1.23e-01 | -3.15e-01 | 4.49e-01 |
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY | 6 | 1.82e-01 | 3.15e-01 | 5.28e-01 |
GOBP L ASCORBIC ACID METABOLIC PROCESS | 7 | 1.49e-01 | 3.15e-01 | 4.82e-01 |
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION | 7 | 1.49e-01 | 3.15e-01 | 4.82e-01 |
GOBP SYNAPTIC VESICLE EXOCYTOSIS | 34 | 1.51e-03 | -3.15e-01 | 4.50e-02 |
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON | 5 | 2.23e-01 | 3.15e-01 | 5.74e-01 |
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE | 6 | 1.82e-01 | -3.14e-01 | 5.28e-01 |
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS | 5 | 2.24e-01 | 3.14e-01 | 5.74e-01 |
GOBP REGULATION OF MICROTUBULE NUCLEATION | 14 | 4.18e-02 | -3.14e-01 | 2.73e-01 |
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 5 | 2.24e-01 | -3.14e-01 | 5.75e-01 |
GOMF CHEMOATTRACTANT ACTIVITY | 9 | 1.03e-01 | 3.14e-01 | 4.13e-01 |
GOBP PIGMENT METABOLIC PROCESS | 36 | 1.12e-03 | 3.14e-01 | 3.79e-02 |
GOBP CELLULAR RESPIRATION | 188 | 1.48e-13 | 3.14e-01 | 6.67e-11 |
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 5 | 2.24e-01 | -3.14e-01 | 5.75e-01 |
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR | 6 | 1.83e-01 | -3.14e-01 | 5.29e-01 |
GOBP NON LYTIC VIRAL RELEASE | 13 | 5.02e-02 | 3.14e-01 | 2.93e-01 |
GOBP CRISTAE FORMATION | 15 | 3.56e-02 | 3.14e-01 | 2.55e-01 |
GOBP PROSTAGLANDIN SECRETION | 6 | 1.84e-01 | 3.13e-01 | 5.29e-01 |
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 | 6 | 1.84e-01 | 3.13e-01 | 5.29e-01 |
GOBP SEQUESTERING OF ACTIN MONOMERS | 5 | 2.25e-01 | 3.13e-01 | 5.75e-01 |
GOCC B WICH COMPLEX | 6 | 1.84e-01 | 3.13e-01 | 5.29e-01 |
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN | 11 | 7.21e-02 | -3.13e-01 | 3.54e-01 |
GOBP PURINE RIBONUCLEOTIDE SALVAGE | 6 | 1.84e-01 | 3.13e-01 | 5.29e-01 |
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION | 12 | 6.05e-02 | 3.13e-01 | 3.22e-01 |
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 5 | 2.26e-01 | -3.13e-01 | 5.75e-01 |
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 9 | 1.04e-01 | -3.13e-01 | 4.16e-01 |
GOBP REGULATION OF MICROVILLUS ORGANIZATION | 5 | 2.26e-01 | 3.13e-01 | 5.75e-01 |
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 14 | 4.29e-02 | -3.13e-01 | 2.77e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION | 14 | 4.31e-02 | 3.12e-01 | 2.77e-01 |
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY | 6 | 1.85e-01 | -3.12e-01 | 5.31e-01 |
GOBP XMP METABOLIC PROCESS | 6 | 1.86e-01 | 3.12e-01 | 5.32e-01 |
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING | 13 | 5.16e-02 | -3.12e-01 | 2.98e-01 |
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 105 | 3.67e-08 | 3.12e-01 | 5.31e-06 |
GOMF G QUADRUPLEX DNA BINDING | 10 | 8.80e-02 | 3.12e-01 | 3.86e-01 |
GOMF PEROXIREDOXIN ACTIVITY | 8 | 1.27e-01 | 3.12e-01 | 4.55e-01 |
GOMF LONG CHAIN FATTY ACID BINDING | 6 | 1.86e-01 | -3.12e-01 | 5.32e-01 |
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE | 5 | 2.28e-01 | -3.12e-01 | 5.76e-01 |
GOMF MITOCHONDRIAL RIBOSOME BINDING | 8 | 1.28e-01 | 3.11e-01 | 4.56e-01 |
GOBP STRIATUM DEVELOPMENT | 8 | 1.28e-01 | -3.11e-01 | 4.56e-01 |
GOBP SUBPALLIUM DEVELOPMENT | 8 | 1.28e-01 | -3.11e-01 | 4.56e-01 |
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX | 6 | 1.88e-01 | 3.11e-01 | 5.34e-01 |
GOCC PLATELET DENSE GRANULE MEMBRANE | 5 | 2.29e-01 | 3.11e-01 | 5.78e-01 |
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS | 10 | 8.92e-02 | 3.10e-01 | 3.88e-01 |
GOBP MAST CELL MIGRATION | 8 | 1.28e-01 | 3.10e-01 | 4.56e-01 |
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 1.55e-01 | 3.10e-01 | 4.90e-01 |
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 5 | 2.30e-01 | -3.10e-01 | 5.78e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 8 | 1.29e-01 | 3.10e-01 | 4.57e-01 |
GOCC POSTSYNAPTIC DENSITY MEMBRANE | 14 | 4.47e-02 | 3.10e-01 | 2.82e-01 |
GOBP PROTEIN DNA COMPLEX DISASSEMBLY | 17 | 2.71e-02 | 3.10e-01 | 2.27e-01 |
GOBP RESPONSE TO INTERLEUKIN 17 | 8 | 1.29e-01 | -3.10e-01 | 4.57e-01 |
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION | 5 | 2.30e-01 | 3.10e-01 | 5.78e-01 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION | 5 | 2.31e-01 | 3.10e-01 | 5.78e-01 |
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS | 11 | 7.55e-02 | -3.10e-01 | 3.62e-01 |
GOMF CARBON NITROGEN LYASE ACTIVITY | 6 | 1.89e-01 | 3.10e-01 | 5.35e-01 |
GOBP DNA DEAMINATION | 8 | 1.30e-01 | 3.09e-01 | 4.57e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 6 | 1.90e-01 | 3.09e-01 | 5.36e-01 |
GOBP PUTRESCINE METABOLIC PROCESS | 5 | 2.31e-01 | -3.09e-01 | 5.78e-01 |
GOBP TERTIARY ALCOHOL METABOLIC PROCESS | 6 | 1.90e-01 | 3.09e-01 | 5.36e-01 |
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT | 10 | 9.12e-02 | -3.09e-01 | 3.92e-01 |
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY | 8 | 1.31e-01 | -3.08e-01 | 4.58e-01 |
GOMF MUTLALPHA COMPLEX BINDING | 6 | 1.92e-01 | 3.08e-01 | 5.37e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS | 15 | 3.91e-02 | 3.08e-01 | 2.66e-01 |
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY | 5 | 2.34e-01 | 3.08e-01 | 5.80e-01 |
GOMF TELOMERASE ACTIVITY | 5 | 2.34e-01 | 3.08e-01 | 5.80e-01 |
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 8 | 1.32e-01 | 3.08e-01 | 4.60e-01 |
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION | 13 | 5.52e-02 | -3.07e-01 | 3.06e-01 |
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS | 7 | 1.60e-01 | -3.07e-01 | 4.98e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION | 7 | 1.60e-01 | -3.07e-01 | 4.98e-01 |
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION | 17 | 2.86e-02 | -3.07e-01 | 2.32e-01 |
GOBP POSITIVE REGULATION OF BLOOD PRESSURE | 7 | 1.60e-01 | -3.07e-01 | 4.98e-01 |
GOBP CELLULAR RESPONSE TO STEROL | 10 | 9.32e-02 | -3.07e-01 | 3.97e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I | 6 | 1.94e-01 | 3.06e-01 | 5.40e-01 |
GOMF GAMMA TUBULIN BINDING | 22 | 1.30e-02 | -3.06e-01 | 1.50e-01 |
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS | 7 | 1.61e-01 | -3.06e-01 | 5.00e-01 |
GOBP CERAMIDE TRANSPORT | 8 | 1.34e-01 | -3.06e-01 | 4.62e-01 |
GOBP ALPHA AMINO ACID CATABOLIC PROCESS | 37 | 1.29e-03 | 3.06e-01 | 4.13e-02 |
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY | 17 | 2.92e-02 | -3.06e-01 | 2.34e-01 |
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY | 9 | 1.12e-01 | -3.06e-01 | 4.30e-01 |
GOBP MONOCYTE CHEMOTAXIS | 15 | 4.06e-02 | -3.06e-01 | 2.70e-01 |
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 8 | 1.35e-01 | 3.05e-01 | 4.64e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 12 | 6.71e-02 | -3.05e-01 | 3.41e-01 |
GOCC RNA POLYMERASE II CORE COMPLEX | 14 | 4.81e-02 | 3.05e-01 | 2.87e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 14 | 4.81e-02 | 3.05e-01 | 2.87e-01 |
GOMF 3 5 DNA HELICASE ACTIVITY | 12 | 6.73e-02 | 3.05e-01 | 3.42e-01 |
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS | 20 | 1.82e-02 | 3.05e-01 | 1.83e-01 |
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE | 21 | 1.56e-02 | 3.05e-01 | 1.68e-01 |
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 7 | 1.63e-01 | 3.05e-01 | 5.01e-01 |
GOBP KETONE BODY METABOLIC PROCESS | 5 | 2.38e-01 | 3.05e-01 | 5.86e-01 |
GOBP NK T CELL DIFFERENTIATION | 8 | 1.36e-01 | -3.05e-01 | 4.64e-01 |
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 35 | 1.83e-03 | -3.05e-01 | 5.20e-02 |
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX | 12 | 6.84e-02 | 3.04e-01 | 3.45e-01 |
GOBP ANIMAL ORGAN MATURATION | 11 | 8.10e-02 | -3.04e-01 | 3.73e-01 |
GOBP BONE MATURATION | 11 | 8.10e-02 | -3.04e-01 | 3.73e-01 |
GOBP GLUCOCORTICOID METABOLIC PROCESS | 7 | 1.64e-01 | -3.04e-01 | 5.03e-01 |
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION | 17 | 3.05e-02 | -3.03e-01 | 2.38e-01 |
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS | 11 | 8.18e-02 | 3.03e-01 | 3.74e-01 |
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 10 | 9.70e-02 | -3.03e-01 | 4.03e-01 |
GOBP AMINO ACID ACTIVATION | 19 | 2.23e-02 | 3.03e-01 | 2.06e-01 |
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION | 9 | 1.16e-01 | -3.03e-01 | 4.37e-01 |
GOBP SNRNA 3 END PROCESSING | 17 | 3.07e-02 | 3.03e-01 | 2.38e-01 |
GOBP C21 STEROID HORMONE METABOLIC PROCESS | 7 | 1.66e-01 | 3.03e-01 | 5.05e-01 |
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 1.66e-01 | 3.02e-01 | 5.05e-01 |
GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS | 5 | 2.42e-01 | -3.02e-01 | 5.90e-01 |
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS | 6 | 2.00e-01 | 3.02e-01 | 5.48e-01 |
GOBP OLFACTORY LOBE DEVELOPMENT | 11 | 8.31e-02 | -3.02e-01 | 3.78e-01 |
GOBP REGULATION OF PROTEIN DEUBIQUITINATION | 8 | 1.39e-01 | -3.02e-01 | 4.69e-01 |
GOBP LAMELLIPODIUM MORPHOGENESIS | 13 | 6.00e-02 | -3.01e-01 | 3.20e-01 |
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS | 24 | 1.07e-02 | 3.01e-01 | 1.37e-01 |
GOMF SPHINGOLIPID BINDING | 15 | 4.36e-02 | -3.01e-01 | 2.78e-01 |
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING | 6 | 2.02e-01 | 3.01e-01 | 5.50e-01 |
GOBP POSITIVE REGULATION OF HEART RATE | 6 | 2.02e-01 | 3.01e-01 | 5.50e-01 |
GOBP ENDODERMAL CELL FATE COMMITMENT | 6 | 2.02e-01 | 3.01e-01 | 5.50e-01 |
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT | 13 | 6.10e-02 | -3.00e-01 | 3.24e-01 |
GOMF DNA HELICASE ACTIVITY | 40 | 1.04e-03 | 3.00e-01 | 3.58e-02 |
GOBP RESPONSE TO MUSCLE STRETCH | 12 | 7.20e-02 | -3.00e-01 | 3.54e-01 |
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 7 | 1.70e-01 | 3.00e-01 | 5.11e-01 |
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 27 | 7.07e-03 | -3.00e-01 | 1.09e-01 |
GOBP FEMALE MEIOSIS I | 5 | 2.46e-01 | 3.00e-01 | 5.92e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY | 18 | 2.79e-02 | -3.00e-01 | 2.30e-01 |
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION | 6 | 2.04e-01 | 2.99e-01 | 5.52e-01 |
GOBP NEGATIVE REGULATION OF HORMONE SECRETION | 23 | 1.30e-02 | -2.99e-01 | 1.50e-01 |
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 7 | 1.71e-01 | 2.99e-01 | 5.11e-01 |
GOCC HAUS COMPLEX | 5 | 2.47e-01 | -2.99e-01 | 5.92e-01 |
GOBP DICARBOXYLIC ACID METABOLIC PROCESS | 51 | 2.25e-04 | 2.99e-01 | 1.18e-02 |
GOMF STEROID DEHYDROGENASE ACTIVITY | 10 | 1.02e-01 | 2.99e-01 | 4.12e-01 |
GOCC SPERM PRINCIPAL PIECE | 5 | 2.47e-01 | -2.99e-01 | 5.93e-01 |
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY | 13 | 6.23e-02 | -2.99e-01 | 3.26e-01 |
GOCC RAGULATOR COMPLEX | 5 | 2.48e-01 | 2.99e-01 | 5.93e-01 |
GOMF E BOX BINDING | 17 | 3.32e-02 | -2.99e-01 | 2.46e-01 |
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CPG ISLAND METHYLATION | 6 | 2.06e-01 | 2.98e-01 | 5.53e-01 |
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 13 | 6.27e-02 | -2.98e-01 | 3.27e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION | 6 | 2.06e-01 | -2.98e-01 | 5.54e-01 |
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION | 6 | 2.06e-01 | -2.98e-01 | 5.54e-01 |
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 8 | 1.45e-01 | 2.98e-01 | 4.77e-01 |
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY | 24 | 1.17e-02 | -2.98e-01 | 1.41e-01 |
GOCC NUCLEAR INCLUSION BODY | 12 | 7.43e-02 | 2.98e-01 | 3.59e-01 |
GOBP DNA STRAND ELONGATION | 32 | 3.61e-03 | 2.98e-01 | 7.51e-02 |
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 5 | 2.50e-01 | -2.97e-01 | 5.96e-01 |
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 8 | 1.45e-01 | -2.97e-01 | 4.78e-01 |
GOBP RETINOL METABOLIC PROCESS | 8 | 1.46e-01 | 2.97e-01 | 4.78e-01 |
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 48 | 3.76e-04 | -2.97e-01 | 1.75e-02 |
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS | 6 | 2.08e-01 | -2.97e-01 | 5.55e-01 |
GOCC POSTSYNAPTIC CYTOSOL | 5 | 2.51e-01 | 2.97e-01 | 5.96e-01 |
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY | 9 | 1.23e-01 | -2.97e-01 | 4.50e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 21 | 1.88e-02 | -2.96e-01 | 1.85e-01 |
GOBP EMBRYONIC EYE MORPHOGENESIS | 9 | 1.24e-01 | -2.96e-01 | 4.51e-01 |
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE | 5 | 2.52e-01 | 2.96e-01 | 5.96e-01 |
GOMF FIBRONECTIN BINDING | 6 | 2.09e-01 | -2.96e-01 | 5.57e-01 |
GOBP BASIC AMINO ACID TRANSPORT | 8 | 1.47e-01 | -2.96e-01 | 4.80e-01 |
GOBP EOSINOPHIL DIFFERENTIATION | 5 | 2.52e-01 | -2.96e-01 | 5.96e-01 |
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY | 40 | 1.22e-03 | 2.96e-01 | 3.98e-02 |
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY | 9 | 1.25e-01 | -2.95e-01 | 4.52e-01 |
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY | 5 | 2.53e-01 | -2.95e-01 | 5.96e-01 |
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT | 64 | 4.52e-05 | -2.95e-01 | 3.20e-03 |
GOCC CELL CELL CONTACT ZONE | 29 | 5.97e-03 | -2.95e-01 | 9.80e-02 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 8 | 1.48e-01 | -2.95e-01 | 4.81e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION | 10 | 1.06e-01 | 2.95e-01 | 4.20e-01 |
GOCC 90S PRERIBOSOME | 21 | 1.93e-02 | 2.95e-01 | 1.88e-01 |
GOBP HEAD MORPHOGENESIS | 16 | 4.11e-02 | -2.95e-01 | 2.71e-01 |
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING | 12 | 7.70e-02 | 2.95e-01 | 3.64e-01 |
GOBP COPPER ION TRANSPORT | 7 | 1.77e-01 | 2.95e-01 | 5.21e-01 |
GOBP FATTY ACID BETA OXIDATION | 47 | 4.80e-04 | 2.95e-01 | 2.08e-02 |
GOBP AZOLE TRANSMEMBRANE TRANSPORT | 5 | 2.54e-01 | -2.95e-01 | 5.97e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL | 11 | 9.12e-02 | 2.94e-01 | 3.92e-01 |
GOBP REGULATION OF SYNAPSE MATURATION | 5 | 2.55e-01 | -2.94e-01 | 5.97e-01 |
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX | 7 | 1.78e-01 | 2.94e-01 | 5.24e-01 |
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE | 23 | 1.47e-02 | 2.94e-01 | 1.62e-01 |
GOBP REGULATION OF CHOLESTEROL STORAGE | 9 | 1.27e-01 | -2.94e-01 | 4.55e-01 |
GOBP DNA REPLICATION CHECKPOINT SIGNALING | 8 | 1.50e-01 | 2.94e-01 | 4.83e-01 |
GOMF BH3 DOMAIN BINDING | 5 | 2.55e-01 | -2.94e-01 | 5.98e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS | 15 | 4.89e-02 | -2.94e-01 | 2.89e-01 |
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 8 | 1.51e-01 | -2.93e-01 | 4.84e-01 |
GOBP ANTIMICROBIAL HUMORAL RESPONSE | 26 | 9.69e-03 | -2.93e-01 | 1.29e-01 |
GOBP DETECTION OF VISIBLE LIGHT | 9 | 1.28e-01 | 2.93e-01 | 4.56e-01 |
GOBP IMMUNOLOGICAL SYNAPSE FORMATION | 9 | 1.28e-01 | 2.93e-01 | 4.56e-01 |
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 14 | 5.79e-02 | -2.93e-01 | 3.15e-01 |
GOBP DNA TEMPLATED DNA REPLICATION | 115 | 6.53e-08 | 2.93e-01 | 9.09e-06 |
GOCC REPLICATION FORK | 47 | 5.31e-04 | 2.92e-01 | 2.23e-02 |
GOBP B CELL APOPTOTIC PROCESS | 20 | 2.36e-02 | -2.92e-01 | 2.11e-01 |
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY | 11 | 9.32e-02 | 2.92e-01 | 3.97e-01 |
GOBP ADHERENS JUNCTION ASSEMBLY | 8 | 1.52e-01 | -2.92e-01 | 4.87e-01 |
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 17 | 3.70e-02 | 2.92e-01 | 2.60e-01 |
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 7 | 1.81e-01 | -2.92e-01 | 5.28e-01 |
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION | 15 | 5.04e-02 | -2.92e-01 | 2.94e-01 |
GOBP DETECTION OF CELL DENSITY | 5 | 2.58e-01 | -2.92e-01 | 6.01e-01 |
GOMF C ACYLTRANSFERASE ACTIVITY | 13 | 6.87e-02 | 2.92e-01 | 3.45e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 2.59e-01 | -2.92e-01 | 6.02e-01 |
GOMF STEROID BINDING | 45 | 7.29e-04 | -2.91e-01 | 2.79e-02 |
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS | 7 | 1.82e-01 | 2.91e-01 | 5.28e-01 |
GOMF ATPASE ACTIVATOR ACTIVITY | 18 | 3.27e-02 | 2.91e-01 | 2.45e-01 |
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 6 | 2.18e-01 | -2.91e-01 | 5.71e-01 |
GOBP MONOCYTE EXTRAVASATION | 6 | 2.18e-01 | -2.90e-01 | 5.71e-01 |
GOMF DEATH RECEPTOR ACTIVITY | 5 | 2.61e-01 | -2.90e-01 | 6.04e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS | 6 | 2.19e-01 | 2.90e-01 | 5.71e-01 |
GOBP DEFINITIVE HEMOPOIESIS | 15 | 5.19e-02 | -2.90e-01 | 2.98e-01 |
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY | 8 | 1.56e-01 | -2.90e-01 | 4.91e-01 |
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 17 | 3.87e-02 | 2.90e-01 | 2.65e-01 |
GOBP MEIOTIC SISTER CHROMATID COHESION | 11 | 9.62e-02 | 2.90e-01 | 4.02e-01 |
GOBP LUNG MORPHOGENESIS | 18 | 3.34e-02 | -2.90e-01 | 2.47e-01 |
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 18 | 3.35e-02 | 2.90e-01 | 2.47e-01 |
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY | 5 | 2.62e-01 | 2.90e-01 | 6.06e-01 |
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS | 16 | 4.50e-02 | -2.90e-01 | 2.82e-01 |
GOBP INTERLEUKIN 2 PRODUCTION | 35 | 3.06e-03 | -2.90e-01 | 6.92e-02 |
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING | 5 | 2.63e-01 | 2.89e-01 | 6.06e-01 |
GOBP VITAMIN K METABOLIC PROCESS | 5 | 2.64e-01 | 2.89e-01 | 6.07e-01 |
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE | 21 | 2.21e-02 | 2.89e-01 | 2.05e-01 |
GOBP ODONTOGENESIS | 31 | 5.47e-03 | -2.89e-01 | 9.56e-02 |
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY | 6 | 2.21e-01 | 2.88e-01 | 5.73e-01 |
GOBP BLASTOCYST GROWTH | 15 | 5.32e-02 | 2.88e-01 | 3.01e-01 |
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY | 24 | 1.45e-02 | -2.88e-01 | 1.61e-01 |
GOBP AMINO ACID CATABOLIC PROCESS | 50 | 4.28e-04 | 2.88e-01 | 1.93e-02 |
GOCC EXORIBONUCLEASE COMPLEX | 18 | 3.44e-02 | 2.88e-01 | 2.51e-01 |
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 133 | 1.10e-08 | 2.88e-01 | 1.77e-06 |
GOBP NUCLEAR MRNA SURVEILLANCE | 9 | 1.35e-01 | 2.88e-01 | 4.64e-01 |
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX | 9 | 1.35e-01 | 2.88e-01 | 4.64e-01 |
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 18 | 3.47e-02 | 2.88e-01 | 2.52e-01 |
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 15 | 5.39e-02 | -2.88e-01 | 3.02e-01 |
GOCC ENDOPEPTIDASE COMPLEX | 70 | 3.29e-05 | 2.88e-01 | 2.48e-03 |
GOBP REGULATION OF MRNA 3 END PROCESSING | 12 | 8.47e-02 | 2.88e-01 | 3.81e-01 |
GOBP LIVER MORPHOGENESIS | 12 | 8.48e-02 | -2.87e-01 | 3.81e-01 |
GOBP PROTEASOME ASSEMBLY | 12 | 8.49e-02 | 2.87e-01 | 3.81e-01 |
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY | 34 | 3.77e-03 | 2.87e-01 | 7.62e-02 |
GOMF SNORNA BINDING | 26 | 1.14e-02 | 2.87e-01 | 1.40e-01 |
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 16 | 4.70e-02 | -2.87e-01 | 2.84e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 13 | 7.34e-02 | -2.87e-01 | 3.58e-01 |
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY | 6 | 2.24e-01 | -2.87e-01 | 5.75e-01 |
GOBP REGULATION OF CARDIAC CONDUCTION | 7 | 1.89e-01 | -2.87e-01 | 5.35e-01 |
GOCC SARCOPLASMIC RETICULUM | 28 | 8.73e-03 | 2.87e-01 | 1.21e-01 |
GOBP PROTEIN DEMETHYLATION | 11 | 1.00e-01 | -2.87e-01 | 4.09e-01 |
GOCC APICAL DENDRITE | 7 | 1.90e-01 | 2.86e-01 | 5.36e-01 |
GOBP CELLULAR RESPONSE TO ETHANOL | 9 | 1.37e-01 | -2.86e-01 | 4.66e-01 |
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY | 13 | 7.44e-02 | 2.86e-01 | 3.59e-01 |
GOBP REGULATION OF ANOIKIS | 12 | 8.66e-02 | -2.86e-01 | 3.84e-01 |
GOCC CELL BODY MEMBRANE | 5 | 2.68e-01 | -2.86e-01 | 6.12e-01 |
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN | 7 | 1.91e-01 | -2.86e-01 | 5.37e-01 |
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE | 10 | 1.18e-01 | -2.86e-01 | 4.39e-01 |
GOBP CHONDROCYTE PROLIFERATION | 7 | 1.91e-01 | -2.86e-01 | 5.37e-01 |
GOBP BOX C D SNORNP ASSEMBLY | 8 | 1.62e-01 | 2.85e-01 | 5.01e-01 |
GOBP RESPONSE TO PROSTAGLANDIN E | 8 | 1.62e-01 | -2.85e-01 | 5.01e-01 |
GOBP FIBROBLAST MIGRATION | 34 | 4.04e-03 | -2.85e-01 | 7.96e-02 |
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 8 | 1.63e-01 | 2.85e-01 | 5.01e-01 |
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH | 12 | 8.78e-02 | -2.85e-01 | 3.86e-01 |
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL | 12 | 8.78e-02 | -2.85e-01 | 3.86e-01 |
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS | 6 | 2.27e-01 | -2.85e-01 | 5.76e-01 |
GOMF PRIMARY MIRNA BINDING | 8 | 1.63e-01 | -2.85e-01 | 5.02e-01 |
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 19 | 3.20e-02 | -2.84e-01 | 2.42e-01 |
GOCC REPLISOME | 12 | 8.83e-02 | 2.84e-01 | 3.86e-01 |
GOBP NEGATIVE REGULATION OF DNA BINDING | 23 | 1.85e-02 | -2.84e-01 | 1.84e-01 |
GOCC PROTEIN FOLDING CHAPERONE COMPLEX | 36 | 3.23e-03 | 2.84e-01 | 7.08e-02 |
GOBP MODULATION OF MICROTUBULE CYTOSKELETON INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 5 | 2.72e-01 | -2.84e-01 | 6.17e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC | 16 | 4.99e-02 | 2.83e-01 | 2.92e-01 |
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 2.73e-01 | -2.83e-01 | 6.17e-01 |
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY | 10 | 1.21e-01 | -2.83e-01 | 4.46e-01 |
GOBP NEUTROPHIL EXTRAVASATION | 9 | 1.42e-01 | -2.83e-01 | 4.72e-01 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN | 18 | 3.78e-02 | 2.83e-01 | 2.63e-01 |
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX | 111 | 2.90e-07 | 2.83e-01 | 3.62e-05 |
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX | 10 | 1.22e-01 | 2.83e-01 | 4.47e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 5 | 2.74e-01 | -2.83e-01 | 6.19e-01 |
GOCC BCL 2 FAMILY PROTEIN COMPLEX | 8 | 1.67e-01 | -2.82e-01 | 5.07e-01 |
GOBP DENDRITIC CELL MIGRATION | 15 | 5.87e-02 | -2.82e-01 | 3.16e-01 |
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY | 6 | 2.32e-01 | -2.82e-01 | 5.78e-01 |
GOBP PRIMARY MIRNA PROCESSING | 16 | 5.10e-02 | -2.82e-01 | 2.96e-01 |
GOMF LAMININ BINDING | 10 | 1.23e-01 | -2.82e-01 | 4.49e-01 |
GOBP REGULATION OF NK T CELL DIFFERENTIATION | 5 | 2.76e-01 | -2.82e-01 | 6.19e-01 |
GOCC F ACTIN CAPPING PROTEIN COMPLEX | 6 | 2.33e-01 | -2.81e-01 | 5.78e-01 |
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT | 11 | 1.06e-01 | -2.81e-01 | 4.20e-01 |
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 7 | 1.98e-01 | -2.81e-01 | 5.45e-01 |
GOBP SEROTONIN TRANSPORT | 5 | 2.77e-01 | -2.81e-01 | 6.20e-01 |
GOBP POSITIVE REGULATION OF MYELINATION | 6 | 2.34e-01 | 2.81e-01 | 5.80e-01 |
GOMF STEROL BINDING | 36 | 3.65e-03 | -2.80e-01 | 7.54e-02 |
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM | 7 | 1.99e-01 | -2.80e-01 | 5.47e-01 |
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT | 9 | 1.46e-01 | -2.80e-01 | 4.78e-01 |
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY | 11 | 1.08e-01 | -2.80e-01 | 4.24e-01 |
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY | 9 | 1.46e-01 | -2.80e-01 | 4.78e-01 |
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 5 | 2.79e-01 | -2.80e-01 | 6.22e-01 |
GOBP CHAPERONE MEDIATED AUTOPHAGY | 10 | 1.26e-01 | 2.80e-01 | 4.54e-01 |
GOBP REGULATION OF MIRNA METABOLIC PROCESS | 46 | 1.08e-03 | -2.79e-01 | 3.71e-02 |
GOBP DETECTION OF BACTERIUM | 6 | 2.37e-01 | 2.79e-01 | 5.84e-01 |
GOBP DETECTION OF OTHER ORGANISM | 6 | 2.37e-01 | 2.79e-01 | 5.84e-01 |
GOBP ADIPOSE TISSUE DEVELOPMENT | 33 | 5.61e-03 | -2.79e-01 | 9.62e-02 |
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING | 7 | 2.02e-01 | -2.79e-01 | 5.50e-01 |
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY | 10 | 1.27e-01 | 2.79e-01 | 4.55e-01 |
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS | 25 | 1.59e-02 | 2.79e-01 | 1.70e-01 |
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY | 8 | 1.73e-01 | 2.79e-01 | 5.15e-01 |
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY | 138 | 1.81e-08 | -2.79e-01 | 2.84e-06 |
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 13 | 8.24e-02 | -2.78e-01 | 3.76e-01 |
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 10 | 1.28e-01 | -2.78e-01 | 4.56e-01 |
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT | 5 | 2.81e-01 | -2.78e-01 | 6.23e-01 |
GOMF SEQUENCE SPECIFIC MRNA BINDING | 8 | 1.73e-01 | 2.78e-01 | 5.16e-01 |
GOBP CAMERA TYPE EYE MORPHOGENESIS | 42 | 1.85e-03 | -2.78e-01 | 5.21e-02 |
GOBP REGULATION OF PLATELET AGGREGATION | 13 | 8.28e-02 | -2.78e-01 | 3.77e-01 |
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY | 24 | 1.85e-02 | 2.78e-01 | 1.84e-01 |
GOBP LAYER FORMATION IN CEREBRAL CORTEX | 6 | 2.39e-01 | -2.78e-01 | 5.87e-01 |
GOBP RENAL SYSTEM PROCESS | 34 | 5.10e-03 | -2.78e-01 | 9.15e-02 |
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 19 | 3.62e-02 | -2.78e-01 | 2.56e-01 |
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS | 12 | 9.59e-02 | -2.78e-01 | 4.01e-01 |
GOCC MICROTUBULE MINUS END | 5 | 2.82e-01 | 2.78e-01 | 6.24e-01 |
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS | 6 | 2.39e-01 | -2.78e-01 | 5.87e-01 |
GOBP SULFATION | 7 | 2.04e-01 | -2.77e-01 | 5.51e-01 |
GOBP RESPONSE TO AUDITORY STIMULUS | 7 | 2.04e-01 | -2.77e-01 | 5.51e-01 |
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.50e-01 | 2.77e-01 | 4.83e-01 |
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 8 | 1.75e-01 | 2.77e-01 | 5.19e-01 |
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 8 | 1.75e-01 | -2.77e-01 | 5.19e-01 |
GOBP UV PROTECTION | 6 | 2.41e-01 | 2.77e-01 | 5.89e-01 |
GOBP BASEMENT MEMBRANE ORGANIZATION | 9 | 1.51e-01 | -2.77e-01 | 4.84e-01 |
GOMF ACID AMINO ACID LIGASE ACTIVITY | 10 | 1.30e-01 | 2.77e-01 | 4.57e-01 |
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 5 | 2.85e-01 | -2.76e-01 | 6.27e-01 |
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY | 9 | 1.51e-01 | 2.76e-01 | 4.86e-01 |
GOBP REGULATION OF SPROUTING ANGIOGENESIS | 15 | 6.41e-02 | -2.76e-01 | 3.31e-01 |
GOMF DNA NUCLEASE ACTIVITY | 35 | 4.77e-03 | 2.76e-01 | 8.72e-02 |
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY | 5 | 2.86e-01 | -2.76e-01 | 6.28e-01 |
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY | 5 | 2.86e-01 | 2.76e-01 | 6.28e-01 |
GOBP PROTEIN HETEROOLIGOMERIZATION | 16 | 5.66e-02 | 2.75e-01 | 3.11e-01 |
GOMF ACYL COA BINDING | 13 | 8.57e-02 | 2.75e-01 | 3.83e-01 |
GOBP REGULATION OF TRANSLATION AT SYNAPSE | 5 | 2.87e-01 | 2.75e-01 | 6.29e-01 |
GOBP LUNG ALVEOLUS DEVELOPMENT | 19 | 3.79e-02 | -2.75e-01 | 2.63e-01 |
GOBP MICROGLIAL CELL MIGRATION | 5 | 2.87e-01 | 2.75e-01 | 6.29e-01 |
GOBP RESPONSE TO PROTOZOAN | 13 | 8.63e-02 | -2.75e-01 | 3.84e-01 |
GOCC TRANSCRIPTION EXPORT COMPLEX | 10 | 1.33e-01 | 2.75e-01 | 4.60e-01 |
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY | 8 | 1.79e-01 | -2.74e-01 | 5.25e-01 |
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY | 7 | 2.09e-01 | 2.74e-01 | 5.57e-01 |
GOBP SUCCINATE METABOLIC PROCESS | 5 | 2.88e-01 | 2.74e-01 | 6.30e-01 |
GOCC SUPER ELONGATION COMPLEX | 5 | 2.88e-01 | -2.74e-01 | 6.30e-01 |
GOCC ER UBIQUITIN LIGASE COMPLEX | 8 | 1.79e-01 | 2.74e-01 | 5.25e-01 |
GOBP SARCOMERE ORGANIZATION | 11 | 1.15e-01 | -2.74e-01 | 4.37e-01 |
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING | 9 | 1.55e-01 | 2.74e-01 | 4.89e-01 |
GOBP HYALURONAN CATABOLIC PROCESS | 6 | 2.45e-01 | -2.74e-01 | 5.92e-01 |
GOCC MIB COMPLEX | 12 | 1.00e-01 | 2.74e-01 | 4.10e-01 |
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 14 | 7.60e-02 | 2.74e-01 | 3.63e-01 |
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 9 | 1.55e-01 | -2.74e-01 | 4.89e-01 |
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY | 6 | 2.46e-01 | 2.74e-01 | 5.92e-01 |
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 7 | 2.10e-01 | 2.74e-01 | 5.58e-01 |
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT | 7 | 2.10e-01 | -2.74e-01 | 5.58e-01 |
GOBP PROTEIN KINASE A SIGNALING | 14 | 7.66e-02 | -2.73e-01 | 3.63e-01 |
GOBP NUCLEAR RNA SURVEILLANCE | 12 | 1.01e-01 | 2.73e-01 | 4.10e-01 |
GOBP DE NOVO PROTEIN FOLDING | 29 | 1.09e-02 | 2.73e-01 | 1.37e-01 |
GOCC ER MEMBRANE INSERTION COMPLEX | 11 | 1.17e-01 | 2.73e-01 | 4.39e-01 |
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS | 10 | 1.35e-01 | -2.73e-01 | 4.64e-01 |
GOBP NUCLEAR MEMBRANE REASSEMBLY | 23 | 2.37e-02 | 2.73e-01 | 2.11e-01 |
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 1.36e-01 | -2.73e-01 | 4.64e-01 |
GOCC CILIARY TRANSITION FIBER | 6 | 2.48e-01 | -2.73e-01 | 5.93e-01 |
GOBP REGULATION OF INTEGRIN ACTIVATION | 8 | 1.82e-01 | -2.73e-01 | 5.28e-01 |
GOBP FOAM CELL DIFFERENTIATION | 19 | 3.99e-02 | -2.73e-01 | 2.68e-01 |
GOBP RESPONSE TO OXYGEN RADICAL | 13 | 8.91e-02 | 2.72e-01 | 3.88e-01 |
GOBP RESPONSE TO HYDROPEROXIDE | 10 | 1.36e-01 | 2.72e-01 | 4.65e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 8 | 1.83e-01 | -2.72e-01 | 5.28e-01 |
GOBP REGULATION OF FATTY ACID BETA OXIDATION | 9 | 1.58e-01 | -2.72e-01 | 4.94e-01 |
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS | 12 | 1.03e-01 | 2.72e-01 | 4.13e-01 |
GOBP RESPONSE TO ETHER | 7 | 2.13e-01 | -2.72e-01 | 5.64e-01 |
GOBP TROPHOBLAST CELL MIGRATION | 7 | 2.13e-01 | 2.72e-01 | 5.64e-01 |
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 31 | 8.87e-03 | -2.72e-01 | 1.22e-01 |
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY | 12 | 1.03e-01 | -2.72e-01 | 4.14e-01 |
GOMF NUCLEOTIDASE ACTIVITY | 8 | 1.83e-01 | 2.72e-01 | 5.29e-01 |
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION | 5 | 2.93e-01 | 2.72e-01 | 6.35e-01 |
GOMF DNA EXONUCLEASE ACTIVITY | 14 | 7.89e-02 | 2.71e-01 | 3.67e-01 |
GOMF HISTONE H3 KINASE ACTIVITY | 8 | 1.84e-01 | 2.71e-01 | 5.29e-01 |
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE | 6 | 2.50e-01 | 2.71e-01 | 5.96e-01 |
GOMF LEUCINE BINDING | 5 | 2.94e-01 | -2.71e-01 | 6.36e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS | 5 | 2.94e-01 | -2.71e-01 | 6.36e-01 |
GOBP ORGANIC CATION TRANSPORT | 16 | 6.11e-02 | -2.71e-01 | 3.25e-01 |
GOBP CELLULAR RESPONSE TO CHOLESTEROL | 7 | 2.16e-01 | -2.70e-01 | 5.68e-01 |
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 7 | 2.16e-01 | -2.70e-01 | 5.68e-01 |
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY | 10 | 1.39e-01 | 2.70e-01 | 4.69e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION | 5 | 2.95e-01 | 2.70e-01 | 6.37e-01 |
GOBP FATTY ACID CATABOLIC PROCESS | 58 | 3.80e-04 | 2.70e-01 | 1.76e-02 |
GOBP CARDIOLIPIN METABOLIC PROCESS | 11 | 1.21e-01 | 2.70e-01 | 4.46e-01 |
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS | 168 | 1.87e-09 | 2.70e-01 | 3.86e-07 |
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT | 7 | 2.17e-01 | -2.70e-01 | 5.69e-01 |
GOCC PEPTIDASE COMPLEX | 97 | 4.71e-06 | 2.70e-01 | 4.73e-04 |
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING | 7 | 2.17e-01 | 2.70e-01 | 5.69e-01 |
GOBP OOCYTE DIFFERENTIATION | 24 | 2.23e-02 | 2.70e-01 | 2.06e-01 |
GOBP NEUROTRANSMITTER SECRETION | 49 | 1.13e-03 | -2.69e-01 | 3.79e-02 |
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION | 6 | 2.54e-01 | -2.69e-01 | 5.97e-01 |
GOCC ORGANELLE INNER MEMBRANE | 404 | 4.32e-20 | 2.69e-01 | 1.04e-16 |
GOBP POSITIVE REGULATION OF CELL SIZE | 6 | 2.54e-01 | -2.69e-01 | 5.97e-01 |
GOBP RESPONSE TO COLD | 21 | 3.29e-02 | -2.69e-01 | 2.46e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 8 | 1.88e-01 | -2.69e-01 | 5.34e-01 |
GOBP GENOMIC IMPRINTING | 10 | 1.41e-01 | -2.69e-01 | 4.72e-01 |
GOBP DENTATE GYRUS DEVELOPMENT | 8 | 1.88e-01 | -2.69e-01 | 5.35e-01 |
GOCC MITOCHONDRIAL MATRIX | 357 | 6.17e-18 | 2.69e-01 | 8.93e-15 |
GOBP COPI COATED VESICLE BUDDING | 6 | 2.55e-01 | 2.69e-01 | 5.97e-01 |
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM | 7 | 2.19e-01 | -2.68e-01 | 5.71e-01 |
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 7 | 2.19e-01 | -2.68e-01 | 5.71e-01 |
GOMF COLLAGEN BINDING | 16 | 6.33e-02 | -2.68e-01 | 3.29e-01 |
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS | 5 | 2.99e-01 | -2.68e-01 | 6.41e-01 |
GOBP CELLULAR RESPONSE TO CAMP | 19 | 4.33e-02 | -2.68e-01 | 2.77e-01 |
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS | 196 | 1.25e-10 | 2.68e-01 | 3.92e-08 |
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 5 | 3.00e-01 | -2.68e-01 | 6.42e-01 |
GOBP RESPONSE TO MURAMYL DIPEPTIDE | 13 | 9.49e-02 | -2.68e-01 | 4.01e-01 |
GOBP REGULATION OF POSITIVE CHEMOTAXIS | 6 | 2.57e-01 | -2.68e-01 | 6.00e-01 |
GOBP CHAPERONE MEDIATED PROTEIN FOLDING | 57 | 4.89e-04 | 2.67e-01 | 2.10e-02 |
GOBP RESPONSE TO NITROSATIVE STRESS | 8 | 1.91e-01 | 2.67e-01 | 5.37e-01 |
GOBP PYRUVATE TRANSPORT | 5 | 3.01e-01 | 2.67e-01 | 6.42e-01 |
GOBP IRON ION TRANSMEMBRANE TRANSPORT | 10 | 1.44e-01 | 2.67e-01 | 4.76e-01 |
GOBP CELLULAR RESPONSE TO CALCIUM ION | 36 | 5.65e-03 | -2.67e-01 | 9.64e-02 |
GOBP RESPONSE TO CAMP | 34 | 7.18e-03 | -2.67e-01 | 1.09e-01 |
GOBP ORGANELLE INHERITANCE | 12 | 1.10e-01 | 2.67e-01 | 4.26e-01 |
GOBP MEIOTIC SPINDLE ASSEMBLY | 9 | 1.66e-01 | 2.67e-01 | 5.05e-01 |
GOCC PROTEASOME REGULATORY PARTICLE | 19 | 4.44e-02 | 2.67e-01 | 2.82e-01 |
GOCC DYNEIN AXONEMAL PARTICLE | 8 | 1.92e-01 | 2.66e-01 | 5.38e-01 |
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 30 | 1.17e-02 | -2.66e-01 | 1.41e-01 |
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE | 6 | 2.59e-01 | 2.66e-01 | 6.02e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 30 | 1.17e-02 | -2.66e-01 | 1.41e-01 |
GOBP PROSTATE GLAND DEVELOPMENT | 19 | 4.47e-02 | -2.66e-01 | 2.82e-01 |
GOBP HINDLIMB MORPHOGENESIS | 7 | 2.23e-01 | -2.66e-01 | 5.74e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES | 19 | 4.48e-02 | 2.66e-01 | 2.82e-01 |
GOBP PHAGOCYTOSIS ENGULFMENT | 29 | 1.32e-02 | -2.66e-01 | 1.51e-01 |
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS | 19 | 4.50e-02 | -2.66e-01 | 2.82e-01 |
GOCC ANNULATE LAMELLAE | 5 | 3.03e-01 | -2.66e-01 | 6.44e-01 |
GOBP TRNA 3 END PROCESSING | 5 | 3.04e-01 | 2.66e-01 | 6.44e-01 |
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY | 6 | 2.60e-01 | 2.66e-01 | 6.03e-01 |
GOMF CARBON CARBON LYASE ACTIVITY | 32 | 9.43e-03 | 2.65e-01 | 1.26e-01 |
GOBP REGULATION OF FATTY ACID OXIDATION | 12 | 1.12e-01 | -2.65e-01 | 4.29e-01 |
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE | 27 | 1.72e-02 | 2.65e-01 | 1.77e-01 |
GOCC MITOTIC SPINDLE MICROTUBULE | 8 | 1.94e-01 | -2.65e-01 | 5.40e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 9 | 1.69e-01 | 2.65e-01 | 5.10e-01 |
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS | 9 | 1.69e-01 | 2.65e-01 | 5.10e-01 |
GOBP FEMALE MEIOTIC NUCLEAR DIVISION | 20 | 4.04e-02 | 2.65e-01 | 2.69e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 28 | 1.54e-02 | -2.65e-01 | 1.67e-01 |
GOBP CELL REDOX HOMEOSTASIS | 29 | 1.37e-02 | 2.65e-01 | 1.55e-01 |
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY | 18 | 5.23e-02 | -2.64e-01 | 2.99e-01 |
GOCC GEMINI OF COILED BODIES | 5 | 3.06e-01 | 2.64e-01 | 6.47e-01 |
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS | 19 | 4.63e-02 | 2.64e-01 | 2.83e-01 |
GOMF POLY A BINDING | 18 | 5.25e-02 | -2.64e-01 | 2.99e-01 |
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE | 6 | 2.63e-01 | -2.64e-01 | 6.06e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY | 12 | 1.14e-01 | -2.64e-01 | 4.34e-01 |
GOMF CYTOSKELETAL ANCHOR ACTIVITY | 11 | 1.30e-01 | -2.64e-01 | 4.57e-01 |
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 6 | 2.64e-01 | -2.64e-01 | 6.07e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING | 20 | 4.15e-02 | -2.63e-01 | 2.72e-01 |
GOMF CHOLESTEROL BINDING | 28 | 1.60e-02 | -2.63e-01 | 1.70e-01 |
GOBP MODIFIED AMINO ACID TRANSPORT | 15 | 7.78e-02 | -2.63e-01 | 3.65e-01 |
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 19 | 4.73e-02 | 2.63e-01 | 2.85e-01 |
GOBP MIDBODY ABSCISSION | 14 | 8.88e-02 | 2.63e-01 | 3.87e-01 |
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 12 | 1.15e-01 | -2.63e-01 | 4.37e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION | 5 | 3.09e-01 | -2.63e-01 | 6.49e-01 |
GOBP REGULATION OF PIGMENTATION | 8 | 1.99e-01 | -2.62e-01 | 5.46e-01 |
GOMF ADENOSINE DEAMINASE ACTIVITY | 8 | 1.99e-01 | 2.62e-01 | 5.46e-01 |
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY | 5 | 3.11e-01 | 2.62e-01 | 6.49e-01 |
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 26 | 2.09e-02 | 2.62e-01 | 1.97e-01 |
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY | 5 | 3.11e-01 | -2.62e-01 | 6.49e-01 |
GOCC FLOTILLIN COMPLEX | 7 | 2.30e-01 | -2.62e-01 | 5.78e-01 |
GOBP CORTICOSTEROID HORMONE SECRETION | 5 | 3.11e-01 | -2.62e-01 | 6.49e-01 |
GOBP GLUCOCORTICOID SECRETION | 5 | 3.11e-01 | -2.62e-01 | 6.49e-01 |
GOMF GAMMA CATENIN BINDING | 6 | 2.67e-01 | -2.62e-01 | 6.11e-01 |
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY | 16 | 7.02e-02 | 2.62e-01 | 3.50e-01 |
GOBP AMP SALVAGE | 5 | 3.11e-01 | 2.62e-01 | 6.49e-01 |
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 8 | 2.00e-01 | -2.62e-01 | 5.48e-01 |
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 21 | 3.81e-02 | 2.62e-01 | 2.63e-01 |
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS | 5 | 3.11e-01 | 2.61e-01 | 6.49e-01 |
GOBP PROTEIN DEPALMITOYLATION | 7 | 2.31e-01 | 2.61e-01 | 5.78e-01 |
GOBP REGULATION OF KERATINOCYTE MIGRATION | 7 | 2.31e-01 | -2.61e-01 | 5.78e-01 |
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 24 | 2.68e-02 | -2.61e-01 | 2.26e-01 |
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 6 | 2.68e-01 | 2.61e-01 | 6.12e-01 |
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 21 | 3.86e-02 | -2.61e-01 | 2.65e-01 |
GOCC OUTER KINETOCHORE | 13 | 1.04e-01 | 2.61e-01 | 4.15e-01 |
GOBP STRIATED MUSCLE CELL DEVELOPMENT | 19 | 4.92e-02 | -2.61e-01 | 2.90e-01 |
GOCC NBAF COMPLEX | 13 | 1.04e-01 | 2.61e-01 | 4.15e-01 |
GOMF DNA ENDONUCLEASE ACTIVITY | 24 | 2.72e-02 | 2.61e-01 | 2.27e-01 |
GOBP ADRENAL GLAND DEVELOPMENT | 12 | 1.19e-01 | -2.60e-01 | 4.40e-01 |
GOBP SECRETION BY TISSUE | 15 | 8.11e-02 | -2.60e-01 | 3.73e-01 |
GOCC U12 TYPE SPLICEOSOMAL COMPLEX | 26 | 2.18e-02 | 2.60e-01 | 2.03e-01 |
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.77e-01 | -2.60e-01 | 5.21e-01 |
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 7 | 2.34e-01 | -2.60e-01 | 5.80e-01 |
GOCC CCAAT BINDING FACTOR COMPLEX | 5 | 3.14e-01 | -2.60e-01 | 6.53e-01 |
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION | 11 | 1.36e-01 | 2.60e-01 | 4.65e-01 |
GOBP CELLULAR RESPONSE TO LEUCINE | 10 | 1.56e-01 | -2.59e-01 | 4.91e-01 |
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY | 30 | 1.40e-02 | -2.59e-01 | 1.56e-01 |
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY | 6 | 2.71e-01 | -2.59e-01 | 6.16e-01 |
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS | 6 | 2.71e-01 | -2.59e-01 | 6.16e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM | 13 | 1.06e-01 | 2.59e-01 | 4.20e-01 |
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 5 | 3.16e-01 | -2.59e-01 | 6.54e-01 |
GOBP CELL CELL RECOGNITION | 20 | 4.51e-02 | 2.59e-01 | 2.82e-01 |
GOBP AMINO SUGAR CATABOLIC PROCESS | 5 | 3.16e-01 | 2.59e-01 | 6.55e-01 |
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 5 | 3.16e-01 | 2.59e-01 | 6.55e-01 |
GOBP POSITIVE REGULATION OF BEHAVIOR | 5 | 3.16e-01 | -2.59e-01 | 6.55e-01 |
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 10 | 1.57e-01 | -2.59e-01 | 4.92e-01 |
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 5 | 3.17e-01 | -2.58e-01 | 6.55e-01 |
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS | 13 | 1.07e-01 | 2.58e-01 | 4.22e-01 |
GOCC BLEB | 6 | 2.73e-01 | -2.58e-01 | 6.18e-01 |
GOBP MITOCHONDRIAL RNA MODIFICATION | 8 | 2.07e-01 | 2.58e-01 | 5.54e-01 |
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 15 | 8.40e-02 | -2.58e-01 | 3.81e-01 |
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 15 | 8.40e-02 | -2.58e-01 | 3.81e-01 |
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION | 5 | 3.18e-01 | 2.58e-01 | 6.56e-01 |
GOBP ALCOHOL CATABOLIC PROCESS | 10 | 1.58e-01 | 2.58e-01 | 4.95e-01 |
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE | 6 | 2.75e-01 | 2.58e-01 | 6.19e-01 |
GOCC NUCLEOID | 35 | 8.42e-03 | 2.58e-01 | 1.19e-01 |
GOBP CELLULAR RESPONSE TO STEROL DEPLETION | 10 | 1.59e-01 | -2.57e-01 | 4.96e-01 |
GOBP REGULATION OF SISTER CHROMATID COHESION | 14 | 9.57e-02 | 2.57e-01 | 4.01e-01 |
GOCC SEH1 ASSOCIATED COMPLEX | 6 | 2.76e-01 | 2.57e-01 | 6.19e-01 |
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE | 22 | 3.71e-02 | -2.57e-01 | 2.60e-01 |
GOBP SNRNA PROCESSING | 22 | 3.72e-02 | 2.57e-01 | 2.60e-01 |
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION | 45 | 2.92e-03 | -2.57e-01 | 6.80e-02 |
GOBP AMINE CATABOLIC PROCESS | 6 | 2.77e-01 | -2.57e-01 | 6.20e-01 |
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS | 5 | 3.21e-01 | 2.56e-01 | 6.59e-01 |
GOCC PRP19 COMPLEX | 12 | 1.24e-01 | 2.56e-01 | 4.51e-01 |
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS | 5 | 3.21e-01 | 2.56e-01 | 6.59e-01 |
GOBP MEIOTIC SPINDLE ORGANIZATION | 12 | 1.25e-01 | 2.56e-01 | 4.52e-01 |
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION | 7 | 2.41e-01 | 2.56e-01 | 5.89e-01 |
GOBP TRANSITION METAL ION TRANSPORT | 43 | 3.73e-03 | 2.56e-01 | 7.61e-02 |
GOBP MITOCHONDRIAL RNA 3 END PROCESSING | 6 | 2.78e-01 | 2.56e-01 | 6.22e-01 |
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER | 29 | 1.73e-02 | -2.56e-01 | 1.77e-01 |
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | 16 | 7.70e-02 | 2.55e-01 | 3.64e-01 |
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY | 12 | 1.26e-01 | 2.55e-01 | 4.54e-01 |
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE | 8 | 2.11e-01 | 2.55e-01 | 5.60e-01 |
GOMF STEROL TRANSPORTER ACTIVITY | 19 | 5.43e-02 | -2.55e-01 | 3.03e-01 |
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY | 9 | 1.85e-01 | -2.55e-01 | 5.31e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 9 | 1.86e-01 | 2.55e-01 | 5.31e-01 |
GOBP G1 TO G0 TRANSITION | 9 | 1.86e-01 | 2.55e-01 | 5.32e-01 |
GOCC ACROSOMAL MEMBRANE | 6 | 2.80e-01 | 2.55e-01 | 6.22e-01 |
GOBP REGULATION OF NADP METABOLIC PROCESS | 7 | 2.44e-01 | 2.54e-01 | 5.92e-01 |
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH | 22 | 3.90e-02 | -2.54e-01 | 2.65e-01 |
GOMF DESUMOYLASE ACTIVITY | 6 | 2.81e-01 | -2.54e-01 | 6.22e-01 |
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 18 | 6.18e-02 | -2.54e-01 | 3.26e-01 |
GOMF PROTEIN KINASE C ACTIVITY | 12 | 1.27e-01 | -2.54e-01 | 4.56e-01 |
GOBP CARBOHYDRATE TRANSMEMBRANE TRANSPORT | 47 | 2.60e-03 | -2.54e-01 | 6.31e-02 |
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 7 | 2.44e-01 | 2.54e-01 | 5.92e-01 |
GOBP NUCLEAR PORE COMPLEX ASSEMBLY | 11 | 1.45e-01 | 2.54e-01 | 4.77e-01 |
GOMF NUCLEOSIDE BINDING | 5 | 3.25e-01 | 2.54e-01 | 6.63e-01 |
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 32 | 1.30e-02 | -2.54e-01 | 1.50e-01 |
GOBP REGULATION OF TRANSLATIONAL FIDELITY | 10 | 1.65e-01 | 2.54e-01 | 5.03e-01 |
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 8 | 2.14e-01 | -2.54e-01 | 5.66e-01 |
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS | 14 | 1.00e-01 | -2.54e-01 | 4.10e-01 |
GOMF PRE MIRNA BINDING | 6 | 2.83e-01 | 2.53e-01 | 6.24e-01 |
GOBP LEUCINE METABOLIC PROCESS | 7 | 2.46e-01 | 2.53e-01 | 5.92e-01 |
GOBP TYPE B PANCREATIC CELL PROLIFERATION | 12 | 1.29e-01 | -2.53e-01 | 4.57e-01 |
GOBP INTRACELLULAR IRON ION HOMEOSTASIS | 41 | 5.08e-03 | 2.53e-01 | 9.14e-02 |
GOCC DENDRITE MEMBRANE | 5 | 3.27e-01 | 2.53e-01 | 6.63e-01 |
GOBP CELLULAR RESPONSE TO UV B | 7 | 2.46e-01 | -2.53e-01 | 5.92e-01 |
GOBP UTP METABOLIC PROCESS | 7 | 2.47e-01 | 2.53e-01 | 5.92e-01 |
GOBP VIRAL TRANSCRIPTION | 42 | 4.63e-03 | -2.53e-01 | 8.58e-02 |
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY | 12 | 1.30e-01 | 2.53e-01 | 4.57e-01 |
GOBP PROTEIN UFMYLATION | 6 | 2.84e-01 | 2.53e-01 | 6.26e-01 |
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 12 | 1.30e-01 | 2.52e-01 | 4.57e-01 |
GOCC FICOLIN 1 RICH GRANULE MEMBRANE | 33 | 1.22e-02 | -2.52e-01 | 1.44e-01 |
GOCC PRC1 COMPLEX | 11 | 1.48e-01 | -2.52e-01 | 4.80e-01 |
GOMF RDNA BINDING | 5 | 3.29e-01 | 2.52e-01 | 6.64e-01 |
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH | 43 | 4.27e-03 | -2.52e-01 | 8.16e-02 |
GOBP DNA CATABOLIC PROCESS | 17 | 7.21e-02 | 2.52e-01 | 3.54e-01 |
GOBP KERATINOCYTE PROLIFERATION | 22 | 4.08e-02 | -2.52e-01 | 2.71e-01 |
GOCC SIGNAL RECOGNITION PARTICLE | 6 | 2.85e-01 | 2.52e-01 | 6.27e-01 |
GOMF 7S RNA BINDING | 6 | 2.85e-01 | 2.52e-01 | 6.27e-01 |
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 27 | 2.36e-02 | -2.52e-01 | 2.11e-01 |
GOMF NADP BINDING | 24 | 3.28e-02 | 2.52e-01 | 2.46e-01 |
GOMF FLOPPASE ACTIVITY | 12 | 1.31e-01 | -2.52e-01 | 4.58e-01 |
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX | 20 | 5.15e-02 | 2.52e-01 | 2.97e-01 |
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX | 5 | 3.30e-01 | 2.52e-01 | 6.65e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 18 | 6.50e-02 | -2.51e-01 | 3.34e-01 |
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 17 | 7.30e-02 | -2.51e-01 | 3.57e-01 |
GOCC CLATHRIN SCULPTED VESICLE | 5 | 3.31e-01 | 2.51e-01 | 6.66e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 7 | 2.50e-01 | -2.51e-01 | 5.96e-01 |
GOCC DNA POLYMERASE COMPLEX | 17 | 7.32e-02 | 2.51e-01 | 3.57e-01 |
GOMF 5 3 EXONUCLEASE ACTIVITY | 14 | 1.04e-01 | 2.51e-01 | 4.15e-01 |
GOBP POSITIVE REGULATION OF MITOPHAGY | 5 | 3.31e-01 | 2.51e-01 | 6.66e-01 |
GOBP CELL ADHESION MOLECULE PRODUCTION | 5 | 3.32e-01 | -2.51e-01 | 6.67e-01 |
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION | 6 | 2.88e-01 | -2.51e-01 | 6.30e-01 |
GOBP ENDOTHELIAL CELL DEVELOPMENT | 33 | 1.28e-02 | -2.51e-01 | 1.48e-01 |
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME | 29 | 1.97e-02 | 2.51e-01 | 1.90e-01 |
GOBP MANNOSE METABOLIC PROCESS | 7 | 2.51e-01 | 2.50e-01 | 5.96e-01 |
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT | 9 | 1.94e-01 | -2.50e-01 | 5.40e-01 |
GOBP HEART VALVE MORPHOGENESIS | 19 | 5.92e-02 | -2.50e-01 | 3.18e-01 |
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY | 6 | 2.89e-01 | -2.50e-01 | 6.32e-01 |
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION | 10 | 1.71e-01 | 2.50e-01 | 5.13e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 19 | 5.96e-02 | -2.50e-01 | 3.20e-01 |
GOBP ENDOTHELIUM DEVELOPMENT | 57 | 1.13e-03 | -2.50e-01 | 3.79e-02 |
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 9 | 1.95e-01 | -2.50e-01 | 5.42e-01 |
GOBP GENITALIA DEVELOPMENT | 9 | 1.95e-01 | -2.49e-01 | 5.42e-01 |
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING | 22 | 4.31e-02 | 2.49e-01 | 2.77e-01 |
GOBP TRNA SURVEILLANCE | 7 | 2.54e-01 | 2.49e-01 | 5.97e-01 |
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 1.96e-01 | 2.49e-01 | 5.43e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 5 | 3.35e-01 | 2.49e-01 | 6.71e-01 |
GOBP POSITIVE REGULATION OF HISTONE ACETYLATION | 8 | 2.23e-01 | 2.49e-01 | 5.74e-01 |
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 10 | 1.73e-01 | 2.49e-01 | 5.15e-01 |
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL | 21 | 4.83e-02 | 2.49e-01 | 2.87e-01 |
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY | 18 | 6.77e-02 | -2.49e-01 | 3.43e-01 |
GOBP REGULATION OF MITOCHONDRIAL FUSION | 8 | 2.23e-01 | 2.49e-01 | 5.74e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 29 | 2.06e-02 | -2.49e-01 | 1.96e-01 |
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS | 15 | 9.56e-02 | -2.49e-01 | 4.01e-01 |
GOBP ENERGY HOMEOSTASIS | 29 | 2.06e-02 | -2.49e-01 | 1.96e-01 |
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 13 | 1.21e-01 | -2.48e-01 | 4.46e-01 |
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY | 6 | 2.92e-01 | -2.48e-01 | 6.34e-01 |
GOBP LIPID DROPLET FORMATION | 8 | 2.24e-01 | 2.48e-01 | 5.75e-01 |
GOBP GOLGI TO ENDOSOME TRANSPORT | 14 | 1.08e-01 | -2.48e-01 | 4.24e-01 |
GOBP AMELOGENESIS | 6 | 2.93e-01 | -2.48e-01 | 6.35e-01 |
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 7 | 2.56e-01 | -2.48e-01 | 6.00e-01 |
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR | 23 | 3.99e-02 | 2.48e-01 | 2.68e-01 |
GOCC LUMENAL SIDE OF MEMBRANE | 30 | 1.90e-02 | 2.48e-01 | 1.86e-01 |
GOBP REGULATION OF BILE ACID METABOLIC PROCESS | 5 | 3.38e-01 | -2.47e-01 | 6.74e-01 |
GOBP NUCLEAR BODY ORGANIZATION | 10 | 1.76e-01 | -2.47e-01 | 5.20e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 2.57e-01 | -2.47e-01 | 6.00e-01 |
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME | 7 | 2.57e-01 | -2.47e-01 | 6.00e-01 |
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION | 23 | 4.03e-02 | 2.47e-01 | 2.69e-01 |
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 7 | 2.58e-01 | -2.47e-01 | 6.00e-01 |
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 14 | 1.10e-01 | 2.47e-01 | 4.25e-01 |
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA | 7 | 2.58e-01 | 2.47e-01 | 6.00e-01 |
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY | 21 | 5.02e-02 | -2.47e-01 | 2.93e-01 |
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 27 | 2.65e-02 | 2.47e-01 | 2.25e-01 |
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 16 | 8.76e-02 | -2.47e-01 | 3.86e-01 |
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 24 | 3.67e-02 | -2.47e-01 | 2.58e-01 |
GOBP HISTONE UBIQUITINATION | 8 | 2.27e-01 | -2.47e-01 | 5.76e-01 |
GOMF POLY A RNA POLYMERASE ACTIVITY | 8 | 2.27e-01 | -2.47e-01 | 5.76e-01 |
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 8 | 2.27e-01 | -2.46e-01 | 5.76e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 12 | 1.40e-01 | -2.46e-01 | 4.69e-01 |
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 7 | 2.59e-01 | -2.46e-01 | 6.02e-01 |
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 8 | 2.28e-01 | -2.46e-01 | 5.76e-01 |
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX | 9 | 2.01e-01 | -2.46e-01 | 5.49e-01 |
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS | 6 | 2.97e-01 | 2.46e-01 | 6.38e-01 |
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS | 5 | 3.41e-01 | 2.46e-01 | 6.76e-01 |
GOBP NEGATIVE REGULATION OF CELL GROWTH | 83 | 1.15e-04 | -2.45e-01 | 7.02e-03 |
GOBP MAMMARY GLAND DUCT MORPHOGENESIS | 9 | 2.03e-01 | -2.45e-01 | 5.51e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 29 | 2.25e-02 | -2.45e-01 | 2.07e-01 |
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 13 | 1.26e-01 | 2.45e-01 | 4.55e-01 |
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION | 15 | 1.01e-01 | -2.45e-01 | 4.10e-01 |
GOBP DIGESTION | 29 | 2.28e-02 | -2.45e-01 | 2.08e-01 |
GOBP AMP METABOLIC PROCESS | 13 | 1.27e-01 | 2.45e-01 | 4.55e-01 |
GOBP MYELIN MAINTENANCE | 10 | 1.81e-01 | -2.44e-01 | 5.28e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS | 32 | 1.69e-02 | 2.44e-01 | 1.75e-01 |
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY | 9 | 2.05e-01 | -2.44e-01 | 5.52e-01 |
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY | 8 | 2.32e-01 | 2.44e-01 | 5.78e-01 |
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE | 8 | 2.32e-01 | 2.44e-01 | 5.78e-01 |
GOBP CHONDROCYTE DIFFERENTIATION | 45 | 4.67e-03 | -2.44e-01 | 8.60e-02 |
GOBP PROTEIN POLYUFMYLATION | 5 | 3.45e-01 | 2.44e-01 | 6.79e-01 |
GOBP AMP BIOSYNTHETIC PROCESS | 10 | 1.82e-01 | 2.44e-01 | 5.28e-01 |
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 6 | 3.01e-01 | -2.44e-01 | 6.42e-01 |
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 33 | 1.56e-02 | -2.44e-01 | 1.67e-01 |
GOBP REGULATION OF PROTEIN KINASE A SIGNALING | 7 | 2.65e-01 | -2.44e-01 | 6.09e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION | 14 | 1.15e-01 | 2.43e-01 | 4.37e-01 |
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS | 9 | 2.07e-01 | 2.43e-01 | 5.54e-01 |
GOBP RESPONSE TO MISFOLDED PROTEIN | 23 | 4.39e-02 | 2.43e-01 | 2.80e-01 |
GOBP REGULATION OF ACTION POTENTIAL | 18 | 7.50e-02 | 2.43e-01 | 3.61e-01 |
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX | 18 | 7.50e-02 | 2.43e-01 | 3.61e-01 |
GOBP BASE EXCISION REPAIR AP SITE FORMATION | 8 | 2.35e-01 | -2.43e-01 | 5.82e-01 |
GOCC NPBAF COMPLEX | 13 | 1.30e-01 | 2.42e-01 | 4.57e-01 |
GOBP REGULATION OF SREBP SIGNALING PATHWAY | 5 | 3.48e-01 | -2.42e-01 | 6.80e-01 |
GOCC U2 SNRNP | 25 | 3.61e-02 | 2.42e-01 | 2.56e-01 |
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 7 | 2.67e-01 | -2.42e-01 | 6.11e-01 |
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION | 10 | 1.85e-01 | -2.42e-01 | 5.31e-01 |
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS | 43 | 6.10e-03 | 2.42e-01 | 9.93e-02 |
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 37 | 1.10e-02 | -2.42e-01 | 1.37e-01 |
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 6 | 3.06e-01 | 2.42e-01 | 6.47e-01 |
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY | 27 | 3.00e-02 | -2.41e-01 | 2.36e-01 |
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION | 18 | 7.68e-02 | -2.41e-01 | 3.63e-01 |
GOBP REGULATION OF GLYCOLYTIC PROCESS | 32 | 1.85e-02 | -2.41e-01 | 1.84e-01 |
GOBP MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY | 20 | 6.24e-02 | 2.41e-01 | 3.26e-01 |
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE | 5 | 3.51e-01 | 2.41e-01 | 6.82e-01 |
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION | 6 | 3.07e-01 | 2.41e-01 | 6.47e-01 |
GOBP AMINO ACID METABOLIC PROCESS | 130 | 2.33e-06 | 2.41e-01 | 2.63e-04 |
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION | 5 | 3.51e-01 | -2.41e-01 | 6.83e-01 |
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 12 | 1.49e-01 | -2.41e-01 | 4.82e-01 |
GOBP RNA GUANINE N7 METHYLATION | 5 | 3.51e-01 | 2.41e-01 | 6.83e-01 |
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 51 | 3.02e-03 | -2.40e-01 | 6.87e-02 |
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS | 7 | 2.71e-01 | -2.40e-01 | 6.16e-01 |
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 22 | 5.12e-02 | -2.40e-01 | 2.96e-01 |
GOBP PHOTOPERIODISM | 18 | 7.80e-02 | -2.40e-01 | 3.66e-01 |
GOCC ISWI TYPE COMPLEX | 12 | 1.50e-01 | 2.40e-01 | 4.83e-01 |
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS | 21 | 5.74e-02 | -2.40e-01 | 3.13e-01 |
GOBP COMPLEMENT ACTIVATION | 17 | 8.75e-02 | -2.40e-01 | 3.86e-01 |
GOBP MUSCLE CELL MIGRATION | 36 | 1.30e-02 | -2.40e-01 | 1.50e-01 |
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 15 | 1.09e-01 | -2.39e-01 | 4.24e-01 |
GOBP LYMPHOCYTE APOPTOTIC PROCESS | 48 | 4.17e-03 | -2.39e-01 | 8.06e-02 |
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY | 15 | 1.09e-01 | -2.39e-01 | 4.24e-01 |
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 1.51e-01 | 2.39e-01 | 4.86e-01 |
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 21 | 5.80e-02 | 2.39e-01 | 3.15e-01 |
GOBP DNA REPLICATION | 198 | 8.04e-09 | 2.39e-01 | 1.39e-06 |
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS | 231 | 5.23e-10 | 2.39e-01 | 1.26e-07 |
GOBP REGULATION OF BONE MINERALIZATION | 26 | 3.52e-02 | -2.39e-01 | 2.54e-01 |
GOCC WNT SIGNALOSOME | 6 | 3.12e-01 | -2.39e-01 | 6.49e-01 |
GOBP INTRACELLULAR TRANSPORT OF VIRUS | 8 | 2.43e-01 | -2.39e-01 | 5.91e-01 |
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 10 | 1.92e-01 | 2.39e-01 | 5.38e-01 |
GOBP CELLULAR EXTRAVASATION | 33 | 1.79e-02 | -2.38e-01 | 1.81e-01 |
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS | 9 | 2.16e-01 | 2.38e-01 | 5.68e-01 |
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 8 | 2.44e-01 | 2.38e-01 | 5.92e-01 |
GOBP REGULATION OF CAMP MEDIATED SIGNALING | 7 | 2.76e-01 | -2.38e-01 | 6.19e-01 |
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION | 6 | 3.13e-01 | 2.38e-01 | 6.51e-01 |
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS | 7 | 2.76e-01 | 2.38e-01 | 6.19e-01 |
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX | 13 | 1.38e-01 | 2.38e-01 | 4.67e-01 |
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS | 5 | 3.57e-01 | -2.38e-01 | 6.87e-01 |
GOBP PANCREAS DEVELOPMENT | 26 | 3.61e-02 | -2.38e-01 | 2.56e-01 |
GOBP MATURATION OF SSU RRNA | 43 | 7.13e-03 | 2.37e-01 | 1.09e-01 |
GOCC PROTEIN PHOSPHATASE 4 COMPLEX | 5 | 3.58e-01 | -2.37e-01 | 6.87e-01 |
GOBP MICROGLIA DIFFERENTIATION | 8 | 2.45e-01 | -2.37e-01 | 5.92e-01 |
GOMF BETA CATENIN BINDING | 44 | 6.56e-03 | -2.37e-01 | 1.04e-01 |
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT | 5 | 3.59e-01 | 2.37e-01 | 6.87e-01 |
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 60 | 1.52e-03 | -2.37e-01 | 4.50e-02 |
GOBP ALPHA AMINO ACID METABOLIC PROCESS | 92 | 8.84e-05 | 2.37e-01 | 5.66e-03 |
GOBP CARDIAC CELL DEVELOPMENT | 29 | 2.73e-02 | -2.37e-01 | 2.28e-01 |
GOCC CKM COMPLEX | 5 | 3.59e-01 | 2.37e-01 | 6.88e-01 |
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS | 17 | 9.11e-02 | -2.37e-01 | 3.92e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 25 | 4.06e-02 | -2.37e-01 | 2.70e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 10 | 1.95e-01 | -2.37e-01 | 5.42e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 12 | 1.56e-01 | 2.36e-01 | 4.92e-01 |
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION | 9 | 2.20e-01 | 2.36e-01 | 5.72e-01 |
GOBP AMINOPHOSPHOLIPID TRANSLOCATION | 5 | 3.60e-01 | 2.36e-01 | 6.88e-01 |
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY | 5 | 3.60e-01 | 2.36e-01 | 6.88e-01 |
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS | 6 | 3.16e-01 | 2.36e-01 | 6.55e-01 |
GOBP REGULATION OF ENDOSOME SIZE | 11 | 1.75e-01 | -2.36e-01 | 5.19e-01 |
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION | 9 | 2.20e-01 | 2.36e-01 | 5.72e-01 |
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS | 9 | 2.20e-01 | -2.36e-01 | 5.72e-01 |
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT | 8 | 2.48e-01 | -2.36e-01 | 5.93e-01 |
GOBP SEMI LUNAR VALVE DEVELOPMENT | 13 | 1.41e-01 | -2.36e-01 | 4.71e-01 |
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES | 6 | 3.17e-01 | 2.36e-01 | 6.55e-01 |
GOBP HYALURONAN BIOSYNTHETIC PROCESS | 6 | 3.17e-01 | 2.36e-01 | 6.55e-01 |
GOMF O METHYLTRANSFERASE ACTIVITY | 15 | 1.14e-01 | -2.36e-01 | 4.34e-01 |
GOBP PSEUDOPODIUM ORGANIZATION | 7 | 2.80e-01 | -2.36e-01 | 6.22e-01 |
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM | 9 | 2.21e-01 | 2.36e-01 | 5.73e-01 |
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER | 16 | 1.03e-01 | 2.36e-01 | 4.13e-01 |
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS | 41 | 9.13e-03 | -2.36e-01 | 1.23e-01 |
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY | 5 | 3.62e-01 | -2.36e-01 | 6.89e-01 |
GOBP SMOOTH MUSCLE CELL MIGRATION | 28 | 3.11e-02 | -2.36e-01 | 2.40e-01 |
GOMF PROLINE RICH REGION BINDING | 9 | 2.22e-01 | 2.35e-01 | 5.74e-01 |
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON | 8 | 2.50e-01 | 2.35e-01 | 5.96e-01 |
GOCC GLYCOPROTEIN COMPLEX | 7 | 2.82e-01 | 2.35e-01 | 6.24e-01 |
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION | 13 | 1.43e-01 | -2.35e-01 | 4.74e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS | 19 | 7.65e-02 | -2.35e-01 | 3.63e-01 |
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT | 9 | 2.23e-01 | 2.35e-01 | 5.74e-01 |
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT | 13 | 1.43e-01 | 2.35e-01 | 4.74e-01 |
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING | 5 | 3.64e-01 | -2.35e-01 | 6.91e-01 |
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY | 7 | 2.83e-01 | 2.35e-01 | 6.24e-01 |
GOMF G QUADRUPLEX RNA BINDING | 6 | 3.20e-01 | -2.35e-01 | 6.58e-01 |
GOBP PROTEIN K6 LINKED UBIQUITINATION | 8 | 2.51e-01 | 2.34e-01 | 5.96e-01 |
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 46 | 6.14e-03 | -2.34e-01 | 9.93e-02 |
GOBP VIRAL RELEASE FROM HOST CELL | 23 | 5.24e-02 | 2.34e-01 | 2.99e-01 |
GOBP ANIMAL ORGAN FORMATION | 15 | 1.17e-01 | -2.34e-01 | 4.39e-01 |
GOMF MISMATCH REPAIR COMPLEX BINDING | 9 | 2.25e-01 | 2.34e-01 | 5.75e-01 |
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 8 | 2.53e-01 | -2.34e-01 | 5.96e-01 |
GOMF ANTIOXIDANT ACTIVITY | 40 | 1.07e-02 | 2.33e-01 | 1.37e-01 |
GOMF 3 5 DNA EXONUCLEASE ACTIVITY | 8 | 2.53e-01 | 2.33e-01 | 5.97e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 30 | 2.71e-02 | 2.33e-01 | 2.27e-01 |
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS | 45 | 6.84e-03 | 2.33e-01 | 1.06e-01 |
GOBP EPITHELIAL CELL CELL ADHESION | 5 | 3.67e-01 | -2.33e-01 | 6.94e-01 |
GOCC AP 3 ADAPTOR COMPLEX | 7 | 2.86e-01 | 2.33e-01 | 6.28e-01 |
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION | 12 | 1.62e-01 | 2.33e-01 | 5.01e-01 |
GOBP REGULATION OF AMINE METABOLIC PROCESS | 15 | 1.18e-01 | -2.33e-01 | 4.40e-01 |
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 34 | 1.88e-02 | -2.33e-01 | 1.85e-01 |
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 38 | 1.31e-02 | -2.33e-01 | 1.50e-01 |
GOBP RNA SURVEILLANCE | 14 | 1.32e-01 | 2.33e-01 | 4.59e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 12 | 1.63e-01 | -2.33e-01 | 5.01e-01 |
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION | 8 | 2.54e-01 | -2.33e-01 | 5.97e-01 |
GOBP P38MAPK CASCADE | 34 | 1.90e-02 | -2.33e-01 | 1.86e-01 |
GOMF CERAMIDE BINDING | 11 | 1.82e-01 | -2.33e-01 | 5.28e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 25 | 4.42e-02 | 2.33e-01 | 2.82e-01 |
GOCC PLATELET ALPHA GRANULE LUMEN | 22 | 5.93e-02 | 2.32e-01 | 3.18e-01 |
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 17 | 9.75e-02 | 2.32e-01 | 4.04e-01 |
GOBP REGULATION OF DENDRITE EXTENSION | 12 | 1.64e-01 | -2.32e-01 | 5.02e-01 |
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS | 10 | 2.04e-01 | 2.32e-01 | 5.51e-01 |
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 473 | 1.55e-17 | -2.32e-01 | 1.61e-14 |
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT | 26 | 4.08e-02 | 2.32e-01 | 2.71e-01 |
GOBP REGULATION OF T CELL APOPTOTIC PROCESS | 20 | 7.27e-02 | -2.32e-01 | 3.56e-01 |
GOCC CONDENSED NUCLEAR CHROMOSOME | 35 | 1.78e-02 | 2.32e-01 | 1.81e-01 |
GOMF BH DOMAIN BINDING | 6 | 3.26e-01 | -2.31e-01 | 6.63e-01 |
GOBP SELF PROTEOLYSIS | 6 | 3.26e-01 | -2.31e-01 | 6.63e-01 |
GOBP REGULATION OF MYOTUBE DIFFERENTIATION | 16 | 1.09e-01 | -2.31e-01 | 4.25e-01 |
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY | 6 | 3.27e-01 | -2.31e-01 | 6.63e-01 |
GOCC ESCRT I COMPLEX | 7 | 2.90e-01 | -2.31e-01 | 6.32e-01 |
GOBP GLUTAMATE METABOLIC PROCESS | 14 | 1.35e-01 | 2.31e-01 | 4.63e-01 |
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION | 8 | 2.58e-01 | 2.31e-01 | 6.00e-01 |
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 518 | 8.42e-19 | -2.31e-01 | 1.52e-15 |
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION | 14 | 1.35e-01 | -2.31e-01 | 4.64e-01 |
GOBP BINDING OF SPERM TO ZONA PELLUCIDA | 11 | 1.86e-01 | 2.31e-01 | 5.31e-01 |
GOBP SPERM EGG RECOGNITION | 11 | 1.86e-01 | 2.31e-01 | 5.31e-01 |
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS | 8 | 2.59e-01 | -2.30e-01 | 6.02e-01 |
GOBP RESPONSE TO ATP | 11 | 1.86e-01 | 2.30e-01 | 5.32e-01 |
GOMF MONOCARBOXYLIC ACID BINDING | 27 | 3.85e-02 | 2.30e-01 | 2.64e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS | 9 | 2.32e-01 | -2.30e-01 | 5.78e-01 |
GOBP REGULATION OF LYSOSOME ORGANIZATION | 8 | 2.60e-01 | -2.30e-01 | 6.03e-01 |
GOBP POSITIVE REGULATION OF SUPEROXIDE ANION GENERATION | 9 | 2.32e-01 | -2.30e-01 | 5.78e-01 |
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION | 61 | 1.92e-03 | -2.30e-01 | 5.28e-02 |
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY | 55 | 3.23e-03 | -2.30e-01 | 7.08e-02 |
GOMF DYNEIN INTERMEDIATE CHAIN BINDING | 15 | 1.23e-01 | -2.30e-01 | 4.50e-01 |
GOBP ETHER METABOLIC PROCESS | 11 | 1.87e-01 | -2.30e-01 | 5.34e-01 |
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 3.74e-01 | -2.30e-01 | 7.00e-01 |
GOMF 3 5 RNA HELICASE ACTIVITY | 5 | 3.74e-01 | 2.30e-01 | 7.00e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS | 5 | 3.74e-01 | -2.30e-01 | 7.00e-01 |
GOBP NATURAL KILLER CELL CHEMOTAXIS | 5 | 3.74e-01 | -2.29e-01 | 7.00e-01 |
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 22 | 6.27e-02 | -2.29e-01 | 3.28e-01 |
GOBP REGULATION OF CD40 SIGNALING PATHWAY | 5 | 3.75e-01 | 2.29e-01 | 7.00e-01 |
GOBP REGULATION OF OSSIFICATION | 42 | 1.02e-02 | -2.29e-01 | 1.33e-01 |
GOBP TRANSPORT OF VIRUS | 12 | 1.69e-01 | -2.29e-01 | 5.11e-01 |
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY | 7 | 2.94e-01 | -2.29e-01 | 6.36e-01 |
GOBP REGULATION OF FAT CELL DIFFERENTIATION | 49 | 5.58e-03 | -2.29e-01 | 9.62e-02 |
GOBP REGULATION OF HAIR CYCLE | 8 | 2.62e-01 | -2.29e-01 | 6.05e-01 |
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 13 | 1.53e-01 | -2.29e-01 | 4.88e-01 |
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION | 8 | 2.62e-01 | -2.29e-01 | 6.05e-01 |
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 23 | 5.74e-02 | -2.29e-01 | 3.13e-01 |
GOCC SECONDARY LYSOSOME | 15 | 1.25e-01 | -2.29e-01 | 4.52e-01 |
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY | 10 | 2.10e-01 | 2.29e-01 | 5.58e-01 |
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 5 | 3.75e-01 | 2.29e-01 | 7.01e-01 |
GOMF DEATH RECEPTOR BINDING | 10 | 2.10e-01 | 2.29e-01 | 5.58e-01 |
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION | 71 | 8.86e-04 | -2.29e-01 | 3.24e-02 |
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY | 15 | 1.25e-01 | -2.29e-01 | 4.53e-01 |
GOBP REGULATION OF P38MAPK CASCADE | 25 | 4.82e-02 | -2.28e-01 | 2.87e-01 |
GOBP IRON SULFUR CLUSTER ASSEMBLY | 23 | 5.81e-02 | 2.28e-01 | 3.15e-01 |
GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 5 | 3.77e-01 | 2.28e-01 | 7.03e-01 |
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY | 17 | 1.03e-01 | 2.28e-01 | 4.15e-01 |
GOBP RESPONSE TO STEROL DEPLETION | 12 | 1.71e-01 | -2.28e-01 | 5.13e-01 |
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY | 15 | 1.26e-01 | 2.28e-01 | 4.55e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS | 28 | 3.68e-02 | -2.28e-01 | 2.59e-01 |
GOBP SPINAL CORD DEVELOPMENT | 31 | 2.81e-02 | 2.28e-01 | 2.30e-01 |
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY | 5 | 3.78e-01 | -2.28e-01 | 7.03e-01 |
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY | 33 | 2.36e-02 | -2.28e-01 | 2.11e-01 |
GOMF PROTEIN FOLDING CHAPERONE | 42 | 1.07e-02 | 2.28e-01 | 1.37e-01 |
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS | 38 | 1.53e-02 | -2.28e-01 | 1.66e-01 |
GOBP ADP TRANSPORT | 8 | 2.65e-01 | 2.27e-01 | 6.09e-01 |
GOMF RNA POLYMERASE ACTIVITY | 24 | 5.39e-02 | 2.27e-01 | 3.02e-01 |
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 18 | 9.52e-02 | 2.27e-01 | 4.01e-01 |
GOBP POSITIVE REGULATION OF GLYCOLYTIC PROCESS | 13 | 1.56e-01 | -2.27e-01 | 4.92e-01 |
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 11 | 1.92e-01 | 2.27e-01 | 5.38e-01 |
GOBP VASCULOGENESIS | 29 | 3.44e-02 | -2.27e-01 | 2.51e-01 |
GOBP ADHERENS JUNCTION ORGANIZATION | 20 | 7.89e-02 | -2.27e-01 | 3.67e-01 |
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE | 5 | 3.79e-01 | 2.27e-01 | 7.04e-01 |
GOMF UBIQUITIN CONJUGATING ENZYME BINDING | 22 | 6.55e-02 | -2.27e-01 | 3.36e-01 |
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS | 16 | 1.16e-01 | -2.27e-01 | 4.37e-01 |
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT | 26 | 4.55e-02 | 2.27e-01 | 2.83e-01 |
GOBP MARGINAL ZONE B CELL DIFFERENTIATION | 5 | 3.80e-01 | 2.27e-01 | 7.05e-01 |
GOBP SNO S RNA PROCESSING | 11 | 1.93e-01 | 2.27e-01 | 5.40e-01 |
GOBP VENTRICULAR SEPTUM MORPHOGENESIS | 13 | 1.57e-01 | -2.27e-01 | 4.93e-01 |
GOMF CHROMO SHADOW DOMAIN BINDING | 6 | 3.37e-01 | 2.26e-01 | 6.73e-01 |
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 32 | 2.69e-02 | -2.26e-01 | 2.26e-01 |
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY | 12 | 1.75e-01 | -2.26e-01 | 5.19e-01 |
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 1.43e-01 | 2.26e-01 | 4.74e-01 |
GOBP GASTRULATION WITH MOUTH FORMING SECOND | 10 | 2.16e-01 | -2.26e-01 | 5.68e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMOSOME | 73 | 8.59e-04 | 2.26e-01 | 3.17e-02 |
GOBP DOPAMINE BIOSYNTHETIC PROCESS | 6 | 3.38e-01 | -2.26e-01 | 6.74e-01 |
GOBP ERBB2 SIGNALING PATHWAY | 5 | 3.82e-01 | 2.26e-01 | 7.05e-01 |
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION | 57 | 3.24e-03 | -2.26e-01 | 7.08e-02 |
GOBP SYNAPSE ASSEMBLY | 49 | 6.32e-03 | -2.26e-01 | 1.01e-01 |
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 12 | 1.76e-01 | 2.26e-01 | 5.20e-01 |
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION | 9 | 2.41e-01 | 2.26e-01 | 5.89e-01 |
GOBP REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 6 | 3.39e-01 | -2.26e-01 | 6.75e-01 |
GOBP NEGATIVE REGULATION OF GROWTH | 102 | 8.69e-05 | -2.26e-01 | 5.62e-03 |
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE | 5 | 3.83e-01 | 2.25e-01 | 7.06e-01 |
GOBP CELLULAR RESPONSE TO X RAY | 7 | 3.02e-01 | -2.25e-01 | 6.43e-01 |
GOBP RESPIRATORY SYSTEM DEVELOPMENT | 67 | 1.47e-03 | -2.25e-01 | 4.45e-02 |
GOMF PHOSPHATASE ACTIVATOR ACTIVITY | 15 | 1.32e-01 | -2.25e-01 | 4.59e-01 |
GOBP NEGATIVE REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 17 | 1.09e-01 | 2.25e-01 | 4.24e-01 |
GOCC PHAGOLYSOSOME | 5 | 3.84e-01 | -2.25e-01 | 7.06e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS | 5 | 3.84e-01 | 2.25e-01 | 7.06e-01 |
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 3.03e-01 | -2.25e-01 | 6.44e-01 |
GOBP TRNA TRANSCRIPTION | 11 | 1.97e-01 | 2.25e-01 | 5.45e-01 |
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION | 6 | 3.41e-01 | 2.25e-01 | 6.76e-01 |
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT | 7 | 3.04e-01 | -2.25e-01 | 6.44e-01 |
GOBP REGULATION OF MUSCLE HYPERTROPHY | 33 | 2.58e-02 | -2.24e-01 | 2.22e-01 |
GOCC TRANSPORTER COMPLEX | 143 | 3.95e-06 | 2.24e-01 | 4.08e-04 |
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION | 14 | 1.46e-01 | 2.24e-01 | 4.78e-01 |
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE | 54 | 4.44e-03 | -2.24e-01 | 8.38e-02 |
GOBP CELLULAR RESPONSE TO VITAMIN | 9 | 2.45e-01 | 2.24e-01 | 5.92e-01 |
GOMF MAP KINASE SCAFFOLD ACTIVITY | 8 | 2.73e-01 | -2.24e-01 | 6.17e-01 |
GOBP MISMATCH REPAIR | 22 | 6.94e-02 | 2.24e-01 | 3.47e-01 |
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 5 | 3.87e-01 | -2.24e-01 | 7.07e-01 |
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY | 17 | 1.11e-01 | 2.24e-01 | 4.27e-01 |
GOBP ENDOTHELIAL CELL ACTIVATION | 7 | 3.06e-01 | -2.24e-01 | 6.47e-01 |
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 13 | 1.63e-01 | -2.24e-01 | 5.01e-01 |
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.06e-01 | 2.23e-01 | 6.47e-01 |
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS | 9 | 2.46e-01 | 2.23e-01 | 5.92e-01 |
GOBP MEMBRANE INVAGINATION | 41 | 1.35e-02 | -2.23e-01 | 1.53e-01 |
GOBP SMOOTHENED SIGNALING PATHWAY | 59 | 3.09e-03 | -2.23e-01 | 6.94e-02 |
GOBP MATURATION OF 5 8S RRNA | 29 | 3.78e-02 | 2.23e-01 | 2.63e-01 |
GOBP CELLULAR RESPONSE TO ANTIBIOTIC | 9 | 2.47e-01 | -2.23e-01 | 5.92e-01 |
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 5 | 3.88e-01 | -2.23e-01 | 7.08e-01 |
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 5 | 3.88e-01 | -2.23e-01 | 7.09e-01 |
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX | 38 | 1.76e-02 | 2.23e-01 | 1.79e-01 |
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 42 | 1.26e-02 | 2.23e-01 | 1.47e-01 |
GOBP HEPATOCYTE APOPTOTIC PROCESS | 16 | 1.23e-01 | -2.23e-01 | 4.50e-01 |
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY | 23 | 6.48e-02 | -2.23e-01 | 3.34e-01 |
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING | 6 | 3.45e-01 | 2.23e-01 | 6.79e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS | 22 | 7.10e-02 | 2.23e-01 | 3.51e-01 |
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE | 8 | 2.76e-01 | -2.22e-01 | 6.20e-01 |
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS | 6 | 3.46e-01 | 2.22e-01 | 6.79e-01 |
GOMF T CELL RECEPTOR BINDING | 7 | 3.08e-01 | 2.22e-01 | 6.48e-01 |
GOBP REGULATION OF DNA REPLICATION | 88 | 3.24e-04 | 2.22e-01 | 1.58e-02 |
GOBP CARBOHYDRATE TRANSPORT | 58 | 3.49e-03 | -2.22e-01 | 7.32e-02 |
GOBP PROSTATE GLAND MORPHOGENESIS | 6 | 3.46e-01 | -2.22e-01 | 6.79e-01 |
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL | 5 | 3.90e-01 | -2.22e-01 | 7.11e-01 |
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY | 10 | 2.25e-01 | -2.22e-01 | 5.75e-01 |
GOCC MEIOTIC COHESIN COMPLEX | 5 | 3.91e-01 | 2.22e-01 | 7.11e-01 |
GOBP DENDRITIC SPINE MAINTENANCE | 13 | 1.67e-01 | 2.21e-01 | 5.07e-01 |
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY | 12 | 1.84e-01 | 2.21e-01 | 5.30e-01 |
GOBP MITOCHONDRION LOCALIZATION | 27 | 4.67e-02 | -2.21e-01 | 2.83e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT | 11 | 2.04e-01 | -2.21e-01 | 5.51e-01 |
GOBP ENDOCARDIAL CUSHION FORMATION | 7 | 3.11e-01 | -2.21e-01 | 6.49e-01 |
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY | 33 | 2.81e-02 | -2.21e-01 | 2.30e-01 |
GOBP TRANSLESION SYNTHESIS | 19 | 9.54e-02 | 2.21e-01 | 4.01e-01 |
GOBP MUSCLE TISSUE DEVELOPMENT | 148 | 3.79e-06 | -2.21e-01 | 4.03e-04 |
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS | 6 | 3.49e-01 | -2.21e-01 | 6.81e-01 |
GOBP COPPER ION HOMEOSTASIS | 11 | 2.05e-01 | 2.21e-01 | 5.52e-01 |
GOBP HISTONE H4 K16 ACETYLATION | 7 | 3.12e-01 | -2.21e-01 | 6.49e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 23 | 6.70e-02 | -2.21e-01 | 3.41e-01 |
GOMF MICROTUBULE MOTOR ACTIVITY | 26 | 5.16e-02 | -2.21e-01 | 2.98e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS | 57 | 4.03e-03 | 2.21e-01 | 7.95e-02 |
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS | 8 | 2.80e-01 | 2.20e-01 | 6.22e-01 |
GOBP POSITIVE T CELL SELECTION | 19 | 9.65e-02 | -2.20e-01 | 4.03e-01 |
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS | 5 | 3.94e-01 | 2.20e-01 | 7.13e-01 |
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 61 | 2.98e-03 | -2.20e-01 | 6.85e-02 |
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS | 17 | 1.16e-01 | 2.20e-01 | 4.37e-01 |
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING | 6 | 3.51e-01 | -2.20e-01 | 6.82e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING | 24 | 6.23e-02 | 2.20e-01 | 3.26e-01 |
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE | 7 | 3.14e-01 | 2.20e-01 | 6.52e-01 |
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR | 10 | 2.29e-01 | -2.20e-01 | 5.78e-01 |
GOBP PROTEIN HETEROTETRAMERIZATION | 11 | 2.07e-01 | 2.20e-01 | 5.54e-01 |
GOBP DIGESTIVE SYSTEM PROCESS | 28 | 4.45e-02 | -2.20e-01 | 2.82e-01 |
GOBP HYPEROSMOTIC RESPONSE | 16 | 1.29e-01 | -2.20e-01 | 4.56e-01 |
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 24 | 6.31e-02 | 2.19e-01 | 3.29e-01 |
GOBP SYNAPTIC VESICLE PRIMING | 7 | 3.15e-01 | -2.19e-01 | 6.54e-01 |
GOBP REGULATION OF CHOLESTEROL EFFLUX | 13 | 1.71e-01 | -2.19e-01 | 5.13e-01 |
GOCC CILIARY ROOTLET | 7 | 3.15e-01 | -2.19e-01 | 6.54e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMATIN | 28 | 4.49e-02 | 2.19e-01 | 2.82e-01 |
GOCC CILIARY BASE | 20 | 9.00e-02 | -2.19e-01 | 3.90e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE | 7 | 3.16e-01 | 2.19e-01 | 6.54e-01 |
GOMF CORECEPTOR ACTIVITY | 17 | 1.18e-01 | -2.19e-01 | 4.39e-01 |
GOBP NEUTRAL LIPID CATABOLIC PROCESS | 11 | 2.09e-01 | -2.19e-01 | 5.57e-01 |
GOBP REGULATION OF B CELL APOPTOTIC PROCESS | 15 | 1.43e-01 | -2.19e-01 | 4.74e-01 |
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 13 | 1.73e-01 | 2.18e-01 | 5.16e-01 |
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS | 49 | 8.32e-03 | -2.18e-01 | 1.19e-01 |
GOCC T TUBULE | 13 | 1.73e-01 | -2.18e-01 | 5.16e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS | 28 | 4.59e-02 | 2.18e-01 | 2.83e-01 |
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION | 11 | 2.11e-01 | -2.18e-01 | 5.59e-01 |
GOBP GLUTATHIONE TRANSPORT | 5 | 3.99e-01 | 2.18e-01 | 7.17e-01 |
GOBP REGULATION OF RELAXATION OF MUSCLE | 5 | 3.99e-01 | 2.18e-01 | 7.18e-01 |
GOBP RESPONSE TO STEROL | 16 | 1.32e-01 | -2.18e-01 | 4.59e-01 |
GOMF MAP KINASE ACTIVITY | 9 | 2.58e-01 | 2.18e-01 | 6.01e-01 |
GOCC POLYSOMAL RIBOSOME | 29 | 4.26e-02 | -2.18e-01 | 2.76e-01 |
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION | 10 | 2.34e-01 | -2.18e-01 | 5.80e-01 |
GOBP OVULATION | 5 | 4.00e-01 | 2.17e-01 | 7.19e-01 |
GOBP NEGATIVE REGULATION OF CELL DIVISION | 6 | 3.56e-01 | 2.17e-01 | 6.86e-01 |
GOBP REGULATION OF MUSCLE ADAPTATION | 40 | 1.75e-02 | -2.17e-01 | 1.79e-01 |
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS | 5 | 4.00e-01 | -2.17e-01 | 7.19e-01 |
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION | 5 | 4.01e-01 | 2.17e-01 | 7.19e-01 |
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS | 69 | 1.86e-03 | 2.17e-01 | 5.22e-02 |
GOBP INTERLEUKIN 4 PRODUCTION | 19 | 1.02e-01 | -2.17e-01 | 4.12e-01 |
GOBP RESPONSE TO PROSTAGLANDIN | 10 | 2.36e-01 | -2.17e-01 | 5.82e-01 |
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY | 190 | 3.04e-07 | -2.17e-01 | 3.67e-05 |
GOBP NEGATIVE REGULATION OF JNK CASCADE | 23 | 7.25e-02 | -2.17e-01 | 3.56e-01 |
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 8 | 2.89e-01 | -2.17e-01 | 6.32e-01 |
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX | 8 | 2.89e-01 | 2.16e-01 | 6.32e-01 |
GOBP KIDNEY MESENCHYME DEVELOPMENT | 5 | 4.02e-01 | 2.16e-01 | 7.20e-01 |
GOBP METANEPHRIC MESENCHYME DEVELOPMENT | 5 | 4.02e-01 | 2.16e-01 | 7.20e-01 |
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 10 | 2.36e-01 | 2.16e-01 | 5.83e-01 |
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS | 6 | 3.59e-01 | -2.16e-01 | 6.88e-01 |
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX | 7 | 3.22e-01 | -2.16e-01 | 6.59e-01 |
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY | 24 | 6.72e-02 | 2.16e-01 | 3.41e-01 |
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 3.60e-01 | -2.16e-01 | 6.88e-01 |
GOCC FEMALE GERM CELL NUCLEUS | 6 | 3.60e-01 | -2.16e-01 | 6.88e-01 |
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS | 8 | 2.91e-01 | 2.16e-01 | 6.33e-01 |
GOBP DERMATAN SULFATE METABOLIC PROCESS | 6 | 3.60e-01 | -2.16e-01 | 6.88e-01 |
GOCC WASH COMPLEX | 9 | 2.63e-01 | -2.16e-01 | 6.06e-01 |
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS | 12 | 1.96e-01 | 2.16e-01 | 5.43e-01 |
GOBP PROTEIN INSERTION INTO ER MEMBRANE | 27 | 5.28e-02 | 2.16e-01 | 2.99e-01 |
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 29 | 4.48e-02 | -2.15e-01 | 2.82e-01 |
GOBP PURINE NUCLEOTIDE TRANSPORT | 22 | 8.05e-02 | 2.15e-01 | 3.72e-01 |
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 17 | 1.24e-01 | 2.15e-01 | 4.52e-01 |
GOBP SPROUTING ANGIOGENESIS | 47 | 1.08e-02 | -2.15e-01 | 1.37e-01 |
GOMF FK506 BINDING | 6 | 3.62e-01 | 2.15e-01 | 6.89e-01 |
GOMF MACROLIDE BINDING | 6 | 3.62e-01 | 2.15e-01 | 6.89e-01 |
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 6 | 3.62e-01 | 2.15e-01 | 6.89e-01 |
GOBP STEROID HORMONE SECRETION | 6 | 3.62e-01 | -2.15e-01 | 6.89e-01 |
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE | 40 | 1.90e-02 | 2.15e-01 | 1.86e-01 |
GOCC MEMBRANE MICRODOMAIN | 131 | 2.40e-05 | -2.15e-01 | 1.87e-03 |
GOBP FEEDING BEHAVIOR | 19 | 1.06e-01 | -2.15e-01 | 4.20e-01 |
GOMF HORMONE ACTIVITY | 6 | 3.63e-01 | 2.14e-01 | 6.90e-01 |
GOBP PROTEIN FOLDING | 149 | 6.86e-06 | 2.14e-01 | 6.36e-04 |
GOCC AZUROPHIL GRANULE MEMBRANE | 42 | 1.63e-02 | -2.14e-01 | 1.72e-01 |
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY | 5 | 4.07e-01 | -2.14e-01 | 7.23e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 16 | 1.38e-01 | -2.14e-01 | 4.67e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 16 | 1.38e-01 | -2.14e-01 | 4.67e-01 |
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE | 5 | 4.07e-01 | -2.14e-01 | 7.23e-01 |
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 2.66e-01 | -2.14e-01 | 6.10e-01 |
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 16 | 1.38e-01 | -2.14e-01 | 4.67e-01 |
GOBP NEUROTRANSMITTER METABOLIC PROCESS | 8 | 2.94e-01 | 2.14e-01 | 6.36e-01 |
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 29 | 4.61e-02 | -2.14e-01 | 2.83e-01 |
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS | 13 | 1.82e-01 | 2.14e-01 | 5.28e-01 |
GOMF FERROUS IRON BINDING | 17 | 1.27e-01 | 2.14e-01 | 4.55e-01 |
GOBP HYPEROSMOTIC SALINITY RESPONSE | 5 | 4.08e-01 | -2.14e-01 | 7.23e-01 |
GOMF SMALL MOLECULE SENSOR ACTIVITY | 21 | 9.00e-02 | 2.14e-01 | 3.90e-01 |
GOMF GABA RECEPTOR BINDING | 9 | 2.67e-01 | -2.14e-01 | 6.11e-01 |
GOBP MITOCHONDRIAL RNA PROCESSING | 17 | 1.27e-01 | 2.14e-01 | 4.55e-01 |
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION | 6 | 3.65e-01 | 2.14e-01 | 6.91e-01 |
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION | 6 | 3.65e-01 | 2.14e-01 | 6.91e-01 |
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS | 8 | 2.95e-01 | 2.14e-01 | 6.37e-01 |
GOBP LEUKOCYTE TETHERING OR ROLLING | 13 | 1.83e-01 | -2.14e-01 | 5.28e-01 |
GOBP MECHANORECEPTOR DIFFERENTIATION | 16 | 1.40e-01 | 2.13e-01 | 4.69e-01 |
GOBP MATING BEHAVIOR | 13 | 1.83e-01 | -2.13e-01 | 5.29e-01 |
GOBP REGULATION OF FIBROBLAST MIGRATION | 23 | 7.67e-02 | -2.13e-01 | 3.63e-01 |
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY | 5 | 4.09e-01 | 2.13e-01 | 7.24e-01 |
GOMF COPPER ION BINDING | 21 | 9.10e-02 | 2.13e-01 | 3.92e-01 |
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION | 26 | 6.03e-02 | 2.13e-01 | 3.22e-01 |
GOBP AUTOPHAGIC CELL DEATH | 8 | 2.97e-01 | -2.13e-01 | 6.39e-01 |
GOMF CD4 RECEPTOR BINDING | 7 | 3.29e-01 | -2.13e-01 | 6.65e-01 |
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION | 39 | 2.15e-02 | -2.13e-01 | 2.02e-01 |
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY | 16 | 1.41e-01 | -2.13e-01 | 4.71e-01 |
GOBP GLUCOSE IMPORT | 29 | 4.74e-02 | -2.13e-01 | 2.85e-01 |
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY | 25 | 6.59e-02 | -2.13e-01 | 3.37e-01 |
GOBP ENDOSOMAL VESICLE FUSION | 10 | 2.45e-01 | 2.13e-01 | 5.92e-01 |
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 10 | 2.45e-01 | 2.13e-01 | 5.92e-01 |
GOBP COBALT ION TRANSPORT | 5 | 4.11e-01 | 2.13e-01 | 7.26e-01 |
GOCC MITOCHONDRIAL ENVELOPE | 576 | 1.12e-17 | 2.12e-01 | 1.35e-14 |
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 23 | 7.82e-02 | -2.12e-01 | 3.66e-01 |
GOBP INTERMEMBRANE LIPID TRANSFER | 26 | 6.12e-02 | -2.12e-01 | 3.25e-01 |
GOMF LIPID TRANSFER ACTIVITY | 26 | 6.12e-02 | -2.12e-01 | 3.25e-01 |
GOCC INSULIN RESPONSIVE COMPARTMENT | 6 | 3.68e-01 | 2.12e-01 | 6.95e-01 |
GOBP GMP BIOSYNTHETIC PROCESS | 12 | 2.03e-01 | 2.12e-01 | 5.51e-01 |
GOBP TROPHECTODERMAL CELL DIFFERENTIATION | 10 | 2.46e-01 | -2.12e-01 | 5.92e-01 |
GOBP DNA CONFORMATION CHANGE | 64 | 3.41e-03 | 2.12e-01 | 7.31e-02 |
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION | 23 | 7.91e-02 | -2.12e-01 | 3.67e-01 |
GOBP NEGATIVE REGULATION OF ORGAN GROWTH | 17 | 1.32e-01 | -2.11e-01 | 4.59e-01 |
GOBP NEGATIVE REGULATION OF PROTEOLYSIS | 112 | 1.18e-04 | -2.11e-01 | 7.09e-03 |
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 8 | 3.01e-01 | -2.11e-01 | 6.42e-01 |
GOBP KYNURENINE METABOLIC PROCESS | 5 | 4.14e-01 | 2.11e-01 | 7.28e-01 |
GOCC BBAF COMPLEX | 9 | 2.73e-01 | 2.11e-01 | 6.17e-01 |
GOBP AMINO ACID BETAINE METABOLIC PROCESS | 5 | 4.14e-01 | -2.11e-01 | 7.28e-01 |
GOBP CARNITINE METABOLIC PROCESS | 5 | 4.14e-01 | -2.11e-01 | 7.28e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 5 | 4.14e-01 | 2.11e-01 | 7.28e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION | 30 | 4.60e-02 | -2.11e-01 | 2.83e-01 |
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE | 56 | 6.49e-03 | 2.11e-01 | 1.03e-01 |
GOBP SERTOLI CELL DIFFERENTIATION | 11 | 2.27e-01 | 2.11e-01 | 5.76e-01 |
GOMF LIGASE ACTIVITY | 98 | 3.30e-04 | 2.11e-01 | 1.60e-02 |
GOBP POSITIVE REGULATION OF MRNA PROCESSING | 23 | 8.08e-02 | 2.10e-01 | 3.72e-01 |
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY | 29 | 5.00e-02 | -2.10e-01 | 2.93e-01 |
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS | 11 | 2.27e-01 | 2.10e-01 | 5.76e-01 |
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 36 | 2.92e-02 | -2.10e-01 | 2.34e-01 |
GOBP REGULATION OF VASCULATURE DEVELOPMENT | 105 | 2.08e-04 | -2.10e-01 | 1.11e-02 |
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 6 | 3.73e-01 | -2.10e-01 | 6.99e-01 |
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY | 8 | 3.04e-01 | 2.10e-01 | 6.44e-01 |
GOMF SIGNALING ADAPTOR ACTIVITY | 65 | 3.47e-03 | -2.10e-01 | 7.32e-02 |
GOCC SWR1 COMPLEX | 13 | 1.90e-01 | 2.10e-01 | 5.36e-01 |
GOBP VENTRICULAR SYSTEM DEVELOPMENT | 17 | 1.34e-01 | -2.10e-01 | 4.62e-01 |
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE | 13 | 1.90e-01 | 2.10e-01 | 5.36e-01 |
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION | 44 | 1.61e-02 | -2.10e-01 | 1.70e-01 |
GOBP MYOSIN FILAMENT ORGANIZATION | 5 | 4.17e-01 | -2.10e-01 | 7.30e-01 |
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING | 5 | 4.17e-01 | 2.09e-01 | 7.30e-01 |
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING | 9 | 2.77e-01 | -2.09e-01 | 6.20e-01 |
GOCC GOLGI MEDIAL CISTERNA | 10 | 2.52e-01 | 2.09e-01 | 5.96e-01 |
GOBP ALPHA BETA T CELL DIFFERENTIATION | 65 | 3.58e-03 | -2.09e-01 | 7.47e-02 |
GOBP REGULATION OF URINE VOLUME | 5 | 4.18e-01 | -2.09e-01 | 7.30e-01 |
GOCC SMOOTH ENDOPLASMIC RETICULUM | 17 | 1.36e-01 | 2.09e-01 | 4.64e-01 |
GOMF MYRISTOYLTRANSFERASE ACTIVITY | 10 | 2.53e-01 | 2.09e-01 | 5.96e-01 |
GOBP RESPONSE TO INTERLEUKIN 12 | 8 | 3.06e-01 | 2.09e-01 | 6.47e-01 |
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I | 11 | 2.30e-01 | 2.09e-01 | 5.78e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 10 | 2.53e-01 | 2.09e-01 | 5.96e-01 |
GOMF MHC CLASS I PROTEIN BINDING | 13 | 1.93e-01 | 2.09e-01 | 5.39e-01 |
GOBP SKELETAL SYSTEM MORPHOGENESIS | 65 | 3.66e-03 | -2.09e-01 | 7.54e-02 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY | 6 | 3.76e-01 | -2.09e-01 | 7.01e-01 |
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 7 | 3.39e-01 | 2.09e-01 | 6.75e-01 |
GOCC MSL COMPLEX | 5 | 4.19e-01 | -2.09e-01 | 7.31e-01 |
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 32 | 4.14e-02 | -2.09e-01 | 2.72e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL | 11 | 2.31e-01 | 2.09e-01 | 5.78e-01 |
GOCC ORGANELLE ENVELOPE LUMEN | 67 | 3.23e-03 | 2.08e-01 | 7.08e-02 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION | 7 | 3.40e-01 | 2.08e-01 | 6.75e-01 |
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT | 16 | 1.49e-01 | 2.08e-01 | 4.82e-01 |
GOCC POLE PLASM | 7 | 3.40e-01 | -2.08e-01 | 6.75e-01 |
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS | 15 | 1.63e-01 | -2.08e-01 | 5.01e-01 |
GOBP CELLULAR HYPEROSMOTIC RESPONSE | 13 | 1.94e-01 | -2.08e-01 | 5.40e-01 |
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS | 17 | 1.37e-01 | 2.08e-01 | 4.67e-01 |
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE | 9 | 2.80e-01 | 2.08e-01 | 6.22e-01 |
GOMF 7SK SNRNA BINDING | 7 | 3.41e-01 | -2.08e-01 | 6.76e-01 |
GOBP MESODERMAL CELL DIFFERENTIATION | 7 | 3.41e-01 | -2.08e-01 | 6.76e-01 |
GOBP REGULATION OF NEURON MIGRATION | 15 | 1.64e-01 | -2.08e-01 | 5.02e-01 |
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS | 7 | 3.42e-01 | -2.08e-01 | 6.77e-01 |
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION | 19 | 1.17e-01 | 2.08e-01 | 4.39e-01 |
GOBP RESPONSE TO FORSKOLIN | 5 | 4.22e-01 | 2.08e-01 | 7.32e-01 |
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 15 | 1.64e-01 | -2.08e-01 | 5.03e-01 |
GOCC NEURON PROJECTION MEMBRANE | 13 | 1.95e-01 | 2.07e-01 | 5.42e-01 |
GOBP ASSOCIATIVE LEARNING | 30 | 4.94e-02 | -2.07e-01 | 2.90e-01 |
GOBP REGULATION OF COLLATERAL SPROUTING | 7 | 3.42e-01 | -2.07e-01 | 6.77e-01 |
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS | 10 | 2.57e-01 | -2.07e-01 | 6.00e-01 |
GOCC CHLORIDE CHANNEL COMPLEX | 9 | 2.82e-01 | -2.07e-01 | 6.24e-01 |
GOCC SPLICEOSOMAL SNRNP COMPLEX | 63 | 4.55e-03 | 2.07e-01 | 8.49e-02 |
GOBP G QUADRUPLEX DNA UNWINDING | 6 | 3.80e-01 | 2.07e-01 | 7.04e-01 |
GOCC CENTRIOLAR SUBDISTAL APPENDAGE | 7 | 3.43e-01 | -2.07e-01 | 6.79e-01 |
GOBP DNA DOUBLE STRAND BREAK PROCESSING | 13 | 1.97e-01 | 2.07e-01 | 5.44e-01 |
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 7 | 3.44e-01 | -2.07e-01 | 6.79e-01 |
GOBP AXIS ELONGATION | 7 | 3.44e-01 | -2.07e-01 | 6.79e-01 |
GOBP NADP METABOLIC PROCESS | 26 | 6.86e-02 | 2.06e-01 | 3.45e-01 |
GOBP REGULATION OF TORC2 SIGNALING | 7 | 3.45e-01 | -2.06e-01 | 6.79e-01 |
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY | 5 | 4.24e-01 | -2.06e-01 | 7.34e-01 |
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX | 13 | 1.98e-01 | 2.06e-01 | 5.45e-01 |
GOBP REGULATION OF GERMINAL CENTER FORMATION | 6 | 3.82e-01 | -2.06e-01 | 7.05e-01 |
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION | 13 | 1.98e-01 | -2.06e-01 | 5.45e-01 |
GOBP ERROR PRONE TRANSLESION SYNTHESIS | 9 | 2.84e-01 | 2.06e-01 | 6.26e-01 |
GOBP NEUTROPHIL DIFFERENTIATION | 9 | 2.84e-01 | -2.06e-01 | 6.26e-01 |
GOBP REGULATION OF MICROTUBULE BINDING | 5 | 4.25e-01 | -2.06e-01 | 7.34e-01 |
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 35 | 3.50e-02 | 2.06e-01 | 2.53e-01 |
GOBP NEUROINFLAMMATORY RESPONSE | 33 | 4.09e-02 | -2.06e-01 | 2.71e-01 |
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS | 34 | 3.80e-02 | 2.06e-01 | 2.63e-01 |
GOBP REGULATION OF LYSOSOME SIZE | 7 | 3.46e-01 | -2.06e-01 | 6.79e-01 |
GOCC BORC COMPLEX | 7 | 3.46e-01 | -2.06e-01 | 6.79e-01 |
GOCC NLRP3 INFLAMMASOME COMPLEX | 6 | 3.83e-01 | 2.06e-01 | 7.06e-01 |
GOMF CARBON OXYGEN LYASE ACTIVITY | 39 | 2.64e-02 | 2.06e-01 | 2.25e-01 |
GOMF DNA POLYMERASE ACTIVITY | 22 | 9.53e-02 | 2.06e-01 | 4.01e-01 |
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL | 6 | 3.83e-01 | 2.06e-01 | 7.06e-01 |
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION | 7 | 3.47e-01 | -2.05e-01 | 6.79e-01 |
GOBP PHAGOSOME MATURATION | 16 | 1.55e-01 | -2.05e-01 | 4.90e-01 |
GOBP ISOPRENOID BIOSYNTHETIC PROCESS | 14 | 1.84e-01 | 2.05e-01 | 5.29e-01 |
GOMF DYNEIN HEAVY CHAIN BINDING | 6 | 3.84e-01 | -2.05e-01 | 7.06e-01 |
GOBP GLIAL CELL ACTIVATION | 24 | 8.24e-02 | -2.05e-01 | 3.76e-01 |
GOCC A BAND | 11 | 2.40e-01 | 2.05e-01 | 5.88e-01 |
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE | 5 | 4.28e-01 | -2.05e-01 | 7.36e-01 |
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING | 15 | 1.70e-01 | 2.05e-01 | 5.11e-01 |
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION | 10 | 2.62e-01 | -2.05e-01 | 6.06e-01 |
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 32 | 4.52e-02 | -2.05e-01 | 2.83e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY | 7 | 3.48e-01 | -2.05e-01 | 6.81e-01 |
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY | 5 | 4.28e-01 | -2.05e-01 | 7.36e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION | 11 | 2.40e-01 | 2.05e-01 | 5.89e-01 |
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 7 | 3.49e-01 | -2.04e-01 | 6.81e-01 |
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR | 5 | 4.29e-01 | -2.04e-01 | 7.36e-01 |
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 3.49e-01 | 2.04e-01 | 6.81e-01 |
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX | 20 | 1.14e-01 | 2.04e-01 | 4.34e-01 |
GOBP REGULATION OF HELICASE ACTIVITY | 10 | 2.64e-01 | 2.04e-01 | 6.07e-01 |
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS | 5 | 4.29e-01 | 2.04e-01 | 7.36e-01 |
GOBP MITOCHONDRIAL DNA REPLICATION | 12 | 2.21e-01 | 2.04e-01 | 5.73e-01 |
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS | 20 | 1.14e-01 | 2.04e-01 | 4.35e-01 |
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS | 6 | 3.87e-01 | -2.04e-01 | 7.08e-01 |
GOBP SOMITE DEVELOPMENT | 21 | 1.06e-01 | 2.04e-01 | 4.20e-01 |
GOBP DOPAMINE METABOLIC PROCESS | 13 | 2.04e-01 | -2.04e-01 | 5.51e-01 |
GOMF DIPEPTIDASE ACTIVITY | 9 | 2.90e-01 | -2.04e-01 | 6.33e-01 |
GOBP TISSUE REGENERATION | 30 | 5.38e-02 | -2.04e-01 | 3.02e-01 |
GOMF ATPASE REGULATOR ACTIVITY | 34 | 4.01e-02 | 2.04e-01 | 2.69e-01 |
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY | 8 | 3.19e-01 | -2.04e-01 | 6.57e-01 |
GOBP POSITIVE REGULATION OF DNA DEMETHYLATION | 5 | 4.31e-01 | -2.04e-01 | 7.37e-01 |
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 18 | 1.35e-01 | -2.03e-01 | 4.64e-01 |
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY | 16 | 1.59e-01 | 2.03e-01 | 4.97e-01 |
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 41 | 2.45e-02 | -2.03e-01 | 2.15e-01 |
GOBP UROGENITAL SYSTEM DEVELOPMENT | 24 | 8.49e-02 | -2.03e-01 | 3.81e-01 |
GOBP T CELL SELECTION | 24 | 8.50e-02 | -2.03e-01 | 3.81e-01 |
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS | 17 | 1.47e-01 | -2.03e-01 | 4.80e-01 |
GOBP PROTEIN HOMOTETRAMERIZATION | 29 | 5.85e-02 | 2.03e-01 | 3.16e-01 |
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY | 7 | 3.52e-01 | 2.03e-01 | 6.83e-01 |
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT | 25 | 7.92e-02 | -2.03e-01 | 3.67e-01 |
GOBP NUCLEOBASE METABOLIC PROCESS | 25 | 7.92e-02 | 2.03e-01 | 3.67e-01 |
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 6 | 3.89e-01 | -2.03e-01 | 7.10e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION | 8 | 3.20e-01 | -2.03e-01 | 6.59e-01 |
GOBP GLUTAMINE TRANSPORT | 7 | 3.53e-01 | -2.03e-01 | 6.83e-01 |
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.53e-01 | -2.03e-01 | 6.83e-01 |
GOBP PROTEIN POLY ADP RIBOSYLATION | 8 | 3.21e-01 | -2.03e-01 | 6.59e-01 |
GOBP REGULATION OF HEART GROWTH | 23 | 9.25e-02 | -2.03e-01 | 3.95e-01 |
GOBP CHROMOSOME SEPARATION | 58 | 7.71e-03 | 2.03e-01 | 1.14e-01 |
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY | 16 | 1.61e-01 | 2.03e-01 | 5.00e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 20 | 1.17e-01 | -2.03e-01 | 4.39e-01 |
GOBP POSTSYNAPTIC DENSITY ASSEMBLY | 5 | 4.33e-01 | 2.02e-01 | 7.39e-01 |
GOBP RNA STABILIZATION | 47 | 1.65e-02 | -2.02e-01 | 1.73e-01 |
GOCC RISC LOADING COMPLEX | 7 | 3.54e-01 | 2.02e-01 | 6.85e-01 |
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY | 6 | 3.91e-01 | -2.02e-01 | 7.11e-01 |
GOBP PYRAMIDAL NEURON DEVELOPMENT | 5 | 4.34e-01 | 2.02e-01 | 7.39e-01 |
GOBP PYRAMIDAL NEURON DIFFERENTIATION | 5 | 4.34e-01 | 2.02e-01 | 7.39e-01 |
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE | 22 | 1.01e-01 | -2.02e-01 | 4.10e-01 |
GOCC FILOPODIUM TIP | 11 | 2.47e-01 | 2.02e-01 | 5.92e-01 |
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS | 26 | 7.51e-02 | -2.02e-01 | 3.61e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT | 12 | 2.26e-01 | 2.02e-01 | 5.76e-01 |
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS | 9 | 2.95e-01 | 2.02e-01 | 6.37e-01 |
GOMF CARDIOLIPIN BINDING | 7 | 3.56e-01 | 2.02e-01 | 6.86e-01 |
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION | 35 | 3.92e-02 | 2.02e-01 | 2.66e-01 |
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT | 17 | 1.51e-01 | 2.02e-01 | 4.84e-01 |
GOCC KINESIN COMPLEX | 22 | 1.02e-01 | -2.01e-01 | 4.12e-01 |
GOBP ENDOCRINE SYSTEM DEVELOPMENT | 43 | 2.25e-02 | -2.01e-01 | 2.07e-01 |
GOMF PALMITOYL COA HYDROLASE ACTIVITY | 6 | 3.93e-01 | -2.01e-01 | 7.13e-01 |
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 3.57e-01 | -2.01e-01 | 6.86e-01 |
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY | 21 | 1.11e-01 | -2.01e-01 | 4.27e-01 |
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS | 14 | 1.93e-01 | -2.01e-01 | 5.39e-01 |
GOBP PROTEIN O LINKED MANNOSYLATION | 10 | 2.71e-01 | 2.01e-01 | 6.16e-01 |
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING | 10 | 2.71e-01 | -2.01e-01 | 6.16e-01 |
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 50 | 1.41e-02 | -2.01e-01 | 1.57e-01 |
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION | 6 | 3.94e-01 | 2.01e-01 | 7.13e-01 |
GOBP N TERMINAL PROTEIN LIPIDATION | 5 | 4.37e-01 | -2.01e-01 | 7.40e-01 |
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 31 | 5.31e-02 | -2.01e-01 | 3.00e-01 |
GOMF MOLECULAR SEQUESTERING ACTIVITY | 26 | 7.65e-02 | -2.01e-01 | 3.63e-01 |
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 19 | 1.30e-01 | 2.01e-01 | 4.57e-01 |
GOBP NEURON MIGRATION | 60 | 7.28e-03 | -2.01e-01 | 1.10e-01 |
GOBP RESPONSE TO COPPER ION | 12 | 2.29e-01 | 2.01e-01 | 5.78e-01 |
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS | 8 | 3.26e-01 | -2.01e-01 | 6.63e-01 |
GOBP DETOXIFICATION | 61 | 6.86e-03 | 2.01e-01 | 1.06e-01 |
GOMF DOPAMINE RECEPTOR BINDING | 8 | 3.26e-01 | -2.00e-01 | 6.63e-01 |
GOBP RESPONSE TO INTERLEUKIN 7 | 12 | 2.30e-01 | 2.00e-01 | 5.78e-01 |
GOBP AMINO ACID BIOSYNTHETIC PROCESS | 41 | 2.66e-02 | 2.00e-01 | 2.26e-01 |
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY | 15 | 1.80e-01 | -2.00e-01 | 5.25e-01 |
GOMF MISFOLDED PROTEIN BINDING | 17 | 1.53e-01 | 2.00e-01 | 4.88e-01 |
GOBP RIBOSOME DISASSEMBLY | 12 | 2.30e-01 | 2.00e-01 | 5.78e-01 |
GOBP REGULATION OF GTP BINDING | 8 | 3.27e-01 | -2.00e-01 | 6.63e-01 |
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS | 24 | 9.00e-02 | -2.00e-01 | 3.90e-01 |
GOBP PROTEIN AUTO ADP RIBOSYLATION | 9 | 2.99e-01 | -2.00e-01 | 6.41e-01 |
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS | 6 | 3.97e-01 | -2.00e-01 | 7.16e-01 |
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY | 7 | 3.60e-01 | 2.00e-01 | 6.88e-01 |
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION | 7 | 3.60e-01 | 2.00e-01 | 6.88e-01 |
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS | 285 | 9.00e-09 | 2.00e-01 | 1.51e-06 |
GOBP INTERLEUKIN 6 PRODUCTION | 70 | 3.96e-03 | -2.00e-01 | 7.86e-02 |
GOMF JUN KINASE BINDING | 8 | 3.29e-01 | -2.00e-01 | 6.64e-01 |
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY | 5 | 4.40e-01 | -1.99e-01 | 7.42e-01 |
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS | 11 | 2.52e-01 | -1.99e-01 | 5.96e-01 |
GOBP POSTREPLICATION REPAIR | 28 | 6.83e-02 | 1.99e-01 | 3.45e-01 |
GOMF POLY PURINE TRACT BINDING | 24 | 9.18e-02 | -1.99e-01 | 3.94e-01 |
GOCC AMPHISOME MEMBRANE | 10 | 2.77e-01 | 1.99e-01 | 6.20e-01 |
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE | 8 | 3.30e-01 | 1.99e-01 | 6.66e-01 |
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 5 | 4.42e-01 | -1.99e-01 | 7.44e-01 |
GOMF PEPTIDOGLYCAN BINDING | 5 | 4.42e-01 | 1.98e-01 | 7.45e-01 |
GOBP REGULATION OF KERATINOCYTE PROLIFERATION | 18 | 1.45e-01 | -1.98e-01 | 4.77e-01 |
GOBP CHEMOKINE PRODUCTION | 33 | 4.87e-02 | -1.98e-01 | 2.88e-01 |
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES | 7 | 3.64e-01 | 1.98e-01 | 6.91e-01 |
GOBP INNERVATION | 8 | 3.32e-01 | 1.98e-01 | 6.67e-01 |
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY | 28 | 6.97e-02 | 1.98e-01 | 3.48e-01 |
GOBP VENTRAL SPINAL CORD DEVELOPMENT | 14 | 1.99e-01 | 1.98e-01 | 5.47e-01 |
GOBP CELL DIFFERENTIATION IN SPINAL CORD | 11 | 2.55e-01 | 1.98e-01 | 5.98e-01 |
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 32 | 5.26e-02 | -1.98e-01 | 2.99e-01 |
GOBP POSITIVE REGULATION OF TELOMERE CAPPING | 12 | 2.35e-01 | -1.98e-01 | 5.82e-01 |
GOBP COENZYME A METABOLIC PROCESS | 12 | 2.35e-01 | 1.98e-01 | 5.82e-01 |
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE | 49 | 1.66e-02 | -1.98e-01 | 1.73e-01 |
GOBP COLLATERAL SPROUTING | 10 | 2.79e-01 | -1.98e-01 | 6.22e-01 |
GOBP EATING BEHAVIOR | 5 | 4.44e-01 | -1.98e-01 | 7.46e-01 |
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE | 12 | 2.35e-01 | -1.98e-01 | 5.82e-01 |
GOBP REGULATION OF NEUROBLAST PROLIFERATION | 16 | 1.71e-01 | -1.98e-01 | 5.12e-01 |
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 20 | 1.26e-01 | -1.98e-01 | 4.54e-01 |
GOBP SNARE COMPLEX ASSEMBLY | 17 | 1.58e-01 | 1.98e-01 | 4.95e-01 |
GOMF RECEPTOR TYROSINE KINASE BINDING | 39 | 3.29e-02 | -1.98e-01 | 2.46e-01 |
GOBP RENAL TUBULE DEVELOPMENT | 20 | 1.26e-01 | 1.98e-01 | 4.55e-01 |
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 37 | 3.78e-02 | -1.98e-01 | 2.63e-01 |
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY | 13 | 2.18e-01 | -1.98e-01 | 5.71e-01 |
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 37 | 3.78e-02 | -1.98e-01 | 2.63e-01 |
GOMF PROTEIN SELF ASSOCIATION | 43 | 2.53e-02 | -1.97e-01 | 2.19e-01 |
GOBP BLOOD VESSEL MORPHOGENESIS | 232 | 2.69e-07 | -1.97e-01 | 3.41e-05 |
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 9 | 3.05e-01 | 1.97e-01 | 6.46e-01 |
GOCC U2 TYPE SPLICEOSOMAL COMPLEX | 88 | 1.42e-03 | 1.97e-01 | 4.33e-02 |
GOBP ORGANIC ACID CATABOLIC PROCESS | 122 | 1.77e-04 | 1.97e-01 | 1.00e-02 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR | 27 | 7.64e-02 | 1.97e-01 | 3.63e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 45 | 2.23e-02 | -1.97e-01 | 2.06e-01 |
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION | 27 | 7.66e-02 | 1.97e-01 | 3.63e-01 |
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT | 31 | 5.81e-02 | -1.97e-01 | 3.15e-01 |
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION | 21 | 1.19e-01 | -1.97e-01 | 4.40e-01 |
GOMF 5 3 DNA EXONUCLEASE ACTIVITY | 5 | 4.46e-01 | 1.97e-01 | 7.48e-01 |
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE | 66 | 5.80e-03 | -1.97e-01 | 9.68e-02 |
GOMF MANNOSYLTRANSFERASE ACTIVITY | 15 | 1.87e-01 | 1.97e-01 | 5.34e-01 |
GOBP BODY MORPHOGENESIS | 21 | 1.19e-01 | -1.97e-01 | 4.40e-01 |
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION | 7 | 3.68e-01 | -1.97e-01 | 6.95e-01 |
GOMF MUTSALPHA COMPLEX BINDING | 5 | 4.47e-01 | -1.97e-01 | 7.48e-01 |
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION | 13 | 2.20e-01 | -1.97e-01 | 5.72e-01 |
GOBP PORE COMPLEX ASSEMBLY | 18 | 1.49e-01 | 1.96e-01 | 4.82e-01 |
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS | 9 | 3.08e-01 | -1.96e-01 | 6.48e-01 |
GOBP AXONAL FASCICULATION | 5 | 4.47e-01 | -1.96e-01 | 7.49e-01 |
GOBP REGULATION OF CHROMATIN BINDING | 9 | 3.08e-01 | 1.96e-01 | 6.48e-01 |
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY | 8 | 3.37e-01 | 1.96e-01 | 6.73e-01 |
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION | 5 | 4.47e-01 | 1.96e-01 | 7.49e-01 |
GOBP MYOBLAST PROLIFERATION | 11 | 2.60e-01 | -1.96e-01 | 6.03e-01 |
GOMF C C CHEMOKINE BINDING | 5 | 4.48e-01 | 1.96e-01 | 7.49e-01 |
GOBP MESONEPHROS DEVELOPMENT | 20 | 1.29e-01 | 1.96e-01 | 4.57e-01 |
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN | 14 | 2.04e-01 | 1.96e-01 | 5.52e-01 |
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION | 7 | 3.70e-01 | -1.96e-01 | 6.96e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 5 | 4.48e-01 | 1.96e-01 | 7.49e-01 |
GOBP TOLL SIGNALING PATHWAY | 8 | 3.38e-01 | -1.96e-01 | 6.74e-01 |
GOMF MONOATOMIC ANION CHANNEL ACTIVITY | 22 | 1.12e-01 | -1.96e-01 | 4.30e-01 |
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY | 6 | 4.07e-01 | -1.96e-01 | 7.23e-01 |
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC | 30 | 6.40e-02 | -1.96e-01 | 3.31e-01 |
GOBP KETONE CATABOLIC PROCESS | 7 | 3.70e-01 | 1.96e-01 | 6.97e-01 |
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY | 11 | 2.62e-01 | -1.96e-01 | 6.05e-01 |
GOBP COBALAMIN METABOLIC PROCESS | 6 | 4.07e-01 | 1.95e-01 | 7.23e-01 |
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS | 6 | 4.08e-01 | 1.95e-01 | 7.23e-01 |
GOMF PHOSPHOLIPASE BINDING | 14 | 2.06e-01 | -1.95e-01 | 5.54e-01 |
GOBP SKELETAL MUSCLE CELL PROLIFERATION | 12 | 2.42e-01 | 1.95e-01 | 5.90e-01 |
GOBP FOREBRAIN CELL MIGRATION | 27 | 8.00e-02 | -1.95e-01 | 3.70e-01 |
GOBP CEREBRAL CORTEX CELL MIGRATION | 24 | 9.88e-02 | -1.95e-01 | 4.07e-01 |
GOBP POLYADENYLATION DEPENDENT SNORNA 3 END PROCESSING | 7 | 3.73e-01 | 1.95e-01 | 6.99e-01 |
GOBP LIPOPROTEIN CATABOLIC PROCESS | 12 | 2.43e-01 | 1.95e-01 | 5.91e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 11 | 2.64e-01 | -1.95e-01 | 6.08e-01 |
GOBP REGULATION OF CELLULAR EXTRAVASATION | 16 | 1.78e-01 | -1.95e-01 | 5.24e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 16 | 1.78e-01 | 1.94e-01 | 5.24e-01 |
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY | 6 | 4.10e-01 | 1.94e-01 | 7.25e-01 |
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION | 81 | 2.56e-03 | -1.94e-01 | 6.28e-02 |
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING | 19 | 1.43e-01 | -1.94e-01 | 4.74e-01 |
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 24 | 9.98e-02 | -1.94e-01 | 4.09e-01 |
GOBP RESPONSE TO IRON ION | 16 | 1.79e-01 | 1.94e-01 | 5.25e-01 |
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 33 | 5.39e-02 | 1.94e-01 | 3.02e-01 |
GOBP MACROPHAGE ACTIVATION | 48 | 2.03e-02 | -1.94e-01 | 1.95e-01 |
GOMF DNA DNA ANNEALING ACTIVITY | 5 | 4.53e-01 | 1.94e-01 | 7.52e-01 |
GOBP ROOF OF MOUTH DEVELOPMENT | 26 | 8.75e-02 | -1.94e-01 | 3.86e-01 |
GOBP FUCOSYLATION | 5 | 4.53e-01 | -1.94e-01 | 7.52e-01 |
GOBP HEART GROWTH | 35 | 4.75e-02 | -1.94e-01 | 2.85e-01 |
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE | 5 | 4.53e-01 | -1.94e-01 | 7.52e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 59 | 1.02e-02 | -1.94e-01 | 1.33e-01 |
GOBP RESPIRATORY BURST | 27 | 8.19e-02 | -1.94e-01 | 3.74e-01 |
GOBP T CELL CHEMOTAXIS | 12 | 2.46e-01 | -1.93e-01 | 5.92e-01 |
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION | 18 | 1.56e-01 | -1.93e-01 | 4.91e-01 |
GOBP VASCULAR TRANSPORT | 32 | 5.86e-02 | 1.93e-01 | 3.16e-01 |
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX | 8 | 3.44e-01 | -1.93e-01 | 6.79e-01 |
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 18 | 1.56e-01 | -1.93e-01 | 4.92e-01 |
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION | 23 | 1.09e-01 | -1.93e-01 | 4.24e-01 |
GOBP ASTROCYTE DIFFERENTIATION | 38 | 3.97e-02 | -1.93e-01 | 2.67e-01 |
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS | 241 | 3.01e-07 | 1.93e-01 | 3.67e-05 |
GOBP MESENCHYMAL CELL PROLIFERATION | 11 | 2.68e-01 | -1.93e-01 | 6.12e-01 |
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION | 11 | 2.68e-01 | -1.93e-01 | 6.12e-01 |
GOBP MITOTIC CYTOKINETIC PROCESS | 20 | 1.36e-01 | 1.93e-01 | 4.64e-01 |
GOBP FAT CELL DIFFERENTIATION | 93 | 1.36e-03 | -1.93e-01 | 4.28e-02 |
GOCC MICROTUBULE ASSOCIATED COMPLEX | 69 | 5.74e-03 | -1.93e-01 | 9.68e-02 |
GOBP PROTEIN INSERTION INTO MEMBRANE | 62 | 8.81e-03 | 1.93e-01 | 1.21e-01 |
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS | 8 | 3.46e-01 | -1.93e-01 | 6.79e-01 |
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 9 | 3.17e-01 | 1.92e-01 | 6.55e-01 |
GOBP GLAND MORPHOGENESIS | 41 | 3.32e-02 | -1.92e-01 | 2.46e-01 |
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 10 | 2.92e-01 | 1.92e-01 | 6.34e-01 |
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 58 | 1.14e-02 | -1.92e-01 | 1.40e-01 |
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS | 11 | 2.70e-01 | -1.92e-01 | 6.14e-01 |
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 5 | 4.57e-01 | -1.92e-01 | 7.54e-01 |
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 8 | 3.47e-01 | -1.92e-01 | 6.79e-01 |
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION | 17 | 1.70e-01 | -1.92e-01 | 5.11e-01 |
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION | 5 | 4.57e-01 | 1.92e-01 | 7.55e-01 |
GOBP ATP TRANSPORT | 11 | 2.70e-01 | 1.92e-01 | 6.15e-01 |
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I | 16 | 1.84e-01 | 1.92e-01 | 5.29e-01 |
GOBP MACROPHAGE APOPTOTIC PROCESS | 7 | 3.79e-01 | -1.92e-01 | 7.04e-01 |
GOBP HOMOLOGOUS RECOMBINATION | 29 | 7.40e-02 | 1.92e-01 | 3.59e-01 |
GOBP FIBROBLAST ACTIVATION | 7 | 3.80e-01 | 1.92e-01 | 7.04e-01 |
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA | 88 | 1.94e-03 | 1.92e-01 | 5.29e-02 |
GOBP MUSCLE ORGAN DEVELOPMENT | 119 | 3.21e-04 | -1.92e-01 | 1.58e-02 |
GOBP DIENCEPHALON DEVELOPMENT | 13 | 2.32e-01 | -1.92e-01 | 5.78e-01 |
GOBP DEVELOPMENTAL PIGMENTATION | 24 | 1.05e-01 | -1.91e-01 | 4.17e-01 |
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 13 | 2.33e-01 | -1.91e-01 | 5.78e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING | 19 | 1.49e-01 | -1.91e-01 | 4.82e-01 |
GOMF OXIDOREDUCTASE ACTIVITY | 366 | 5.17e-10 | 1.91e-01 | 1.26e-07 |
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION | 6 | 4.17e-01 | 1.91e-01 | 7.30e-01 |
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY | 8 | 3.49e-01 | -1.91e-01 | 6.81e-01 |
GOBP NUCLEAR MIGRATION | 19 | 1.49e-01 | -1.91e-01 | 4.82e-01 |
GOMF LYASE ACTIVITY | 100 | 9.93e-04 | 1.91e-01 | 3.49e-02 |
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT | 97 | 1.18e-03 | 1.91e-01 | 3.91e-02 |
GOBP FATTY ACID ELONGATION | 9 | 3.21e-01 | 1.91e-01 | 6.59e-01 |
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 14 | 2.16e-01 | 1.91e-01 | 5.68e-01 |
GOBP RESPONSE TO DSRNA | 25 | 9.86e-02 | -1.91e-01 | 4.07e-01 |
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY | 6 | 4.18e-01 | -1.91e-01 | 7.30e-01 |
GOCC BASEMENT MEMBRANE | 17 | 1.74e-01 | 1.91e-01 | 5.16e-01 |
GOCC CHROMATOID BODY | 5 | 4.60e-01 | -1.91e-01 | 7.57e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 60 | 1.08e-02 | -1.91e-01 | 1.37e-01 |
GOMF TAT PROTEIN BINDING | 8 | 3.51e-01 | -1.91e-01 | 6.82e-01 |
GOBP RESPONSE TO CHEMOKINE | 25 | 9.94e-02 | -1.91e-01 | 4.09e-01 |
GOBP RRNA PSEUDOURIDINE SYNTHESIS | 6 | 4.19e-01 | 1.91e-01 | 7.31e-01 |
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION | 11 | 2.74e-01 | 1.90e-01 | 6.19e-01 |
GOBP PHOSPHOLIPID TRANSLOCATION | 28 | 8.15e-02 | -1.90e-01 | 3.74e-01 |
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY | 8 | 3.51e-01 | -1.90e-01 | 6.83e-01 |
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT | 29 | 7.65e-02 | -1.90e-01 | 3.63e-01 |
GOBP PROTEIN N LINKED GLYCOSYLATION | 47 | 2.43e-02 | 1.90e-01 | 2.14e-01 |
GOCC AUTOLYSOSOME | 10 | 2.98e-01 | -1.90e-01 | 6.40e-01 |
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS | 18 | 1.63e-01 | 1.90e-01 | 5.01e-01 |
GOBP AMIDE CATABOLIC PROCESS | 5 | 4.62e-01 | 1.90e-01 | 7.59e-01 |
GOBP INTRACILIARY RETROGRADE TRANSPORT | 8 | 3.52e-01 | -1.90e-01 | 6.83e-01 |
GOBP ALPHA BETA T CELL PROLIFERATION | 27 | 8.77e-02 | -1.90e-01 | 3.86e-01 |
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX | 5 | 4.62e-01 | 1.90e-01 | 7.59e-01 |
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY | 44 | 2.95e-02 | -1.90e-01 | 2.35e-01 |
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT | 16 | 1.89e-01 | -1.90e-01 | 5.35e-01 |
GOBP T CELL APOPTOTIC PROCESS | 32 | 6.33e-02 | -1.90e-01 | 3.29e-01 |
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION | 7 | 3.85e-01 | 1.90e-01 | 7.06e-01 |
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE | 6 | 4.21e-01 | -1.90e-01 | 7.32e-01 |
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION | 16 | 1.89e-01 | -1.90e-01 | 5.35e-01 |
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION | 53 | 1.72e-02 | -1.90e-01 | 1.77e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 23 | 1.16e-01 | -1.89e-01 | 4.37e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN | 8 | 3.54e-01 | 1.89e-01 | 6.84e-01 |
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY | 16 | 1.90e-01 | -1.89e-01 | 5.36e-01 |
GOCC PREFOLDIN COMPLEX | 7 | 3.86e-01 | 1.89e-01 | 7.07e-01 |
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 8 | 3.54e-01 | -1.89e-01 | 6.85e-01 |
GOBP VITAMIN METABOLIC PROCESS | 46 | 2.66e-02 | 1.89e-01 | 2.26e-01 |
GOBP SINGLE STRAND BREAK REPAIR | 9 | 3.26e-01 | 1.89e-01 | 6.63e-01 |
GOBP DIOL BIOSYNTHETIC PROCESS | 12 | 2.57e-01 | 1.89e-01 | 6.00e-01 |
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY | 5 | 4.64e-01 | -1.89e-01 | 7.61e-01 |
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS | 7 | 3.86e-01 | -1.89e-01 | 7.07e-01 |
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 14 | 2.21e-01 | -1.89e-01 | 5.73e-01 |
GOBP RHYTHMIC BEHAVIOR | 16 | 1.91e-01 | -1.89e-01 | 5.37e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION | 24 | 1.09e-01 | -1.89e-01 | 4.25e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I | 9 | 3.27e-01 | 1.89e-01 | 6.63e-01 |
GOMF CIS TRANS ISOMERASE ACTIVITY | 29 | 7.89e-02 | 1.89e-01 | 3.67e-01 |
GOBP DENDRITE MORPHOGENESIS | 60 | 1.17e-02 | -1.89e-01 | 1.41e-01 |
GOCC NUCLEAR PORE OUTER RING | 9 | 3.28e-01 | 1.89e-01 | 6.63e-01 |
GOBP PRESYNAPSE ORGANIZATION | 11 | 2.79e-01 | -1.89e-01 | 6.22e-01 |
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION | 28 | 8.46e-02 | -1.88e-01 | 3.81e-01 |
GOBP SKELETAL MUSCLE TISSUE REGENERATION | 18 | 1.67e-01 | -1.88e-01 | 5.06e-01 |
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY | 14 | 2.22e-01 | -1.88e-01 | 5.74e-01 |
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION | 6 | 4.24e-01 | 1.88e-01 | 7.34e-01 |
GOBP REGULATION OF JUN KINASE ACTIVITY | 24 | 1.11e-01 | -1.88e-01 | 4.27e-01 |
GOBP T CELL LINEAGE COMMITMENT | 17 | 1.79e-01 | -1.88e-01 | 5.25e-01 |
GOBP SALIVARY GLAND DEVELOPMENT | 7 | 3.88e-01 | 1.88e-01 | 7.09e-01 |
GOBP RESPONSE TO ELECTRICAL STIMULUS | 15 | 2.07e-01 | -1.88e-01 | 5.54e-01 |
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION | 5 | 4.66e-01 | -1.88e-01 | 7.62e-01 |
GOCC PRESYNAPTIC ENDOCYTIC ZONE | 6 | 4.25e-01 | 1.88e-01 | 7.34e-01 |
GOBP GALACTOSE METABOLIC PROCESS | 6 | 4.25e-01 | 1.88e-01 | 7.34e-01 |
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION | 35 | 5.44e-02 | -1.88e-01 | 3.03e-01 |
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY | 6 | 4.25e-01 | 1.88e-01 | 7.34e-01 |
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY | 19 | 1.56e-01 | -1.88e-01 | 4.92e-01 |
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING | 9 | 3.30e-01 | -1.88e-01 | 6.65e-01 |
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY | 8 | 3.58e-01 | -1.88e-01 | 6.87e-01 |
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 13 | 2.42e-01 | -1.88e-01 | 5.90e-01 |
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING | 14 | 2.25e-01 | -1.87e-01 | 5.75e-01 |
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY | 11 | 2.82e-01 | -1.87e-01 | 6.24e-01 |
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 41 | 3.82e-02 | -1.87e-01 | 2.63e-01 |
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 29 | 8.11e-02 | -1.87e-01 | 3.73e-01 |
GOBP REGULATION OF TRANSLATIONAL ELONGATION | 8 | 3.59e-01 | 1.87e-01 | 6.88e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 53 | 1.86e-02 | -1.87e-01 | 1.85e-01 |
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY | 14 | 2.26e-01 | 1.87e-01 | 5.75e-01 |
GOBP NEURAL CREST FORMATION | 6 | 4.28e-01 | 1.87e-01 | 7.36e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 5 | 4.69e-01 | 1.87e-01 | 7.65e-01 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 22 | 1.29e-01 | -1.87e-01 | 4.57e-01 |
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER | 6 | 4.28e-01 | -1.87e-01 | 7.36e-01 |
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES | 5 | 4.70e-01 | 1.87e-01 | 7.65e-01 |
GOMF POLY G BINDING | 8 | 3.60e-01 | -1.87e-01 | 6.88e-01 |
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 5 | 4.70e-01 | -1.87e-01 | 7.65e-01 |
GOBP EYE MORPHOGENESIS | 49 | 2.39e-02 | -1.87e-01 | 2.13e-01 |
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY | 5 | 4.70e-01 | -1.87e-01 | 7.65e-01 |
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY | 8 | 3.61e-01 | 1.87e-01 | 6.88e-01 |
GOBP VISUAL BEHAVIOR | 20 | 1.49e-01 | -1.87e-01 | 4.82e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS | 25 | 1.07e-01 | 1.87e-01 | 4.21e-01 |
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS | 6 | 4.29e-01 | -1.86e-01 | 7.36e-01 |
GOBP PROTON TRANSMEMBRANE TRANSPORT | 93 | 1.95e-03 | 1.86e-01 | 5.31e-02 |
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY | 18 | 1.72e-01 | -1.86e-01 | 5.13e-01 |
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST | 11 | 2.85e-01 | -1.86e-01 | 6.27e-01 |
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS | 22 | 1.31e-01 | -1.86e-01 | 4.58e-01 |
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT | 15 | 2.12e-01 | -1.86e-01 | 5.62e-01 |
GOBP NEUTROPHIL MIGRATION | 50 | 2.30e-02 | -1.86e-01 | 2.09e-01 |
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 37 | 5.04e-02 | -1.86e-01 | 2.94e-01 |
GOBP SMALL MOLECULE CATABOLIC PROCESS | 174 | 2.53e-05 | 1.86e-01 | 1.95e-03 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 36 | 5.36e-02 | 1.86e-01 | 3.02e-01 |
GOBP LEUKOCYTE APOPTOTIC PROCESS | 67 | 8.63e-03 | -1.86e-01 | 1.21e-01 |
GOBP POSITIVE REGULATION OF STEROL TRANSPORT | 12 | 2.65e-01 | -1.86e-01 | 6.09e-01 |
GOBP VIRION ASSEMBLY | 30 | 7.85e-02 | 1.86e-01 | 3.67e-01 |
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 10 | 3.10e-01 | -1.85e-01 | 6.49e-01 |
GOBP CHONDROITIN SULFATE METABOLIC PROCESS | 14 | 2.30e-01 | -1.85e-01 | 5.78e-01 |
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT | 15 | 2.14e-01 | 1.85e-01 | 5.66e-01 |
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE | 59 | 1.40e-02 | 1.85e-01 | 1.56e-01 |
GOBP REGULATION OF INCLUSION BODY ASSEMBLY | 10 | 3.10e-01 | -1.85e-01 | 6.49e-01 |
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS | 15 | 2.15e-01 | 1.85e-01 | 5.66e-01 |
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 9 | 3.37e-01 | -1.85e-01 | 6.73e-01 |
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE | 6 | 4.33e-01 | -1.85e-01 | 7.39e-01 |
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 23 | 1.25e-01 | 1.85e-01 | 4.52e-01 |
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE | 11 | 2.88e-01 | 1.85e-01 | 6.31e-01 |
GOCC TORC2 COMPLEX | 7 | 3.97e-01 | 1.85e-01 | 7.16e-01 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS | 357 | 3.02e-09 | 1.85e-01 | 5.91e-07 |
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS | 5 | 4.75e-01 | 1.85e-01 | 7.69e-01 |
GOMF UNFOLDED PROTEIN BINDING | 80 | 4.39e-03 | 1.85e-01 | 8.33e-02 |
GOBP REGULATION OF CELL JUNCTION ASSEMBLY | 69 | 8.12e-03 | -1.85e-01 | 1.18e-01 |
GOBP NEGATIVE REGULATION OF EXOCYTOSIS | 24 | 1.18e-01 | -1.85e-01 | 4.39e-01 |
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL | 5 | 4.75e-01 | -1.84e-01 | 7.69e-01 |
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 34 | 6.30e-02 | -1.84e-01 | 3.29e-01 |
GOBP RISC COMPLEX ASSEMBLY | 8 | 3.67e-01 | 1.84e-01 | 6.94e-01 |
GOBP MRNA 5 SPLICE SITE RECOGNITION | 5 | 4.75e-01 | -1.84e-01 | 7.69e-01 |
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY | 25 | 1.11e-01 | 1.84e-01 | 4.27e-01 |
GOBP REGULATION OF PROSTAGLANDIN SECRETION | 5 | 4.76e-01 | 1.84e-01 | 7.69e-01 |
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O | 13 | 2.50e-01 | 1.84e-01 | 5.96e-01 |
GOMF CARBON SULFUR LYASE ACTIVITY | 9 | 3.39e-01 | -1.84e-01 | 6.75e-01 |
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR | 9 | 3.39e-01 | 1.84e-01 | 6.75e-01 |
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING | 11 | 2.90e-01 | 1.84e-01 | 6.33e-01 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 6 | 4.35e-01 | 1.84e-01 | 7.40e-01 |
GOBP PROTEOGLYCAN METABOLIC PROCESS | 35 | 6.00e-02 | -1.84e-01 | 3.20e-01 |
GOBP REGULATION OF NEUROTRANSMITTER SECRETION | 30 | 8.16e-02 | -1.84e-01 | 3.74e-01 |
GOCC GOLGI LUMEN | 15 | 2.18e-01 | 1.84e-01 | 5.71e-01 |
GOMF STAT FAMILY PROTEIN BINDING | 6 | 4.36e-01 | -1.84e-01 | 7.40e-01 |
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE | 71 | 7.63e-03 | 1.84e-01 | 1.13e-01 |
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS | 55 | 1.88e-02 | -1.83e-01 | 1.85e-01 |
GOMF COMPLEMENT BINDING | 6 | 4.37e-01 | 1.83e-01 | 7.40e-01 |
GOBP ZINC ION TRANSPORT | 13 | 2.53e-01 | 1.83e-01 | 5.96e-01 |
GOBP CELLULAR OXIDANT DETOXIFICATION | 48 | 2.83e-02 | 1.83e-01 | 2.31e-01 |
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN | 6 | 4.37e-01 | 1.83e-01 | 7.41e-01 |
GOBP MITOTIC RECOMBINATION | 17 | 1.91e-01 | 1.83e-01 | 5.37e-01 |
GOCC MITOCHONDRIAL PYRUVATE DEHYDROGENASE COMPLEX | 6 | 4.38e-01 | 1.83e-01 | 7.41e-01 |
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE | 8 | 3.70e-01 | 1.83e-01 | 6.97e-01 |
GOCC EXCITATORY SYNAPSE | 13 | 2.54e-01 | -1.83e-01 | 5.97e-01 |
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX | 7 | 4.02e-01 | 1.83e-01 | 7.20e-01 |
GOBP AROMATIC AMINO ACID TRANSPORT | 7 | 4.02e-01 | -1.83e-01 | 7.20e-01 |
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM | 41 | 4.30e-02 | 1.83e-01 | 2.77e-01 |
GOBP REPRODUCTIVE BEHAVIOR | 16 | 2.06e-01 | -1.83e-01 | 5.53e-01 |
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX | 8 | 3.71e-01 | -1.83e-01 | 6.98e-01 |
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR | 25 | 1.14e-01 | 1.83e-01 | 4.34e-01 |
GOBP DETECTION OF CALCIUM ION | 6 | 4.38e-01 | 1.83e-01 | 7.41e-01 |
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION | 8 | 3.71e-01 | 1.83e-01 | 6.98e-01 |
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS | 9 | 3.43e-01 | -1.83e-01 | 6.78e-01 |
GOBP HISTONE H3 ACETYLATION | 5 | 4.80e-01 | 1.83e-01 | 7.72e-01 |
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS | 15 | 2.21e-01 | 1.82e-01 | 5.74e-01 |
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 12 | 2.74e-01 | -1.82e-01 | 6.19e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE | 36 | 5.87e-02 | 1.82e-01 | 3.16e-01 |
GOBP TRANSCRIPTION BY RNA POLYMERASE I | 52 | 2.33e-02 | 1.82e-01 | 2.10e-01 |
GOBP RESPONSE TO MECHANICAL STIMULUS | 80 | 4.99e-03 | -1.82e-01 | 9.00e-02 |
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA | 18 | 1.82e-01 | 1.82e-01 | 5.28e-01 |
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION | 13 | 2.56e-01 | -1.82e-01 | 6.00e-01 |
GOBP NCRNA EXPORT FROM NUCLEUS | 8 | 3.73e-01 | 1.82e-01 | 7.00e-01 |
GOBP MYELOID LEUKOCYTE ACTIVATION | 118 | 6.82e-04 | -1.82e-01 | 2.68e-02 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN | 9 | 3.45e-01 | 1.82e-01 | 6.79e-01 |
GOBP GRANULOCYTE MIGRATION | 60 | 1.51e-02 | -1.82e-01 | 1.66e-01 |
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY | 5 | 4.82e-01 | -1.82e-01 | 7.72e-01 |
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS | 43 | 3.96e-02 | 1.82e-01 | 2.67e-01 |
GOCC PLATELET ALPHA GRANULE | 36 | 5.96e-02 | 1.82e-01 | 3.20e-01 |
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 199 | 1.14e-05 | 1.82e-01 | 9.69e-04 |
GOBP ENDOCRINE PANCREAS DEVELOPMENT | 18 | 1.83e-01 | -1.81e-01 | 5.29e-01 |
GOBP AUTOPHAGOSOME LYSOSOME FUSION | 8 | 3.74e-01 | 1.81e-01 | 7.00e-01 |
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION | 10 | 3.21e-01 | 1.81e-01 | 6.59e-01 |
GOBP MAMMARY GLAND MORPHOGENESIS | 14 | 2.40e-01 | -1.81e-01 | 5.89e-01 |
GOBP CELLULAR RESPONSE TO NUTRIENT | 20 | 1.61e-01 | 1.81e-01 | 5.00e-01 |
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT | 6 | 4.42e-01 | -1.81e-01 | 7.45e-01 |
GOMF SIGNAL RECOGNITION PARTICLE BINDING | 7 | 4.07e-01 | 1.81e-01 | 7.23e-01 |
GOBP ALPHA BETA T CELL ACTIVATION | 94 | 2.48e-03 | -1.81e-01 | 6.15e-02 |
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY | 9 | 3.47e-01 | -1.81e-01 | 6.79e-01 |
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 15 | 2.25e-01 | -1.81e-01 | 5.75e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 3.22e-01 | 1.81e-01 | 6.59e-01 |
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 78 | 5.90e-03 | -1.81e-01 | 9.76e-02 |
GOCC MYELIN SHEATH ABAXONAL REGION | 5 | 4.84e-01 | 1.81e-01 | 7.74e-01 |
GOMF HELICASE ACTIVITY | 114 | 8.98e-04 | 1.81e-01 | 3.26e-02 |
GOMF TRANSCRIPTION COACTIVATOR BINDING | 32 | 7.72e-02 | -1.81e-01 | 3.64e-01 |
GOBP CEREBRAL CORTEX DEVELOPMENT | 63 | 1.33e-02 | -1.81e-01 | 1.51e-01 |
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION | 14 | 2.42e-01 | -1.81e-01 | 5.90e-01 |
GOBP PLATELET MORPHOGENESIS | 17 | 1.98e-01 | 1.81e-01 | 5.45e-01 |
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT | 10 | 3.23e-01 | -1.81e-01 | 6.60e-01 |
GOBP 2 OXOGLUTARATE METABOLIC PROCESS | 10 | 3.23e-01 | 1.81e-01 | 6.60e-01 |
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY | 13 | 2.60e-01 | 1.80e-01 | 6.03e-01 |
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER | 13 | 2.60e-01 | -1.80e-01 | 6.04e-01 |
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 17 | 1.98e-01 | -1.80e-01 | 5.46e-01 |
GOBP ARTERY MORPHOGENESIS | 21 | 1.53e-01 | -1.80e-01 | 4.88e-01 |
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE | 12 | 2.80e-01 | 1.80e-01 | 6.22e-01 |
GOMF G RICH STRAND TELOMERIC DNA BINDING | 10 | 3.24e-01 | -1.80e-01 | 6.62e-01 |
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE | 11 | 3.01e-01 | -1.80e-01 | 6.42e-01 |
GOBP PROTEIN KINASE C SIGNALING | 9 | 3.50e-01 | -1.80e-01 | 6.81e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 11 | 3.01e-01 | -1.80e-01 | 6.42e-01 |
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION | 13 | 2.61e-01 | 1.80e-01 | 6.05e-01 |
GOBP MUSCLE ADAPTATION | 48 | 3.12e-02 | -1.80e-01 | 2.40e-01 |
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY | 15 | 2.28e-01 | 1.80e-01 | 5.76e-01 |
GOCC GID COMPLEX | 5 | 4.86e-01 | -1.80e-01 | 7.76e-01 |
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY | 15 | 2.28e-01 | -1.80e-01 | 5.76e-01 |
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX | 9 | 3.51e-01 | 1.80e-01 | 6.82e-01 |
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION | 6 | 4.46e-01 | -1.80e-01 | 7.48e-01 |
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR | 29 | 9.44e-02 | 1.80e-01 | 3.99e-01 |
GOMF SUMO TRANSFERASE ACTIVITY | 18 | 1.87e-01 | -1.80e-01 | 5.34e-01 |
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS | 21 | 1.55e-01 | -1.80e-01 | 4.89e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 22 | 1.45e-01 | 1.80e-01 | 4.77e-01 |
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION | 8 | 3.79e-01 | -1.80e-01 | 7.04e-01 |
GOBP REGULATION OF NCRNA TRANSCRIPTION | 51 | 2.68e-02 | -1.80e-01 | 2.26e-01 |
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS | 13 | 2.63e-01 | -1.80e-01 | 6.06e-01 |
GOBP LIPOPROTEIN LOCALIZATION | 10 | 3.26e-01 | 1.79e-01 | 6.63e-01 |
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 53 | 2.41e-02 | -1.79e-01 | 2.14e-01 |
GOBP CONNECTIVE TISSUE DEVELOPMENT | 99 | 2.12e-03 | -1.79e-01 | 5.57e-02 |
GOBP INFLAMMATORY RESPONSE TO WOUNDING | 12 | 2.83e-01 | -1.79e-01 | 6.24e-01 |
GOBP PIGMENT CELL DIFFERENTIATION | 18 | 1.88e-01 | -1.79e-01 | 5.34e-01 |
GOCC EMC COMPLEX | 10 | 3.27e-01 | 1.79e-01 | 6.63e-01 |
GOBP PROTEIN TARGETING TO MITOCHONDRION | 87 | 3.97e-03 | 1.79e-01 | 7.86e-02 |
GOBP RAB PROTEIN SIGNAL TRANSDUCTION | 15 | 2.30e-01 | 1.79e-01 | 5.78e-01 |
GOBP LOCOMOTOR RHYTHM | 8 | 3.80e-01 | -1.79e-01 | 7.05e-01 |
GOBP EPITHELIAL STRUCTURE MAINTENANCE | 5 | 4.88e-01 | -1.79e-01 | 7.76e-01 |
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT | 34 | 7.11e-02 | -1.79e-01 | 3.51e-01 |
GOBP RELAXATION OF SMOOTH MUSCLE | 5 | 4.88e-01 | 1.79e-01 | 7.76e-01 |
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION | 5 | 4.89e-01 | 1.79e-01 | 7.76e-01 |
GOCC MISMATCH REPAIR COMPLEX | 7 | 4.13e-01 | 1.79e-01 | 7.27e-01 |
GOCC DESMOSOME | 10 | 3.28e-01 | -1.79e-01 | 6.63e-01 |
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE | 31 | 8.51e-02 | -1.79e-01 | 3.81e-01 |
GOBP LYSOSOMAL MICROAUTOPHAGY | 10 | 3.28e-01 | -1.79e-01 | 6.63e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA | 80 | 5.82e-03 | 1.79e-01 | 9.68e-02 |
GOMF ATPASE BINDING | 54 | 2.33e-02 | 1.79e-01 | 2.10e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS | 7 | 4.13e-01 | -1.79e-01 | 7.28e-01 |
GOMF PHOSPHOLIPASE A1 ACTIVITY | 6 | 4.49e-01 | 1.79e-01 | 7.49e-01 |
GOCC TRANSCRIPTION PREINITIATION COMPLEX | 11 | 3.05e-01 | -1.79e-01 | 6.46e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 8 | 3.82e-01 | -1.79e-01 | 7.05e-01 |
GOBP NUCLEOTIDE TRANSPORT | 27 | 1.09e-01 | 1.79e-01 | 4.24e-01 |
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION | 7 | 4.14e-01 | -1.79e-01 | 7.28e-01 |
GOBP BEHAVIORAL RESPONSE TO COCAINE | 5 | 4.90e-01 | -1.78e-01 | 7.76e-01 |
GOBP REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA | 7 | 4.14e-01 | -1.78e-01 | 7.28e-01 |
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE | 18 | 1.90e-01 | -1.78e-01 | 5.37e-01 |
GOBP ACTION POTENTIAL | 39 | 5.43e-02 | 1.78e-01 | 3.03e-01 |
GOBP MRNA 3 SPLICE SITE RECOGNITION | 6 | 4.50e-01 | 1.78e-01 | 7.50e-01 |
GOBP CELL ADHESION MEDIATED BY INTEGRIN | 42 | 4.60e-02 | -1.78e-01 | 2.83e-01 |
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 6 | 4.50e-01 | 1.78e-01 | 7.50e-01 |
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION | 6 | 4.50e-01 | 1.78e-01 | 7.50e-01 |
GOBP PRIMARY ALCOHOL METABOLIC PROCESS | 25 | 1.24e-01 | 1.78e-01 | 4.50e-01 |
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS | 32 | 8.17e-02 | -1.78e-01 | 3.74e-01 |
GOBP REGULATION OF DNA DUPLEX UNWINDING | 5 | 4.91e-01 | 1.78e-01 | 7.77e-01 |
GOBP TOOTH MINERALIZATION | 5 | 4.91e-01 | -1.78e-01 | 7.77e-01 |
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS | 5 | 4.91e-01 | -1.78e-01 | 7.77e-01 |
GOBP RRNA METHYLATION | 19 | 1.80e-01 | 1.78e-01 | 5.26e-01 |
GOMF RNA EXONUCLEASE ACTIVITY | 35 | 6.94e-02 | 1.78e-01 | 3.47e-01 |
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 4.51e-01 | 1.78e-01 | 7.51e-01 |
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE | 10 | 3.31e-01 | -1.78e-01 | 6.66e-01 |
GOCC MULTIVESICULAR BODY MEMBRANE | 18 | 1.93e-01 | 1.78e-01 | 5.39e-01 |
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.52e-01 | -1.77e-01 | 7.51e-01 |
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION | 9 | 3.57e-01 | -1.77e-01 | 6.86e-01 |
GOBP NUCLEOSIDE METABOLIC PROCESS | 30 | 9.29e-02 | 1.77e-01 | 3.96e-01 |
GOBP REGULATION OF GLUCOSE IMPORT | 24 | 1.33e-01 | -1.77e-01 | 4.60e-01 |
GOMF BUBBLE DNA BINDING | 6 | 4.52e-01 | 1.77e-01 | 7.51e-01 |
GOCC DENSE CORE GRANULE | 9 | 3.57e-01 | -1.77e-01 | 6.87e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 47 | 3.59e-02 | -1.77e-01 | 2.55e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION | 5 | 4.93e-01 | -1.77e-01 | 7.78e-01 |
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 16 | 2.20e-01 | -1.77e-01 | 5.72e-01 |
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL | 6 | 4.52e-01 | -1.77e-01 | 7.52e-01 |
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY | 11 | 3.09e-01 | 1.77e-01 | 6.49e-01 |
GOBP NEUROTRANSMITTER TRANSPORT | 60 | 1.79e-02 | -1.77e-01 | 1.81e-01 |
GOCC AP 1 ADAPTOR COMPLEX | 9 | 3.58e-01 | -1.77e-01 | 6.87e-01 |
GOBP EXOCRINE SYSTEM DEVELOPMENT | 9 | 3.58e-01 | 1.77e-01 | 6.87e-01 |
GOBP O GLYCAN PROCESSING | 21 | 1.61e-01 | -1.77e-01 | 5.00e-01 |
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE | 25 | 1.27e-01 | 1.77e-01 | 4.55e-01 |
GOBP PLASMA MEMBRANE REPAIR | 21 | 1.61e-01 | 1.77e-01 | 5.00e-01 |
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 24 | 1.35e-01 | 1.77e-01 | 4.63e-01 |
GOBP DIOL METABOLIC PROCESS | 16 | 2.22e-01 | 1.77e-01 | 5.74e-01 |
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 66 | 1.33e-02 | -1.77e-01 | 1.51e-01 |
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX | 5 | 4.94e-01 | 1.77e-01 | 7.79e-01 |
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY | 14 | 2.53e-01 | 1.77e-01 | 5.96e-01 |
GOBP RRNA CATABOLIC PROCESS | 16 | 2.22e-01 | 1.76e-01 | 5.74e-01 |
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN | 22 | 1.53e-01 | 1.76e-01 | 4.88e-01 |
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 | 42 | 4.85e-02 | -1.76e-01 | 2.88e-01 |
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 14 | 2.54e-01 | 1.76e-01 | 5.97e-01 |
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 2.23e-01 | 1.76e-01 | 5.74e-01 |
GOCC NUCLEAR CHROMOSOME | 154 | 1.74e-04 | 1.76e-01 | 9.96e-03 |
GOBP REGULATION OF MEMBRANE TUBULATION | 5 | 4.95e-01 | -1.76e-01 | 7.79e-01 |
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY | 13 | 2.72e-01 | -1.76e-01 | 6.16e-01 |
GOBP REGULATION OF STRESS GRANULE ASSEMBLY | 7 | 4.20e-01 | -1.76e-01 | 7.32e-01 |
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR | 11 | 3.12e-01 | -1.76e-01 | 6.50e-01 |
GOBP SUBSTRATE DEPENDENT CELL MIGRATION | 10 | 3.36e-01 | -1.76e-01 | 6.71e-01 |
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR | 6 | 4.56e-01 | 1.76e-01 | 7.54e-01 |
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 1.45e-01 | 1.76e-01 | 4.77e-01 |
GOBP PROSTAGLANDIN TRANSPORT | 7 | 4.21e-01 | 1.76e-01 | 7.32e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS | 13 | 2.73e-01 | -1.76e-01 | 6.17e-01 |
GOMF PROTEIN DISULFIDE REDUCTASE ACTIVITY | 22 | 1.54e-01 | 1.76e-01 | 4.88e-01 |
GOCC PLASMA MEMBRANE RAFT | 49 | 3.35e-02 | -1.76e-01 | 2.47e-01 |
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 5 | 4.96e-01 | -1.76e-01 | 7.79e-01 |
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 37 | 6.46e-02 | -1.76e-01 | 3.33e-01 |
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION | 37 | 6.48e-02 | 1.76e-01 | 3.34e-01 |
GOCC POSTSYNAPTIC RECYCLING ENDOSOME | 7 | 4.21e-01 | -1.76e-01 | 7.32e-01 |
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY | 80 | 6.81e-03 | 1.75e-01 | 1.06e-01 |
GOMF PROTEIN TYROSINE KINASE BINDING | 55 | 2.47e-02 | -1.75e-01 | 2.16e-01 |
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 46 | 3.99e-02 | -1.75e-01 | 2.68e-01 |
GOBP MEIOTIC TELOMERE CLUSTERING | 5 | 4.97e-01 | -1.75e-01 | 7.79e-01 |
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY | 17 | 2.11e-01 | 1.75e-01 | 5.60e-01 |
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 16 | 2.25e-01 | 1.75e-01 | 5.75e-01 |
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT | 38 | 6.18e-02 | -1.75e-01 | 3.26e-01 |
GOBP CORONARY VASCULATURE DEVELOPMENT | 16 | 2.26e-01 | -1.75e-01 | 5.75e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION | 20 | 1.76e-01 | -1.75e-01 | 5.20e-01 |
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS | 5 | 4.98e-01 | 1.75e-01 | 7.79e-01 |
GOBP AXO DENDRITIC PROTEIN TRANSPORT | 5 | 4.98e-01 | -1.75e-01 | 7.79e-01 |
GOBP MICROTUBULE BASED PROTEIN TRANSPORT | 5 | 4.98e-01 | -1.75e-01 | 7.79e-01 |
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE | 5 | 4.98e-01 | -1.75e-01 | 7.79e-01 |
GOBP VITAMIN TRANSPORT | 13 | 2.75e-01 | -1.75e-01 | 6.19e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY | 16 | 2.26e-01 | -1.75e-01 | 5.75e-01 |
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS | 6 | 4.58e-01 | 1.75e-01 | 7.56e-01 |
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT | 54 | 2.65e-02 | -1.75e-01 | 2.25e-01 |
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS | 19 | 1.88e-01 | 1.75e-01 | 5.34e-01 |
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM | 16 | 2.27e-01 | 1.75e-01 | 5.76e-01 |
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 13 | 2.76e-01 | 1.75e-01 | 6.19e-01 |
GOBP POSITIVE REGULATION OF CHROMATIN BINDING | 7 | 4.24e-01 | 1.75e-01 | 7.34e-01 |
GOBP NEGATIVE REGULATION OF WOUND HEALING | 18 | 2.00e-01 | -1.75e-01 | 5.47e-01 |
GOBP REGULATION OF HEPATOCYTE PROLIFERATION | 7 | 4.24e-01 | -1.75e-01 | 7.34e-01 |
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS | 16 | 2.27e-01 | 1.75e-01 | 5.76e-01 |
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION | 58 | 2.18e-02 | -1.75e-01 | 2.03e-01 |
GOBP MEIOTIC CELL CYCLE PROCESS | 84 | 5.83e-03 | 1.74e-01 | 9.68e-02 |
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY | 6 | 4.59e-01 | -1.74e-01 | 7.56e-01 |
GOBP SNO S RNA METABOLIC PROCESS | 13 | 2.76e-01 | 1.74e-01 | 6.20e-01 |
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 7 | 4.24e-01 | -1.74e-01 | 7.34e-01 |
GOBP RESPONSE TO DOPAMINE | 23 | 1.48e-01 | -1.74e-01 | 4.81e-01 |
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY | 323 | 9.70e-08 | 1.74e-01 | 1.32e-05 |
GOBP DENDRITE DEVELOPMENT | 103 | 2.33e-03 | -1.74e-01 | 5.92e-02 |
GOBP INNER CELL MASS CELL PROLIFERATION | 9 | 3.66e-01 | 1.74e-01 | 6.93e-01 |
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 4.61e-01 | -1.74e-01 | 7.57e-01 |
GOMF HISTONE KINASE ACTIVITY | 13 | 2.78e-01 | 1.74e-01 | 6.22e-01 |
GOBP MELANOCYTE DIFFERENTIATION | 10 | 3.41e-01 | -1.74e-01 | 6.76e-01 |
GOBP HEART VALVE DEVELOPMENT | 25 | 1.33e-01 | -1.74e-01 | 4.60e-01 |
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 56 | 2.48e-02 | -1.74e-01 | 2.16e-01 |
GOBP MIRNA METABOLIC PROCESS | 61 | 1.92e-02 | -1.74e-01 | 1.87e-01 |
GOCC CHROMOSOME TELOMERIC REGION | 113 | 1.48e-03 | 1.74e-01 | 4.47e-02 |
GOCC POTASSIUM CHANNEL COMPLEX | 15 | 2.45e-01 | 1.74e-01 | 5.92e-01 |
GOBP STORE OPERATED CALCIUM ENTRY | 11 | 3.19e-01 | -1.74e-01 | 6.57e-01 |
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS | 11 | 3.19e-01 | -1.74e-01 | 6.57e-01 |
GOCC MITOCHONDRION | 1116 | 4.39e-21 | 1.74e-01 | 1.59e-17 |
GOBP CENTROMERIC SISTER CHROMATID COHESION | 7 | 4.27e-01 | 1.74e-01 | 7.35e-01 |
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION | 9 | 3.68e-01 | 1.74e-01 | 6.95e-01 |
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY | 13 | 2.79e-01 | -1.73e-01 | 6.22e-01 |
GOBP MYELOID DENDRITIC CELL ACTIVATION | 14 | 2.61e-01 | -1.73e-01 | 6.05e-01 |
GOBP REGULATION OF ATP DEPENDENT ACTIVITY | 37 | 6.82e-02 | 1.73e-01 | 3.45e-01 |
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS | 16 | 2.30e-01 | 1.73e-01 | 5.78e-01 |
GOBP CELLULAR RESPONSE TO DSRNA | 13 | 2.79e-01 | -1.73e-01 | 6.22e-01 |
GOBP RESPONSE TO TUMOR NECROSIS FACTOR | 123 | 9.50e-04 | -1.73e-01 | 3.37e-02 |
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION | 38 | 6.50e-02 | 1.73e-01 | 3.34e-01 |
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 11 | 3.20e-01 | -1.73e-01 | 6.58e-01 |
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING | 89 | 4.87e-03 | 1.73e-01 | 8.81e-02 |
GOBP FACE DEVELOPMENT | 21 | 1.70e-01 | -1.73e-01 | 5.11e-01 |
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT | 10 | 3.44e-01 | -1.73e-01 | 6.79e-01 |
GOBP RESPONSE TO REDOX STATE | 7 | 4.28e-01 | 1.73e-01 | 7.36e-01 |
GOBP REGULATION OF OSTEOBLAST PROLIFERATION | 12 | 3.00e-01 | -1.73e-01 | 6.42e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY | 10 | 3.45e-01 | -1.73e-01 | 6.79e-01 |
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 25 | 1.36e-01 | -1.73e-01 | 4.64e-01 |
GOBP HYPERSENSITIVITY | 8 | 3.98e-01 | -1.73e-01 | 7.17e-01 |
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 8 | 3.99e-01 | 1.72e-01 | 7.17e-01 |
GOBP TELENCEPHALON GLIAL CELL MIGRATION | 17 | 2.19e-01 | -1.72e-01 | 5.71e-01 |
GOMF ISOMERASE ACTIVITY | 100 | 3.01e-03 | 1.72e-01 | 6.86e-02 |
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 22 | 1.63e-01 | -1.72e-01 | 5.01e-01 |
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY | 102 | 2.76e-03 | -1.72e-01 | 6.60e-02 |
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING | 31 | 9.80e-02 | -1.72e-01 | 4.06e-01 |
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 136 | 5.70e-04 | -1.72e-01 | 2.34e-02 |
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL | 5 | 5.06e-01 | 1.72e-01 | 7.86e-01 |
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS | 6 | 4.66e-01 | -1.72e-01 | 7.62e-01 |
GOBP TRNA METHYLATION | 32 | 9.30e-02 | 1.72e-01 | 3.97e-01 |
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM | 8 | 4.01e-01 | -1.72e-01 | 7.19e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 14 | 2.66e-01 | -1.72e-01 | 6.11e-01 |
GOMF TRNA BINDING | 50 | 3.62e-02 | 1.72e-01 | 2.56e-01 |
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION | 11 | 3.25e-01 | 1.72e-01 | 6.62e-01 |
GOMF PRERIBOSOME BINDING | 7 | 4.32e-01 | 1.71e-01 | 7.39e-01 |
GOCC COMPACT MYELIN | 6 | 4.67e-01 | -1.71e-01 | 7.63e-01 |
GOCC TRANSCRIPTION REPRESSOR COMPLEX | 55 | 2.81e-02 | -1.71e-01 | 2.30e-01 |
GOMF TRANSLATION REPRESSOR ACTIVITY | 21 | 1.74e-01 | 1.71e-01 | 5.17e-01 |
GOBP PIGMENT GRANULE LOCALIZATION | 11 | 3.25e-01 | -1.71e-01 | 6.63e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION | 9 | 3.74e-01 | 1.71e-01 | 7.00e-01 |
GOBP MITOCHONDRIAL TRNA PROCESSING | 12 | 3.04e-01 | 1.71e-01 | 6.45e-01 |
GOMF CELL ADHESION MEDIATOR ACTIVITY | 19 | 1.96e-01 | -1.71e-01 | 5.43e-01 |
GOBP STRIATED MUSCLE ADAPTATION | 16 | 2.36e-01 | -1.71e-01 | 5.82e-01 |
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS | 5 | 5.07e-01 | -1.71e-01 | 7.86e-01 |
GOBP STRIATED MUSCLE CELL DIFFERENTIATION | 103 | 2.82e-03 | -1.71e-01 | 6.62e-02 |
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS | 5 | 5.08e-01 | -1.71e-01 | 7.86e-01 |
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION | 13 | 2.87e-01 | -1.71e-01 | 6.29e-01 |
GOBP MYOTUBE DIFFERENTIATION | 45 | 4.82e-02 | -1.70e-01 | 2.87e-01 |
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 8 | 4.04e-01 | 1.70e-01 | 7.21e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION | 8 | 4.04e-01 | 1.70e-01 | 7.21e-01 |
GOBP RRNA METABOLIC PROCESS | 211 | 2.27e-05 | 1.70e-01 | 1.81e-03 |
GOBP SPLICEOSOMAL SNRNP ASSEMBLY | 31 | 1.02e-01 | 1.70e-01 | 4.11e-01 |
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE | 5 | 5.10e-01 | -1.70e-01 | 7.88e-01 |
GOBP PIGMENT ACCUMULATION | 8 | 4.05e-01 | -1.70e-01 | 7.22e-01 |
GOBP PIGMENT GRANULE MATURATION | 8 | 4.05e-01 | -1.70e-01 | 7.22e-01 |
GOBP LIPID DROPLET ORGANIZATION | 21 | 1.78e-01 | 1.70e-01 | 5.24e-01 |
GOCC GAMMA TUBULIN RING COMPLEX | 6 | 4.71e-01 | 1.70e-01 | 7.67e-01 |
GOCC ENDOPLASMIC RETICULUM LUMEN | 112 | 1.98e-03 | 1.70e-01 | 5.36e-02 |
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 37 | 7.44e-02 | -1.70e-01 | 3.59e-01 |
GOCC SMALL SUBUNIT PROCESSOME | 64 | 1.91e-02 | 1.70e-01 | 1.86e-01 |
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT | 8 | 4.06e-01 | 1.70e-01 | 7.23e-01 |
GOMF PHOSPHATE ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 5.12e-01 | 1.69e-01 | 7.88e-01 |
GOBP GASTRULATION | 71 | 1.38e-02 | -1.69e-01 | 1.55e-01 |
GOMF RNA CAP BINDING | 19 | 2.01e-01 | 1.69e-01 | 5.50e-01 |
GOBP ER OVERLOAD RESPONSE | 10 | 3.54e-01 | -1.69e-01 | 6.85e-01 |
GOBP PEPTIDYL LYSINE TRIMETHYLATION | 5 | 5.13e-01 | 1.69e-01 | 7.88e-01 |
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY | 13 | 2.92e-01 | -1.69e-01 | 6.34e-01 |
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT | 8 | 4.08e-01 | -1.69e-01 | 7.23e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS | 7 | 4.39e-01 | -1.69e-01 | 7.42e-01 |
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION | 12 | 3.11e-01 | -1.69e-01 | 6.49e-01 |
GOBP TRNA METABOLIC PROCESS | 136 | 7.11e-04 | 1.69e-01 | 2.77e-02 |
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS | 41 | 6.18e-02 | -1.69e-01 | 3.26e-01 |
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 16 | 2.43e-01 | -1.69e-01 | 5.91e-01 |
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION | 47 | 4.59e-02 | -1.69e-01 | 2.83e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS | 13 | 2.93e-01 | 1.68e-01 | 6.35e-01 |
GOBP SNRNA CATABOLIC PROCESS | 5 | 5.14e-01 | -1.68e-01 | 7.89e-01 |
GOBP REGULATION OF ERAD PATHWAY | 16 | 2.44e-01 | -1.68e-01 | 5.92e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX | 11 | 3.34e-01 | 1.68e-01 | 6.70e-01 |
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 16 | 2.44e-01 | -1.68e-01 | 5.92e-01 |
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY | 11 | 3.34e-01 | 1.68e-01 | 6.70e-01 |
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING | 14 | 2.76e-01 | 1.68e-01 | 6.19e-01 |
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT | 7 | 4.41e-01 | -1.68e-01 | 7.43e-01 |
GOBP SIGNAL RELEASE | 164 | 2.18e-04 | -1.68e-01 | 1.16e-02 |
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION | 6 | 4.76e-01 | -1.68e-01 | 7.69e-01 |
GOBP ATRIAL SEPTUM MORPHOGENESIS | 6 | 4.76e-01 | 1.68e-01 | 7.70e-01 |
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS | 5 | 5.15e-01 | -1.68e-01 | 7.90e-01 |
GOBP DENDRITIC SPINE DEVELOPMENT | 49 | 4.24e-02 | -1.68e-01 | 2.75e-01 |
GOBP UBIQUITIN DEPENDENT ERAD PATHWAY | 64 | 2.05e-02 | 1.68e-01 | 1.96e-01 |
GOCC MRNA CLEAVAGE FACTOR COMPLEX | 16 | 2.46e-01 | 1.68e-01 | 5.92e-01 |
GOMF TRANSCRIPTION REGULATOR ACTIVITY | 878 | 2.60e-16 | -1.68e-01 | 2.35e-13 |
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 40 | 6.69e-02 | -1.68e-01 | 3.40e-01 |
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS | 36 | 8.21e-02 | 1.68e-01 | 3.75e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION | 6 | 4.77e-01 | 1.68e-01 | 7.71e-01 |
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 11 | 3.36e-01 | -1.68e-01 | 6.72e-01 |
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY | 42 | 6.07e-02 | -1.68e-01 | 3.23e-01 |
GOMF SEQUENCE SPECIFIC DNA BINDING | 704 | 1.34e-13 | -1.68e-01 | 6.46e-11 |
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION | 5 | 5.17e-01 | 1.68e-01 | 7.90e-01 |
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 29 | 1.19e-01 | -1.67e-01 | 4.40e-01 |
GOBP CELL JUNCTION ASSEMBLY | 142 | 6.03e-04 | -1.67e-01 | 2.42e-02 |
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS | 94 | 5.14e-03 | -1.67e-01 | 9.19e-02 |
GOMF SUMO BINDING | 14 | 2.78e-01 | -1.67e-01 | 6.22e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR | 5 | 5.17e-01 | 1.67e-01 | 7.91e-01 |
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT | 9 | 3.85e-01 | -1.67e-01 | 7.06e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING | 8 | 4.13e-01 | -1.67e-01 | 7.28e-01 |
GOBP CEREBELLAR CORTEX MORPHOGENESIS | 14 | 2.79e-01 | -1.67e-01 | 6.22e-01 |
GOMF ALCOHOL BINDING | 38 | 7.49e-02 | -1.67e-01 | 3.60e-01 |
GOBP GLUTATHIONE METABOLIC PROCESS | 23 | 1.66e-01 | 1.67e-01 | 5.05e-01 |
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY | 5 | 5.18e-01 | 1.67e-01 | 7.91e-01 |
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION | 23 | 1.66e-01 | -1.67e-01 | 5.05e-01 |
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT | 5 | 5.18e-01 | -1.67e-01 | 7.91e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 28 | 1.26e-01 | -1.67e-01 | 4.55e-01 |
GOMF G PROTEIN ALPHA SUBUNIT BINDING | 14 | 2.80e-01 | 1.67e-01 | 6.22e-01 |
GOBP RRNA MODIFICATION | 26 | 1.41e-01 | 1.67e-01 | 4.72e-01 |
GOCC NEURONAL DENSE CORE VESICLE | 5 | 5.19e-01 | -1.67e-01 | 7.92e-01 |
GOBP NUCLEOLAR CHROMATIN ORGANIZATION | 8 | 4.14e-01 | 1.67e-01 | 7.28e-01 |
GOCC PERIKARYON | 36 | 8.41e-02 | -1.67e-01 | 3.81e-01 |
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS | 38 | 7.60e-02 | 1.67e-01 | 3.63e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 49 | 4.42e-02 | 1.66e-01 | 2.82e-01 |
GOCC CONDENSED CHROMOSOME | 187 | 9.71e-05 | 1.66e-01 | 6.10e-03 |
GOBP RNA DECAPPING | 13 | 3.00e-01 | -1.66e-01 | 6.42e-01 |
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 13 | 3.01e-01 | 1.66e-01 | 6.42e-01 |
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION | 7 | 4.47e-01 | 1.66e-01 | 7.49e-01 |
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE | 12 | 3.20e-01 | 1.66e-01 | 6.58e-01 |
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY | 42 | 6.35e-02 | -1.66e-01 | 3.29e-01 |
GOMF RNA 7 METHYLGUANOSINE CAP BINDING | 12 | 3.20e-01 | 1.66e-01 | 6.59e-01 |
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT | 7 | 4.48e-01 | 1.66e-01 | 7.49e-01 |
GOBP PINOCYTOSIS | 15 | 2.67e-01 | -1.66e-01 | 6.11e-01 |
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 5 | 5.21e-01 | -1.66e-01 | 7.94e-01 |
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS | 5 | 5.21e-01 | -1.66e-01 | 7.94e-01 |
GOBP N GLYCAN PROCESSING | 13 | 3.02e-01 | 1.66e-01 | 6.43e-01 |
GOBP STRESS GRANULE ASSEMBLY | 28 | 1.30e-01 | -1.66e-01 | 4.57e-01 |
GOBP INTERLEUKIN 8 PRODUCTION | 33 | 1.01e-01 | -1.65e-01 | 4.10e-01 |
GOBP REGULATION OF PROTEIN MATURATION | 33 | 1.01e-01 | -1.65e-01 | 4.10e-01 |
GOBP SMOOTH MUSCLE CELL PROLIFERATION | 62 | 2.48e-02 | -1.65e-01 | 2.16e-01 |
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT | 43 | 6.13e-02 | 1.65e-01 | 3.25e-01 |
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT | 88 | 7.58e-03 | -1.65e-01 | 1.13e-01 |
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION | 13 | 3.03e-01 | 1.65e-01 | 6.44e-01 |
GOCC SAGA COMPLEX | 20 | 2.01e-01 | 1.65e-01 | 5.50e-01 |
GOBP ACTIVATION OF GTPASE ACTIVITY | 44 | 5.86e-02 | -1.65e-01 | 3.16e-01 |
GOCC ENVELOPE | 885 | 6.30e-16 | 1.65e-01 | 5.06e-13 |
GOBP RNA 3 END PROCESSING | 76 | 1.32e-02 | 1.65e-01 | 1.50e-01 |
GOBP DENDRITIC SPINE MORPHOGENESIS | 25 | 1.54e-01 | -1.65e-01 | 4.89e-01 |
GOBP REGULATION OF XENOPHAGY | 7 | 4.51e-01 | 1.65e-01 | 7.50e-01 |
GOBP ARACHIDONIC ACID SECRETION | 6 | 4.85e-01 | -1.65e-01 | 7.74e-01 |
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS | 17 | 2.40e-01 | -1.65e-01 | 5.88e-01 |
GOBP GLUTAMINE METABOLIC PROCESS | 16 | 2.54e-01 | 1.65e-01 | 5.97e-01 |
GOBP RIBONUCLEOSIDE METABOLIC PROCESS | 16 | 2.54e-01 | 1.65e-01 | 5.97e-01 |
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 4.85e-01 | -1.65e-01 | 7.74e-01 |
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING | 6 | 4.85e-01 | -1.65e-01 | 7.74e-01 |
GOBP SKELETAL MUSCLE CONTRACTION | 8 | 4.20e-01 | -1.65e-01 | 7.32e-01 |
GOBP TRANSCRIPTION BY RNA POLYMERASE III | 49 | 4.65e-02 | 1.65e-01 | 2.83e-01 |
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT | 8 | 4.20e-01 | 1.65e-01 | 7.32e-01 |
GOBP G0 TO G1 TRANSITION | 26 | 1.47e-01 | 1.65e-01 | 4.79e-01 |
GOBP DOSAGE COMPENSATION | 28 | 1.32e-01 | -1.65e-01 | 4.60e-01 |
GOBP REGULATION OF CHROMOSOME SEGREGATION | 96 | 5.49e-03 | 1.64e-01 | 9.56e-02 |
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 4.51e-01 | 1.64e-01 | 7.51e-01 |
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY | 10 | 3.69e-01 | 1.64e-01 | 6.95e-01 |
GOMF LIGAND GATED CHANNEL ACTIVITY | 16 | 2.56e-01 | 1.64e-01 | 5.98e-01 |
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY | 14 | 2.88e-01 | 1.64e-01 | 6.30e-01 |
GOBP RESPONSE TO NICOTINE | 17 | 2.42e-01 | 1.64e-01 | 5.90e-01 |
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 9 | 3.94e-01 | 1.64e-01 | 7.13e-01 |
GOBP GOLGI RIBBON FORMATION | 9 | 3.94e-01 | -1.64e-01 | 7.14e-01 |
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE | 35 | 9.36e-02 | -1.64e-01 | 3.98e-01 |
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS | 5 | 5.26e-01 | -1.64e-01 | 7.97e-01 |
GOCC MALE PRONUCLEUS | 5 | 5.26e-01 | -1.64e-01 | 7.97e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 5 | 5.26e-01 | -1.64e-01 | 7.97e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 49 | 4.76e-02 | 1.64e-01 | 2.85e-01 |
GOMF LIPASE ACTIVATOR ACTIVITY | 12 | 3.26e-01 | 1.64e-01 | 6.63e-01 |
GOCC PLATELET ALPHA GRANULE MEMBRANE | 11 | 3.47e-01 | 1.64e-01 | 6.79e-01 |
GOBP ARF PROTEIN SIGNAL TRANSDUCTION | 14 | 2.89e-01 | -1.64e-01 | 6.32e-01 |
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION | 11 | 3.48e-01 | -1.64e-01 | 6.80e-01 |
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 12 | 3.27e-01 | 1.64e-01 | 6.63e-01 |
GOBP CELL PROLIFERATION IN FOREBRAIN | 9 | 3.96e-01 | -1.63e-01 | 7.15e-01 |
GOCC TOR COMPLEX | 8 | 4.24e-01 | 1.63e-01 | 7.34e-01 |
GOCC CHROMOSOME CENTROMERIC REGION | 180 | 1.77e-04 | 1.63e-01 | 1.00e-02 |
GOBP GAMMA DELTA T CELL ACTIVATION | 12 | 3.29e-01 | -1.63e-01 | 6.64e-01 |
GOBP CELLULAR RESPONSE TO SALT | 82 | 1.10e-02 | -1.63e-01 | 1.38e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY | 5 | 5.29e-01 | 1.63e-01 | 8.00e-01 |
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 41 | 7.17e-02 | -1.63e-01 | 3.53e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN | 10 | 3.73e-01 | -1.63e-01 | 6.99e-01 |
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 13 | 3.10e-01 | -1.63e-01 | 6.49e-01 |
GOMF CYCLIN BINDING | 21 | 1.97e-01 | -1.63e-01 | 5.45e-01 |
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT | 13 | 3.11e-01 | -1.62e-01 | 6.49e-01 |
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY | 17 | 2.47e-01 | -1.62e-01 | 5.92e-01 |
GOBP GOLGI TO VACUOLE TRANSPORT | 15 | 2.77e-01 | -1.62e-01 | 6.20e-01 |
GOBP REGULATION OF LYASE ACTIVITY | 13 | 3.11e-01 | 1.62e-01 | 6.49e-01 |
GOBP INTRACELLULAR LIPID TRANSPORT | 31 | 1.18e-01 | -1.62e-01 | 4.39e-01 |
GOBP MATURATION OF LSU RRNA | 26 | 1.52e-01 | 1.62e-01 | 4.87e-01 |
GOBP EMBRYONIC HEMOPOIESIS | 17 | 2.47e-01 | -1.62e-01 | 5.92e-01 |
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS | 16 | 2.61e-01 | 1.62e-01 | 6.05e-01 |
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS | 8 | 4.27e-01 | 1.62e-01 | 7.35e-01 |
GOCC EXOCYST | 8 | 4.27e-01 | 1.62e-01 | 7.35e-01 |
GOBP REGULATION OF BMP SIGNALING PATHWAY | 32 | 1.13e-01 | -1.62e-01 | 4.31e-01 |
GOCC CHROMOSOMAL REGION | 282 | 3.40e-06 | 1.62e-01 | 3.67e-04 |
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY | 6 | 4.92e-01 | 1.62e-01 | 7.77e-01 |
GOBP L GLUTAMATE IMPORT | 16 | 2.62e-01 | -1.62e-01 | 6.05e-01 |
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE | 21 | 1.99e-01 | 1.62e-01 | 5.46e-01 |
GOBP OXIDATIVE DEMETHYLATION | 5 | 5.30e-01 | 1.62e-01 | 8.01e-01 |
GOBP OXIDATIVE RNA DEMETHYLATION | 5 | 5.30e-01 | 1.62e-01 | 8.01e-01 |
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY | 5 | 5.30e-01 | 1.62e-01 | 8.01e-01 |
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 16 | 2.62e-01 | 1.62e-01 | 6.06e-01 |
GOMF EXONUCLEASE ACTIVITY | 59 | 3.17e-02 | 1.62e-01 | 2.42e-01 |
GOBP REGULATION OF HORMONE SECRETION | 89 | 8.44e-03 | -1.62e-01 | 1.19e-01 |
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE | 52 | 4.37e-02 | -1.62e-01 | 2.79e-01 |
GOBP EPITHELIAL CELL DEVELOPMENT | 94 | 6.84e-03 | -1.62e-01 | 1.06e-01 |
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS | 28 | 1.39e-01 | 1.62e-01 | 4.68e-01 |
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE | 13 | 3.13e-01 | 1.62e-01 | 6.50e-01 |
GOBP CELLULAR RESPONSE TO RETINOIC ACID | 21 | 2.00e-01 | 1.62e-01 | 5.47e-01 |
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE | 11 | 3.53e-01 | -1.62e-01 | 6.84e-01 |
GOBP VASCULATURE DEVELOPMENT | 280 | 3.93e-06 | -1.62e-01 | 4.08e-04 |
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION | 9 | 4.01e-01 | 1.62e-01 | 7.20e-01 |
GOBP REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS | 5 | 5.31e-01 | -1.62e-01 | 8.01e-01 |
GOBP ADULT LOCOMOTORY BEHAVIOR | 38 | 8.51e-02 | -1.62e-01 | 3.81e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION | 14 | 2.95e-01 | 1.62e-01 | 6.37e-01 |
GOBP INTERFERON BETA PRODUCTION | 38 | 8.53e-02 | -1.62e-01 | 3.81e-01 |
GOBP CELL KILLING | 86 | 9.82e-03 | -1.62e-01 | 1.30e-01 |
GOBP MEMBRANE RAFT ORGANIZATION | 17 | 2.49e-01 | -1.61e-01 | 5.96e-01 |
GOCC SMALL RIBOSOMAL SUBUNIT | 72 | 1.81e-02 | 1.61e-01 | 1.82e-01 |
GOBP CAMP MEDIATED SIGNALING | 17 | 2.50e-01 | -1.61e-01 | 5.96e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION | 28 | 1.40e-01 | -1.61e-01 | 4.69e-01 |
GOCC HETEROCHROMATIN | 52 | 4.46e-02 | 1.61e-01 | 2.82e-01 |
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS | 16 | 2.65e-01 | -1.61e-01 | 6.09e-01 |
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 4.95e-01 | 1.61e-01 | 7.79e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION | 10 | 3.78e-01 | -1.61e-01 | 7.03e-01 |
GOBP REGULATION OF VESICLE FUSION | 9 | 4.04e-01 | 1.61e-01 | 7.21e-01 |
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY | 5 | 5.34e-01 | -1.61e-01 | 8.03e-01 |
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT | 41 | 7.55e-02 | 1.61e-01 | 3.62e-01 |
GOBP CELL VOLUME HOMEOSTASIS | 16 | 2.66e-01 | -1.61e-01 | 6.11e-01 |
GOBP SPERMATID NUCLEUS DIFFERENTIATION | 13 | 3.17e-01 | -1.61e-01 | 6.55e-01 |
GOMF LNCRNA BINDING | 10 | 3.80e-01 | 1.61e-01 | 7.04e-01 |
GOCC PRECATALYTIC SPLICEOSOME | 52 | 4.57e-02 | 1.60e-01 | 2.83e-01 |
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY | 6 | 4.96e-01 | 1.60e-01 | 7.79e-01 |
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION | 25 | 1.66e-01 | -1.60e-01 | 5.05e-01 |
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY | 54 | 4.22e-02 | -1.60e-01 | 2.74e-01 |
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS | 21 | 2.05e-01 | 1.60e-01 | 5.52e-01 |
GOMF WIDE PORE CHANNEL ACTIVITY | 6 | 4.98e-01 | 1.60e-01 | 7.79e-01 |
GOBP MICROVILLUS ASSEMBLY | 16 | 2.69e-01 | -1.60e-01 | 6.12e-01 |
GOBP APPENDAGE MORPHOGENESIS | 50 | 5.11e-02 | -1.60e-01 | 2.96e-01 |
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION | 8 | 4.34e-01 | 1.60e-01 | 7.39e-01 |
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY | 30 | 1.31e-01 | 1.60e-01 | 4.58e-01 |
GOBP GLYCEROL ETHER METABOLIC PROCESS | 10 | 3.82e-01 | -1.60e-01 | 7.06e-01 |
GOCC MITOTIC SPINDLE MIDZONE | 8 | 4.35e-01 | -1.60e-01 | 7.39e-01 |
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 30 | 1.31e-01 | -1.60e-01 | 4.58e-01 |
GOBP CARTILAGE DEVELOPMENT | 62 | 3.02e-02 | -1.60e-01 | 2.37e-01 |
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION | 14 | 3.02e-01 | -1.59e-01 | 6.43e-01 |
GOBP RESPONSE TO CALCIUM ION | 63 | 2.91e-02 | -1.59e-01 | 2.34e-01 |
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION | 27 | 1.52e-01 | -1.59e-01 | 4.87e-01 |
GOCC CYTOSOLIC RIBOSOME | 104 | 5.17e-03 | -1.59e-01 | 9.20e-02 |
GOCC SMAD PROTEIN COMPLEX | 6 | 5.00e-01 | -1.59e-01 | 7.80e-01 |
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY | 8 | 4.36e-01 | -1.59e-01 | 7.40e-01 |
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION | 5 | 5.38e-01 | -1.59e-01 | 8.04e-01 |
GOBP NEPHRON MORPHOGENESIS | 13 | 3.21e-01 | 1.59e-01 | 6.59e-01 |
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR | 36 | 9.92e-02 | -1.59e-01 | 4.09e-01 |
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT | 5 | 5.38e-01 | -1.59e-01 | 8.04e-01 |
GOBP RESPONSE TO IMMOBILIZATION STRESS | 10 | 3.85e-01 | -1.59e-01 | 7.06e-01 |
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 5 | 5.39e-01 | -1.59e-01 | 8.04e-01 |
GOBP REGULATION OF NEUTROPHIL MIGRATION | 19 | 2.31e-01 | -1.59e-01 | 5.78e-01 |
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 23 | 1.88e-01 | -1.59e-01 | 5.34e-01 |
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 17 | 2.58e-01 | -1.59e-01 | 6.00e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION | 18 | 2.45e-01 | -1.59e-01 | 5.92e-01 |
GOBP VENTRICULAR SEPTUM DEVELOPMENT | 27 | 1.55e-01 | -1.58e-01 | 4.89e-01 |
GOBP REGULATION OF MACROPHAGE MIGRATION | 19 | 2.33e-01 | 1.58e-01 | 5.79e-01 |
GOMF GLUCOSE BINDING | 6 | 5.02e-01 | -1.58e-01 | 7.82e-01 |
GOCC MICROBODY | 86 | 1.16e-02 | 1.58e-01 | 1.41e-01 |
GOBP SKELETAL SYSTEM DEVELOPMENT | 175 | 3.39e-04 | -1.58e-01 | 1.62e-02 |
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR | 15 | 2.90e-01 | 1.58e-01 | 6.33e-01 |
GOCC EXTRINSIC COMPONENT OF ENDOSOME MEMBRANE | 5 | 5.41e-01 | 1.58e-01 | 8.05e-01 |
GOBP NEGATIVE REGULATION OF TISSUE REMODELING | 8 | 4.40e-01 | -1.58e-01 | 7.42e-01 |
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS | 55 | 4.34e-02 | -1.58e-01 | 2.78e-01 |
GOBP NEGATIVE REGULATION OF CELL KILLING | 17 | 2.61e-01 | -1.58e-01 | 6.04e-01 |
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 22 | 2.01e-01 | 1.58e-01 | 5.49e-01 |
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI | 30 | 1.36e-01 | 1.58e-01 | 4.64e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION | 75 | 1.87e-02 | -1.57e-01 | 1.85e-01 |
GOBP POSITIVE REGULATION OF ERAD PATHWAY | 12 | 3.46e-01 | -1.57e-01 | 6.79e-01 |
GOMF PROTEIN SERINE THREONINE KINASE BINDING | 7 | 4.71e-01 | -1.57e-01 | 7.67e-01 |
GOBP REGULATION OF HEART RATE | 22 | 2.02e-01 | 1.57e-01 | 5.50e-01 |
GOBP MEMORY | 42 | 7.83e-02 | -1.57e-01 | 3.66e-01 |
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY | 11 | 3.67e-01 | -1.57e-01 | 6.94e-01 |
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION | 7 | 4.72e-01 | -1.57e-01 | 7.67e-01 |
GOBP REGULATED EXOCYTOSIS | 105 | 5.57e-03 | -1.57e-01 | 9.62e-02 |
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 10 | 3.90e-01 | -1.57e-01 | 7.11e-01 |
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION | 136 | 1.67e-03 | 1.57e-01 | 4.86e-02 |
GOBP BASE EXCISION REPAIR | 33 | 1.20e-01 | 1.57e-01 | 4.42e-01 |
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 32 | 1.25e-01 | 1.57e-01 | 4.53e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION | 15 | 2.94e-01 | -1.57e-01 | 6.36e-01 |
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 30 | 1.38e-01 | -1.57e-01 | 4.67e-01 |
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS | 28 | 1.52e-01 | -1.57e-01 | 4.86e-01 |
GOBP T CELL PROLIFERATION | 109 | 4.87e-03 | -1.57e-01 | 8.81e-02 |
GOBP V D J RECOMBINATION | 14 | 3.11e-01 | 1.57e-01 | 6.49e-01 |
GOBP T CELL TOLERANCE INDUCTION | 5 | 5.45e-01 | -1.57e-01 | 8.08e-01 |
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY | 10 | 3.92e-01 | -1.57e-01 | 7.12e-01 |
GOBP T CELL RECEPTOR SIGNALING PATHWAY | 90 | 1.05e-02 | -1.56e-01 | 1.35e-01 |
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS | 6 | 5.07e-01 | -1.56e-01 | 7.86e-01 |
GOBP CATECHOLAMINE UPTAKE | 5 | 5.45e-01 | 1.56e-01 | 8.08e-01 |
GOBP VESICLE FUSION WITH GOLGI APPARATUS | 8 | 4.44e-01 | 1.56e-01 | 7.46e-01 |
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT | 25 | 1.77e-01 | -1.56e-01 | 5.21e-01 |
GOBP MUCUS SECRETION | 8 | 4.44e-01 | -1.56e-01 | 7.46e-01 |
GOCC POSTSYNAPTIC ENDOSOME | 9 | 4.17e-01 | -1.56e-01 | 7.30e-01 |
GOBP CELLULAR LIPID CATABOLIC PROCESS | 99 | 7.46e-03 | 1.56e-01 | 1.12e-01 |
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY | 6 | 5.08e-01 | -1.56e-01 | 7.86e-01 |
GOCC COATED VESICLE MEMBRANE | 128 | 2.39e-03 | 1.56e-01 | 6.02e-02 |
GOMF CAMP RESPONSE ELEMENT BINDING | 9 | 4.18e-01 | -1.56e-01 | 7.30e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS | 12 | 3.50e-01 | -1.56e-01 | 6.81e-01 |
GOCC SARCOPLASMIC RETICULUM MEMBRANE | 17 | 2.66e-01 | 1.56e-01 | 6.11e-01 |
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS | 387 | 2.09e-07 | 1.56e-01 | 2.74e-05 |
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 9 | 4.19e-01 | 1.56e-01 | 7.31e-01 |
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 66 | 2.92e-02 | -1.56e-01 | 2.34e-01 |
GOBP LIPID OXIDATION | 61 | 3.60e-02 | 1.56e-01 | 2.56e-01 |
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 22 | 2.07e-01 | 1.56e-01 | 5.54e-01 |
GOBP ADULT BEHAVIOR | 53 | 5.06e-02 | -1.55e-01 | 2.95e-01 |
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION | 262 | 1.74e-05 | -1.55e-01 | 1.45e-03 |
GOCC SPECIFIC GRANULE LUMEN | 28 | 1.55e-01 | 1.55e-01 | 4.90e-01 |
GOBP PROTEIN TARGETING TO LYSOSOME | 27 | 1.63e-01 | 1.55e-01 | 5.01e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 88 | 1.20e-02 | 1.55e-01 | 1.43e-01 |
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE | 15 | 2.98e-01 | 1.55e-01 | 6.40e-01 |
GOBP NEGATIVE REGULATION OF BONE REMODELING | 6 | 5.11e-01 | -1.55e-01 | 7.88e-01 |
GOBP REGULATION OF PLASMINOGEN ACTIVATION | 7 | 4.78e-01 | 1.55e-01 | 7.71e-01 |
GOBP CIRCADIAN RHYTHM | 103 | 6.75e-03 | -1.55e-01 | 1.05e-01 |
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT | 11 | 3.74e-01 | -1.55e-01 | 7.00e-01 |
GOBP PROTEIN K27 LINKED UBIQUITINATION | 5 | 5.49e-01 | 1.55e-01 | 8.11e-01 |
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 9 | 4.21e-01 | -1.55e-01 | 7.32e-01 |
GOBP REGULATION OF CELL KILLING | 45 | 7.32e-02 | -1.55e-01 | 3.57e-01 |
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE | 12 | 3.54e-01 | -1.55e-01 | 6.85e-01 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING | 24 | 1.91e-01 | -1.54e-01 | 5.37e-01 |
GOBP PLASMA MEMBRANE TUBULATION | 12 | 3.54e-01 | -1.54e-01 | 6.85e-01 |
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE | 50 | 5.93e-02 | 1.54e-01 | 3.18e-01 |
GOBP STEM CELL DIVISION | 16 | 2.85e-01 | -1.54e-01 | 6.27e-01 |
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING | 20 | 2.32e-01 | 1.54e-01 | 5.78e-01 |
GOBP REGULATION OF DNA METHYLATION | 13 | 3.36e-01 | 1.54e-01 | 6.71e-01 |
GOBP OPTIC NERVE DEVELOPMENT | 5 | 5.50e-01 | -1.54e-01 | 8.12e-01 |
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY | 6 | 5.13e-01 | 1.54e-01 | 7.88e-01 |
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY | 140 | 1.72e-03 | -1.54e-01 | 4.95e-02 |
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE | 45 | 7.40e-02 | -1.54e-01 | 3.59e-01 |
GOBP CLATHRIN COATED VESICLE CARGO LOADING | 6 | 5.13e-01 | 1.54e-01 | 7.88e-01 |
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION | 15 | 3.02e-01 | -1.54e-01 | 6.43e-01 |
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA | 8 | 4.51e-01 | 1.54e-01 | 7.51e-01 |
GOCC SM LIKE PROTEIN FAMILY COMPLEX | 76 | 2.07e-02 | 1.54e-01 | 1.96e-01 |
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT | 9 | 4.25e-01 | 1.54e-01 | 7.34e-01 |
GOBP REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY | 38 | 1.01e-01 | -1.54e-01 | 4.11e-01 |
GOBP DENDRITE EXTENSION | 20 | 2.34e-01 | -1.54e-01 | 5.81e-01 |
GOBP SNRNA TRANSPORT | 6 | 5.14e-01 | 1.54e-01 | 7.89e-01 |
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION | 14 | 3.20e-01 | 1.54e-01 | 6.58e-01 |
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 490 | 9.89e-09 | -1.54e-01 | 1.63e-06 |
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI | 24 | 1.93e-01 | 1.54e-01 | 5.40e-01 |
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION | 7 | 4.82e-01 | -1.54e-01 | 7.72e-01 |
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 59 | 4.19e-02 | -1.53e-01 | 2.73e-01 |
GOBP CELLULAR METABOLIC COMPOUND SALVAGE | 20 | 2.35e-01 | 1.53e-01 | 5.82e-01 |
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY | 206 | 1.63e-04 | -1.53e-01 | 9.46e-03 |
GOBP RAC PROTEIN SIGNAL TRANSDUCTION | 32 | 1.34e-01 | -1.53e-01 | 4.62e-01 |
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 8 | 4.53e-01 | -1.53e-01 | 7.52e-01 |
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION | 32 | 1.34e-01 | -1.53e-01 | 4.62e-01 |
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS | 11 | 3.79e-01 | -1.53e-01 | 7.04e-01 |
GOBP MONONUCLEAR CELL MIGRATION | 82 | 1.68e-02 | -1.53e-01 | 1.75e-01 |
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS | 14 | 3.22e-01 | 1.53e-01 | 6.59e-01 |
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY | 23 | 2.05e-01 | 1.53e-01 | 5.52e-01 |
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX | 12 | 3.60e-01 | 1.53e-01 | 6.88e-01 |
GOMF SCAFFOLD PROTEIN BINDING | 31 | 1.41e-01 | -1.53e-01 | 4.72e-01 |
GOBP REGULATION OF STEM CELL PROLIFERATION | 30 | 1.48e-01 | -1.53e-01 | 4.81e-01 |
GOMF TRIGLYCERIDE LIPASE ACTIVITY | 5 | 5.54e-01 | 1.53e-01 | 8.14e-01 |
GOBP CAMP METABOLIC PROCESS | 7 | 4.85e-01 | 1.53e-01 | 7.74e-01 |
GOBP LEARNING | 54 | 5.29e-02 | -1.53e-01 | 3.00e-01 |
GOBP REGULATION OF GLIAL CELL PROLIFERATION | 21 | 2.27e-01 | -1.53e-01 | 5.76e-01 |
GOCC RNA POLYMERASE II HOLOENZYME | 58 | 4.49e-02 | 1.53e-01 | 2.82e-01 |
GOBP REGULATION OF T CELL CHEMOTAXIS | 6 | 5.18e-01 | -1.53e-01 | 7.91e-01 |
GOBP RESPONSE TO COBALT ION | 8 | 4.55e-01 | 1.52e-01 | 7.54e-01 |
GOBP REGULATION OF PROTEIN GLYCOSYLATION | 5 | 5.55e-01 | 1.52e-01 | 8.14e-01 |
GOBP INTERFERON ALPHA PRODUCTION | 15 | 3.07e-01 | 1.52e-01 | 6.48e-01 |
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS | 61 | 4.01e-02 | -1.52e-01 | 2.69e-01 |
GOBP RESPONSE TO CATECHOLAMINE | 30 | 1.49e-01 | -1.52e-01 | 4.82e-01 |
GOBP FOLIC ACID METABOLIC PROCESS | 10 | 4.05e-01 | 1.52e-01 | 7.22e-01 |
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION | 23 | 2.07e-01 | -1.52e-01 | 5.54e-01 |
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS | 60 | 4.21e-02 | -1.52e-01 | 2.74e-01 |
GOBP NEURAL TUBE PATTERNING | 14 | 3.25e-01 | -1.52e-01 | 6.63e-01 |
GOBP RESPONSE TO GLYCOPROTEIN | 7 | 4.86e-01 | 1.52e-01 | 7.76e-01 |
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 66 | 3.31e-02 | 1.52e-01 | 2.46e-01 |
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION | 21 | 2.28e-01 | -1.52e-01 | 5.76e-01 |
GOBP MANNOSYLATION | 15 | 3.09e-01 | 1.52e-01 | 6.48e-01 |
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT | 19 | 2.52e-01 | 1.52e-01 | 5.96e-01 |
GOCC TERTIARY GRANULE MEMBRANE | 40 | 9.69e-02 | -1.52e-01 | 4.03e-01 |
GOBP RESPONSE TO ACETYLCHOLINE | 15 | 3.09e-01 | -1.52e-01 | 6.48e-01 |
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS | 8 | 4.57e-01 | 1.52e-01 | 7.55e-01 |
GOBP NEGATIVE REGULATION OF SECRETION | 69 | 2.97e-02 | -1.52e-01 | 2.35e-01 |
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY | 6 | 5.20e-01 | -1.52e-01 | 7.93e-01 |
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 54 | 5.45e-02 | -1.52e-01 | 3.03e-01 |
GOBP STEROL BIOSYNTHETIC PROCESS | 35 | 1.21e-01 | -1.52e-01 | 4.46e-01 |
GOBP REGULATION OF MYELINATION | 23 | 2.09e-01 | 1.52e-01 | 5.57e-01 |
GOBP ENDOCHONDRAL BONE MORPHOGENESIS | 17 | 2.80e-01 | -1.51e-01 | 6.22e-01 |
GOBP REGULATION OF VIRAL TRANSCRIPTION | 13 | 3.45e-01 | -1.51e-01 | 6.79e-01 |
GOBP REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 13 | 3.45e-01 | 1.51e-01 | 6.79e-01 |
GOBP ENTRAINMENT OF CIRCADIAN CLOCK | 19 | 2.54e-01 | -1.51e-01 | 5.97e-01 |
GOBP DNA LIGATION | 12 | 3.64e-01 | 1.51e-01 | 6.91e-01 |
GOBP EXTRACELLULAR EXOSOME ASSEMBLY | 5 | 5.58e-01 | -1.51e-01 | 8.16e-01 |
GOBP MYOBLAST MIGRATION | 7 | 4.89e-01 | -1.51e-01 | 7.76e-01 |
GOBP FATTY ACID HOMEOSTASIS | 5 | 5.58e-01 | -1.51e-01 | 8.16e-01 |
GOCC MICROVILLUS MEMBRANE | 12 | 3.65e-01 | -1.51e-01 | 6.91e-01 |
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS | 57 | 4.89e-02 | -1.51e-01 | 2.89e-01 |
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS | 53 | 5.75e-02 | 1.51e-01 | 3.13e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION | 14 | 3.28e-01 | -1.51e-01 | 6.64e-01 |
GOCC EXON EXON JUNCTION COMPLEX | 11 | 3.86e-01 | 1.51e-01 | 7.07e-01 |
GOBP RESPONSE TO DIETARY EXCESS | 9 | 4.33e-01 | -1.51e-01 | 7.39e-01 |
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS | 5 | 5.59e-01 | 1.51e-01 | 8.16e-01 |
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS | 55 | 5.35e-02 | 1.51e-01 | 3.02e-01 |
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 7 | 4.90e-01 | 1.51e-01 | 7.76e-01 |
GOBP ACIDIC AMINO ACID TRANSPORT | 23 | 2.11e-01 | -1.51e-01 | 5.60e-01 |
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE | 15 | 3.13e-01 | 1.50e-01 | 6.51e-01 |
GOBP METHYLGUANOSINE CAP DECAPPING | 12 | 3.67e-01 | -1.50e-01 | 6.94e-01 |
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY | 10 | 4.10e-01 | -1.50e-01 | 7.26e-01 |
GOMF ALPHA TUBULIN BINDING | 22 | 2.22e-01 | -1.50e-01 | 5.74e-01 |
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 25 | 1.93e-01 | -1.50e-01 | 5.40e-01 |
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION | 10 | 4.10e-01 | -1.50e-01 | 7.26e-01 |
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT | 6 | 5.24e-01 | 1.50e-01 | 7.96e-01 |
GOCC TRAMP COMPLEX | 5 | 5.61e-01 | -1.50e-01 | 8.17e-01 |
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY | 7 | 4.91e-01 | -1.50e-01 | 7.77e-01 |
GOMF G PROTEIN ACTIVITY | 30 | 1.55e-01 | -1.50e-01 | 4.90e-01 |
GOBP RELAXATION OF CARDIAC MUSCLE | 10 | 4.11e-01 | -1.50e-01 | 7.26e-01 |
GOMF MOLECULAR TAG ACTIVITY | 11 | 3.89e-01 | 1.50e-01 | 7.09e-01 |
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 39 | 1.05e-01 | -1.50e-01 | 4.18e-01 |
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 37 | 1.14e-01 | 1.50e-01 | 4.35e-01 |
GOBP XENOBIOTIC TRANSPORT | 12 | 3.68e-01 | 1.50e-01 | 6.95e-01 |
GOBP REGULATION OF CELL FATE COMMITMENT | 13 | 3.49e-01 | 1.50e-01 | 6.81e-01 |
GOBP REGULATION OF CELL FATE SPECIFICATION | 13 | 3.49e-01 | 1.50e-01 | 6.81e-01 |
GOBP ACUTE PHASE RESPONSE | 8 | 4.63e-01 | -1.50e-01 | 7.60e-01 |
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION | 5 | 5.62e-01 | -1.50e-01 | 8.17e-01 |
GOBP PROTEIN LOCALIZATION TO MICROTUBULE | 11 | 3.90e-01 | 1.50e-01 | 7.11e-01 |
GOBP CELLULAR RESPONSE TO FATTY ACID | 9 | 4.37e-01 | -1.50e-01 | 7.41e-01 |
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 6 | 5.26e-01 | 1.50e-01 | 7.97e-01 |
GOBP MITOCHONDRIAL FISSION | 28 | 1.71e-01 | 1.50e-01 | 5.13e-01 |
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 29 | 1.64e-01 | -1.49e-01 | 5.02e-01 |
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION | 10 | 4.13e-01 | -1.49e-01 | 7.28e-01 |
GOBP DOPAMINERGIC NEURON DIFFERENTIATION | 10 | 4.13e-01 | -1.49e-01 | 7.28e-01 |
GOMF PROTEIN KINASE A BINDING | 34 | 1.32e-01 | -1.49e-01 | 4.60e-01 |
GOBP RESPONSE TO FOOD | 11 | 3.92e-01 | -1.49e-01 | 7.12e-01 |
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY | 7 | 4.95e-01 | 1.49e-01 | 7.79e-01 |
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 5 | 5.64e-01 | -1.49e-01 | 8.17e-01 |
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL | 5 | 5.64e-01 | -1.49e-01 | 8.17e-01 |
GOMF PHOSPHATASE INHIBITOR ACTIVITY | 23 | 2.16e-01 | -1.49e-01 | 5.68e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN | 45 | 8.43e-02 | 1.49e-01 | 3.81e-01 |
GOCC NUCLEAR PORE | 80 | 2.16e-02 | 1.49e-01 | 2.02e-01 |
GOBP NEUTROPHIL CHEMOTAXIS | 40 | 1.04e-01 | -1.49e-01 | 4.15e-01 |
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE | 62 | 4.31e-02 | -1.49e-01 | 2.77e-01 |
GOBP VITAMIN BIOSYNTHETIC PROCESS | 9 | 4.40e-01 | 1.49e-01 | 7.42e-01 |
GOBP TUBE MORPHOGENESIS | 317 | 6.48e-06 | -1.49e-01 | 6.16e-04 |
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY | 76 | 2.53e-02 | -1.49e-01 | 2.19e-01 |
GOCC CATALYTIC STEP 1 SPLICEOSOME | 12 | 3.72e-01 | 1.49e-01 | 6.99e-01 |
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY | 42 | 9.59e-02 | 1.49e-01 | 4.01e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 20 | 2.50e-01 | 1.49e-01 | 5.96e-01 |
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY | 5 | 5.65e-01 | -1.49e-01 | 8.18e-01 |
GOBP SEBACEOUS GLAND DEVELOPMENT | 6 | 5.28e-01 | -1.49e-01 | 8.00e-01 |
GOBP MITOTIC SISTER CHROMATID SEPARATION | 45 | 8.50e-02 | 1.49e-01 | 3.81e-01 |
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY | 12 | 3.73e-01 | 1.49e-01 | 6.99e-01 |
GOBP HIPPO SIGNALING | 20 | 2.50e-01 | -1.49e-01 | 5.96e-01 |
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION | 106 | 8.47e-03 | 1.49e-01 | 1.19e-01 |
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 126 | 4.14e-03 | -1.49e-01 | 8.05e-02 |
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS | 5 | 5.65e-01 | 1.48e-01 | 8.18e-01 |
GOBP NUCLEAR MEMBRANE ORGANIZATION | 36 | 1.24e-01 | 1.48e-01 | 4.51e-01 |
GOMF TRANSFERRIN RECEPTOR BINDING | 6 | 5.30e-01 | 1.48e-01 | 8.00e-01 |
GOBP MULTIVESICULAR BODY SORTING PATHWAY | 41 | 1.01e-01 | 1.48e-01 | 4.10e-01 |
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY PHOSPHOTRANSFERASES | 6 | 5.30e-01 | 1.48e-01 | 8.01e-01 |
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 57 | 5.37e-02 | -1.48e-01 | 3.02e-01 |
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION | 7 | 4.98e-01 | -1.48e-01 | 7.79e-01 |
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY | 5 | 5.67e-01 | -1.48e-01 | 8.19e-01 |
GOMF NUCLEAR RETINOID X RECEPTOR BINDING | 11 | 3.96e-01 | -1.48e-01 | 7.15e-01 |
GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY | 5 | 5.67e-01 | -1.48e-01 | 8.19e-01 |
GOBP CELLULAR COMPONENT MAINTENANCE | 28 | 1.77e-01 | 1.48e-01 | 5.21e-01 |
GOBP NEGATIVE REGULATION OF MRNA PROCESSING | 20 | 2.54e-01 | 1.48e-01 | 5.97e-01 |
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 27 | 1.85e-01 | -1.47e-01 | 5.31e-01 |
GOMF PRE MRNA BINDING | 28 | 1.77e-01 | -1.47e-01 | 5.22e-01 |
GOMF BHLH TRANSCRIPTION FACTOR BINDING | 16 | 3.08e-01 | -1.47e-01 | 6.48e-01 |
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL | 7 | 5.00e-01 | 1.47e-01 | 7.80e-01 |
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL | 7 | 5.00e-01 | 1.47e-01 | 7.80e-01 |
GOBP ACYLGLYCEROL HOMEOSTASIS | 9 | 4.44e-01 | -1.47e-01 | 7.46e-01 |
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR | 5 | 5.68e-01 | 1.47e-01 | 8.19e-01 |
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION | 18 | 2.79e-01 | -1.47e-01 | 6.22e-01 |
GOCC POSTSYNAPTIC DENSITY INTRACELLULAR COMPONENT | 6 | 5.32e-01 | -1.47e-01 | 8.02e-01 |
GOBP FACULTATIVE HETEROCHROMATIN FORMATION | 33 | 1.44e-01 | 1.47e-01 | 4.75e-01 |
GOCC RSC TYPE COMPLEX | 14 | 3.40e-01 | 1.47e-01 | 6.76e-01 |
GOMF MRNA METHYLTRANSFERASE ACTIVITY | 11 | 3.98e-01 | -1.47e-01 | 7.17e-01 |
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS | 15 | 3.24e-01 | -1.47e-01 | 6.61e-01 |
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING | 75 | 2.80e-02 | 1.47e-01 | 2.30e-01 |
GOMF MAP KINASE KINASE ACTIVITY | 14 | 3.41e-01 | -1.47e-01 | 6.76e-01 |
GOMF NEUREXIN FAMILY PROTEIN BINDING | 6 | 5.33e-01 | -1.47e-01 | 8.03e-01 |
GOBP REGULATION OF REGULATED SECRETORY PATHWAY | 59 | 5.15e-02 | -1.47e-01 | 2.97e-01 |
GOCC HOST CELLULAR COMPONENT | 6 | 5.33e-01 | -1.47e-01 | 8.03e-01 |
GOCC CATENIN COMPLEX | 6 | 5.34e-01 | -1.47e-01 | 8.03e-01 |
GOMF MEMBRANE INSERTASE ACTIVITY | 17 | 2.96e-01 | 1.47e-01 | 6.37e-01 |
GOMF SIRNA BINDING | 8 | 4.73e-01 | -1.47e-01 | 7.68e-01 |
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS | 15 | 3.26e-01 | -1.47e-01 | 6.63e-01 |
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 5 | 5.70e-01 | -1.47e-01 | 8.21e-01 |
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 30 | 1.65e-01 | 1.47e-01 | 5.04e-01 |
GOBP CONSTITUTIVE SECRETORY PATHWAY | 5 | 5.71e-01 | 1.47e-01 | 8.21e-01 |
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION | 7 | 5.02e-01 | -1.46e-01 | 7.82e-01 |
GOBP MUSCLE CELL DIFFERENTIATION | 147 | 2.29e-03 | -1.46e-01 | 5.88e-02 |
GOMF TRNA CYTOSINE METHYLTRANSFERASE ACTIVITY | 9 | 4.47e-01 | -1.46e-01 | 7.48e-01 |
GOBP REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 12 | 3.80e-01 | -1.46e-01 | 7.05e-01 |
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS | 12 | 3.81e-01 | -1.46e-01 | 7.05e-01 |
GOBP MALE MEIOSIS I | 8 | 4.74e-01 | 1.46e-01 | 7.69e-01 |
GOBP RESPONSE TO HYDROXYUREA | 8 | 4.74e-01 | 1.46e-01 | 7.69e-01 |
GOCC COATED VESICLE | 195 | 4.69e-04 | 1.46e-01 | 2.05e-02 |
GOBP HORMONE TRANSPORT | 109 | 8.62e-03 | -1.46e-01 | 1.21e-01 |
GOBP NEGATIVE REGULATION OF AXON EXTENSION | 12 | 3.81e-01 | -1.46e-01 | 7.05e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION | 6 | 5.35e-01 | -1.46e-01 | 8.03e-01 |
GOBP REGULATION OF RECEPTOR CLUSTERING | 7 | 5.04e-01 | 1.46e-01 | 7.83e-01 |
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION | 15 | 3.28e-01 | -1.46e-01 | 6.63e-01 |
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY | 17 | 2.98e-01 | -1.46e-01 | 6.40e-01 |
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS | 5 | 5.72e-01 | -1.46e-01 | 8.21e-01 |
GOBP RECEPTOR CLUSTERING | 25 | 2.07e-01 | 1.46e-01 | 5.54e-01 |
GOMF MOLECULAR CARRIER ACTIVITY | 73 | 3.16e-02 | 1.46e-01 | 2.41e-01 |
GOBP PEPTIDYL PROLINE MODIFICATION | 22 | 2.37e-01 | 1.46e-01 | 5.84e-01 |
GOBP RESPONSE TO CAFFEINE | 5 | 5.73e-01 | 1.46e-01 | 8.22e-01 |
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 14 | 3.46e-01 | -1.46e-01 | 6.79e-01 |
GOMF AMINOPEPTIDASE ACTIVITY | 24 | 2.17e-01 | 1.46e-01 | 5.70e-01 |
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION | 18 | 2.85e-01 | -1.46e-01 | 6.27e-01 |
GOBP RESPONSE TO INTERLEUKIN 6 | 16 | 3.14e-01 | -1.46e-01 | 6.52e-01 |
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS | 7 | 5.05e-01 | -1.45e-01 | 7.85e-01 |
GOBP MULTIVESICULAR BODY ORGANIZATION | 29 | 1.76e-01 | 1.45e-01 | 5.20e-01 |
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS | 8 | 4.77e-01 | -1.45e-01 | 7.70e-01 |
GOBP ACUTE INFLAMMATORY RESPONSE | 31 | 1.62e-01 | -1.45e-01 | 5.01e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 33 | 1.50e-01 | -1.45e-01 | 4.83e-01 |
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES | 11 | 4.05e-01 | 1.45e-01 | 7.22e-01 |
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 26 | 2.01e-01 | -1.45e-01 | 5.49e-01 |
GOBP PROTEIN K48 LINKED DEUBIQUITINATION | 19 | 2.75e-01 | -1.45e-01 | 6.19e-01 |
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION | 6 | 5.39e-01 | -1.45e-01 | 8.04e-01 |
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION | 37 | 1.28e-01 | -1.45e-01 | 4.56e-01 |
GOBP RESPONSE TO TOXIC SUBSTANCE | 102 | 1.19e-02 | 1.45e-01 | 1.42e-01 |
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 19 | 2.76e-01 | -1.45e-01 | 6.19e-01 |
GOBP MEIOSIS I CELL CYCLE PROCESS | 47 | 8.70e-02 | 1.45e-01 | 3.85e-01 |
GOCC SPECIFIC GRANULE MEMBRANE | 60 | 5.33e-02 | -1.45e-01 | 3.01e-01 |
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX | 5 | 5.76e-01 | -1.44e-01 | 8.24e-01 |
GOBP CELLULAR RESPONSE TO AMYLOID BETA | 17 | 3.03e-01 | -1.44e-01 | 6.44e-01 |
GOBP RESPONSE TO AMYLOID BETA | 17 | 3.03e-01 | -1.44e-01 | 6.44e-01 |
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY | 7 | 5.08e-01 | -1.44e-01 | 7.86e-01 |
GOBP CYTOPLASM ORGANIZATION | 7 | 5.09e-01 | 1.44e-01 | 7.87e-01 |
GOMF CASPASE BINDING | 5 | 5.77e-01 | -1.44e-01 | 8.25e-01 |
GOBP POSITIVE REGULATION OF LYASE ACTIVITY | 9 | 4.54e-01 | 1.44e-01 | 7.53e-01 |
GOMF CARGO ADAPTOR ACTIVITY | 15 | 3.34e-01 | -1.44e-01 | 6.70e-01 |
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE | 8 | 4.81e-01 | 1.44e-01 | 7.72e-01 |
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION | 9 | 4.55e-01 | -1.44e-01 | 7.53e-01 |
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX | 29 | 1.80e-01 | 1.44e-01 | 5.26e-01 |
GOBP PYRIMIDINE DIMER REPAIR | 8 | 4.81e-01 | -1.44e-01 | 7.72e-01 |
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 7 | 5.10e-01 | -1.44e-01 | 7.87e-01 |
GOBP CANONICAL WNT SIGNALING PATHWAY | 134 | 4.18e-03 | -1.44e-01 | 8.07e-02 |
GOBP IMMUNOGLOBULIN PRODUCTION | 80 | 2.65e-02 | 1.44e-01 | 2.25e-01 |
GOCC CELL CELL JUNCTION | 187 | 7.52e-04 | -1.44e-01 | 2.85e-02 |
GOCC PRERIBOSOME | 90 | 1.88e-02 | 1.44e-01 | 1.85e-01 |
GOMF RETROMER COMPLEX BINDING | 8 | 4.82e-01 | -1.44e-01 | 7.72e-01 |
GOBP EMBRYONIC ORGAN MORPHOGENESIS | 74 | 3.33e-02 | -1.43e-01 | 2.46e-01 |
GOMF PEPTIDE ANTIGEN BINDING | 24 | 2.24e-01 | 1.43e-01 | 5.75e-01 |
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT | 9 | 4.57e-01 | -1.43e-01 | 7.54e-01 |
GOCC CRD MEDIATED MRNA STABILITY COMPLEX | 5 | 5.79e-01 | 1.43e-01 | 8.26e-01 |
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS | 12 | 3.90e-01 | -1.43e-01 | 7.11e-01 |
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION | 20 | 2.68e-01 | 1.43e-01 | 6.12e-01 |
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION | 9 | 4.57e-01 | -1.43e-01 | 7.55e-01 |
GOBP FOREBRAIN NEURON DEVELOPMENT | 8 | 4.84e-01 | -1.43e-01 | 7.74e-01 |
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT | 100 | 1.38e-02 | -1.43e-01 | 1.55e-01 |
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT | 21 | 2.57e-01 | -1.43e-01 | 6.00e-01 |
GOBP REGULATION OF DNA BINDING | 51 | 7.79e-02 | -1.43e-01 | 3.66e-01 |
GOMF SODIUM PROTON ANTIPORTER ACTIVITY | 7 | 5.13e-01 | 1.43e-01 | 7.88e-01 |
GOBP SOMITOGENESIS | 16 | 3.23e-01 | 1.43e-01 | 6.60e-01 |
GOBP PHAGOCYTOSIS | 119 | 7.32e-03 | -1.43e-01 | 1.10e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION | 13 | 3.73e-01 | -1.43e-01 | 6.99e-01 |
GOMF MAP KINASE KINASE KINASE ACTIVITY | 19 | 2.81e-01 | -1.43e-01 | 6.23e-01 |
GOBP CARDIOCYTE DIFFERENTIATION | 53 | 7.26e-02 | -1.43e-01 | 3.56e-01 |
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.13e-01 | -1.43e-01 | 7.88e-01 |
GOBP BARBED END ACTIN FILAMENT CAPPING | 17 | 3.08e-01 | -1.43e-01 | 6.48e-01 |
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS | 89 | 2.03e-02 | 1.43e-01 | 1.95e-01 |
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY | 10 | 4.35e-01 | -1.43e-01 | 7.39e-01 |
GOBP RIBOSOME BIOGENESIS | 269 | 6.53e-05 | 1.43e-01 | 4.46e-03 |
GOBP REGULATION OF AMINO ACID TRANSPORT | 19 | 2.82e-01 | -1.43e-01 | 6.24e-01 |
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT | 9 | 4.59e-01 | -1.43e-01 | 7.56e-01 |
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 23 | 2.37e-01 | -1.43e-01 | 5.84e-01 |
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS | 11 | 4.13e-01 | -1.42e-01 | 7.28e-01 |
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT | 118 | 7.74e-03 | 1.42e-01 | 1.14e-01 |
GOCC ATPASE COMPLEX | 123 | 6.59e-03 | 1.42e-01 | 1.04e-01 |
GOMF UBIQUITIN LIGASE SUBSTRATE ADAPTOR ACTIVITY | 35 | 1.46e-01 | -1.42e-01 | 4.78e-01 |
GOMF BETA 2 MICROGLOBULIN BINDING | 5 | 5.82e-01 | 1.42e-01 | 8.28e-01 |
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 22 | 2.49e-01 | -1.42e-01 | 5.95e-01 |
GOBP MEMBRANE DISASSEMBLY | 9 | 4.61e-01 | 1.42e-01 | 7.57e-01 |
GOMF 3 5 EXONUCLEASE ACTIVITY | 41 | 1.16e-01 | 1.42e-01 | 4.37e-01 |
GOBP ENDODERM DEVELOPMENT | 30 | 1.78e-01 | -1.42e-01 | 5.24e-01 |
GOBP TRANSLOCATION OF MOLECULES INTO HOST | 8 | 4.87e-01 | 1.42e-01 | 7.76e-01 |
GOBP GRANULOCYTE CHEMOTAXIS | 49 | 8.61e-02 | -1.42e-01 | 3.83e-01 |
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS | 11 | 4.15e-01 | 1.42e-01 | 7.29e-01 |
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS | 6 | 5.47e-01 | -1.42e-01 | 8.10e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 36 | 1.41e-01 | -1.42e-01 | 4.72e-01 |
GOCC PARASPECKLES | 7 | 5.16e-01 | -1.42e-01 | 7.90e-01 |
GOCC SEPTIN CYTOSKELETON | 8 | 4.88e-01 | -1.42e-01 | 7.76e-01 |
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION | 66 | 4.70e-02 | 1.42e-01 | 2.84e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 10 | 4.38e-01 | -1.42e-01 | 7.41e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION | 10 | 4.38e-01 | -1.42e-01 | 7.41e-01 |
GOBP PHOTORECEPTOR CELL DIFFERENTIATION | 13 | 3.77e-01 | -1.42e-01 | 7.03e-01 |
GOCC TRAPPIII PROTEIN COMPLEX | 12 | 3.96e-01 | 1.41e-01 | 7.16e-01 |
GOMF PROTEIN DEMETHYLASE ACTIVITY | 24 | 2.31e-01 | -1.41e-01 | 5.78e-01 |
GOCC PHOTORECEPTOR RIBBON SYNAPSE | 5 | 5.84e-01 | -1.41e-01 | 8.30e-01 |
GOCC BRUSH BORDER MEMBRANE | 11 | 4.17e-01 | -1.41e-01 | 7.30e-01 |
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT | 6 | 5.49e-01 | 1.41e-01 | 8.11e-01 |
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH | 5 | 5.85e-01 | -1.41e-01 | 8.30e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 34 | 1.55e-01 | -1.41e-01 | 4.89e-01 |
GOBP DOPAMINE TRANSPORT | 13 | 3.79e-01 | 1.41e-01 | 7.04e-01 |
GOMF CHANNEL REGULATOR ACTIVITY | 46 | 9.84e-02 | 1.41e-01 | 4.07e-01 |
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 56 | 6.84e-02 | -1.41e-01 | 3.45e-01 |
GOBP TORC2 SIGNALING | 13 | 3.79e-01 | -1.41e-01 | 7.04e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 5.50e-01 | 1.41e-01 | 8.12e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX | 6 | 5.50e-01 | 1.41e-01 | 8.12e-01 |
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION | 5 | 5.85e-01 | 1.41e-01 | 8.30e-01 |
GOBP LENS FIBER CELL DIFFERENTIATION | 19 | 2.88e-01 | -1.41e-01 | 6.30e-01 |
GOBP RESPONSE TO MINERALOCORTICOID | 12 | 3.98e-01 | -1.41e-01 | 7.17e-01 |
GOBP REGULATION OF RIBONUCLEASE ACTIVITY | 6 | 5.50e-01 | 1.41e-01 | 8.12e-01 |
GOBP MACROPHAGE CHEMOTAXIS | 17 | 3.15e-01 | 1.41e-01 | 6.53e-01 |
GOMF TRANSLATION INITIATION FACTOR ACTIVITY | 47 | 9.52e-02 | 1.41e-01 | 4.01e-01 |
GOBP RESPONSE TO PURINE CONTAINING COMPOUND | 53 | 7.65e-02 | -1.41e-01 | 3.63e-01 |
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY | 21 | 2.64e-01 | -1.41e-01 | 6.08e-01 |
GOBP MYOBLAST FUSION | 18 | 3.02e-01 | -1.41e-01 | 6.43e-01 |
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS | 6 | 5.51e-01 | 1.41e-01 | 8.12e-01 |
GOBP PHOSPHOLIPID DEPHOSPHORYLATION | 23 | 2.43e-01 | -1.41e-01 | 5.92e-01 |
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY | 5 | 5.86e-01 | -1.41e-01 | 8.31e-01 |
GOBP CARDIAC ATRIUM MORPHOGENESIS | 8 | 4.91e-01 | 1.41e-01 | 7.77e-01 |
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY | 64 | 5.24e-02 | -1.41e-01 | 2.99e-01 |
GOMF FATTY ACID LIGASE ACTIVITY | 9 | 4.66e-01 | 1.40e-01 | 7.62e-01 |
GOBP ENDOCARDIAL CUSHION DEVELOPMENT | 13 | 3.81e-01 | -1.40e-01 | 7.05e-01 |
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 34 | 1.57e-01 | -1.40e-01 | 4.92e-01 |
GOCC PRESYNAPTIC MEMBRANE | 37 | 1.40e-01 | -1.40e-01 | 4.70e-01 |
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION | 6 | 5.52e-01 | 1.40e-01 | 8.13e-01 |
GOBP RESPONSE TO GROWTH FACTOR | 300 | 3.49e-05 | -1.40e-01 | 2.57e-03 |
GOBP INFLAMMATORY RESPONSE | 340 | 1.10e-05 | -1.40e-01 | 9.57e-04 |
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION | 19 | 2.90e-01 | -1.40e-01 | 6.33e-01 |
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS | 14 | 3.64e-01 | -1.40e-01 | 6.91e-01 |
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION | 11 | 4.21e-01 | -1.40e-01 | 7.32e-01 |
GOBP OSTEOBLAST PROLIFERATION | 15 | 3.48e-01 | -1.40e-01 | 6.80e-01 |
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN | 8 | 4.93e-01 | 1.40e-01 | 7.78e-01 |
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING | 19 | 2.91e-01 | -1.40e-01 | 6.33e-01 |
GOBP REGULATION OF JNK CASCADE | 75 | 3.64e-02 | -1.40e-01 | 2.57e-01 |
GOBP GLIAL CELL MIGRATION | 30 | 1.85e-01 | -1.40e-01 | 5.31e-01 |
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION | 6 | 5.53e-01 | 1.40e-01 | 8.13e-01 |
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX | 13 | 3.83e-01 | -1.40e-01 | 7.06e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 26 | 2.17e-01 | -1.40e-01 | 5.70e-01 |
GOBP LOCOMOTORY BEHAVIOR | 80 | 3.11e-02 | -1.40e-01 | 2.40e-01 |
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 37 | 1.42e-01 | -1.40e-01 | 4.72e-01 |
GOMF NUCLEOSOME BINDING | 51 | 8.48e-02 | 1.40e-01 | 3.81e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION | 13 | 3.83e-01 | -1.40e-01 | 7.06e-01 |
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS | 370 | 5.11e-06 | 1.40e-01 | 5.00e-04 |
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 20 | 2.80e-01 | 1.40e-01 | 6.22e-01 |
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 3.34e-01 | -1.40e-01 | 6.70e-01 |
GOBP LIPID STORAGE | 49 | 9.13e-02 | -1.40e-01 | 3.93e-01 |
GOCC MEMBRANE PROTEIN COMPLEX | 631 | 4.56e-09 | 1.40e-01 | 8.69e-07 |
GOBP MITOCHONDRIAL PROTEIN PROCESSING | 12 | 4.03e-01 | 1.40e-01 | 7.20e-01 |
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION | 9 | 4.69e-01 | -1.39e-01 | 7.65e-01 |
GOBP LEUKOCYTE MIGRATION | 166 | 2.06e-03 | -1.39e-01 | 5.45e-02 |
GOBP METANEPHROS DEVELOPMENT | 17 | 3.20e-01 | 1.39e-01 | 6.58e-01 |
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS | 29 | 1.95e-01 | 1.39e-01 | 5.41e-01 |
GOBP ANTEROGRADE DENDRITIC TRANSPORT | 6 | 5.55e-01 | 1.39e-01 | 8.14e-01 |
GOBP THYROID GLAND DEVELOPMENT | 9 | 4.70e-01 | -1.39e-01 | 7.65e-01 |
GOMF VOLTAGE GATED CHANNEL ACTIVITY | 29 | 1.95e-01 | -1.39e-01 | 5.42e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 9 | 4.70e-01 | 1.39e-01 | 7.65e-01 |
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS | 13 | 3.85e-01 | -1.39e-01 | 7.06e-01 |
GOBP RESPONSE TO GROWTH HORMONE | 19 | 2.94e-01 | -1.39e-01 | 6.36e-01 |
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 83 | 2.89e-02 | -1.39e-01 | 2.34e-01 |
GOBP NEGATIVE REGULATION OF CELL SIZE | 6 | 5.56e-01 | -1.39e-01 | 8.14e-01 |
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER | 7 | 5.24e-01 | -1.39e-01 | 7.96e-01 |
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 13 | 3.86e-01 | -1.39e-01 | 7.07e-01 |
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY | 5 | 5.91e-01 | 1.39e-01 | 8.33e-01 |
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 2.82e-01 | 1.39e-01 | 6.24e-01 |
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 362 | 7.22e-06 | -1.39e-01 | 6.53e-04 |
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 11 | 4.26e-01 | -1.39e-01 | 7.34e-01 |
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 29 | 1.96e-01 | 1.39e-01 | 5.43e-01 |
GOMF SERINE HYDROLASE ACTIVITY | 43 | 1.16e-01 | 1.39e-01 | 4.37e-01 |
GOMF CYCLOSPORIN A BINDING | 14 | 3.69e-01 | 1.39e-01 | 6.96e-01 |
GOBP PROTEIN TETRAMERIZATION | 48 | 9.69e-02 | 1.39e-01 | 4.03e-01 |
GOBP ENDODERM FORMATION | 19 | 2.96e-01 | -1.39e-01 | 6.37e-01 |
GOMF DISORDERED DOMAIN SPECIFIC BINDING | 20 | 2.84e-01 | -1.39e-01 | 6.26e-01 |
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY | 24 | 2.41e-01 | -1.38e-01 | 5.89e-01 |
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY | 45 | 1.09e-01 | 1.38e-01 | 4.24e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 10 | 4.49e-01 | 1.38e-01 | 7.49e-01 |
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 25 | 2.32e-01 | -1.38e-01 | 5.78e-01 |
GOBP CARBOHYDRATE PHOSPHORYLATION | 9 | 4.73e-01 | 1.38e-01 | 7.68e-01 |
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION | 6 | 5.58e-01 | -1.38e-01 | 8.16e-01 |
GOBP REGULATION OF ACTIN NUCLEATION | 26 | 2.24e-01 | -1.38e-01 | 5.74e-01 |
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY | 11 | 4.28e-01 | -1.38e-01 | 7.36e-01 |
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST | 29 | 1.99e-01 | -1.38e-01 | 5.46e-01 |
GOCC RNA POLYMERASE COMPLEX | 78 | 3.58e-02 | 1.38e-01 | 2.55e-01 |
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III | 6 | 5.59e-01 | 1.38e-01 | 8.16e-01 |
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX | 6 | 5.59e-01 | 1.38e-01 | 8.16e-01 |
GOCC CATALYTIC STEP 2 SPLICEOSOME | 84 | 2.96e-02 | 1.38e-01 | 2.35e-01 |
GOMF FOUR WAY JUNCTION DNA BINDING | 15 | 3.56e-01 | 1.38e-01 | 6.86e-01 |
GOBP RESPONSE TO VITAMIN A | 5 | 5.95e-01 | 1.37e-01 | 8.35e-01 |
GOBP NEGATIVE REGULATION OF CELL ADHESION | 120 | 9.64e-03 | -1.37e-01 | 1.28e-01 |
GOBP QUINONE METABOLIC PROCESS | 24 | 2.45e-01 | 1.37e-01 | 5.92e-01 |
GOBP GMP METABOLIC PROCESS | 21 | 2.76e-01 | 1.37e-01 | 6.20e-01 |
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION | 13 | 3.92e-01 | -1.37e-01 | 7.12e-01 |
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 1.94e-01 | 1.37e-01 | 5.40e-01 |
GOBP AMEBOIDAL TYPE CELL MIGRATION | 185 | 1.37e-03 | -1.37e-01 | 4.29e-02 |
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS | 41 | 1.29e-01 | 1.37e-01 | 4.57e-01 |
GOBP SURFACTANT HOMEOSTASIS | 5 | 5.96e-01 | -1.37e-01 | 8.35e-01 |
GOBP SYNCYTIUM FORMATION | 25 | 2.36e-01 | -1.37e-01 | 5.83e-01 |
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION | 13 | 3.93e-01 | -1.37e-01 | 7.12e-01 |
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME | 53 | 8.52e-02 | -1.37e-01 | 3.81e-01 |
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 5.31e-01 | 1.37e-01 | 8.01e-01 |
GOBP INTEGRATED STRESS RESPONSE SIGNALING | 31 | 1.88e-01 | -1.37e-01 | 5.34e-01 |
GOMF OXYGEN BINDING | 7 | 5.31e-01 | 1.37e-01 | 8.01e-01 |
GOCC ZYMOGEN GRANULE | 5 | 5.96e-01 | 1.37e-01 | 8.36e-01 |
GOBP REGULATION OF VESICLE SIZE | 16 | 3.44e-01 | -1.37e-01 | 6.79e-01 |
GOMF INORGANIC PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 6 | 5.62e-01 | -1.37e-01 | 8.17e-01 |
GOBP LIPOPHAGY | 5 | 5.97e-01 | 1.37e-01 | 8.36e-01 |
GOBP POLYAMINE TRANSPORT | 5 | 5.97e-01 | 1.37e-01 | 8.36e-01 |
GOBP CARDIAC VENTRICLE MORPHOGENESIS | 16 | 3.45e-01 | -1.37e-01 | 6.79e-01 |
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION | 34 | 1.69e-01 | -1.37e-01 | 5.10e-01 |
GOBP RESPONSE TO COCAINE | 17 | 3.30e-01 | -1.36e-01 | 6.66e-01 |
GOCC MRNA EDITING COMPLEX | 13 | 3.95e-01 | -1.36e-01 | 7.14e-01 |
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION | 6 | 5.63e-01 | -1.36e-01 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL | 6 | 5.63e-01 | 1.36e-01 | 8.17e-01 |
GOMF MOLECULAR TRANSDUCER ACTIVITY | 241 | 2.99e-04 | -1.36e-01 | 1.49e-02 |
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING | 9 | 4.79e-01 | -1.36e-01 | 7.72e-01 |
GOBP REGULATION OF PROTON TRANSPORT | 11 | 4.35e-01 | 1.36e-01 | 7.39e-01 |
GOBP POSITIVE REGULATION OF PROTEIN BINDING | 40 | 1.37e-01 | -1.36e-01 | 4.66e-01 |
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 14 | 3.79e-01 | -1.36e-01 | 7.04e-01 |
GOBP BONE MINERALIZATION | 40 | 1.37e-01 | -1.36e-01 | 4.66e-01 |
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 15 | 3.62e-01 | -1.36e-01 | 6.89e-01 |
GOBP FATTY ACYL COA METABOLIC PROCESS | 22 | 2.70e-01 | 1.36e-01 | 6.15e-01 |
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 11 | 4.35e-01 | -1.36e-01 | 7.40e-01 |
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS | 31 | 1.91e-01 | 1.36e-01 | 5.37e-01 |
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 9 | 4.81e-01 | 1.36e-01 | 7.72e-01 |
GOMF PENTOSYLTRANSFERASE ACTIVITY | 36 | 1.59e-01 | -1.36e-01 | 4.97e-01 |
GOBP REGULATION OF BLOOD PRESSURE | 47 | 1.08e-01 | -1.36e-01 | 4.24e-01 |
GOBP NATURAL KILLER CELL ACTIVATION | 45 | 1.16e-01 | -1.36e-01 | 4.37e-01 |
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER | 8 | 5.07e-01 | -1.36e-01 | 7.86e-01 |
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT | 35 | 1.66e-01 | -1.36e-01 | 5.05e-01 |
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS | 45 | 1.16e-01 | 1.35e-01 | 4.38e-01 |
GOBP HISTONE DEACETYLATION | 17 | 3.34e-01 | 1.35e-01 | 6.70e-01 |
GOBP VACUOLE FUSION | 11 | 4.37e-01 | 1.35e-01 | 7.41e-01 |
GOBP T CELL MIGRATION | 39 | 1.44e-01 | -1.35e-01 | 4.76e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON DNA | 168 | 2.62e-03 | 1.35e-01 | 6.33e-02 |
GOBP RESPONSE TO CARBOHYDRATE | 89 | 2.80e-02 | -1.35e-01 | 2.30e-01 |
GOMF SUPERCOILED DNA BINDING | 6 | 5.67e-01 | -1.35e-01 | 8.19e-01 |
GOMF KINASE INHIBITOR ACTIVITY | 45 | 1.18e-01 | -1.35e-01 | 4.39e-01 |
GOBP PROTEIN TRANSMEMBRANE TRANSPORT | 46 | 1.14e-01 | 1.35e-01 | 4.34e-01 |
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT | 6 | 5.67e-01 | 1.35e-01 | 8.19e-01 |
GOBP NEGATIVE REGULATION OF HEMOPOIESIS | 44 | 1.22e-01 | -1.35e-01 | 4.48e-01 |
GOBP OOGENESIS | 37 | 1.56e-01 | 1.35e-01 | 4.92e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS | 37 | 1.56e-01 | 1.35e-01 | 4.92e-01 |
GOBP SULFUR AMINO ACID TRANSPORT | 5 | 6.02e-01 | -1.35e-01 | 8.38e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 11 | 4.39e-01 | -1.35e-01 | 7.42e-01 |
GOMF GTPASE ACTIVITY | 183 | 1.77e-03 | -1.35e-01 | 5.06e-02 |
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 13 | 4.00e-01 | -1.35e-01 | 7.19e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION | 5 | 6.02e-01 | 1.35e-01 | 8.38e-01 |
GOBP CELLULAR RESPONSE TO ACID CHEMICAL | 48 | 1.07e-01 | -1.35e-01 | 4.22e-01 |
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS | 7 | 5.38e-01 | -1.35e-01 | 8.04e-01 |
GOBP RESPONSE TO LIGHT INTENSITY | 7 | 5.38e-01 | -1.35e-01 | 8.04e-01 |
GOCC DENDRITE TERMINUS | 6 | 5.68e-01 | -1.35e-01 | 8.19e-01 |
GOMF PHOSPHATIDYLETHANOLAMINE BINDING | 9 | 4.85e-01 | -1.34e-01 | 7.74e-01 |
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 30 | 2.03e-01 | -1.34e-01 | 5.51e-01 |
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 28 | 2.19e-01 | 1.34e-01 | 5.71e-01 |
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 33 | 1.82e-01 | -1.34e-01 | 5.28e-01 |
GOMF DNA DAMAGE SENSOR ACTIVITY | 13 | 4.02e-01 | 1.34e-01 | 7.20e-01 |
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT | 27 | 2.28e-01 | -1.34e-01 | 5.76e-01 |
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT | 32 | 1.89e-01 | 1.34e-01 | 5.35e-01 |
GOBP T CELL ACTIVATION | 301 | 7.33e-05 | -1.34e-01 | 4.86e-03 |
GOBP REGULATION OF PROTEIN NEDDYLATION | 16 | 3.54e-01 | -1.34e-01 | 6.84e-01 |
GOCC CYTOLYTIC GRANULE | 12 | 4.22e-01 | -1.34e-01 | 7.33e-01 |
GOBP GLOMERULAR EPITHELIAL CELL DIFFERENTIATION | 9 | 4.87e-01 | -1.34e-01 | 7.76e-01 |
GOCC DYNEIN COMPLEX | 20 | 3.01e-01 | -1.34e-01 | 6.42e-01 |
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 24 | 2.57e-01 | -1.34e-01 | 6.00e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY | 12 | 4.23e-01 | -1.34e-01 | 7.33e-01 |
GOBP LIVER REGENERATION | 14 | 3.87e-01 | 1.34e-01 | 7.07e-01 |
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 8 | 5.13e-01 | 1.34e-01 | 7.88e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION | 43 | 1.30e-01 | -1.34e-01 | 4.57e-01 |
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY | 15 | 3.71e-01 | -1.34e-01 | 6.98e-01 |
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT | 10 | 4.65e-01 | -1.33e-01 | 7.62e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS NAD OR NADP AS ACCEPTOR | 21 | 2.90e-01 | 1.33e-01 | 6.33e-01 |
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS | 12 | 4.24e-01 | 1.33e-01 | 7.34e-01 |
GOCC CILIARY TIP | 26 | 2.39e-01 | -1.33e-01 | 5.88e-01 |
GOBP LEUKOCYTE CELL CELL ADHESION | 216 | 7.91e-04 | -1.33e-01 | 2.96e-02 |
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 11 | 4.44e-01 | -1.33e-01 | 7.46e-01 |
GOBP REGULATION OF MITOPHAGY | 12 | 4.24e-01 | -1.33e-01 | 7.34e-01 |
GOMF HISTONE READER ACTIVITY | 9 | 4.89e-01 | 1.33e-01 | 7.76e-01 |
GOBP NEGATIVE REGULATION OF OSSIFICATION | 13 | 4.06e-01 | -1.33e-01 | 7.22e-01 |
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT | 9 | 4.89e-01 | -1.33e-01 | 7.76e-01 |
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING | 18 | 3.29e-01 | 1.33e-01 | 6.64e-01 |
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS | 15 | 3.73e-01 | 1.33e-01 | 6.99e-01 |
GOBP DEFENSE RESPONSE TO BACTERIUM | 93 | 2.70e-02 | -1.33e-01 | 2.27e-01 |
GOBP CELLULAR RESPONSE TO VIRUS | 38 | 1.57e-01 | -1.33e-01 | 4.92e-01 |
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 19 | 3.16e-01 | -1.33e-01 | 6.55e-01 |
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA | 57 | 8.34e-02 | 1.33e-01 | 3.79e-01 |
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION | 10 | 4.67e-01 | 1.33e-01 | 7.63e-01 |
GOBP NUCLEOPHAGY | 16 | 3.58e-01 | -1.33e-01 | 6.87e-01 |
GOMF MHC CLASS II PROTEIN COMPLEX BINDING | 23 | 2.71e-01 | 1.33e-01 | 6.16e-01 |
GOBP EMBRYONIC DIGIT MORPHOGENESIS | 21 | 2.93e-01 | -1.33e-01 | 6.35e-01 |
GOBP ANIMAL ORGAN MORPHOGENESIS | 315 | 6.16e-05 | -1.33e-01 | 4.24e-03 |
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT | 82 | 3.84e-02 | -1.33e-01 | 2.64e-01 |
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 7 | 5.44e-01 | 1.33e-01 | 8.07e-01 |
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 7 | 5.44e-01 | 1.33e-01 | 8.07e-01 |
GOBP POLYOL BIOSYNTHETIC PROCESS | 28 | 2.25e-01 | 1.33e-01 | 5.75e-01 |
GOBP TIGHT JUNCTION ORGANIZATION | 25 | 2.52e-01 | -1.33e-01 | 5.96e-01 |
GOBP PROTEIN LOCALIZATION TO ENDOSOME | 20 | 3.05e-01 | -1.32e-01 | 6.46e-01 |
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 6 | 5.74e-01 | -1.32e-01 | 8.23e-01 |
GOMF SH3 DOMAIN BINDING | 70 | 5.59e-02 | -1.32e-01 | 3.08e-01 |
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY | 13 | 4.09e-01 | 1.32e-01 | 7.24e-01 |
GOBP NUCLEUS LOCALIZATION | 25 | 2.52e-01 | -1.32e-01 | 5.96e-01 |
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 45 | 1.25e-01 | 1.32e-01 | 4.53e-01 |
GOBP MITOCHONDRION ORGANIZATION | 402 | 7.08e-06 | 1.32e-01 | 6.48e-04 |
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS | 5 | 6.09e-01 | -1.32e-01 | 8.43e-01 |
GOBP EPITHELIAL CELL DIFFERENTIATION | 240 | 4.65e-04 | -1.32e-01 | 2.05e-02 |
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 110 | 1.70e-02 | -1.32e-01 | 1.76e-01 |
GOBP ISOPRENOID METABOLIC PROCESS | 46 | 1.22e-01 | 1.32e-01 | 4.47e-01 |
GOCC PRESYNAPTIC ACTIVE ZONE | 22 | 2.84e-01 | -1.32e-01 | 6.26e-01 |
GOBP FOCAL ADHESION ASSEMBLY | 42 | 1.40e-01 | -1.32e-01 | 4.69e-01 |
GOBP PEPTIDYL CYSTEINE MODIFICATION | 23 | 2.74e-01 | -1.32e-01 | 6.18e-01 |
GOBP NUCLEOTIDE SALVAGE | 12 | 4.29e-01 | 1.32e-01 | 7.36e-01 |
GOBP REGULATION OF INFLAMMATORY RESPONSE | 160 | 4.20e-03 | -1.32e-01 | 8.07e-02 |
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION | 78 | 4.47e-02 | -1.32e-01 | 2.82e-01 |
GOBP RESPONSE TO RETINOIC ACID | 33 | 1.91e-01 | 1.32e-01 | 5.37e-01 |
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 5 | 6.10e-01 | 1.32e-01 | 8.44e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION | 61 | 7.58e-02 | -1.32e-01 | 3.63e-01 |
GOBP NEGATIVE REGULATION OF CELL ACTIVATION | 93 | 2.86e-02 | -1.32e-01 | 2.32e-01 |
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT | 6 | 5.77e-01 | -1.32e-01 | 8.25e-01 |
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS | 7 | 5.46e-01 | 1.32e-01 | 8.09e-01 |
GOBP BIOMINERAL TISSUE DEVELOPMENT | 52 | 1.01e-01 | -1.32e-01 | 4.11e-01 |
GOBP OTOLITH DEVELOPMENT | 5 | 6.11e-01 | -1.32e-01 | 8.44e-01 |
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING | 22 | 2.86e-01 | 1.32e-01 | 6.28e-01 |
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 16 | 3.63e-01 | -1.32e-01 | 6.89e-01 |
GOMF INSULIN LIKE GROWTH FACTOR BINDING | 6 | 5.77e-01 | -1.32e-01 | 8.25e-01 |
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY | 31 | 2.06e-01 | -1.31e-01 | 5.54e-01 |
GOBP AMIDE TRANSPORT | 128 | 1.06e-02 | -1.31e-01 | 1.36e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 23 | 2.76e-01 | -1.31e-01 | 6.19e-01 |
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 9 | 4.95e-01 | -1.31e-01 | 7.79e-01 |
GOBP SEMINIFEROUS TUBULE DEVELOPMENT | 11 | 4.51e-01 | 1.31e-01 | 7.51e-01 |
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING | 5 | 6.11e-01 | 1.31e-01 | 8.45e-01 |
GOBP NEURON PROJECTION ARBORIZATION | 10 | 4.73e-01 | -1.31e-01 | 7.68e-01 |
GOMF PROTEOGLYCAN BINDING | 6 | 5.78e-01 | -1.31e-01 | 8.25e-01 |
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 53 | 9.94e-02 | -1.31e-01 | 4.09e-01 |
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY | 5 | 6.12e-01 | 1.31e-01 | 8.45e-01 |
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 28 | 2.30e-01 | -1.31e-01 | 5.78e-01 |
GOMF 14 3 3 PROTEIN BINDING | 27 | 2.39e-01 | -1.31e-01 | 5.87e-01 |
GOBP RHYTHMIC PROCESS | 137 | 8.42e-03 | -1.31e-01 | 1.19e-01 |
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION | 12 | 4.32e-01 | 1.31e-01 | 7.39e-01 |
GOBP REGULATION OF PEPTIDE TRANSPORT | 74 | 5.21e-02 | -1.31e-01 | 2.99e-01 |
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING | 45 | 1.29e-01 | 1.31e-01 | 4.57e-01 |
GOCC HRD1P UBIQUITIN LIGASE ERAD L COMPLEX | 6 | 5.79e-01 | 1.31e-01 | 8.26e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON RNA | 267 | 2.70e-04 | 1.31e-01 | 1.36e-02 |
GOBP CELLULAR RESPONSE TO VITAMIN D | 7 | 5.50e-01 | 1.31e-01 | 8.12e-01 |
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 48 | 1.18e-01 | -1.31e-01 | 4.39e-01 |
GOBP VESICLE COATING | 36 | 1.76e-01 | 1.31e-01 | 5.20e-01 |
GOBP REGULATION OF CYTOPLASMIC TRANSPORT | 28 | 2.32e-01 | -1.31e-01 | 5.78e-01 |
GOBP FOREBRAIN DEVELOPMENT | 154 | 5.43e-03 | -1.30e-01 | 9.54e-02 |
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION | 5 | 6.14e-01 | 1.30e-01 | 8.46e-01 |
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT | 10 | 4.75e-01 | -1.30e-01 | 7.69e-01 |
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS | 38 | 1.65e-01 | 1.30e-01 | 5.04e-01 |
GOBP MRNA POLYADENYLATION | 21 | 3.02e-01 | 1.30e-01 | 6.43e-01 |
GOBP POSITIVE REGULATION OF GLIOGENESIS | 29 | 2.25e-01 | -1.30e-01 | 5.75e-01 |
GOBP REGULATION OF LIPID STORAGE | 26 | 2.51e-01 | -1.30e-01 | 5.96e-01 |
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS | 13 | 4.17e-01 | 1.30e-01 | 7.30e-01 |
GOBP SERTOLI CELL DEVELOPMENT | 9 | 5.00e-01 | 1.30e-01 | 7.80e-01 |
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE | 88 | 3.56e-02 | -1.30e-01 | 2.55e-01 |
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 5 | 6.15e-01 | -1.30e-01 | 8.47e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION | 174 | 3.30e-03 | -1.30e-01 | 7.13e-02 |
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 22 | 2.92e-01 | 1.30e-01 | 6.34e-01 |
GOBP NEURAL CREST CELL DIFFERENTIATION | 27 | 2.44e-01 | -1.30e-01 | 5.92e-01 |
GOBP ESTABLISHMENT OF TISSUE POLARITY | 28 | 2.35e-01 | -1.30e-01 | 5.82e-01 |
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING | 6 | 5.82e-01 | -1.30e-01 | 8.28e-01 |
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION | 6 | 5.83e-01 | -1.30e-01 | 8.29e-01 |
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 37 | 1.73e-01 | 1.30e-01 | 5.16e-01 |
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 14 | 4.02e-01 | 1.30e-01 | 7.20e-01 |
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT | 12 | 4.38e-01 | -1.30e-01 | 7.41e-01 |
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS | 5 | 6.16e-01 | -1.29e-01 | 8.47e-01 |
GOBP REGULATION OF NEURON PROJECTION REGENERATION | 12 | 4.38e-01 | -1.29e-01 | 7.41e-01 |
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS | 10 | 4.79e-01 | -1.29e-01 | 7.72e-01 |
GOBP ER NUCLEUS SIGNALING PATHWAY | 38 | 1.68e-01 | -1.29e-01 | 5.09e-01 |
GOBP CGMP MEDIATED SIGNALING | 7 | 5.53e-01 | 1.29e-01 | 8.14e-01 |
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION | 52 | 1.07e-01 | -1.29e-01 | 4.22e-01 |
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 26 | 2.54e-01 | -1.29e-01 | 5.97e-01 |
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION | 5 | 6.17e-01 | 1.29e-01 | 8.47e-01 |
GOCC CLATHRIN COAT OF COATED PIT | 13 | 4.20e-01 | 1.29e-01 | 7.31e-01 |
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE | 6 | 5.84e-01 | -1.29e-01 | 8.29e-01 |
GOBP REGENERATION | 76 | 5.20e-02 | -1.29e-01 | 2.98e-01 |
GOBP CYTOPLASMIC TRANSLATION | 142 | 8.14e-03 | -1.29e-01 | 1.18e-01 |
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX | 59 | 8.66e-02 | -1.29e-01 | 3.84e-01 |
GOCC CYTOPLASMIC SIDE OF MEMBRANE | 116 | 1.66e-02 | -1.29e-01 | 1.73e-01 |
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY | 11 | 4.58e-01 | 1.29e-01 | 7.56e-01 |
GOBP GLYCEROLIPID CATABOLIC PROCESS | 22 | 2.95e-01 | -1.29e-01 | 6.37e-01 |
GOBP TERPENOID METABOLIC PROCESS | 21 | 3.06e-01 | 1.29e-01 | 6.47e-01 |
GOBP GLIAL CELL DEVELOPMENT | 51 | 1.11e-01 | -1.29e-01 | 4.28e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 42 | 1.49e-01 | -1.29e-01 | 4.82e-01 |
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 21 | 3.07e-01 | -1.29e-01 | 6.47e-01 |
GOBP TUBE DEVELOPMENT | 406 | 1.11e-05 | -1.29e-01 | 9.57e-04 |
GOBP GLOMERULUS DEVELOPMENT | 24 | 2.75e-01 | -1.29e-01 | 6.19e-01 |
GOBP CELL CELL ADHESION | 350 | 4.27e-05 | -1.29e-01 | 3.06e-03 |
GOBP DNA REPLICATION SYNTHESIS OF RNA PRIMER | 5 | 6.18e-01 | 1.29e-01 | 8.48e-01 |
GOBP MRNA ALTERNATIVE POLYADENYLATION | 5 | 6.18e-01 | 1.29e-01 | 8.48e-01 |
GOMF MRNA 5 UTR BINDING | 22 | 2.96e-01 | 1.29e-01 | 6.38e-01 |
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT | 6 | 5.85e-01 | -1.29e-01 | 8.30e-01 |
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS | 14 | 4.05e-01 | 1.29e-01 | 7.22e-01 |
GOBP REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS | 8 | 5.29e-01 | -1.29e-01 | 8.00e-01 |
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION | 7 | 5.56e-01 | -1.29e-01 | 8.14e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 20 | 3.20e-01 | -1.29e-01 | 6.58e-01 |
GOBP PROTEIN MATURATION | 322 | 8.70e-05 | 1.29e-01 | 5.62e-03 |
GOBP EXPORT ACROSS PLASMA MEMBRANE | 21 | 3.08e-01 | 1.29e-01 | 6.48e-01 |
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY | 120 | 1.55e-02 | -1.28e-01 | 1.67e-01 |
GOBP NEURON PROJECTION REGENERATION | 22 | 2.98e-01 | -1.28e-01 | 6.40e-01 |
GOBP MITRAL VALVE DEVELOPMENT | 5 | 6.20e-01 | -1.28e-01 | 8.49e-01 |
GOBP PATTERN SPECIFICATION PROCESS | 121 | 1.53e-02 | -1.28e-01 | 1.66e-01 |
GOBP LATERAL VENTRICLE DEVELOPMENT | 5 | 6.20e-01 | 1.28e-01 | 8.49e-01 |
GOBP T CELL DIFFERENTIATION | 170 | 4.20e-03 | -1.28e-01 | 8.07e-02 |
GOBP RESPONSE TO BMP | 50 | 1.18e-01 | -1.28e-01 | 4.39e-01 |
GOBP DETECTION OF ABIOTIC STIMULUS | 27 | 2.50e-01 | 1.28e-01 | 5.96e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS | 12 | 4.43e-01 | -1.28e-01 | 7.46e-01 |
GOBP GLYOXYLATE METABOLIC PROCESS | 5 | 6.21e-01 | 1.28e-01 | 8.49e-01 |
GOBP INSULIN SECRETION | 78 | 5.20e-02 | -1.28e-01 | 2.98e-01 |
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 27 | 2.52e-01 | -1.28e-01 | 5.96e-01 |
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 56 | 9.93e-02 | -1.28e-01 | 4.09e-01 |
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID | 416 | 1.09e-05 | 1.27e-01 | 9.57e-04 |
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS | 684 | 2.80e-08 | -1.27e-01 | 4.13e-06 |
GOBP REGULATION OF DENDRITE DEVELOPMENT | 42 | 1.54e-01 | -1.27e-01 | 4.88e-01 |
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 37 | 1.81e-01 | -1.27e-01 | 5.27e-01 |
GOBP NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS | 11 | 4.65e-01 | -1.27e-01 | 7.62e-01 |
GOBP MUSCLE STRUCTURE DEVELOPMENT | 270 | 3.57e-04 | -1.27e-01 | 1.70e-02 |
GOBP TISSUE MIGRATION | 139 | 9.93e-03 | -1.27e-01 | 1.31e-01 |
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM | 14 | 4.10e-01 | 1.27e-01 | 7.26e-01 |
GOMF GTP DEPENDENT PROTEIN BINDING | 12 | 4.46e-01 | -1.27e-01 | 7.48e-01 |
GOBP SYNAPTIC VESICLE CLUSTERING | 5 | 6.23e-01 | -1.27e-01 | 8.51e-01 |
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY | 36 | 1.88e-01 | -1.27e-01 | 5.34e-01 |
GOMF CAMP BINDING | 8 | 5.34e-01 | -1.27e-01 | 8.03e-01 |
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY | 9 | 5.10e-01 | 1.27e-01 | 7.87e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 37 | 1.82e-01 | -1.27e-01 | 5.28e-01 |
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY | 65 | 7.76e-02 | -1.27e-01 | 3.65e-01 |
GOBP SEQUESTERING OF METAL ION | 8 | 5.35e-01 | -1.27e-01 | 8.03e-01 |
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 5 | 6.24e-01 | -1.27e-01 | 8.51e-01 |
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH | 10 | 4.88e-01 | -1.27e-01 | 7.76e-01 |
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION | 18 | 3.52e-01 | -1.27e-01 | 6.83e-01 |
GOBP CELL GROWTH | 235 | 9.08e-04 | -1.27e-01 | 3.27e-02 |
GOMF METALLOAMINOPEPTIDASE ACTIVITY | 16 | 3.81e-01 | 1.27e-01 | 7.05e-01 |
GOBP GROWTH HORMONE SECRETION | 6 | 5.92e-01 | -1.27e-01 | 8.34e-01 |
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS | 16 | 3.81e-01 | 1.27e-01 | 7.05e-01 |
GOBP CELL CELL SIGNALING BY WNT | 205 | 1.92e-03 | -1.27e-01 | 5.28e-02 |
GOCC RNAI EFFECTOR COMPLEX | 17 | 3.67e-01 | 1.26e-01 | 6.94e-01 |
GOMF HISTONE CHAPERONE ACTIVITY | 10 | 4.89e-01 | -1.26e-01 | 7.76e-01 |
GOBP MUSCLE CELL DEVELOPMENT | 59 | 9.38e-02 | -1.26e-01 | 3.98e-01 |
GOBP MAST CELL PROLIFERATION | 5 | 6.25e-01 | 1.26e-01 | 8.51e-01 |
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM | 13 | 4.31e-01 | -1.26e-01 | 7.37e-01 |
GOMF PROTEIN PHOSPHATASE ACTIVATOR ACTIVITY | 13 | 4.31e-01 | -1.26e-01 | 7.37e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR | 7 | 5.63e-01 | 1.26e-01 | 8.17e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION | 15 | 3.98e-01 | -1.26e-01 | 7.17e-01 |
GOBP PEPTIDE TRANSPORT | 96 | 3.33e-02 | -1.26e-01 | 2.46e-01 |
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY | 7 | 5.64e-01 | -1.26e-01 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION | 27 | 2.58e-01 | -1.26e-01 | 6.01e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 5 | 6.26e-01 | 1.26e-01 | 8.52e-01 |
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION | 10 | 4.91e-01 | -1.26e-01 | 7.77e-01 |
GOMF WNT PROTEIN BINDING | 5 | 6.27e-01 | -1.26e-01 | 8.52e-01 |
GOBP SODIUM ION HOMEOSTASIS | 8 | 5.38e-01 | -1.26e-01 | 8.04e-01 |
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS | 13 | 4.33e-01 | -1.26e-01 | 7.39e-01 |
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION | 13 | 4.33e-01 | 1.26e-01 | 7.39e-01 |
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE | 18 | 3.57e-01 | -1.26e-01 | 6.86e-01 |
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION | 15 | 4.00e-01 | -1.25e-01 | 7.19e-01 |
GOBP RRNA TRANSCRIPTION | 30 | 2.35e-01 | 1.25e-01 | 5.82e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 19 | 3.44e-01 | -1.25e-01 | 6.79e-01 |
GOBP AMINOPHOSPHOLIPID TRANSPORT | 7 | 5.66e-01 | 1.25e-01 | 8.18e-01 |
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 8 | 5.39e-01 | 1.25e-01 | 8.04e-01 |
GOCC EUCHROMATIN | 37 | 1.88e-01 | -1.25e-01 | 5.34e-01 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY | 13 | 4.34e-01 | -1.25e-01 | 7.39e-01 |
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY | 7 | 5.66e-01 | 1.25e-01 | 8.18e-01 |
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN | 9 | 5.15e-01 | 1.25e-01 | 7.90e-01 |
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE | 9 | 5.15e-01 | 1.25e-01 | 7.90e-01 |
GOMF POTASSIUM CHANNEL ACTIVITY | 10 | 4.93e-01 | -1.25e-01 | 7.78e-01 |
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON | 57 | 1.03e-01 | -1.25e-01 | 4.13e-01 |
GOBP PURINE NUCLEOBASE METABOLIC PROCESS | 15 | 4.02e-01 | 1.25e-01 | 7.20e-01 |
GOBP CHOLESTEROL EFFLUX | 21 | 3.21e-01 | -1.25e-01 | 6.59e-01 |
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS | 8 | 5.40e-01 | -1.25e-01 | 8.05e-01 |
GOBP SMALL MOLECULE METABOLIC PROCESS | 908 | 5.82e-10 | 1.25e-01 | 1.36e-07 |
GOBP KINETOCHORE ORGANIZATION | 19 | 3.46e-01 | 1.25e-01 | 6.79e-01 |
GOBP ASTRAL MICROTUBULE ORGANIZATION | 8 | 5.41e-01 | -1.25e-01 | 8.05e-01 |
GOBP REGULATION OF GLUCONEOGENESIS | 25 | 2.80e-01 | -1.25e-01 | 6.22e-01 |
GOCC CIS GOLGI NETWORK MEMBRANE | 5 | 6.29e-01 | 1.25e-01 | 8.54e-01 |
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY | 5 | 6.29e-01 | 1.25e-01 | 8.54e-01 |
GOBP GLUCAN METABOLIC PROCESS | 38 | 1.84e-01 | -1.25e-01 | 5.29e-01 |
GOBP MANGANESE ION TRANSPORT | 6 | 5.97e-01 | 1.25e-01 | 8.36e-01 |
GOMF GLUTATHIONE PEROXIDASE ACTIVITY | 12 | 4.55e-01 | 1.25e-01 | 7.53e-01 |
GOCC RUFFLE MEMBRANE | 62 | 9.07e-02 | -1.24e-01 | 3.92e-01 |
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 2.39e-01 | -1.24e-01 | 5.87e-01 |
GOMF RIBOSOMAL SMALL SUBUNIT BINDING | 17 | 3.75e-01 | 1.24e-01 | 7.00e-01 |
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 5.98e-01 | -1.24e-01 | 8.36e-01 |
GOBP JNK CASCADE | 98 | 3.41e-02 | -1.24e-01 | 2.49e-01 |
GOBP POSITIVE REGULATION OF COAGULATION | 11 | 4.76e-01 | 1.24e-01 | 7.69e-01 |
GOBP EMBRYONIC HEART TUBE DEVELOPMENT | 27 | 2.65e-01 | -1.24e-01 | 6.09e-01 |
GOCC AGGRESOME | 19 | 3.49e-01 | -1.24e-01 | 6.81e-01 |
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY | 13 | 4.39e-01 | 1.24e-01 | 7.41e-01 |
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS | 6 | 5.99e-01 | -1.24e-01 | 8.37e-01 |
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY | 21 | 3.25e-01 | -1.24e-01 | 6.63e-01 |
GOMF DYNACTIN BINDING | 8 | 5.44e-01 | 1.24e-01 | 8.07e-01 |
GOBP EMBRYONIC AXIS SPECIFICATION | 10 | 4.97e-01 | -1.24e-01 | 7.79e-01 |
GOBP CARDIAC MUSCLE CELL PROLIFERATION | 17 | 3.77e-01 | -1.24e-01 | 7.03e-01 |
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 31 | 2.33e-01 | -1.24e-01 | 5.80e-01 |
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 6 | 6.00e-01 | 1.24e-01 | 8.37e-01 |
GOBP NOTCH RECEPTOR PROCESSING | 7 | 5.71e-01 | -1.24e-01 | 8.21e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR | 7 | 5.71e-01 | -1.24e-01 | 8.21e-01 |
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION | 20 | 3.39e-01 | -1.24e-01 | 6.75e-01 |
GOMF RIBOSOME BINDING | 88 | 4.58e-02 | 1.24e-01 | 2.83e-01 |
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS | 557 | 9.99e-07 | 1.23e-01 | 1.17e-04 |
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS | 5 | 6.33e-01 | -1.23e-01 | 8.56e-01 |
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 29 | 2.51e-01 | -1.23e-01 | 5.96e-01 |
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 22 | 3.17e-01 | -1.23e-01 | 6.55e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE | 12 | 4.60e-01 | 1.23e-01 | 7.57e-01 |
GOBP MIDDLE EAR MORPHOGENESIS | 6 | 6.01e-01 | -1.23e-01 | 8.38e-01 |
GOCC AUTOPHAGOSOME MEMBRANE | 38 | 1.89e-01 | -1.23e-01 | 5.35e-01 |
GOMF SULFUR COMPOUND BINDING | 83 | 5.30e-02 | 1.23e-01 | 3.00e-01 |
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 6 | 6.01e-01 | -1.23e-01 | 8.38e-01 |
GOBP PROTEIN PALMITOYLATION | 17 | 3.80e-01 | -1.23e-01 | 7.04e-01 |
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 3.53e-01 | 1.23e-01 | 6.84e-01 |
GOBP MYELIN ASSEMBLY | 6 | 6.02e-01 | -1.23e-01 | 8.38e-01 |
GOBP POLYPRENOL METABOLIC PROCESS | 16 | 3.94e-01 | 1.23e-01 | 7.14e-01 |
GOBP CYCLIC NUCLEOTIDE MEDIATED SIGNALING | 24 | 2.98e-01 | -1.23e-01 | 6.39e-01 |
GOMF PROTON CHANNEL ACTIVITY | 17 | 3.81e-01 | 1.23e-01 | 7.05e-01 |
GOCC CIS GOLGI NETWORK | 41 | 1.74e-01 | 1.23e-01 | 5.17e-01 |
GOCC MITOCHONDRIAL TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 11 | 4.81e-01 | 1.23e-01 | 7.72e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 15 | 4.11e-01 | 1.23e-01 | 7.26e-01 |
GOBP MODIFICATION OF SYNAPTIC STRUCTURE | 16 | 3.96e-01 | -1.23e-01 | 7.15e-01 |
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY | 7 | 5.74e-01 | -1.23e-01 | 8.23e-01 |
GOBP URONIC ACID METABOLIC PROCESS | 6 | 6.03e-01 | -1.23e-01 | 8.39e-01 |
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY | 8 | 5.48e-01 | -1.23e-01 | 8.11e-01 |
GOBP BONE DEVELOPMENT | 78 | 6.19e-02 | -1.23e-01 | 3.26e-01 |
GOBP ACETYL COA BIOSYNTHETIC PROCESS | 14 | 4.28e-01 | 1.22e-01 | 7.36e-01 |
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY | 17 | 3.82e-01 | -1.22e-01 | 7.06e-01 |
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 6 | 6.03e-01 | -1.22e-01 | 8.40e-01 |
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES | 5 | 6.36e-01 | 1.22e-01 | 8.57e-01 |
GOBP POSITIVE REGULATION OF GROWTH | 102 | 3.33e-02 | -1.22e-01 | 2.46e-01 |
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 20 | 3.44e-01 | -1.22e-01 | 6.79e-01 |
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 18 | 3.69e-01 | -1.22e-01 | 6.96e-01 |
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS | 55 | 1.17e-01 | -1.22e-01 | 4.39e-01 |
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING | 5 | 6.36e-01 | 1.22e-01 | 8.57e-01 |
GOBP MUSCLE CELL PROLIFERATION | 88 | 4.82e-02 | -1.22e-01 | 2.87e-01 |
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY | 14 | 4.29e-01 | -1.22e-01 | 7.36e-01 |
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING | 22 | 3.22e-01 | 1.22e-01 | 6.59e-01 |
GOBP MESENCHYMAL CELL MIGRATION | 11 | 4.83e-01 | -1.22e-01 | 7.74e-01 |
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 22 | 3.22e-01 | -1.22e-01 | 6.59e-01 |
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS | 46 | 1.53e-01 | 1.22e-01 | 4.87e-01 |
GOBP TRNA PROCESSING | 100 | 3.55e-02 | 1.22e-01 | 2.55e-01 |
GOCC ATAC COMPLEX | 11 | 4.84e-01 | 1.22e-01 | 7.74e-01 |
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 25 | 2.91e-01 | -1.22e-01 | 6.34e-01 |
GOBP UV DAMAGE EXCISION REPAIR | 10 | 5.04e-01 | 1.22e-01 | 7.84e-01 |
GOBP KERATINOCYTE DIFFERENTIATION | 46 | 1.53e-01 | -1.22e-01 | 4.88e-01 |
GOMF HEPARIN BINDING | 28 | 2.65e-01 | 1.22e-01 | 6.09e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 96 | 3.98e-02 | -1.22e-01 | 2.68e-01 |
GOBP TRNA WOBBLE BASE MODIFICATION | 15 | 4.14e-01 | 1.22e-01 | 7.28e-01 |
GOBP REGULATION OF LEUKOCYTE DEGRANULATION | 33 | 2.27e-01 | -1.22e-01 | 5.76e-01 |
GOBP COLLAGEN BIOSYNTHETIC PROCESS | 12 | 4.66e-01 | 1.22e-01 | 7.62e-01 |
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY | 13 | 4.48e-01 | -1.22e-01 | 7.49e-01 |
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY | 12 | 4.66e-01 | 1.22e-01 | 7.62e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT | 15 | 4.15e-01 | -1.22e-01 | 7.29e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION | 15 | 4.15e-01 | 1.22e-01 | 7.29e-01 |
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 13 | 4.48e-01 | 1.22e-01 | 7.49e-01 |
GOBP CARDIAC VENTRICLE DEVELOPMENT | 40 | 1.84e-01 | -1.22e-01 | 5.29e-01 |
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT | 5 | 6.38e-01 | -1.22e-01 | 8.58e-01 |
GOBP MEGAKARYOCYTE DIFFERENTIATION | 34 | 2.21e-01 | -1.22e-01 | 5.73e-01 |
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM | 18 | 3.72e-01 | 1.22e-01 | 6.99e-01 |
GOMF MODIFIED AMINO ACID BINDING | 27 | 2.75e-01 | 1.21e-01 | 6.19e-01 |
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY | 13 | 4.48e-01 | -1.21e-01 | 7.49e-01 |
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 23 | 3.14e-01 | -1.21e-01 | 6.52e-01 |
GOBP NCRNA PROCESSING | 326 | 1.91e-04 | 1.21e-01 | 1.04e-02 |
GOCC SITE OF DNA DAMAGE | 87 | 5.09e-02 | 1.21e-01 | 2.96e-01 |
GOMF NAD BINDING | 41 | 1.79e-01 | 1.21e-01 | 5.25e-01 |
GOMF MICROTUBULE PLUS END BINDING | 17 | 3.87e-01 | -1.21e-01 | 7.07e-01 |
GOCC INO80 TYPE COMPLEX | 25 | 2.95e-01 | 1.21e-01 | 6.37e-01 |
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 19 | 3.61e-01 | 1.21e-01 | 6.88e-01 |
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION | 19 | 3.61e-01 | -1.21e-01 | 6.88e-01 |
GOBP ACTIVATION OF IMMUNE RESPONSE | 302 | 3.35e-04 | -1.21e-01 | 1.62e-02 |
GOBP REGULATION OF NUCLEAR DIVISION | 73 | 7.44e-02 | 1.21e-01 | 3.59e-01 |
GOBP MITOTIC SISTER CHROMATID SEGREGATION | 132 | 1.69e-02 | 1.21e-01 | 1.75e-01 |
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY | 5 | 6.40e-01 | 1.21e-01 | 8.59e-01 |
GOBP CAMKK AMPK SIGNALING CASCADE | 5 | 6.40e-01 | 1.21e-01 | 8.59e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN | 6 | 6.08e-01 | -1.21e-01 | 8.43e-01 |
GOMF PHOSPHATASE REGULATOR ACTIVITY | 63 | 9.77e-02 | -1.21e-01 | 4.04e-01 |
GOCC NSL COMPLEX | 11 | 4.88e-01 | -1.21e-01 | 7.76e-01 |
GOBP EOSINOPHIL MEDIATED IMMUNITY | 6 | 6.09e-01 | 1.21e-01 | 8.44e-01 |
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 16 | 4.04e-01 | -1.21e-01 | 7.21e-01 |
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING | 10 | 5.10e-01 | -1.20e-01 | 7.87e-01 |
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION | 92 | 4.65e-02 | 1.20e-01 | 2.83e-01 |
GOBP SPERM DNA CONDENSATION | 6 | 6.10e-01 | -1.20e-01 | 8.44e-01 |
GOBP MIRNA PROCESSING | 35 | 2.18e-01 | -1.20e-01 | 5.71e-01 |
GOBP PRO B CELL DIFFERENTIATION | 7 | 5.81e-01 | 1.20e-01 | 8.28e-01 |
GOBP RESPONSE TO MONOSACCHARIDE | 77 | 6.85e-02 | -1.20e-01 | 3.45e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 8 | 5.56e-01 | 1.20e-01 | 8.14e-01 |
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 22 | 3.29e-01 | -1.20e-01 | 6.64e-01 |
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY | 59 | 1.11e-01 | -1.20e-01 | 4.27e-01 |
GOBP CHROMOSOME ORGANIZATION | 406 | 4.09e-05 | 1.20e-01 | 2.96e-03 |
GOBP RESPONSE TO INTERLEUKIN 1 | 57 | 1.17e-01 | -1.20e-01 | 4.39e-01 |
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT | 8 | 5.56e-01 | -1.20e-01 | 8.14e-01 |
GOBP RESPONSE TO TYPE II INTERFERON | 69 | 8.51e-02 | -1.20e-01 | 3.81e-01 |
GOMF RNA NUCLEASE ACTIVITY | 77 | 6.93e-02 | 1.20e-01 | 3.47e-01 |
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 10 | 5.11e-01 | 1.20e-01 | 7.88e-01 |
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING | 98 | 4.09e-02 | 1.20e-01 | 2.71e-01 |
GOBP INTRACELLULAR STEROL TRANSPORT | 22 | 3.31e-01 | -1.20e-01 | 6.66e-01 |
GOMF TRANSLATION REGULATOR ACTIVITY | 105 | 3.45e-02 | 1.20e-01 | 2.51e-01 |
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT | 7 | 5.83e-01 | 1.20e-01 | 8.29e-01 |
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT | 25 | 3.01e-01 | 1.20e-01 | 6.42e-01 |
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH | 6 | 6.12e-01 | -1.20e-01 | 8.45e-01 |
GOMF PHOSPHOTYROSINE RESIDUE BINDING | 30 | 2.58e-01 | -1.19e-01 | 6.01e-01 |
GOBP RESPONSE TO MANGANESE ION | 11 | 4.93e-01 | -1.19e-01 | 7.78e-01 |
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 47 | 1.57e-01 | -1.19e-01 | 4.93e-01 |
GOBP COGNITION | 117 | 2.64e-02 | -1.19e-01 | 2.25e-01 |
GOMF ATP DEPENDENT ACTIVITY | 335 | 2.08e-04 | 1.19e-01 | 1.11e-02 |
GOBP CIRCULATORY SYSTEM DEVELOPMENT | 428 | 3.06e-05 | -1.19e-01 | 2.33e-03 |
GOCC DYNACTIN COMPLEX | 8 | 5.60e-01 | 1.19e-01 | 8.16e-01 |
GOBP ANOIKIS | 18 | 3.82e-01 | -1.19e-01 | 7.05e-01 |
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY | 266 | 9.22e-04 | -1.19e-01 | 3.29e-02 |
GOBP FC RECEPTOR SIGNALING PATHWAY | 40 | 1.93e-01 | -1.19e-01 | 5.40e-01 |
GOBP MEMBRANE FISSION | 38 | 2.05e-01 | 1.19e-01 | 5.52e-01 |
GOBP NEUTROPHIL HOMEOSTASIS | 11 | 4.95e-01 | -1.19e-01 | 7.79e-01 |
GOMF GDP BINDING | 51 | 1.43e-01 | -1.19e-01 | 4.74e-01 |
GOMF COBALAMIN BINDING | 6 | 6.14e-01 | -1.19e-01 | 8.46e-01 |
GOBP CELLULAR RESPONSE TO ALCOHOL | 45 | 1.68e-01 | -1.19e-01 | 5.10e-01 |
GOBP ORGAN GROWTH | 68 | 9.09e-02 | -1.19e-01 | 3.92e-01 |
GOBP AUTOPHAGY OF PEROXISOME | 9 | 5.37e-01 | 1.19e-01 | 8.04e-01 |
GOBP INTESTINAL CHOLESTEROL ABSORPTION | 5 | 6.46e-01 | 1.19e-01 | 8.62e-01 |
GOBP LIPID DIGESTION | 5 | 6.46e-01 | 1.19e-01 | 8.62e-01 |
GOMF GROWTH HORMONE RECEPTOR BINDING | 5 | 6.46e-01 | 1.19e-01 | 8.62e-01 |
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS | 27 | 2.86e-01 | 1.19e-01 | 6.28e-01 |
GOBP SPLEEN DEVELOPMENT | 21 | 3.47e-01 | -1.19e-01 | 6.79e-01 |
GOBP MYELOID LEUKOCYTE MIGRATION | 95 | 4.63e-02 | -1.19e-01 | 2.83e-01 |
GOBP TELENCEPHALON DEVELOPMENT | 111 | 3.14e-02 | -1.19e-01 | 2.41e-01 |
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS | 33 | 2.39e-01 | 1.19e-01 | 5.87e-01 |
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 9 | 5.38e-01 | 1.19e-01 | 8.04e-01 |
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY | 17 | 3.98e-01 | -1.18e-01 | 7.17e-01 |
GOBP REGULATION OF PROTEIN UBIQUITINATION | 152 | 1.22e-02 | -1.18e-01 | 1.44e-01 |
GOBP FEMALE GAMETE GENERATION | 59 | 1.16e-01 | 1.18e-01 | 4.38e-01 |
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS | 7 | 5.88e-01 | -1.18e-01 | 8.31e-01 |
GOBP NEGATIVE REGULATION OF CHEMOTAXIS | 16 | 4.13e-01 | 1.18e-01 | 7.28e-01 |
GOBP NUCLEAR PORE ORGANIZATION | 15 | 4.28e-01 | 1.18e-01 | 7.36e-01 |
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT | 45 | 1.71e-01 | 1.18e-01 | 5.11e-01 |
GOBP REGULATION OF WNT SIGNALING PATHWAY | 155 | 1.15e-02 | -1.18e-01 | 1.41e-01 |
GOBP EMBRYONIC BODY MORPHOGENESIS | 5 | 6.47e-01 | 1.18e-01 | 8.63e-01 |
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE | 20 | 3.61e-01 | -1.18e-01 | 6.88e-01 |
GOBP ORGANOPHOSPHATE METABOLIC PROCESS | 528 | 5.02e-06 | 1.18e-01 | 4.98e-04 |
GOBP REGULATION OF CHROMOSOME ORGANIZATION | 194 | 4.82e-03 | 1.18e-01 | 8.75e-02 |
GOCC MEMBRANE COAT | 72 | 8.41e-02 | 1.18e-01 | 3.81e-01 |
GOCC TRAPPII PROTEIN COMPLEX | 11 | 4.98e-01 | 1.18e-01 | 7.79e-01 |
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY | 19 | 3.74e-01 | -1.18e-01 | 7.00e-01 |
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 10 | 5.19e-01 | 1.18e-01 | 7.92e-01 |
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 9 | 5.41e-01 | -1.18e-01 | 8.05e-01 |
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 29 | 2.73e-01 | 1.18e-01 | 6.17e-01 |
GOBP SISTER CHROMATID SEGREGATION | 163 | 9.91e-03 | 1.18e-01 | 1.31e-01 |
GOMF PEPTIDE RECEPTOR ACTIVITY | 12 | 4.81e-01 | -1.18e-01 | 7.72e-01 |
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE | 5 | 6.49e-01 | -1.18e-01 | 8.63e-01 |
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT | 9 | 5.41e-01 | -1.18e-01 | 8.05e-01 |
GOBP CELL CYCLE CHECKPOINT SIGNALING | 132 | 2.02e-02 | 1.18e-01 | 1.94e-01 |
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 350 | 1.87e-04 | -1.18e-01 | 1.03e-02 |
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY | 15 | 4.31e-01 | -1.18e-01 | 7.37e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS | 40 | 1.99e-01 | 1.18e-01 | 5.46e-01 |
GOBP VIRAL BUDDING | 22 | 3.41e-01 | 1.17e-01 | 6.76e-01 |
GOBP PERICARDIUM DEVELOPMENT | 5 | 6.50e-01 | 1.17e-01 | 8.64e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING | 10 | 5.21e-01 | 1.17e-01 | 7.93e-01 |
GOBP LAMELLIPODIUM ORGANIZATION | 57 | 1.26e-01 | -1.17e-01 | 4.55e-01 |
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS | 20 | 3.64e-01 | 1.17e-01 | 6.91e-01 |
GOBP MEIOTIC CELL CYCLE | 123 | 2.53e-02 | 1.17e-01 | 2.19e-01 |
GOBP AUTOPHAGOSOME MEMBRANE DOCKING | 7 | 5.91e-01 | 1.17e-01 | 8.34e-01 |
GOBP MEMBRANE BIOGENESIS | 40 | 2.00e-01 | 1.17e-01 | 5.48e-01 |
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 5 | 6.50e-01 | 1.17e-01 | 8.65e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II | 648 | 6.50e-07 | -1.17e-01 | 7.71e-05 |
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS | 28 | 2.85e-01 | 1.17e-01 | 6.27e-01 |
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 229 | 2.48e-03 | -1.17e-01 | 6.15e-02 |
GOCC PHAGOCYTIC CUP | 17 | 4.04e-01 | -1.17e-01 | 7.22e-01 |
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 8 | 5.67e-01 | -1.17e-01 | 8.19e-01 |
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY | 11 | 5.02e-01 | 1.17e-01 | 7.82e-01 |
GOMF KINESIN BINDING | 23 | 3.33e-01 | -1.17e-01 | 6.68e-01 |
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS | 7 | 5.93e-01 | 1.17e-01 | 8.34e-01 |
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY | 169 | 9.19e-03 | 1.17e-01 | 1.24e-01 |
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION | 35 | 2.33e-01 | -1.17e-01 | 5.78e-01 |
GOMF ARACHIDONATE COA LIGASE ACTIVITY | 5 | 6.51e-01 | 1.17e-01 | 8.65e-01 |
GOBP REGULATION OF SYNAPTIC PLASTICITY | 67 | 9.93e-02 | -1.17e-01 | 4.09e-01 |
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 217 | 3.27e-03 | -1.17e-01 | 7.10e-02 |
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY | 5 | 6.52e-01 | 1.17e-01 | 8.65e-01 |
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY | 12 | 4.84e-01 | 1.17e-01 | 7.74e-01 |
GOBP HEPARIN METABOLIC PROCESS | 7 | 5.93e-01 | 1.17e-01 | 8.34e-01 |
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS | 27 | 2.95e-01 | -1.17e-01 | 6.37e-01 |
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI | 5 | 6.52e-01 | 1.17e-01 | 8.65e-01 |
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY | 24 | 3.23e-01 | 1.17e-01 | 6.61e-01 |
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION | 38 | 2.15e-01 | -1.16e-01 | 5.67e-01 |
GOCC DOPAMINERGIC SYNAPSE | 5 | 6.52e-01 | -1.16e-01 | 8.65e-01 |
GOBP EXCITATORY SYNAPSE ASSEMBLY | 10 | 5.24e-01 | 1.16e-01 | 7.96e-01 |
GOMF DYNEIN COMPLEX BINDING | 15 | 4.36e-01 | -1.16e-01 | 7.40e-01 |
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS | 5 | 6.53e-01 | -1.16e-01 | 8.66e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION | 24 | 3.25e-01 | -1.16e-01 | 6.63e-01 |
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE | 162 | 1.12e-02 | -1.16e-01 | 1.39e-01 |
GOCC RIBOSOMAL SUBUNIT | 176 | 8.31e-03 | 1.16e-01 | 1.19e-01 |
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION | 9 | 5.47e-01 | 1.16e-01 | 8.10e-01 |
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE | 16 | 4.22e-01 | -1.16e-01 | 7.33e-01 |
GOCC PML BODY | 90 | 5.81e-02 | -1.16e-01 | 3.15e-01 |
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY | 6 | 6.23e-01 | 1.16e-01 | 8.51e-01 |
GOMF SMAD BINDING | 49 | 1.61e-01 | -1.16e-01 | 5.00e-01 |
GOBP ENSHEATHMENT OF NEURONS | 68 | 9.96e-02 | -1.16e-01 | 4.09e-01 |
GOBP REGULATION OF CALCIUM ION TRANSPORT | 88 | 6.15e-02 | -1.16e-01 | 3.25e-01 |
GOBP CELL MATRIX ADHESION | 98 | 4.87e-02 | -1.16e-01 | 2.88e-01 |
GOBP STEM CELL PROLIFERATION | 44 | 1.86e-01 | -1.15e-01 | 5.31e-01 |
GOBP EPIDERMAL CELL DIFFERENTIATION | 62 | 1.17e-01 | -1.15e-01 | 4.39e-01 |
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS | 31 | 2.67e-01 | 1.15e-01 | 6.11e-01 |
GOBP MEIOTIC CHROMOSOME SEGREGATION | 38 | 2.19e-01 | 1.15e-01 | 5.72e-01 |
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS | 26 | 3.09e-01 | 1.15e-01 | 6.49e-01 |
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 9 | 5.50e-01 | 1.15e-01 | 8.12e-01 |
GOBP CELL ADHESION | 552 | 5.62e-06 | -1.15e-01 | 5.42e-04 |
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY | 28 | 2.93e-01 | 1.15e-01 | 6.35e-01 |
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 24 | 3.30e-01 | -1.15e-01 | 6.65e-01 |
GOMF MICROTUBULE BINDING | 149 | 1.59e-02 | -1.15e-01 | 1.70e-01 |
GOBP TRNA MODIFICATION | 71 | 9.51e-02 | 1.15e-01 | 4.01e-01 |
GOMF P53 BINDING | 52 | 1.53e-01 | -1.15e-01 | 4.88e-01 |
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS | 395 | 1.12e-04 | 1.15e-01 | 6.85e-03 |
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE | 7 | 5.99e-01 | -1.15e-01 | 8.37e-01 |
GOMF LIPOPOLYSACCHARIDE BINDING | 11 | 5.10e-01 | -1.15e-01 | 7.88e-01 |
GOBP SENSORY ORGAN MORPHOGENESIS | 73 | 9.11e-02 | -1.15e-01 | 3.92e-01 |
GOBP POSITIVE REGULATION OF JNK CASCADE | 46 | 1.79e-01 | -1.15e-01 | 5.25e-01 |
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 11 | 5.11e-01 | -1.15e-01 | 7.88e-01 |
GOMF HSP70 PROTEIN BINDING | 35 | 2.41e-01 | 1.15e-01 | 5.89e-01 |
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY | 66 | 1.08e-01 | -1.15e-01 | 4.24e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 10 | 5.31e-01 | -1.14e-01 | 8.01e-01 |
GOBP NUCLEAR CHROMOSOME SEGREGATION | 199 | 5.69e-03 | 1.14e-01 | 9.68e-02 |
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION | 6 | 6.28e-01 | -1.14e-01 | 8.53e-01 |
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS | 67 | 1.06e-01 | 1.14e-01 | 4.21e-01 |
GOBP MITOTIC NUCLEAR DIVISION | 182 | 8.21e-03 | 1.14e-01 | 1.18e-01 |
GOCC VESICLE LUMEN | 191 | 6.81e-03 | 1.14e-01 | 1.06e-01 |
GOBP SULFUR COMPOUND METABOLIC PROCESS | 162 | 1.26e-02 | 1.14e-01 | 1.47e-01 |
GOCC MITOCHONDRIAL ALPHA KETOGLUTARATE DEHYDROGENASE COMPLEX | 6 | 6.28e-01 | 1.14e-01 | 8.53e-01 |
GOCC GOLGI ASSOCIATED VESICLE | 64 | 1.15e-01 | 1.14e-01 | 4.36e-01 |
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 12 | 4.94e-01 | -1.14e-01 | 7.79e-01 |
GOBP REGULATION OF ENDOCYTIC RECYCLING | 11 | 5.12e-01 | -1.14e-01 | 7.88e-01 |
GOBP SPERMIDINE METABOLIC PROCESS | 6 | 6.29e-01 | -1.14e-01 | 8.53e-01 |
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING | 28 | 2.97e-01 | 1.14e-01 | 6.39e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING | 9 | 5.54e-01 | -1.14e-01 | 8.14e-01 |
GOCC VESICLE COAT | 50 | 1.65e-01 | 1.14e-01 | 5.03e-01 |
GOBP AXONAL TRANSPORT OF MITOCHONDRION | 9 | 5.55e-01 | -1.14e-01 | 8.14e-01 |
GOBP REGULATION OF HISTONE H3 K4 METHYLATION | 12 | 4.96e-01 | -1.14e-01 | 7.79e-01 |
GOBP PROTEIN LOCALIZATION TO SYNAPSE | 24 | 3.35e-01 | 1.14e-01 | 6.71e-01 |
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT | 22 | 3.57e-01 | -1.14e-01 | 6.86e-01 |
GOBP CARDIAC MUSCLE CONTRACTION | 43 | 1.98e-01 | 1.14e-01 | 5.45e-01 |
GOBP CARDIAC SEPTUM MORPHOGENESIS | 19 | 3.92e-01 | -1.14e-01 | 7.12e-01 |
GOMF CLATHRIN HEAVY CHAIN BINDING | 7 | 6.03e-01 | -1.14e-01 | 8.39e-01 |
GOBP ORGANELLE FISSION | 273 | 1.38e-03 | 1.14e-01 | 4.29e-02 |
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX | 10 | 5.34e-01 | -1.14e-01 | 8.03e-01 |
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME | 78 | 8.39e-02 | -1.13e-01 | 3.81e-01 |
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY | 14 | 4.63e-01 | -1.13e-01 | 7.60e-01 |
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX | 17 | 4.19e-01 | 1.13e-01 | 7.31e-01 |
GOMF MHC PROTEIN BINDING | 17 | 4.19e-01 | 1.13e-01 | 7.31e-01 |
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY | 292 | 9.67e-04 | -1.13e-01 | 3.41e-02 |
GOBP SMOOTH MUSCLE CONTRACTION | 28 | 3.00e-01 | -1.13e-01 | 6.42e-01 |
GOCC NUCLEAR ENVELOPE LUMEN | 7 | 6.04e-01 | -1.13e-01 | 8.40e-01 |
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 38 | 2.28e-01 | -1.13e-01 | 5.76e-01 |
GOBP COENZYME A BIOSYNTHETIC PROCESS | 8 | 5.80e-01 | 1.13e-01 | 8.27e-01 |
GOBP POTASSIUM ION HOMEOSTASIS | 8 | 5.80e-01 | -1.13e-01 | 8.27e-01 |
GOBP RESPONSE TO DEXAMETHASONE | 15 | 4.49e-01 | 1.13e-01 | 7.49e-01 |
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 16 | 4.35e-01 | -1.13e-01 | 7.39e-01 |
GOBP VASOCONSTRICTION | 20 | 3.83e-01 | -1.13e-01 | 7.06e-01 |
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION | 40 | 2.18e-01 | -1.13e-01 | 5.71e-01 |
GOMF ADP BINDING | 26 | 3.20e-01 | 1.13e-01 | 6.58e-01 |
GOCC DIHYDROLIPOYL DEHYDROGENASE COMPLEX | 8 | 5.81e-01 | 1.13e-01 | 8.28e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION | 7 | 6.06e-01 | -1.13e-01 | 8.41e-01 |
GOMF IMMUNOGLOBULIN BINDING | 11 | 5.18e-01 | -1.13e-01 | 7.91e-01 |
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS | 41 | 2.13e-01 | -1.13e-01 | 5.63e-01 |
GOMF FATTY ACID BINDING | 17 | 4.22e-01 | 1.13e-01 | 7.32e-01 |
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 46 | 1.87e-01 | -1.13e-01 | 5.34e-01 |
GOBP RNA MODIFICATION | 134 | 2.51e-02 | 1.13e-01 | 2.18e-01 |
GOCC NUCLEAR LAMINA | 9 | 5.59e-01 | 1.13e-01 | 8.16e-01 |
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION | 16 | 4.36e-01 | 1.13e-01 | 7.40e-01 |
GOBP PLATELET DEGRANULATION | 5 | 6.63e-01 | -1.13e-01 | 8.72e-01 |
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 403 | 1.31e-04 | -1.13e-01 | 7.76e-03 |
GOCC ENDONUCLEASE COMPLEX | 27 | 3.13e-01 | 1.12e-01 | 6.50e-01 |
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY | 6 | 6.34e-01 | -1.12e-01 | 8.56e-01 |
GOBP DORSAL VENTRAL PATTERN FORMATION | 21 | 3.73e-01 | -1.12e-01 | 6.99e-01 |
GOBP REGULATION OF CELL CELL ADHESION | 235 | 3.24e-03 | -1.12e-01 | 7.08e-02 |
GOMF PHOSPHATIDYLGLYCEROL BINDING | 9 | 5.60e-01 | 1.12e-01 | 8.16e-01 |
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 6 | 6.34e-01 | 1.12e-01 | 8.56e-01 |
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 32 | 2.72e-01 | -1.12e-01 | 6.17e-01 |
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 12 | 5.01e-01 | -1.12e-01 | 7.81e-01 |
GOBP REGULATION OF CELL GROWTH | 196 | 7.11e-03 | -1.12e-01 | 1.09e-01 |
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 12 | 5.01e-01 | -1.12e-01 | 7.81e-01 |
GOBP FIBROBLAST APOPTOTIC PROCESS | 20 | 3.85e-01 | -1.12e-01 | 7.06e-01 |
GOBP TRANSCYTOSIS | 10 | 5.39e-01 | 1.12e-01 | 8.04e-01 |
GOCC ESCRT COMPLEX | 22 | 3.63e-01 | 1.12e-01 | 6.90e-01 |
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY | 7 | 6.08e-01 | -1.12e-01 | 8.43e-01 |
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY | 19 | 3.98e-01 | -1.12e-01 | 7.17e-01 |
GOBP MONOCARBOXYLIC ACID TRANSPORT | 48 | 1.80e-01 | 1.12e-01 | 5.26e-01 |
GOBP DNA RECOMBINATION | 204 | 6.14e-03 | 1.12e-01 | 9.93e-02 |
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 15 | 4.53e-01 | -1.12e-01 | 7.52e-01 |
GOBP TRANSLATIONAL TERMINATION | 13 | 4.85e-01 | 1.12e-01 | 7.74e-01 |
GOMF POTASSIUM ION BINDING | 6 | 6.35e-01 | 1.12e-01 | 8.57e-01 |
GOBP RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 18 | 4.11e-01 | 1.12e-01 | 7.26e-01 |
GOCC RIBONUCLEOPROTEIN COMPLEX | 618 | 3.24e-06 | 1.12e-01 | 3.60e-04 |
GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 5 | 6.65e-01 | -1.12e-01 | 8.72e-01 |
GOCC COPII VESICLE COAT | 15 | 4.53e-01 | 1.12e-01 | 7.52e-01 |
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX | 6 | 6.35e-01 | 1.12e-01 | 8.57e-01 |
GOCC MANCHETTE | 7 | 6.08e-01 | 1.12e-01 | 8.43e-01 |
GOBP LIPID IMPORT INTO CELL | 12 | 5.03e-01 | -1.12e-01 | 7.82e-01 |
GOBP CELL MOTILITY | 667 | 1.47e-06 | -1.12e-01 | 1.69e-04 |
GOBP SPECIFICATION OF SYMMETRY | 42 | 2.11e-01 | -1.12e-01 | 5.60e-01 |
GOBP BONE MORPHOGENESIS | 29 | 2.99e-01 | -1.12e-01 | 6.40e-01 |
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 11 | 5.22e-01 | -1.12e-01 | 7.94e-01 |
GOBP REGULATION OF GROWTH | 267 | 1.88e-03 | -1.11e-01 | 5.25e-02 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 13 | 4.87e-01 | -1.11e-01 | 7.76e-01 |
GOBP CILIUM MOVEMENT | 35 | 2.54e-01 | -1.11e-01 | 5.97e-01 |
GOMF KINASE BINDING | 448 | 6.80e-05 | -1.11e-01 | 4.59e-03 |
GOBP ENTRY OF BACTERIUM INTO HOST CELL | 6 | 6.37e-01 | 1.11e-01 | 8.57e-01 |
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 13 | 4.87e-01 | 1.11e-01 | 7.76e-01 |
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 12 | 5.04e-01 | -1.11e-01 | 7.84e-01 |
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE | 5 | 6.67e-01 | 1.11e-01 | 8.73e-01 |
GOBP RESPONSE TO AMPHETAMINE | 13 | 4.88e-01 | -1.11e-01 | 7.76e-01 |
GOBP REGULATION OF SISTER CHROMATID SEGREGATION | 76 | 9.47e-02 | 1.11e-01 | 4.00e-01 |
GOBP EMBRYONIC CLEAVAGE | 5 | 6.67e-01 | 1.11e-01 | 8.73e-01 |
GOMF HISTONE DECROTONYLASE ACTIVITY | 5 | 6.67e-01 | 1.11e-01 | 8.73e-01 |
GOBP MONOATOMIC ANION HOMEOSTASIS | 6 | 6.37e-01 | 1.11e-01 | 8.58e-01 |
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE | 9 | 5.64e-01 | 1.11e-01 | 8.17e-01 |
GOBP TELOMERE ORGANIZATION | 126 | 3.21e-02 | 1.11e-01 | 2.43e-01 |
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 20 | 3.91e-01 | 1.11e-01 | 7.11e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 303 | 1.01e-03 | -1.11e-01 | 3.52e-02 |
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS | 9 | 5.65e-01 | -1.11e-01 | 8.17e-01 |
GOBP TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 259 | 2.31e-03 | -1.11e-01 | 5.90e-02 |
GOBP CELLULAR RESPONSE TO CADMIUM ION | 17 | 4.29e-01 | 1.11e-01 | 7.36e-01 |
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 22 | 3.68e-01 | -1.11e-01 | 6.95e-01 |
GOBP REGULATION OF EPIDERMIS DEVELOPMENT | 22 | 3.68e-01 | -1.11e-01 | 6.95e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION | 28 | 3.10e-01 | -1.11e-01 | 6.49e-01 |
GOMF MONOSACCHARIDE BINDING | 37 | 2.44e-01 | -1.11e-01 | 5.92e-01 |
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 71 | 1.07e-01 | -1.11e-01 | 4.22e-01 |
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS | 223 | 4.65e-03 | -1.11e-01 | 8.58e-02 |
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 8 | 5.88e-01 | -1.11e-01 | 8.31e-01 |
GOCC BLOC 1 COMPLEX | 8 | 5.88e-01 | -1.11e-01 | 8.31e-01 |
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS | 12 | 5.07e-01 | 1.11e-01 | 7.86e-01 |
GOBP REGULATION OF BEHAVIOR | 20 | 3.93e-01 | -1.11e-01 | 7.12e-01 |
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION | 5 | 6.69e-01 | -1.10e-01 | 8.74e-01 |
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING | 9 | 5.67e-01 | 1.10e-01 | 8.19e-01 |
GOBP CELL CELL SIGNALING | 564 | 1.11e-05 | -1.10e-01 | 9.57e-04 |
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION | 11 | 5.27e-01 | -1.10e-01 | 7.98e-01 |
GOBP MORPHOGENESIS OF AN ENDOTHELIUM | 9 | 5.68e-01 | -1.10e-01 | 8.19e-01 |
GOBP B CELL RECEPTOR SIGNALING PATHWAY | 62 | 1.35e-01 | -1.10e-01 | 4.63e-01 |
GOMF DEMETHYLASE ACTIVITY | 30 | 2.97e-01 | -1.10e-01 | 6.39e-01 |
GOBP REGULATION OF DEVELOPMENTAL GROWTH | 127 | 3.29e-02 | -1.10e-01 | 2.46e-01 |
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS | 59 | 1.45e-01 | 1.10e-01 | 4.77e-01 |
GOBP OLEFINIC COMPOUND METABOLIC PROCESS | 34 | 2.67e-01 | 1.10e-01 | 6.11e-01 |
GOBP LIPID CATABOLIC PROCESS | 129 | 3.17e-02 | 1.10e-01 | 2.42e-01 |
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE | 6 | 6.41e-01 | -1.10e-01 | 8.59e-01 |
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 9 | 5.68e-01 | -1.10e-01 | 8.19e-01 |
GOBP DEPYRIMIDINATION | 5 | 6.71e-01 | -1.10e-01 | 8.75e-01 |
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY | 217 | 5.63e-03 | -1.10e-01 | 9.62e-02 |
GOMF PROTEIN SERINE KINASE ACTIVITY | 228 | 4.56e-03 | -1.10e-01 | 8.49e-02 |
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT | 22 | 3.73e-01 | -1.10e-01 | 6.99e-01 |
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS | 36 | 2.55e-01 | 1.10e-01 | 5.97e-01 |
GOBP PROTEIN LOCALIZATION TO LYSOSOME | 41 | 2.24e-01 | 1.10e-01 | 5.75e-01 |
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 24 | 3.52e-01 | -1.10e-01 | 6.83e-01 |
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY | 139 | 2.62e-02 | -1.10e-01 | 2.25e-01 |
GOBP REGULATION OF REGULATORY NCRNA PROCESSING | 8 | 5.91e-01 | -1.10e-01 | 8.33e-01 |
GOBP DNA TOPOLOGICAL CHANGE | 7 | 6.15e-01 | 1.10e-01 | 8.47e-01 |
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS | 19 | 4.08e-01 | -1.10e-01 | 7.23e-01 |
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX | 21 | 3.85e-01 | 1.10e-01 | 7.06e-01 |
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 25 | 3.43e-01 | 1.10e-01 | 6.78e-01 |
GOBP ORGANIC ACID METABOLIC PROCESS | 444 | 9.60e-05 | 1.10e-01 | 6.09e-03 |
GOCC 9PLUS2 MOTILE CILIUM | 50 | 1.81e-01 | -1.10e-01 | 5.28e-01 |
GOBP BICARBONATE TRANSPORT | 9 | 5.70e-01 | 1.09e-01 | 8.20e-01 |
GOCC TRICARBOXYLIC ACID CYCLE ENZYME COMPLEX | 15 | 4.63e-01 | 1.09e-01 | 7.60e-01 |
GOMF U6 SNRNA BINDING | 13 | 4.95e-01 | 1.09e-01 | 7.79e-01 |
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS | 5 | 6.72e-01 | 1.09e-01 | 8.75e-01 |
GOBP LEUKOCYTE DEGRANULATION | 54 | 1.65e-01 | -1.09e-01 | 5.04e-01 |
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 15 | 4.64e-01 | -1.09e-01 | 7.61e-01 |
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION | 7 | 6.17e-01 | 1.09e-01 | 8.47e-01 |
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY | 12 | 5.12e-01 | 1.09e-01 | 7.88e-01 |
GOMF G PROTEIN COUPLED RECEPTOR BINDING | 69 | 1.18e-01 | -1.09e-01 | 4.39e-01 |
GOBP REGULATION OF SYNAPSE ASSEMBLY | 25 | 3.45e-01 | -1.09e-01 | 6.79e-01 |
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE | 37 | 2.51e-01 | 1.09e-01 | 5.96e-01 |
GOBP HUMORAL IMMUNE RESPONSE | 62 | 1.38e-01 | -1.09e-01 | 4.67e-01 |
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 120 | 3.97e-02 | 1.09e-01 | 2.67e-01 |
GOBP VESICLE DOCKING | 39 | 2.39e-01 | 1.09e-01 | 5.87e-01 |
GOBP VESICLE TARGETING | 58 | 1.52e-01 | 1.09e-01 | 4.87e-01 |
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS | 13 | 4.97e-01 | 1.09e-01 | 7.79e-01 |
GOBP MITOCHONDRIAL TRANSPORT | 140 | 2.69e-02 | 1.09e-01 | 2.26e-01 |
GOBP CELLULAR RESPONSE TO INTERFERON BETA | 18 | 4.24e-01 | 1.09e-01 | 7.34e-01 |
GOCC RECEPTOR COMPLEX | 105 | 5.51e-02 | -1.09e-01 | 3.05e-01 |
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION | 9 | 5.73e-01 | -1.09e-01 | 8.22e-01 |
GOBP DIACYLGLYCEROL METABOLIC PROCESS | 8 | 5.95e-01 | -1.09e-01 | 8.35e-01 |
GOBP ACTIVATED T CELL PROLIFERATION | 20 | 4.01e-01 | -1.09e-01 | 7.19e-01 |
GOMF CCR5 CHEMOKINE RECEPTOR BINDING | 6 | 6.45e-01 | -1.09e-01 | 8.62e-01 |
GOMF CCR CHEMOKINE RECEPTOR BINDING | 6 | 6.45e-01 | -1.09e-01 | 8.62e-01 |
GOBP RUFFLE ASSEMBLY | 29 | 3.12e-01 | -1.09e-01 | 6.50e-01 |
GOBP RESPONSE TO FUNGUS | 22 | 3.79e-01 | -1.08e-01 | 7.04e-01 |
GOBP REGULATION OF SECRETION | 244 | 3.80e-03 | -1.08e-01 | 7.65e-02 |
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION | 56 | 1.61e-01 | -1.08e-01 | 5.00e-01 |
GOBP REGULATION OF PRESYNAPSE ORGANIZATION | 5 | 6.75e-01 | -1.08e-01 | 8.78e-01 |
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS | 832 | 2.41e-07 | -1.08e-01 | 3.11e-05 |
GOCC TELOMERASE HOLOENZYME COMPLEX | 17 | 4.39e-01 | 1.08e-01 | 7.42e-01 |
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE | 5 | 6.75e-01 | 1.08e-01 | 8.78e-01 |
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 7 | 6.20e-01 | 1.08e-01 | 8.49e-01 |
GOMF ENZYME INHIBITOR ACTIVITY | 163 | 1.76e-02 | -1.08e-01 | 1.79e-01 |
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 9 | 5.74e-01 | 1.08e-01 | 8.23e-01 |
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM | 39 | 2.43e-01 | -1.08e-01 | 5.91e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY | 8 | 5.96e-01 | -1.08e-01 | 8.35e-01 |
GOMF CYCLOHYDROLASE ACTIVITY | 5 | 6.75e-01 | 1.08e-01 | 8.78e-01 |
GOBP HINDBRAIN DEVELOPMENT | 63 | 1.38e-01 | -1.08e-01 | 4.68e-01 |
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY | 6 | 6.46e-01 | 1.08e-01 | 8.63e-01 |
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 57 | 1.59e-01 | -1.08e-01 | 4.96e-01 |
GOBP MEMBRANE RAFT LOCALIZATION | 5 | 6.76e-01 | -1.08e-01 | 8.78e-01 |
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE | 7 | 6.21e-01 | 1.08e-01 | 8.49e-01 |
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING | 8 | 5.97e-01 | -1.08e-01 | 8.36e-01 |
GOMF CYTOSKELETAL MOTOR ACTIVITY | 42 | 2.26e-01 | -1.08e-01 | 5.76e-01 |
GOBP AORTA DEVELOPMENT | 18 | 4.28e-01 | -1.08e-01 | 7.36e-01 |
GOBP RESPONSE TO NERVE GROWTH FACTOR | 26 | 3.41e-01 | -1.08e-01 | 6.76e-01 |
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING | 33 | 2.84e-01 | 1.08e-01 | 6.26e-01 |
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY | 6 | 6.47e-01 | 1.08e-01 | 8.63e-01 |
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY | 6 | 6.47e-01 | 1.08e-01 | 8.63e-01 |
GOMF PHOSPHATASE BINDING | 125 | 3.81e-02 | -1.08e-01 | 2.63e-01 |
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN | 8 | 5.98e-01 | 1.08e-01 | 8.36e-01 |
GOBP RESPONSE TO ACTIVITY | 32 | 2.92e-01 | -1.08e-01 | 6.34e-01 |
GOBP CEREBELLAR CORTEX DEVELOPMENT | 23 | 3.72e-01 | -1.08e-01 | 6.99e-01 |
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS | 5 | 6.77e-01 | 1.08e-01 | 8.78e-01 |
GOBP POSTSYNAPSE ASSEMBLY | 10 | 5.56e-01 | -1.08e-01 | 8.14e-01 |
GOBP MRNA METHYLATION | 16 | 4.56e-01 | -1.08e-01 | 7.54e-01 |
GOCC TRANSCRIPTION REGULATOR COMPLEX | 304 | 1.39e-03 | -1.08e-01 | 4.31e-02 |
GOBP NEGATIVE REGULATION OF MAPK CASCADE | 84 | 8.91e-02 | -1.08e-01 | 3.88e-01 |
GOBP REGULATION OF ORGAN GROWTH | 38 | 2.52e-01 | -1.07e-01 | 5.96e-01 |
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION | 23 | 3.73e-01 | -1.07e-01 | 6.99e-01 |
GOBP PROTEIN K48 LINKED UBIQUITINATION | 54 | 1.73e-01 | -1.07e-01 | 5.15e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING | 18 | 4.30e-01 | 1.07e-01 | 7.37e-01 |
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY | 55 | 1.69e-01 | -1.07e-01 | 5.10e-01 |
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT | 20 | 4.06e-01 | 1.07e-01 | 7.22e-01 |
GOCC INTRACILIARY TRANSPORT PARTICLE B | 11 | 5.37e-01 | -1.07e-01 | 8.04e-01 |
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX | 12 | 5.19e-01 | -1.07e-01 | 7.93e-01 |
GOBP REGULATION OF POTASSIUM ION TRANSPORT | 31 | 3.01e-01 | 1.07e-01 | 6.42e-01 |
GOBP LYMPHOCYTE MIGRATION | 50 | 1.90e-01 | -1.07e-01 | 5.36e-01 |
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING | 8 | 5.99e-01 | 1.07e-01 | 8.37e-01 |
GOBP MRNA CIS SPLICING VIA SPLICEOSOME | 21 | 3.95e-01 | 1.07e-01 | 7.14e-01 |
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 14 | 4.87e-01 | -1.07e-01 | 7.76e-01 |
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION | 117 | 4.59e-02 | -1.07e-01 | 2.83e-01 |
GOMF VITAMIN BINDING | 57 | 1.62e-01 | 1.07e-01 | 5.01e-01 |
GOBP MITOTIC G2 M TRANSITION CHECKPOINT | 40 | 2.42e-01 | 1.07e-01 | 5.90e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 6 | 6.50e-01 | 1.07e-01 | 8.64e-01 |
GOBP REGULATION OF INSULIN SECRETION | 65 | 1.36e-01 | -1.07e-01 | 4.65e-01 |
GOCC CYTOPLASMIC DYNEIN COMPLEX | 15 | 4.73e-01 | -1.07e-01 | 7.68e-01 |
GOMF PH DOMAIN BINDING | 7 | 6.24e-01 | 1.07e-01 | 8.51e-01 |
GOCC PLATELET DENSE GRANULE | 10 | 5.58e-01 | 1.07e-01 | 8.16e-01 |
GOMF TITIN BINDING | 5 | 6.79e-01 | 1.07e-01 | 8.79e-01 |
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 9 | 5.79e-01 | -1.07e-01 | 8.26e-01 |
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION | 373 | 4.68e-04 | -1.07e-01 | 2.05e-02 |
GOCC TERTIARY GRANULE | 93 | 7.61e-02 | -1.07e-01 | 3.63e-01 |
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY | 5 | 6.80e-01 | -1.07e-01 | 8.79e-01 |
GOMF HEAT SHOCK PROTEIN BINDING | 85 | 9.01e-02 | 1.07e-01 | 3.90e-01 |
GOCC SPINDLE POLE CENTROSOME | 8 | 6.02e-01 | -1.07e-01 | 8.38e-01 |
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS | 39 | 2.50e-01 | -1.07e-01 | 5.96e-01 |
GOBP PALLIUM DEVELOPMENT | 87 | 8.70e-02 | -1.06e-01 | 3.85e-01 |
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS | 9 | 5.81e-01 | 1.06e-01 | 8.27e-01 |
GOMF PDZ DOMAIN BINDING | 30 | 3.14e-01 | -1.06e-01 | 6.52e-01 |
GOCC AZUROPHIL GRANULE LUMEN | 63 | 1.45e-01 | 1.06e-01 | 4.78e-01 |
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING | 19 | 4.23e-01 | 1.06e-01 | 7.33e-01 |
GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION | 5 | 6.81e-01 | -1.06e-01 | 8.80e-01 |
GOMF MANGANESE ION BINDING | 41 | 2.40e-01 | -1.06e-01 | 5.88e-01 |
GOBP POSITIVE REGULATION OF HORMONE SECRETION | 47 | 2.08e-01 | -1.06e-01 | 5.56e-01 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS | 16 | 4.62e-01 | 1.06e-01 | 7.59e-01 |
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS | 8 | 6.03e-01 | -1.06e-01 | 8.40e-01 |
GOBP EPITHELIAL CELL MATURATION | 9 | 5.82e-01 | 1.06e-01 | 8.28e-01 |
GOBP THIOESTER METABOLIC PROCESS | 52 | 1.86e-01 | 1.06e-01 | 5.32e-01 |
GOMF PROTEIN FOLDING CHAPERONE BINDING | 86 | 8.99e-02 | 1.06e-01 | 3.90e-01 |
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY | 9 | 5.82e-01 | -1.06e-01 | 8.28e-01 |
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS | 22 | 3.90e-01 | -1.06e-01 | 7.10e-01 |
GOBP CENTROSOME SEPARATION | 11 | 5.43e-01 | 1.06e-01 | 8.07e-01 |
GOBP REGULATION OF T CELL MIGRATION | 26 | 3.50e-01 | -1.06e-01 | 6.81e-01 |
GOBP NEGATIVE REGULATION OF TOR SIGNALING | 50 | 1.96e-01 | -1.06e-01 | 5.43e-01 |
GOBP KETONE BIOSYNTHETIC PROCESS | 19 | 4.25e-01 | 1.06e-01 | 7.34e-01 |
GOBP CHROMOSOME SEGREGATION | 282 | 2.46e-03 | 1.06e-01 | 6.15e-02 |
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT | 44 | 2.26e-01 | -1.06e-01 | 5.75e-01 |
GOCC PINOSOME | 5 | 6.83e-01 | -1.06e-01 | 8.81e-01 |
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION | 5 | 6.83e-01 | -1.06e-01 | 8.81e-01 |
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY | 16 | 4.65e-01 | -1.06e-01 | 7.62e-01 |
GOMF ATP HYDROLYSIS ACTIVITY | 248 | 4.54e-03 | 1.06e-01 | 8.48e-02 |
GOMF MIRNA BINDING | 26 | 3.52e-01 | -1.05e-01 | 6.83e-01 |
GOBP REGULATION OF CARTILAGE DEVELOPMENT | 19 | 4.26e-01 | -1.05e-01 | 7.35e-01 |
GOBP REGULATION OF BINDING | 157 | 2.34e-02 | -1.05e-01 | 2.10e-01 |
GOCC TETRASPANIN ENRICHED MICRODOMAIN | 5 | 6.83e-01 | 1.05e-01 | 8.81e-01 |
GOBP IMPORT ACROSS PLASMA MEMBRANE | 64 | 1.46e-01 | -1.05e-01 | 4.78e-01 |
GOBP NEGATIVE REGULATION OF DNA REPLICATION | 15 | 4.80e-01 | 1.05e-01 | 7.72e-01 |
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY | 8 | 6.06e-01 | 1.05e-01 | 8.42e-01 |
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 12 | 5.28e-01 | -1.05e-01 | 7.99e-01 |
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.84e-01 | 1.05e-01 | 8.81e-01 |
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 6.84e-01 | 1.05e-01 | 8.81e-01 |
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 97 | 7.42e-02 | -1.05e-01 | 3.59e-01 |
GOBP MICROVILLUS ORGANIZATION | 18 | 4.40e-01 | -1.05e-01 | 7.42e-01 |
GOCC PHOSPHATASE COMPLEX | 37 | 2.69e-01 | -1.05e-01 | 6.13e-01 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY | 7 | 6.30e-01 | 1.05e-01 | 8.54e-01 |
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS | 14 | 4.97e-01 | -1.05e-01 | 7.79e-01 |
GOBP MUSCLE HYPERTROPHY | 48 | 2.09e-01 | -1.05e-01 | 5.57e-01 |
GOBP BILE ACID BIOSYNTHETIC PROCESS | 15 | 4.82e-01 | 1.05e-01 | 7.72e-01 |
GOMF RIBOSOMAL LARGE SUBUNIT BINDING | 12 | 5.29e-01 | -1.05e-01 | 8.00e-01 |
GOBP REGULATION OF TELOMERE CAPPING | 20 | 4.17e-01 | -1.05e-01 | 7.30e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION | 72 | 1.25e-01 | 1.05e-01 | 4.52e-01 |
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS | 42 | 2.40e-01 | -1.05e-01 | 5.89e-01 |
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING | 7 | 6.31e-01 | 1.05e-01 | 8.55e-01 |
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS | 20 | 4.17e-01 | 1.05e-01 | 7.30e-01 |
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 21 | 4.06e-01 | -1.05e-01 | 7.22e-01 |
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY | 5 | 6.85e-01 | -1.05e-01 | 8.81e-01 |
GOBP DNA DEALKYLATION INVOLVED IN DNA REPAIR | 8 | 6.08e-01 | -1.05e-01 | 8.43e-01 |
GOBP GLIAL CELL DIFFERENTIATION | 100 | 7.13e-02 | -1.05e-01 | 3.52e-01 |
GOMF CALCIUM RELEASE CHANNEL ACTIVITY | 9 | 5.87e-01 | 1.05e-01 | 8.31e-01 |
GOMF INTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY | 9 | 5.87e-01 | 1.05e-01 | 8.31e-01 |
GOBP MIRNA CATABOLIC PROCESS | 14 | 4.98e-01 | -1.05e-01 | 7.79e-01 |
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY | 8 | 6.08e-01 | -1.05e-01 | 8.43e-01 |
GOBP PEPTIDE CATABOLIC PROCESS | 14 | 4.98e-01 | -1.05e-01 | 7.79e-01 |
GOBP REGULATION OF RESPONSE TO WOUNDING | 56 | 1.77e-01 | -1.05e-01 | 5.21e-01 |
GOBP EXTRACELLULAR TRANSPORT | 11 | 5.49e-01 | -1.05e-01 | 8.11e-01 |
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 142 | 3.25e-02 | -1.04e-01 | 2.45e-01 |
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 11 | 5.50e-01 | -1.04e-01 | 8.12e-01 |
GOBP REGULATION OF BONE REMODELING | 18 | 4.45e-01 | -1.04e-01 | 7.46e-01 |
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY | 8 | 6.10e-01 | -1.04e-01 | 8.44e-01 |
GOBP RESPONSE TO UV C | 9 | 5.89e-01 | 1.04e-01 | 8.32e-01 |
GOCC INTERMEDIATE FILAMENT CYTOSKELETON | 45 | 2.28e-01 | -1.04e-01 | 5.76e-01 |
GOCC CATALYTIC COMPLEX | 1278 | 2.26e-09 | 1.04e-01 | 4.55e-07 |
GOBP TRACHEA DEVELOPMENT | 8 | 6.10e-01 | 1.04e-01 | 8.44e-01 |
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY | 9 | 5.89e-01 | 1.04e-01 | 8.32e-01 |
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 6.34e-01 | 1.04e-01 | 8.56e-01 |
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING | 5 | 6.88e-01 | 1.04e-01 | 8.83e-01 |
GOBP TOLERANCE INDUCTION | 11 | 5.52e-01 | -1.04e-01 | 8.13e-01 |
GOMF FLIPPASE ACTIVITY | 10 | 5.71e-01 | -1.04e-01 | 8.21e-01 |
GOMF IMMUNE RECEPTOR ACTIVITY | 42 | 2.46e-01 | -1.04e-01 | 5.92e-01 |
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS | 40 | 2.58e-01 | 1.04e-01 | 6.00e-01 |
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY | 26 | 3.61e-01 | 1.04e-01 | 6.88e-01 |
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY | 7 | 6.36e-01 | -1.03e-01 | 8.57e-01 |
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 98 | 7.77e-02 | -1.03e-01 | 3.65e-01 |
GOBP LAMELLIPODIUM ASSEMBLY | 45 | 2.31e-01 | -1.03e-01 | 5.78e-01 |
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX | 11 | 5.53e-01 | -1.03e-01 | 8.13e-01 |
GOCC INTEGRATOR COMPLEX | 15 | 4.89e-01 | 1.03e-01 | 7.76e-01 |
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY | 78 | 1.16e-01 | -1.03e-01 | 4.37e-01 |
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT | 11 | 5.53e-01 | -1.03e-01 | 8.13e-01 |
GOCC NUCLEAR SPECK | 324 | 1.58e-03 | -1.03e-01 | 4.63e-02 |
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE | 245 | 5.78e-03 | -1.03e-01 | 9.68e-02 |
GOBP MONONUCLEAR CELL DIFFERENTIATION | 265 | 4.14e-03 | -1.03e-01 | 8.05e-02 |
GOMF MRNA 3 UTR AU RICH REGION BINDING | 20 | 4.25e-01 | 1.03e-01 | 7.34e-01 |
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 47 | 2.22e-01 | -1.03e-01 | 5.74e-01 |
GOCC FEMALE PRONUCLEUS | 7 | 6.37e-01 | -1.03e-01 | 8.57e-01 |
GOBP POSITIVE REGULATION OF AUTOPHAGY | 99 | 7.72e-02 | -1.03e-01 | 3.64e-01 |
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS | 1119 | 2.20e-08 | 1.03e-01 | 3.39e-06 |
GOCC NEURON PROJECTION CYTOPLASM | 57 | 1.79e-01 | -1.03e-01 | 5.25e-01 |
GOBP HEART TRABECULA MORPHOGENESIS | 10 | 5.73e-01 | 1.03e-01 | 8.22e-01 |
GOBP REGULATION OF ORGANIC ACID TRANSPORT | 33 | 3.06e-01 | -1.03e-01 | 6.47e-01 |
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS | 147 | 3.19e-02 | -1.03e-01 | 2.42e-01 |
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 7 | 6.37e-01 | -1.03e-01 | 8.58e-01 |
GOBP AGGREPHAGY | 5 | 6.90e-01 | 1.03e-01 | 8.83e-01 |
GOBP CELL CELL JUNCTION ASSEMBLY | 46 | 2.28e-01 | -1.03e-01 | 5.76e-01 |
GOMF PHOSPHOLIPASE A2 ACTIVITY | 9 | 5.93e-01 | 1.03e-01 | 8.34e-01 |
GOBP RECEPTOR RECYCLING | 30 | 3.30e-01 | -1.03e-01 | 6.65e-01 |
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING | 11 | 5.55e-01 | -1.03e-01 | 8.14e-01 |
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY | 181 | 1.77e-02 | -1.03e-01 | 1.79e-01 |
GOBP ARGININE METABOLIC PROCESS | 6 | 6.63e-01 | 1.03e-01 | 8.72e-01 |
GOMF ORGANIC ACID BINDING | 72 | 1.33e-01 | 1.03e-01 | 4.60e-01 |
GOBP REGULATION OF CELL DIVISION | 89 | 9.56e-02 | 1.03e-01 | 4.01e-01 |
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 9 | 5.95e-01 | -1.02e-01 | 8.35e-01 |
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY | 9 | 5.95e-01 | -1.02e-01 | 8.35e-01 |
GOBP PROTEIN K63 LINKED UBIQUITINATION | 42 | 2.51e-01 | -1.02e-01 | 5.96e-01 |
GOBP REGULATION OF MEMBRANE DEPOLARIZATION | 16 | 4.79e-01 | -1.02e-01 | 7.72e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 34 | 3.02e-01 | -1.02e-01 | 6.43e-01 |
GOMF REGULATORY RNA BINDING | 32 | 3.17e-01 | -1.02e-01 | 6.55e-01 |
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 9 | 5.95e-01 | -1.02e-01 | 8.35e-01 |
GOBP SEQUESTERING OF TRIGLYCERIDE | 8 | 6.16e-01 | -1.02e-01 | 8.47e-01 |
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS | 7 | 6.39e-01 | -1.02e-01 | 8.59e-01 |
GOBP REGULATION OF COMPLEMENT ACTIVATION | 7 | 6.39e-01 | 1.02e-01 | 8.59e-01 |
GOBP EMBRYONIC ORGAN DEVELOPMENT | 139 | 3.82e-02 | -1.02e-01 | 2.63e-01 |
GOMF NUCLEOSOMAL DNA BINDING | 24 | 3.86e-01 | 1.02e-01 | 7.07e-01 |
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS | 22 | 4.07e-01 | -1.02e-01 | 7.23e-01 |
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS | 42 | 2.52e-01 | 1.02e-01 | 5.96e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 255 | 5.33e-03 | -1.02e-01 | 9.41e-02 |
GOBP ENDOSOMAL LUMEN ACIDIFICATION | 12 | 5.40e-01 | 1.02e-01 | 8.05e-01 |
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY | 29 | 3.42e-01 | 1.02e-01 | 6.77e-01 |
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 13 | 5.24e-01 | 1.02e-01 | 7.96e-01 |
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 11 | 5.58e-01 | 1.02e-01 | 8.16e-01 |
GOBP CELLULAR RESPONSE TO DECREASED OXYGEN LEVELS | 78 | 1.20e-01 | -1.02e-01 | 4.44e-01 |
GOBP POSITIVE REGULATION OF TOR SIGNALING | 51 | 2.09e-01 | -1.02e-01 | 5.56e-01 |
GOBP HEAD DEVELOPMENT | 313 | 2.14e-03 | -1.02e-01 | 5.59e-02 |
GOBP BASE CONVERSION OR SUBSTITUTION EDITING | 8 | 6.18e-01 | 1.02e-01 | 8.48e-01 |
GOBP LEUKOCYTE CHEMOTAXIS | 94 | 8.87e-02 | -1.02e-01 | 3.87e-01 |
GOCC CHROMOCENTER | 6 | 6.66e-01 | -1.02e-01 | 8.73e-01 |
GOCC ENZYME ACTIVATOR COMPLEX | 14 | 5.10e-01 | -1.02e-01 | 7.87e-01 |
GOBP THYMOCYTE APOPTOTIC PROCESS | 13 | 5.25e-01 | -1.02e-01 | 7.97e-01 |
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION | 59 | 1.77e-01 | -1.02e-01 | 5.22e-01 |
GOBP NUCLEOLUS ORGANIZATION | 15 | 4.96e-01 | 1.02e-01 | 7.79e-01 |
GOBP REGULATION OF FILOPODIUM ASSEMBLY | 25 | 3.80e-01 | -1.02e-01 | 7.04e-01 |
GOCC SPINDLE MIDZONE | 21 | 4.21e-01 | -1.02e-01 | 7.32e-01 |
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 21 | 4.21e-01 | -1.01e-01 | 7.32e-01 |
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY | 7 | 6.42e-01 | 1.01e-01 | 8.60e-01 |
GOBP REGULATION OF HISTONE ACETYLATION | 15 | 4.97e-01 | 1.01e-01 | 7.79e-01 |
GOBP PHOTORECEPTOR CELL DEVELOPMENT | 8 | 6.20e-01 | -1.01e-01 | 8.49e-01 |
GOBP MAST CELL MEDIATED IMMUNITY | 38 | 2.81e-01 | -1.01e-01 | 6.22e-01 |
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY | 8 | 6.20e-01 | -1.01e-01 | 8.49e-01 |
GOBP MESONEPHRIC TUBULE MORPHOGENESIS | 11 | 5.61e-01 | 1.01e-01 | 8.17e-01 |
GOBP REGULATION OF PROTEIN SECRETION | 105 | 7.45e-02 | -1.01e-01 | 3.59e-01 |
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION | 45 | 2.42e-01 | 1.01e-01 | 5.90e-01 |
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT | 7 | 6.44e-01 | 1.01e-01 | 8.61e-01 |
GOBP DEVELOPMENTAL CELL GROWTH | 102 | 7.91e-02 | -1.01e-01 | 3.67e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 65 | 1.60e-01 | -1.01e-01 | 4.98e-01 |
GOBP NCRNA TRANSCRIPTION | 85 | 1.09e-01 | -1.01e-01 | 4.24e-01 |
GOCC FICOLIN 1 RICH GRANULE LUMEN | 106 | 7.37e-02 | 1.01e-01 | 3.59e-01 |
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 6 | 6.69e-01 | -1.01e-01 | 8.74e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME | 6 | 6.69e-01 | -1.01e-01 | 8.74e-01 |
GOBP VIRAL PROTEIN PROCESSING | 28 | 3.56e-01 | 1.01e-01 | 6.86e-01 |
GOBP GLYCOSYLATION | 120 | 5.76e-02 | 1.01e-01 | 3.13e-01 |
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 31 | 3.32e-01 | 1.01e-01 | 6.68e-01 |
GOCC X CHROMOSOME | 6 | 6.69e-01 | -1.01e-01 | 8.74e-01 |
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 6 | 6.70e-01 | -1.01e-01 | 8.74e-01 |
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY | 10 | 5.82e-01 | 1.01e-01 | 8.28e-01 |
GOCC SCF UBIQUITIN LIGASE COMPLEX | 40 | 2.72e-01 | 1.01e-01 | 6.16e-01 |
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION | 5 | 6.97e-01 | -1.01e-01 | 8.88e-01 |
GOCC NEURON PROJECTION TERMINUS | 39 | 2.78e-01 | -1.00e-01 | 6.22e-01 |
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS | 25 | 3.85e-01 | -1.00e-01 | 7.06e-01 |
GOBP LENS FIBER CELL DEVELOPMENT | 8 | 6.23e-01 | 1.00e-01 | 8.51e-01 |
GOBP DEFENSE RESPONSE TO FUNGUS | 15 | 5.01e-01 | -1.00e-01 | 7.81e-01 |
GOBP CENTROMERE COMPLEX ASSEMBLY | 22 | 4.16e-01 | 1.00e-01 | 7.29e-01 |
GOBP PROTEIN DEPOLYMERIZATION | 63 | 1.69e-01 | 1.00e-01 | 5.11e-01 |
GOBP MAST CELL ACTIVATION | 44 | 2.50e-01 | -1.00e-01 | 5.96e-01 |
GOBP VESICLE TETHERING | 31 | 3.34e-01 | 1.00e-01 | 6.70e-01 |
GOBP DOUBLE STRAND BREAK REPAIR | 213 | 1.23e-02 | 1.00e-01 | 1.45e-01 |
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION | 367 | 1.12e-03 | -1.00e-01 | 3.79e-02 |
GOCC MICROBODY MEMBRANE | 47 | 2.35e-01 | 1.00e-01 | 5.82e-01 |
GOCC CASPASE COMPLEX | 9 | 6.03e-01 | 1.00e-01 | 8.39e-01 |
GOBP TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 159 | 3.01e-02 | -1.00e-01 | 2.36e-01 |
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 170 | 2.51e-02 | -1.00e-01 | 2.18e-01 |
GOBP LONG TERM SYNAPTIC POTENTIATION | 35 | 3.06e-01 | -1.00e-01 | 6.47e-01 |
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 10 | 5.84e-01 | -1.00e-01 | 8.30e-01 |
GOBP CELL PART MORPHOGENESIS | 261 | 5.83e-03 | -1.00e-01 | 9.68e-02 |
GOBP RESPONSE TO NUTRIENT | 63 | 1.72e-01 | 9.98e-02 | 5.13e-01 |
GOBP CENTRIOLE ASSEMBLY | 33 | 3.22e-01 | 9.97e-02 | 6.59e-01 |
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 430 | 4.71e-04 | -9.97e-02 | 2.05e-02 |
GOBP NUCLEAR ENVELOPE ORGANIZATION | 45 | 2.48e-01 | 9.97e-02 | 5.94e-01 |
GOBP REGULATION OF AUTOPHAGOSOME MATURATION | 12 | 5.50e-01 | -9.97e-02 | 8.12e-01 |
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 76 | 1.34e-01 | -9.96e-02 | 4.62e-01 |
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 11 | 5.67e-01 | -9.96e-02 | 8.19e-01 |
GOBP CELL JUNCTION ORGANIZATION | 264 | 5.77e-03 | -9.96e-02 | 9.68e-02 |
GOBP REGULATION OF CELL CYCLE CHECKPOINT | 35 | 3.09e-01 | 9.96e-02 | 6.48e-01 |
GOCC ENDOLYSOSOME | 16 | 4.91e-01 | -9.94e-02 | 7.77e-01 |
GOBP LOCOMOTION | 500 | 1.83e-04 | -9.94e-02 | 1.02e-02 |
GOBP ORGANELLE MEMBRANE FUSION | 81 | 1.23e-01 | 9.93e-02 | 4.50e-01 |
GOBP RNA METHYLATION | 72 | 1.47e-01 | 9.92e-02 | 4.79e-01 |
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION | 12 | 5.53e-01 | -9.91e-02 | 8.13e-01 |
GOBP EXTRACELLULAR MATRIX DISASSEMBLY | 19 | 4.55e-01 | -9.90e-02 | 7.54e-01 |
GOBP TYPE B PANCREATIC CELL DEVELOPMENT | 11 | 5.70e-01 | -9.90e-02 | 8.20e-01 |
GOCC SITE OF DOUBLE STRAND BREAK | 65 | 1.69e-01 | 9.89e-02 | 5.10e-01 |
GOBP CHROMATIN LOOPING | 10 | 5.88e-01 | 9.89e-02 | 8.32e-01 |
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING | 10 | 5.89e-01 | -9.88e-02 | 8.32e-01 |
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 17 | 4.81e-01 | 9.88e-02 | 7.72e-01 |
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE | 15 | 5.08e-01 | -9.88e-02 | 7.86e-01 |
GOBP SISTER CHROMATID COHESION | 40 | 2.80e-01 | 9.88e-02 | 6.22e-01 |
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE | 6 | 6.75e-01 | -9.88e-02 | 8.78e-01 |
GOBP REGULATION OF TISSUE REMODELING | 28 | 3.66e-01 | -9.87e-02 | 6.94e-01 |
GOBP LUNG SACCULE DEVELOPMENT | 5 | 7.02e-01 | -9.87e-02 | 8.91e-01 |
GOBP ACTIN FILAMENT BASED TRANSPORT | 11 | 5.71e-01 | 9.87e-02 | 8.21e-01 |
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY | 94 | 9.93e-02 | 9.87e-02 | 4.09e-01 |
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION | 80 | 1.28e-01 | -9.87e-02 | 4.56e-01 |
GOCC GAMMA TUBULIN COMPLEX | 13 | 5.39e-01 | -9.86e-02 | 8.04e-01 |
GOBP MAGNESIUM ION TRANSPORT | 11 | 5.72e-01 | 9.85e-02 | 8.21e-01 |
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 591 | 6.06e-05 | -9.85e-02 | 4.21e-03 |
GOCC INTRACILIARY TRANSPORT PARTICLE | 16 | 4.96e-01 | -9.85e-02 | 7.79e-01 |
GOBP REGULATION OF MICROTUBULE POLYMERIZATION | 36 | 3.08e-01 | -9.83e-02 | 6.48e-01 |
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION | 46 | 2.50e-01 | 9.81e-02 | 5.96e-01 |
GOBP GPI ANCHOR METABOLIC PROCESS | 20 | 4.48e-01 | 9.81e-02 | 7.49e-01 |
GOBP BILE ACID METABOLIC PROCESS | 21 | 4.37e-01 | 9.81e-02 | 7.40e-01 |
GOBP RENAL ABSORPTION | 9 | 6.11e-01 | -9.81e-02 | 8.44e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING | 7 | 6.54e-01 | 9.80e-02 | 8.66e-01 |
GOBP NEURAL PRECURSOR CELL PROLIFERATION | 66 | 1.70e-01 | -9.80e-02 | 5.11e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 206 | 1.61e-02 | -9.80e-02 | 1.70e-01 |
GOBP REGULATION OF EPITHELIAL CELL MIGRATION | 108 | 7.98e-02 | -9.79e-02 | 3.69e-01 |
GOBP LONG TERM MEMORY | 14 | 5.26e-01 | -9.79e-02 | 7.97e-01 |
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION | 5 | 7.05e-01 | -9.79e-02 | 8.93e-01 |
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION | 5 | 7.05e-01 | -9.79e-02 | 8.93e-01 |
GOBP VACUOLAR LOCALIZATION | 60 | 1.91e-01 | -9.77e-02 | 5.37e-01 |
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 33 | 3.32e-01 | 9.77e-02 | 6.67e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS | 146 | 4.25e-02 | 9.77e-02 | 2.76e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 24 | 4.08e-01 | -9.77e-02 | 7.23e-01 |
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS | 18 | 4.73e-01 | -9.77e-02 | 7.68e-01 |
GOBP EPITHELIAL CELL APOPTOTIC PROCESS | 61 | 1.88e-01 | -9.77e-02 | 5.34e-01 |
GOBP RESPONSE TO INCREASED OXYGEN LEVELS | 17 | 4.86e-01 | 9.76e-02 | 7.76e-01 |
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY | 6 | 6.79e-01 | 9.76e-02 | 8.79e-01 |
GOMF FRIZZLED BINDING | 7 | 6.55e-01 | -9.75e-02 | 8.66e-01 |
GOBP MEIOTIC CYTOKINESIS | 5 | 7.06e-01 | 9.75e-02 | 8.93e-01 |
GOBP MAINTENANCE OF PROTEIN LOCATION | 63 | 1.82e-01 | 9.74e-02 | 5.28e-01 |
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY | 8 | 6.34e-01 | -9.73e-02 | 8.56e-01 |
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY | 12 | 5.60e-01 | 9.73e-02 | 8.16e-01 |
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION | 5 | 7.07e-01 | 9.72e-02 | 8.93e-01 |
GOBP CARDIAC SEPTUM DEVELOPMENT | 37 | 3.07e-01 | -9.72e-02 | 6.47e-01 |
GOCC INTERCELLULAR BRIDGE | 48 | 2.45e-01 | 9.72e-02 | 5.92e-01 |
GOBP ARTERY DEVELOPMENT | 31 | 3.50e-01 | -9.71e-02 | 6.81e-01 |
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION | 15 | 5.15e-01 | -9.71e-02 | 7.90e-01 |
GOBP APICAL JUNCTION ASSEMBLY | 26 | 3.92e-01 | -9.71e-02 | 7.12e-01 |
GOBP INTERLEUKIN 1 PRODUCTION | 44 | 2.66e-01 | -9.70e-02 | 6.11e-01 |
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION | 6 | 6.81e-01 | -9.70e-02 | 8.80e-01 |
GOBP REGULATION OF TUBE SIZE | 39 | 2.95e-01 | -9.70e-02 | 6.37e-01 |
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE | 10 | 5.95e-01 | 9.70e-02 | 8.35e-01 |
GOCC INTRACILIARY TRANSPORT PARTICLE A | 6 | 6.81e-01 | -9.70e-02 | 8.80e-01 |
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 10 | 5.96e-01 | 9.69e-02 | 8.35e-01 |
GOMF NUCLEASE ACTIVITY | 126 | 6.13e-02 | 9.69e-02 | 3.25e-01 |
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE | 12 | 5.61e-01 | -9.69e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION | 26 | 3.93e-01 | -9.69e-02 | 7.12e-01 |
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION | 30 | 3.59e-01 | -9.69e-02 | 6.88e-01 |
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE | 16 | 5.03e-01 | -9.69e-02 | 7.82e-01 |
GOMF KINASE ACTIVATOR ACTIVITY | 73 | 1.54e-01 | -9.68e-02 | 4.88e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE | 181 | 2.55e-02 | 9.68e-02 | 2.20e-01 |
GOCC TRAPP COMPLEX | 15 | 5.17e-01 | 9.67e-02 | 7.90e-01 |
GOMF DNA N GLYCOSYLASE ACTIVITY | 10 | 5.97e-01 | -9.67e-02 | 8.36e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION | 27 | 3.85e-01 | 9.67e-02 | 7.06e-01 |
GOBP NEGATIVE REGULATION OF MYELINATION | 6 | 6.82e-01 | -9.65e-02 | 8.81e-01 |
GOBP EXOCYTOSIS | 179 | 2.68e-02 | -9.65e-02 | 2.26e-01 |
GOBP PURINE NUCLEOTIDE SALVAGE | 9 | 6.16e-01 | 9.65e-02 | 8.47e-01 |
GOBP SENSORY SYSTEM DEVELOPMENT | 118 | 7.15e-02 | -9.64e-02 | 3.52e-01 |
GOCC RIBOSOME | 211 | 1.66e-02 | 9.63e-02 | 1.73e-01 |
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 185 | 2.48e-02 | -9.63e-02 | 2.16e-01 |
GOBP RESPONSE TO TUMOR CELL | 18 | 4.80e-01 | -9.62e-02 | 7.72e-01 |
GOMF PEPTIDASE REGULATOR ACTIVITY | 78 | 1.43e-01 | -9.62e-02 | 4.74e-01 |
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 17 | 4.93e-01 | 9.61e-02 | 7.78e-01 |
GOBP INNATE IMMUNE RESPONSE | 461 | 5.01e-04 | -9.61e-02 | 2.14e-02 |
GOMF UBIQUITIN MODIFICATION DEPENDENT HISTONE BINDING | 6 | 6.84e-01 | 9.60e-02 | 8.81e-01 |
GOCC SPLICEOSOMAL COMPLEX | 180 | 2.72e-02 | 9.60e-02 | 2.27e-01 |
GOBP CHLORIDE TRANSPORT | 25 | 4.07e-01 | -9.60e-02 | 7.23e-01 |
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE | 401 | 1.14e-03 | -9.60e-02 | 3.79e-02 |
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 79 | 1.42e-01 | -9.59e-02 | 4.72e-01 |
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY | 38 | 3.07e-01 | -9.59e-02 | 6.47e-01 |
GOBP TYPE 2 IMMUNE RESPONSE | 15 | 5.21e-01 | 9.59e-02 | 7.93e-01 |
GOBP APOPTOTIC CELL CLEARANCE | 14 | 5.35e-01 | -9.59e-02 | 8.03e-01 |
GOBP GLYCOLIPID CATABOLIC PROCESS | 7 | 6.61e-01 | 9.59e-02 | 8.70e-01 |
GOBP GLYCOSPHINGOLIPID CATABOLIC PROCESS | 7 | 6.61e-01 | 9.59e-02 | 8.70e-01 |
GOBP INORGANIC ION HOMEOSTASIS | 211 | 1.72e-02 | 9.58e-02 | 1.77e-01 |
GOBP SYNAPTIC VESICLE BUDDING | 6 | 6.85e-01 | -9.58e-02 | 8.81e-01 |
GOMF GTPASE INHIBITOR ACTIVITY | 10 | 6.00e-01 | 9.58e-02 | 8.38e-01 |
GOBP FATTY ACID METABOLIC PROCESS | 176 | 2.96e-02 | 9.56e-02 | 2.35e-01 |
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT | 5 | 7.11e-01 | -9.56e-02 | 8.96e-01 |
GOBP ORGANELLE FUSION | 108 | 8.76e-02 | 9.55e-02 | 3.86e-01 |
GOCC PALMITOYLTRANSFERASE COMPLEX | 8 | 6.40e-01 | 9.55e-02 | 8.59e-01 |
GOBP ANATOMICAL STRUCTURE MATURATION | 92 | 1.15e-01 | -9.55e-02 | 4.35e-01 |
GOBP TELOMERE MAINTENANCE | 121 | 7.09e-02 | 9.55e-02 | 3.51e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 38 | 3.09e-01 | -9.55e-02 | 6.49e-01 |
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE | 6 | 6.86e-01 | 9.54e-02 | 8.82e-01 |
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS | 6 | 6.86e-01 | 9.54e-02 | 8.82e-01 |
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 49 | 2.49e-01 | 9.54e-02 | 5.95e-01 |
GOBP REGULATION OF INNATE IMMUNE RESPONSE | 248 | 1.03e-02 | -9.54e-02 | 1.34e-01 |
GOBP REGULATION OF NOTCH SIGNALING PATHWAY | 39 | 3.03e-01 | -9.54e-02 | 6.44e-01 |
GOBP INTERLEUKIN 13 PRODUCTION | 9 | 6.21e-01 | -9.53e-02 | 8.49e-01 |
GOBP PROTEIN LOCALIZATION TO CELL SURFACE | 37 | 3.16e-01 | -9.53e-02 | 6.55e-01 |
GOBP GLYCOLYTIC PROCESS | 52 | 2.35e-01 | -9.53e-02 | 5.82e-01 |
GOBP RESPONSE TO ETHANOL | 57 | 2.14e-01 | -9.52e-02 | 5.66e-01 |
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 38 | 3.10e-01 | -9.52e-02 | 6.49e-01 |
GOBP MYOBLAST DIFFERENTIATION | 55 | 2.23e-01 | -9.51e-02 | 5.74e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 13 | 5.53e-01 | -9.51e-02 | 8.13e-01 |
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 35 | 3.31e-01 | -9.51e-02 | 6.66e-01 |
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 55 | 2.24e-01 | -9.51e-02 | 5.74e-01 |
GOMF VITAMIN B6 BINDING | 23 | 4.30e-01 | 9.51e-02 | 7.37e-01 |
GOBP RESPONSE TO LEAD ION | 12 | 5.69e-01 | 9.50e-02 | 8.20e-01 |
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 14 | 5.39e-01 | 9.50e-02 | 8.04e-01 |
GOCC GTPASE COMPLEX | 22 | 4.41e-01 | -9.50e-02 | 7.43e-01 |
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE | 19 | 4.74e-01 | -9.50e-02 | 7.69e-01 |
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING | 8 | 6.42e-01 | 9.49e-02 | 8.60e-01 |
GOBP GLUTAMATE SECRETION | 9 | 6.22e-01 | 9.49e-02 | 8.50e-01 |
GOMF MANNOSIDASE ACTIVITY | 13 | 5.54e-01 | 9.49e-02 | 8.14e-01 |
GOBP CALCIUM ION TRANSPORT | 154 | 4.32e-02 | -9.49e-02 | 2.77e-01 |
GOBP LYMPHOCYTE ACTIVATION | 455 | 6.36e-04 | -9.49e-02 | 2.54e-02 |
GOBP PEROXISOME ORGANIZATION | 26 | 4.03e-01 | 9.48e-02 | 7.20e-01 |
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION | 27 | 3.94e-01 | -9.48e-02 | 7.14e-01 |
GOBP REGULATION OF MAP KINASE ACTIVITY | 69 | 1.75e-01 | -9.47e-02 | 5.18e-01 |
GOBP UBIQUINONE METABOLIC PROCESS | 13 | 5.55e-01 | 9.47e-02 | 8.14e-01 |
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 8 | 6.43e-01 | 9.47e-02 | 8.61e-01 |
GOCC BLOC COMPLEX | 12 | 5.71e-01 | -9.46e-02 | 8.21e-01 |
GOCC CORNIFIED ENVELOPE | 9 | 6.23e-01 | 9.46e-02 | 8.51e-01 |
GOBP REGULATION OF CELL DIFFERENTIATION | 683 | 3.83e-05 | -9.46e-02 | 2.80e-03 |
GOBP CELLULAR RESPONSE TO SALT STRESS | 7 | 6.65e-01 | -9.46e-02 | 8.72e-01 |
GOMF CYCLASE ACTIVITY | 6 | 6.89e-01 | 9.45e-02 | 8.83e-01 |
GOBP THIOESTER BIOSYNTHETIC PROCESS | 35 | 3.34e-01 | 9.44e-02 | 6.70e-01 |
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT | 7 | 6.66e-01 | 9.43e-02 | 8.73e-01 |
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE | 5 | 7.15e-01 | 9.43e-02 | 8.97e-01 |
GOBP POLYOL METABOLIC PROCESS | 51 | 2.46e-01 | 9.41e-02 | 5.92e-01 |
GOBP REGULATION OF RESPONSE TO TUMOR CELL | 9 | 6.25e-01 | 9.40e-02 | 8.51e-01 |
GOBP BONE CELL DEVELOPMENT | 11 | 5.90e-01 | 9.39e-02 | 8.33e-01 |
GOCC PROTEIN KINASE COMPLEX | 93 | 1.19e-01 | -9.38e-02 | 4.40e-01 |
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 16 | 5.16e-01 | 9.38e-02 | 7.90e-01 |
GOBP REGULATION OF CIRCADIAN RHYTHM | 63 | 1.99e-01 | -9.38e-02 | 5.46e-01 |
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE | 11 | 5.90e-01 | 9.38e-02 | 8.33e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 44 | 2.83e-01 | -9.38e-02 | 6.24e-01 |
GOMF AMIDE BINDING | 178 | 3.20e-02 | 9.37e-02 | 2.42e-01 |
GOCC LEWY BODY | 7 | 6.68e-01 | -9.37e-02 | 8.73e-01 |
GOBP BERGMANN GLIAL CELL DIFFERENTIATION | 7 | 6.68e-01 | 9.36e-02 | 8.73e-01 |
GOBP ERAD PATHWAY | 84 | 1.39e-01 | 9.36e-02 | 4.69e-01 |
GOBP METENCEPHALON DEVELOPMENT | 51 | 2.49e-01 | -9.36e-02 | 5.95e-01 |
GOBP OSSIFICATION | 161 | 4.16e-02 | -9.36e-02 | 2.72e-01 |
GOCC ACTIN FILAMENT BUNDLE | 37 | 3.25e-01 | 9.35e-02 | 6.63e-01 |
GOBP MYOTUBE CELL DEVELOPMENT | 14 | 5.45e-01 | -9.35e-02 | 8.08e-01 |
GOBP REGULATION OF MONOCYTE DIFFERENTIATION | 12 | 5.75e-01 | 9.34e-02 | 8.24e-01 |
GOBP INCLUSION BODY ASSEMBLY | 13 | 5.60e-01 | -9.34e-02 | 8.16e-01 |
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION | 35 | 3.40e-01 | -9.34e-02 | 6.75e-01 |
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 21 | 4.59e-01 | 9.34e-02 | 7.56e-01 |
GOBP REGULATION OF VASOCONSTRICTION | 18 | 4.93e-01 | -9.34e-02 | 7.78e-01 |
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 52 | 2.46e-01 | -9.32e-02 | 5.92e-01 |
GOMF L ASCORBIC ACID BINDING | 11 | 5.93e-01 | -9.32e-02 | 8.34e-01 |
GOMF CLATHRIN BINDING | 38 | 3.21e-01 | -9.32e-02 | 6.59e-01 |
GOBP CELL CHEMOTAXIS | 118 | 8.16e-02 | -9.32e-02 | 3.74e-01 |
GOBP REGULATION OF PROTEIN BINDING | 84 | 1.41e-01 | -9.31e-02 | 4.72e-01 |
GOBP IMMUNE EFFECTOR PROCESS | 326 | 4.24e-03 | -9.31e-02 | 8.11e-02 |
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX | 8 | 6.49e-01 | 9.31e-02 | 8.63e-01 |
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE | 35 | 3.41e-01 | 9.31e-02 | 6.76e-01 |
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 34 | 3.48e-01 | 9.31e-02 | 6.80e-01 |
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY | 35 | 3.41e-01 | -9.30e-02 | 6.76e-01 |
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS | 14 | 5.47e-01 | 9.30e-02 | 8.10e-01 |
GOBP CELL CELL JUNCTION ORGANIZATION | 70 | 1.80e-01 | -9.29e-02 | 5.26e-01 |
GOBP VIRAL GENE EXPRESSION | 88 | 1.33e-01 | -9.29e-02 | 4.60e-01 |
GOBP FATTY ACID TRANSPORT | 36 | 3.35e-01 | 9.29e-02 | 6.71e-01 |
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 101 | 1.08e-01 | -9.29e-02 | 4.24e-01 |
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX | 164 | 4.13e-02 | -9.29e-02 | 2.72e-01 |
GOBP DEFENSE RESPONSE | 777 | 1.81e-05 | -9.29e-02 | 1.49e-03 |
GOBP NEGATIVE REGULATION OF LOCOMOTION | 148 | 5.24e-02 | -9.28e-02 | 2.99e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS | 188 | 2.95e-02 | 9.26e-02 | 2.35e-01 |
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS | 9 | 6.31e-01 | 9.26e-02 | 8.54e-01 |
GOBP SPERM AXONEME ASSEMBLY | 7 | 6.72e-01 | 9.26e-02 | 8.75e-01 |
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION | 24 | 4.33e-01 | -9.26e-02 | 7.39e-01 |
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX | 6 | 6.95e-01 | 9.25e-02 | 8.87e-01 |
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION | 38 | 3.25e-01 | -9.25e-02 | 6.62e-01 |
GOBP PEPTIDYL HISTIDINE MODIFICATION | 5 | 7.20e-01 | 9.25e-02 | 8.99e-01 |
GOBP RECOMBINATIONAL REPAIR | 123 | 7.78e-02 | 9.24e-02 | 3.65e-01 |
GOBP CELL PROJECTION ASSEMBLY | 300 | 6.40e-03 | -9.24e-02 | 1.02e-01 |
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 18 | 4.98e-01 | 9.24e-02 | 7.79e-01 |
GOBP POST EMBRYONIC DEVELOPMENT | 52 | 2.50e-01 | -9.23e-02 | 5.96e-01 |
GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS | 5 | 7.21e-01 | 9.23e-02 | 8.99e-01 |
GOBP CELL MORPHOGENESIS | 390 | 2.01e-03 | -9.23e-02 | 5.39e-02 |
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS | 5 | 7.21e-01 | 9.23e-02 | 8.99e-01 |
GOCC AXONEMAL MICROTUBULE | 8 | 6.52e-01 | -9.22e-02 | 8.65e-01 |
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME | 154 | 4.97e-02 | 9.21e-02 | 2.91e-01 |
GOBP REGULATION OF LIPID CATABOLIC PROCESS | 25 | 4.26e-01 | -9.21e-02 | 7.34e-01 |
GOMF PROTEIN CARRIER CHAPERONE | 29 | 3.91e-01 | 9.21e-02 | 7.11e-01 |
GOBP POSITIVE REGULATION OF TRANSLATION | 103 | 1.08e-01 | 9.21e-02 | 4.23e-01 |
GOBP RESPONSE TO ALCOHOL | 112 | 9.40e-02 | -9.19e-02 | 3.98e-01 |
GOBP DNA REPAIR | 419 | 1.46e-03 | 9.19e-02 | 4.44e-02 |
GOMF SINGLE STRANDED DNA BINDING | 96 | 1.21e-01 | 9.19e-02 | 4.46e-01 |
GOBP REGULATION OF MITOCHONDRIAL FISSION | 19 | 4.88e-01 | 9.19e-02 | 7.76e-01 |
GOBP EPITHELIAL CELL PROLIFERATION | 168 | 4.11e-02 | -9.19e-02 | 2.71e-01 |
GOBP HISTONE H3 K4 METHYLATION | 18 | 5.01e-01 | -9.16e-02 | 7.81e-01 |
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY | 9 | 6.35e-01 | -9.15e-02 | 8.56e-01 |
GOBP AMIDE METABOLIC PROCESS | 781 | 2.28e-05 | 9.15e-02 | 1.81e-03 |
GOBP REGULATION OF HIPPO SIGNALING | 12 | 5.83e-01 | -9.15e-02 | 8.29e-01 |
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS | 13 | 5.68e-01 | -9.15e-02 | 8.19e-01 |
GOBP MRNA 3 END PROCESSING | 41 | 3.12e-01 | 9.15e-02 | 6.49e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 59 | 2.25e-01 | -9.14e-02 | 5.75e-01 |
GOMF TRANSCRIPTION COREGULATOR BINDING | 80 | 1.59e-01 | -9.14e-02 | 4.96e-01 |
GOBP AMINO SUGAR METABOLIC PROCESS | 20 | 4.80e-01 | -9.14e-02 | 7.72e-01 |
GOBP CELLULAR COMPONENT MORPHOGENESIS | 291 | 7.94e-03 | -9.13e-02 | 1.16e-01 |
GOBP NEUTRAL LIPID METABOLIC PROCESS | 49 | 2.70e-01 | -9.13e-02 | 6.14e-01 |
GOMF MHC PROTEIN COMPLEX BINDING | 27 | 4.12e-01 | 9.13e-02 | 7.27e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 9 | 6.36e-01 | 9.12e-02 | 8.57e-01 |
GOBP REGULATION OF AEROBIC RESPIRATION | 20 | 4.80e-01 | 9.12e-02 | 7.72e-01 |
GOCC SEX CHROMOSOME | 19 | 4.92e-01 | -9.11e-02 | 7.78e-01 |
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY | 7 | 6.77e-01 | 9.09e-02 | 8.78e-01 |
GOBP POSITIVE REGULATION OF CELL ADHESION | 240 | 1.61e-02 | -9.09e-02 | 1.70e-01 |
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY | 11 | 6.02e-01 | 9.09e-02 | 8.38e-01 |
GOCC RNA CAP BINDING COMPLEX | 19 | 4.93e-01 | 9.09e-02 | 7.78e-01 |
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY | 7 | 6.77e-01 | -9.09e-02 | 8.78e-01 |
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION | 7 | 6.77e-01 | 9.09e-02 | 8.78e-01 |
GOBP POSITIVE REGULATION OF INSULIN SECRETION | 34 | 3.60e-01 | -9.08e-02 | 6.88e-01 |
GOBP DNA METABOLIC PROCESS | 680 | 7.97e-05 | 9.08e-02 | 5.24e-03 |
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS | 14 | 5.57e-01 | 9.08e-02 | 8.14e-01 |
GOBP REGULATION OF DNA METABOLIC PROCESS | 356 | 3.64e-03 | 9.08e-02 | 7.54e-02 |
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION | 117 | 9.11e-02 | -9.08e-02 | 3.92e-01 |
GOBP SYNAPTIC SIGNALING | 240 | 1.63e-02 | -9.08e-02 | 1.71e-01 |
GOBP REGULATION OF CELL ADHESION | 369 | 3.10e-03 | -9.07e-02 | 6.94e-02 |
GOMF PROTEIN KINASE ACTIVITY | 329 | 5.14e-03 | -9.07e-02 | 9.19e-02 |
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION | 156 | 5.18e-02 | -9.07e-02 | 2.98e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS | 61 | 2.22e-01 | 9.07e-02 | 5.74e-01 |
GOBP GLIAL CELL PROLIFERATION | 28 | 4.07e-01 | -9.06e-02 | 7.23e-01 |
GOBP AUTOPHAGOSOME MATURATION | 50 | 2.68e-01 | 9.06e-02 | 6.12e-01 |
GOMF METALLOEXOPEPTIDASE ACTIVITY | 29 | 3.99e-01 | 9.05e-02 | 7.18e-01 |
GOBP ESTABLISHMENT OF CELL POLARITY | 91 | 1.37e-01 | -9.05e-02 | 4.65e-01 |
GOBP PEPTIDE METABOLIC PROCESS | 631 | 1.50e-04 | 9.03e-02 | 8.79e-03 |
GOBP CELL ACTIVATION | 582 | 2.60e-04 | -9.03e-02 | 1.34e-02 |
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY | 5 | 7.27e-01 | -9.03e-02 | 9.02e-01 |
GOCC LARGE RIBOSOMAL SUBUNIT | 108 | 1.07e-01 | 9.02e-02 | 4.21e-01 |
GOBP BROWN FAT CELL DIFFERENTIATION | 19 | 4.97e-01 | -9.01e-02 | 7.79e-01 |
GOMF PYRUVATE DEHYDROGENASE ACTIVITY | 5 | 7.27e-01 | 9.01e-02 | 9.02e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT | 40 | 3.25e-01 | 9.01e-02 | 6.62e-01 |
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY | 973 | 4.28e-06 | 9.01e-02 | 4.36e-04 |
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY | 8 | 6.59e-01 | -9.00e-02 | 8.69e-01 |
GOBP EXPLORATION BEHAVIOR | 10 | 6.22e-01 | -9.00e-02 | 8.50e-01 |
GOBP SUBSTANTIA NIGRA DEVELOPMENT | 29 | 4.02e-01 | 9.00e-02 | 7.20e-01 |
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY | 15 | 5.46e-01 | -9.00e-02 | 8.09e-01 |
GOCC MLL3 4 COMPLEX | 12 | 5.90e-01 | 9.00e-02 | 8.32e-01 |
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION | 14 | 5.60e-01 | 9.00e-02 | 8.16e-01 |
GOBP SECONDARY METABOLIC PROCESS | 15 | 5.47e-01 | 8.99e-02 | 8.10e-01 |
GOBP NEGATIVE CHEMOTAXIS | 7 | 6.81e-01 | -8.98e-02 | 8.80e-01 |
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS | 34 | 3.65e-01 | -8.98e-02 | 6.92e-01 |
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION | 14 | 5.61e-01 | -8.98e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION | 236 | 1.84e-02 | -8.98e-02 | 1.84e-01 |
GOMF PORIN ACTIVITY | 5 | 7.28e-01 | 8.97e-02 | 9.03e-01 |
GOBP PROTEIN AUTOPHOSPHORYLATION | 112 | 1.02e-01 | -8.97e-02 | 4.13e-01 |
GOCC PIGMENT GRANULE | 84 | 1.57e-01 | 8.96e-02 | 4.92e-01 |
GOCC SAGA TYPE COMPLEX | 29 | 4.04e-01 | 8.96e-02 | 7.21e-01 |
GOMF GALACTOSYLTRANSFERASE ACTIVITY | 10 | 6.24e-01 | -8.96e-02 | 8.51e-01 |
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 8 | 6.61e-01 | -8.95e-02 | 8.70e-01 |
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION | 15 | 5.49e-01 | 8.94e-02 | 8.11e-01 |
GOBP CARDIAC MUSCLE CELL CONTRACTION | 20 | 4.89e-01 | 8.94e-02 | 7.76e-01 |
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS | 22 | 4.68e-01 | -8.94e-02 | 7.64e-01 |
GOBP MITOCHONDRION DISTRIBUTION | 9 | 6.43e-01 | -8.94e-02 | 8.60e-01 |
GOBP REGULATION OF T CELL ACTIVATION | 201 | 3.00e-02 | -8.94e-02 | 2.36e-01 |
GOBP APPENDAGE DEVELOPMENT | 62 | 2.25e-01 | -8.93e-02 | 5.75e-01 |
GOBP RESPONSE TO ISCHEMIA | 33 | 3.75e-01 | 8.93e-02 | 7.01e-01 |
GOBP INTERLEUKIN 12 PRODUCTION | 32 | 3.83e-01 | -8.93e-02 | 7.06e-01 |
GOBP POSITIVE REGULATION OF CELL KILLING | 29 | 4.06e-01 | -8.93e-02 | 7.22e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS | 13 | 5.78e-01 | 8.92e-02 | 8.25e-01 |
GOBP GROWTH | 404 | 2.40e-03 | -8.92e-02 | 6.02e-02 |
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 204 | 2.92e-02 | -8.92e-02 | 2.34e-01 |
GOBP RESPONSE TO CYTOKINE | 450 | 1.41e-03 | -8.92e-02 | 4.31e-02 |
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS | 8 | 6.63e-01 | -8.91e-02 | 8.71e-01 |
GOBP AXONAL TRANSPORT | 44 | 3.07e-01 | -8.91e-02 | 6.47e-01 |
GOCC MHC PROTEIN COMPLEX | 20 | 4.91e-01 | 8.91e-02 | 7.77e-01 |
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT | 32 | 3.84e-01 | -8.91e-02 | 7.06e-01 |
GOBP CLATHRIN COAT ASSEMBLY | 12 | 5.93e-01 | 8.91e-02 | 8.34e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 75 | 1.83e-01 | -8.91e-02 | 5.29e-01 |
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY | 18 | 5.13e-01 | -8.90e-02 | 7.88e-01 |
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL | 11 | 6.09e-01 | -8.90e-02 | 8.44e-01 |
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 199 | 3.16e-02 | -8.89e-02 | 2.42e-01 |
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 16 | 5.38e-01 | 8.89e-02 | 8.04e-01 |
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 16 | 5.38e-01 | -8.89e-02 | 8.04e-01 |
GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS | 8 | 6.63e-01 | 8.89e-02 | 8.72e-01 |
GOBP FILOPODIUM ASSEMBLY | 34 | 3.71e-01 | -8.88e-02 | 6.98e-01 |
GOBP CELLULAR RESPONSE TO COPPER ION | 8 | 6.64e-01 | 8.88e-02 | 8.72e-01 |
GOCC NURD COMPLEX | 15 | 5.52e-01 | 8.88e-02 | 8.13e-01 |
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION | 10 | 6.27e-01 | -8.88e-02 | 8.53e-01 |
GOBP CMP METABOLIC PROCESS | 5 | 7.31e-01 | -8.87e-02 | 9.04e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS | 5 | 7.31e-01 | 8.86e-02 | 9.04e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR | 5 | 7.31e-01 | 8.86e-02 | 9.04e-01 |
GOBP POSITIVE REGULATION OF CELL CELL ADHESION | 170 | 4.74e-02 | -8.86e-02 | 2.85e-01 |
GOMF TRANSPORTER ACTIVITY | 448 | 1.53e-03 | 8.86e-02 | 4.53e-02 |
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 6 | 7.07e-01 | -8.85e-02 | 8.94e-01 |
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY | 5 | 7.32e-01 | 8.85e-02 | 9.04e-01 |
GOBP DNA INTEGRITY CHECKPOINT SIGNALING | 94 | 1.40e-01 | 8.84e-02 | 4.69e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 138 | 7.44e-02 | -8.84e-02 | 3.59e-01 |
GOBP HISTONE H3 K9 METHYLATION | 5 | 7.32e-01 | -8.84e-02 | 9.04e-01 |
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 85 | 1.60e-01 | 8.84e-02 | 4.98e-01 |
GOCC CORTICAL CYTOSKELETON | 52 | 2.71e-01 | 8.83e-02 | 6.16e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 7.33e-01 | 8.83e-02 | 9.04e-01 |
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS | 5 | 7.33e-01 | 8.83e-02 | 9.04e-01 |
GOBP GLIOGENESIS | 143 | 7.00e-02 | -8.82e-02 | 3.49e-01 |
GOBP POSITIVE REGULATION OF CELL GROWTH | 77 | 1.82e-01 | -8.81e-02 | 5.28e-01 |
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 6 | 7.09e-01 | -8.81e-02 | 8.95e-01 |
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY | 11 | 6.13e-01 | 8.80e-02 | 8.46e-01 |
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT | 6 | 7.09e-01 | -8.80e-02 | 8.95e-01 |
GOBP ACTIN MEDIATED CELL CONTRACTION | 27 | 4.29e-01 | 8.80e-02 | 7.36e-01 |
GOBP INTRACILIARY ANTEROGRADE TRANSPORT | 11 | 6.14e-01 | -8.78e-02 | 8.46e-01 |
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION | 8 | 6.67e-01 | -8.78e-02 | 8.73e-01 |
GOBP POLYSACCHARIDE METABOLIC PROCESS | 47 | 2.99e-01 | -8.78e-02 | 6.40e-01 |
GOBP BRAIN MORPHOGENESIS | 16 | 5.44e-01 | -8.78e-02 | 8.07e-01 |
GOBP SEQUESTERING OF IRON ION | 5 | 7.34e-01 | 8.77e-02 | 9.05e-01 |
GOBP RESCUE OF STALLED RIBOSOME | 18 | 5.20e-01 | 8.77e-02 | 7.93e-01 |
GOBP PROTEIN REFOLDING | 14 | 5.70e-01 | 8.77e-02 | 8.21e-01 |
GOCC RUFFLE | 113 | 1.09e-01 | -8.77e-02 | 4.24e-01 |
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS | 10 | 6.31e-01 | -8.77e-02 | 8.55e-01 |
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES | 10 | 6.32e-01 | 8.75e-02 | 8.55e-01 |
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY | 83 | 1.69e-01 | -8.75e-02 | 5.11e-01 |
GOBP NON MOTILE CILIUM ASSEMBLY | 34 | 3.78e-01 | -8.75e-02 | 7.03e-01 |
GOCC ACTOMYOSIN | 38 | 3.52e-01 | 8.74e-02 | 6.83e-01 |
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION | 7 | 6.89e-01 | -8.74e-02 | 8.83e-01 |
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 8 | 6.69e-01 | -8.74e-02 | 8.74e-01 |
GOBP MALE GAMETE GENERATION | 215 | 2.84e-02 | -8.74e-02 | 2.31e-01 |
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION | 28 | 4.24e-01 | 8.73e-02 | 7.34e-01 |
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION | 27 | 4.33e-01 | 8.73e-02 | 7.39e-01 |
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY | 16 | 5.46e-01 | -8.73e-02 | 8.09e-01 |
GOBP REGULATION OF GLIOGENESIS | 44 | 3.17e-01 | -8.73e-02 | 6.55e-01 |
GOCC MICROTUBULE END | 19 | 5.11e-01 | 8.71e-02 | 7.88e-01 |
GOCC PHOTORECEPTOR OUTER SEGMENT | 24 | 4.60e-01 | 8.71e-02 | 7.57e-01 |
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY | 33 | 3.87e-01 | -8.70e-02 | 7.08e-01 |
GOBP PEPTIDE BIOSYNTHETIC PROCESS | 554 | 5.86e-04 | 8.70e-02 | 2.39e-02 |
GOMF O ACYLTRANSFERASE ACTIVITY | 26 | 4.43e-01 | 8.70e-02 | 7.45e-01 |
GOBP PROTEIN RNA COMPLEX DISASSEMBLY | 7 | 6.91e-01 | 8.69e-02 | 8.83e-01 |
GOMF 5S RRNA BINDING | 8 | 6.70e-01 | 8.69e-02 | 8.75e-01 |
GOMF GTPASE ACTIVATING PROTEIN BINDING | 8 | 6.70e-01 | -8.69e-02 | 8.75e-01 |
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS | 18 | 5.24e-01 | 8.69e-02 | 7.96e-01 |
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS | 27 | 4.35e-01 | 8.68e-02 | 7.40e-01 |
GOBP HAIR FOLLICLE MATURATION | 6 | 7.14e-01 | 8.65e-02 | 8.96e-01 |
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION | 116 | 1.09e-01 | 8.65e-02 | 4.24e-01 |
GOMF SULFATIDE BINDING | 5 | 7.38e-01 | 8.64e-02 | 9.06e-01 |
GOBP GOLGI LOCALIZATION | 12 | 6.05e-01 | 8.64e-02 | 8.41e-01 |
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT | 12 | 6.05e-01 | 8.64e-02 | 8.41e-01 |
GOBP PROTEIN SUMOYLATION | 49 | 2.97e-01 | -8.63e-02 | 6.38e-01 |
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE | 12 | 6.05e-01 | 8.63e-02 | 8.41e-01 |
GOCC GAMMA SECRETASE COMPLEX | 6 | 7.15e-01 | 8.62e-02 | 8.97e-01 |
GOBP GLIAL CELL APOPTOTIC PROCESS | 9 | 6.55e-01 | -8.61e-02 | 8.66e-01 |
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 12 | 6.06e-01 | -8.61e-02 | 8.41e-01 |
GOBP EMBRYONIC PLACENTA MORPHOGENESIS | 10 | 6.38e-01 | -8.60e-02 | 8.58e-01 |
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 7.15e-01 | 8.60e-02 | 8.97e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II | 24 | 4.66e-01 | -8.60e-02 | 7.62e-01 |
GOBP OVULATION CYCLE PROCESS | 11 | 6.22e-01 | -8.60e-02 | 8.50e-01 |
GOBP NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION | 36 | 3.72e-01 | 8.60e-02 | 6.99e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 26 | 4.48e-01 | -8.60e-02 | 7.49e-01 |
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE | 60 | 2.51e-01 | -8.59e-02 | 5.96e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M | 7 | 6.94e-01 | 8.59e-02 | 8.86e-01 |
GOMF ALPHA ACTININ BINDING | 8 | 6.74e-01 | 8.59e-02 | 8.78e-01 |
GOBP ALCOHOL METABOLIC PROCESS | 155 | 6.66e-02 | 8.58e-02 | 3.39e-01 |
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY | 10 | 6.39e-01 | -8.58e-02 | 8.59e-01 |
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY | 5 | 7.40e-01 | -8.58e-02 | 9.06e-01 |
GOBP REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 50 | 2.95e-01 | -8.57e-02 | 6.37e-01 |
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 6 | 7.16e-01 | 8.57e-02 | 8.98e-01 |
GOMF CARBOHYDRATE KINASE ACTIVITY | 9 | 6.57e-01 | 8.56e-02 | 8.67e-01 |
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL | 12 | 6.08e-01 | 8.56e-02 | 8.43e-01 |
GOBP CYTOCHROME COMPLEX ASSEMBLY | 34 | 3.88e-01 | 8.56e-02 | 7.09e-01 |
GOBP REGULATION OF CELL MATURATION | 7 | 6.95e-01 | -8.56e-02 | 8.87e-01 |
GOBP TONGUE DEVELOPMENT | 6 | 7.17e-01 | 8.56e-02 | 8.98e-01 |
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING | 5 | 7.41e-01 | 8.55e-02 | 9.06e-01 |
GOBP NEURAL TUBE FORMATION | 53 | 2.83e-01 | 8.55e-02 | 6.24e-01 |
GOBP PROTEIN TARGETING | 238 | 2.43e-02 | 8.55e-02 | 2.14e-01 |
GOBP DNA BIOSYNTHETIC PROCESS | 129 | 9.53e-02 | 8.54e-02 | 4.01e-01 |
GOBP EPIBOLY | 18 | 5.31e-01 | -8.54e-02 | 8.01e-01 |
GOBP REGULATION OF LIPID METABOLIC PROCESS | 139 | 8.37e-02 | -8.54e-02 | 3.80e-01 |
GOMF MRNA 3 UTR BINDING | 71 | 2.15e-01 | -8.53e-02 | 5.67e-01 |
GOBP RESPONSE TO ORGANOPHOSPHORUS | 48 | 3.07e-01 | -8.53e-02 | 6.47e-01 |
GOBP EXOCYTIC PROCESS | 46 | 3.17e-01 | -8.53e-02 | 6.55e-01 |
GOBP CENTROSOME DUPLICATION | 54 | 2.80e-01 | 8.51e-02 | 6.22e-01 |
GOBP CELL SUBSTRATE ADHESION | 147 | 7.65e-02 | -8.51e-02 | 3.63e-01 |
GOBP REGULATION OF PROTEIN ACETYLATION | 30 | 4.21e-01 | -8.50e-02 | 7.32e-01 |
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 228 | 2.81e-02 | -8.50e-02 | 2.30e-01 |
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING | 28 | 4.37e-01 | -8.50e-02 | 7.40e-01 |
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION | 99 | 1.45e-01 | -8.50e-02 | 4.77e-01 |
GOBP GLYCOLIPID TRANSPORT | 6 | 7.19e-01 | 8.47e-02 | 8.99e-01 |
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT | 5 | 7.43e-01 | -8.47e-02 | 9.08e-01 |
GOMF MAGNESIUM ION BINDING | 140 | 8.50e-02 | 8.47e-02 | 3.81e-01 |
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 14 | 5.83e-01 | 8.47e-02 | 8.29e-01 |
GOMF PRENYLTRANSFERASE ACTIVITY | 15 | 5.70e-01 | -8.47e-02 | 8.21e-01 |
GOBP REGULATION OF RIG I SIGNALING PATHWAY | 14 | 5.84e-01 | 8.47e-02 | 8.29e-01 |
GOBP VESICLE CARGO LOADING | 26 | 4.55e-01 | 8.47e-02 | 7.54e-01 |
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION | 13 | 5.98e-01 | -8.46e-02 | 8.36e-01 |
GOBP REGULATION OF CELL SHAPE | 75 | 2.07e-01 | -8.46e-02 | 5.54e-01 |
GOBP VASODILATION | 13 | 5.98e-01 | -8.45e-02 | 8.36e-01 |
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION | 9 | 6.61e-01 | 8.45e-02 | 8.70e-01 |
GOBP PARAXIAL MESODERM DEVELOPMENT | 6 | 7.20e-01 | 8.45e-02 | 8.99e-01 |
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 6 | 7.20e-01 | -8.45e-02 | 8.99e-01 |
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY | 6 | 7.20e-01 | -8.45e-02 | 8.99e-01 |
GOBP PHOSPHOLIPID EFFLUX | 6 | 7.20e-01 | 8.45e-02 | 8.99e-01 |
GOBP METAPHASE CHROMOSOME ALIGNMENT | 68 | 2.31e-01 | 8.42e-02 | 5.78e-01 |
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE | 17 | 5.48e-01 | -8.41e-02 | 8.11e-01 |
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 29 | 4.34e-01 | -8.41e-02 | 7.39e-01 |
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION | 11 | 6.29e-01 | 8.40e-02 | 8.54e-01 |
GOMF ENDONUCLEASE ACTIVITY | 68 | 2.32e-01 | 8.40e-02 | 5.78e-01 |
GOBP NCRNA METABOLIC PROCESS | 438 | 2.98e-03 | 8.40e-02 | 6.85e-02 |
GOBP NEGATIVE REGULATION OF BINDING | 67 | 2.36e-01 | -8.39e-02 | 5.82e-01 |
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY | 6 | 7.22e-01 | -8.39e-02 | 9.00e-01 |
GOMF CHEMOKINE ACTIVITY | 6 | 7.22e-01 | -8.39e-02 | 9.00e-01 |
GOBP REGULATION OF MEMBRANE POTENTIAL | 129 | 1.01e-01 | 8.39e-02 | 4.10e-01 |
GOBP MACROPHAGE MIGRATION | 25 | 4.68e-01 | 8.39e-02 | 7.64e-01 |
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION | 7 | 7.01e-01 | 8.39e-02 | 8.91e-01 |
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY | 13 | 6.01e-01 | -8.39e-02 | 8.38e-01 |
GOCC ADHERENS JUNCTION | 73 | 2.16e-01 | -8.39e-02 | 5.69e-01 |
GOBP MACROPHAGE DIFFERENTIATION | 32 | 4.12e-01 | -8.39e-02 | 7.27e-01 |
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS | 122 | 1.11e-01 | -8.38e-02 | 4.27e-01 |
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY | 43 | 3.42e-01 | 8.38e-02 | 6.77e-01 |
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING | 28 | 4.43e-01 | 8.38e-02 | 7.46e-01 |
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 20 | 5.17e-01 | 8.38e-02 | 7.91e-01 |
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION | 16 | 5.62e-01 | -8.37e-02 | 8.17e-01 |
GOMF TUBULIN BINDING | 209 | 3.84e-02 | -8.37e-02 | 2.64e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION | 82 | 1.91e-01 | -8.37e-02 | 5.37e-01 |
GOCC NUCLEAR INNER MEMBRANE | 31 | 4.21e-01 | -8.37e-02 | 7.32e-01 |
GOBP STEM CELL DIFFERENTIATION | 104 | 1.42e-01 | -8.36e-02 | 4.72e-01 |
GOMF MICROFILAMENT MOTOR ACTIVITY | 12 | 6.16e-01 | 8.36e-02 | 8.47e-01 |
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY | 12 | 6.16e-01 | -8.35e-02 | 8.47e-01 |
GOBP SCHWANN CELL DIFFERENTIATION | 19 | 5.29e-01 | -8.35e-02 | 8.00e-01 |
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION | 7 | 7.02e-01 | 8.35e-02 | 8.91e-01 |
GOMF ENDOPEPTIDASE ACTIVITY | 134 | 9.67e-02 | 8.35e-02 | 4.03e-01 |
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS | 12 | 6.17e-01 | 8.35e-02 | 8.47e-01 |
GOBP LEUKOCYTE PROLIFERATION | 180 | 5.54e-02 | -8.33e-02 | 3.06e-01 |
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS | 201 | 4.33e-02 | 8.32e-02 | 2.77e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS | 54 | 2.91e-01 | 8.32e-02 | 6.33e-01 |
GOBP CELLULAR DEFENSE RESPONSE | 19 | 5.30e-01 | -8.32e-02 | 8.01e-01 |
GOBP CELL PROJECTION ORGANIZATION | 681 | 3.01e-04 | -8.31e-02 | 1.49e-02 |
GOMF THIOLESTER HYDROLASE ACTIVITY | 19 | 5.31e-01 | 8.31e-02 | 8.01e-01 |
GOMF CALMODULIN BINDING | 79 | 2.03e-01 | -8.31e-02 | 5.51e-01 |
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 15 | 5.78e-01 | -8.30e-02 | 8.25e-01 |
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY | 8 | 6.84e-01 | -8.30e-02 | 8.81e-01 |
GOBP REGULATION OF LYMPHOCYTE MIGRATION | 36 | 3.89e-01 | -8.30e-02 | 7.10e-01 |
GOCC CATION CHANNEL COMPLEX | 33 | 4.10e-01 | 8.30e-02 | 7.25e-01 |
GOCC POLYSOME | 60 | 2.67e-01 | -8.30e-02 | 6.11e-01 |
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY | 8 | 6.85e-01 | 8.29e-02 | 8.81e-01 |
GOMF RNA ENDONUCLEASE ACTIVITY | 38 | 3.77e-01 | 8.29e-02 | 7.03e-01 |
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS | 13 | 6.05e-01 | -8.29e-02 | 8.41e-01 |
GOBP REGULATION OF STEROID METABOLIC PROCESS | 37 | 3.84e-01 | -8.28e-02 | 7.06e-01 |
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 33 | 4.12e-01 | 8.26e-02 | 7.27e-01 |
GOBP BEHAVIOR | 229 | 3.26e-02 | -8.26e-02 | 2.45e-01 |
GOCC INO80 COMPLEX | 14 | 5.93e-01 | 8.26e-02 | 8.34e-01 |
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION | 6 | 7.26e-01 | -8.26e-02 | 9.02e-01 |
GOBP RESPONSE TO XENOBIOTIC STIMULUS | 152 | 8.05e-02 | -8.26e-02 | 3.72e-01 |
GOBP NEURON DEVELOPMENT | 440 | 3.44e-03 | -8.26e-02 | 7.32e-02 |
GOBP RESPIRATORY SYSTEM PROCESS | 12 | 6.21e-01 | 8.25e-02 | 8.49e-01 |
GOBP MITOCHONDRIAL FUSION | 27 | 4.58e-01 | 8.25e-02 | 7.56e-01 |
GOBP NODAL SIGNALING PATHWAY | 5 | 7.49e-01 | -8.25e-02 | 9.11e-01 |
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS | 76 | 2.15e-01 | -8.25e-02 | 5.67e-01 |
GOBP TELOMERIC D LOOP DISASSEMBLY | 5 | 7.50e-01 | 8.24e-02 | 9.11e-01 |
GOBP TELOMERIC LOOP DISASSEMBLY | 5 | 7.50e-01 | 8.24e-02 | 9.11e-01 |
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 27 | 4.59e-01 | -8.24e-02 | 7.56e-01 |
GOBP REGULATION OF DEFENSE RESPONSE | 389 | 5.94e-03 | -8.23e-02 | 9.77e-02 |
GOBP REGULATION OF TRANSLATIONAL TERMINATION | 6 | 7.27e-01 | -8.23e-02 | 9.02e-01 |
GOBP RESPONSE TO INTERLEUKIN 3 | 7 | 7.06e-01 | 8.23e-02 | 8.93e-01 |
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 7 | 7.07e-01 | -8.22e-02 | 8.93e-01 |
GOBP CELL DIVISION | 401 | 5.33e-03 | 8.22e-02 | 9.41e-02 |
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE | 10 | 6.53e-01 | -8.22e-02 | 8.66e-01 |
GOBP REGULATION OF LOCOMOTION | 436 | 3.77e-03 | -8.21e-02 | 7.62e-02 |
GOBP DEFENSE RESPONSE TO OTHER ORGANISM | 562 | 1.10e-03 | -8.21e-02 | 3.76e-02 |
GOMF LIPID KINASE ACTIVITY | 27 | 4.61e-01 | -8.20e-02 | 7.58e-01 |
GOMF METALLOPEPTIDASE ACTIVITY | 73 | 2.27e-01 | 8.20e-02 | 5.76e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR | 5 | 7.51e-01 | -8.20e-02 | 9.11e-01 |
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX | 81 | 2.03e-01 | 8.20e-02 | 5.51e-01 |
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS | 9 | 6.71e-01 | -8.19e-02 | 8.75e-01 |
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION | 10 | 6.54e-01 | 8.18e-02 | 8.66e-01 |
GOBP MODULATION BY HOST OF SYMBIONT PROCESS | 56 | 2.91e-01 | -8.18e-02 | 6.33e-01 |
GOBP NATURAL KILLER CELL PROLIFERATION | 10 | 6.55e-01 | -8.18e-02 | 8.66e-01 |
GOBP PURINE RIBONUCLEOSIDE SALVAGE | 5 | 7.52e-01 | 8.18e-02 | 9.12e-01 |
GOBP VESICLE FUSION TO PLASMA MEMBRANE | 6 | 7.29e-01 | -8.18e-02 | 9.03e-01 |
GOCC P BODY | 73 | 2.28e-01 | 8.18e-02 | 5.76e-01 |
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 441 | 3.73e-03 | -8.17e-02 | 7.61e-02 |
GOBP NUCLEOSOME ORGANIZATION | 56 | 2.91e-01 | 8.17e-02 | 6.33e-01 |
GOBP MAINTENANCE OF SISTER CHROMATID COHESION | 11 | 6.39e-01 | 8.17e-02 | 8.59e-01 |
GOBP REGULATION OF SULFUR METABOLIC PROCESS | 8 | 6.89e-01 | -8.17e-02 | 8.83e-01 |
GOBP SEGMENTATION | 23 | 4.98e-01 | 8.17e-02 | 7.79e-01 |
GOBP APICAL PROTEIN LOCALIZATION | 7 | 7.08e-01 | 8.17e-02 | 8.95e-01 |
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 79 | 2.11e-01 | -8.17e-02 | 5.59e-01 |
GOMF JUN KINASE KINASE KINASE ACTIVITY | 9 | 6.72e-01 | -8.17e-02 | 8.75e-01 |
GOBP BONE GROWTH | 8 | 6.89e-01 | -8.16e-02 | 8.83e-01 |
GOBP SULFUR COMPOUND CATABOLIC PROCESS | 19 | 5.38e-01 | 8.16e-02 | 8.04e-01 |
GOBP REGULATION OF IMMUNE RESPONSE | 498 | 2.18e-03 | -8.16e-02 | 5.67e-02 |
GOCC SUMO LIGASE COMPLEX | 11 | 6.40e-01 | 8.15e-02 | 8.59e-01 |
GOBP REGULATION OF AXONOGENESIS | 59 | 2.81e-01 | -8.14e-02 | 6.22e-01 |
GOBP RESPONSE TO HEAT | 58 | 2.85e-01 | 8.13e-02 | 6.27e-01 |
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 132 | 1.09e-01 | 8.13e-02 | 4.24e-01 |
GOBP REGULATION OF MYOBLAST FUSION | 11 | 6.41e-01 | -8.11e-02 | 8.59e-01 |
GOBP CELLULAR RESPONSE TO NITROGEN STARVATION | 7 | 7.10e-01 | -8.11e-02 | 8.95e-01 |
GOBP SIRNA PROCESSING | 6 | 7.31e-01 | -8.10e-02 | 9.04e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 61 | 2.75e-01 | 8.09e-02 | 6.19e-01 |
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 60 | 2.79e-01 | 8.09e-02 | 6.22e-01 |
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION | 8 | 6.92e-01 | -8.09e-02 | 8.85e-01 |
GOBP LACTATION | 17 | 5.64e-01 | 8.09e-02 | 8.17e-01 |
GOCC MOTILE CILIUM | 72 | 2.37e-01 | -8.09e-02 | 5.83e-01 |
GOMF METALLOENDOPEPTIDASE ACTIVITY | 29 | 4.52e-01 | 8.08e-02 | 7.51e-01 |
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 43 | 3.60e-01 | -8.08e-02 | 6.88e-01 |
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING | 25 | 4.85e-01 | -8.08e-02 | 7.74e-01 |
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 35 | 4.09e-01 | -8.07e-02 | 7.24e-01 |
GOBP POSITIVE REGULATION OF AXON EXTENSION | 16 | 5.76e-01 | 8.07e-02 | 8.25e-01 |
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 15 | 5.88e-01 | 8.07e-02 | 8.32e-01 |
GOBP PLASMINOGEN ACTIVATION | 8 | 6.93e-01 | 8.07e-02 | 8.86e-01 |
GOBP LEUKOCYTE DIFFERENTIATION | 338 | 1.17e-02 | -8.07e-02 | 1.41e-01 |
GOBP MITOTIC SPINDLE ORGANIZATION | 88 | 1.93e-01 | 8.06e-02 | 5.39e-01 |
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE | 7 | 7.12e-01 | 8.06e-02 | 8.96e-01 |
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS | 152 | 8.81e-02 | 8.05e-02 | 3.86e-01 |
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 26 | 4.78e-01 | -8.05e-02 | 7.71e-01 |
GOBP REGULATION OF AMYLOID FIBRIL FORMATION | 12 | 6.29e-01 | 8.05e-02 | 8.54e-01 |
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX | 7 | 7.12e-01 | 8.05e-02 | 8.96e-01 |
GOCC SMC5 SMC6 COMPLEX | 8 | 6.94e-01 | 8.05e-02 | 8.86e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 70 | 2.46e-01 | -8.05e-02 | 5.92e-01 |
GOCC I BAND | 50 | 3.26e-01 | 8.04e-02 | 6.63e-01 |
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING | 312 | 1.56e-02 | -8.04e-02 | 1.68e-01 |
GOMF TELOMERASE RNA BINDING | 20 | 5.34e-01 | 8.03e-02 | 8.03e-01 |
GOCC MALE GERM CELL NUCLEUS | 27 | 4.70e-01 | 8.03e-02 | 7.66e-01 |
GOBP REGULATION OF CELLULAR SENESCENCE | 25 | 4.87e-01 | 8.03e-02 | 7.76e-01 |
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM | 58 | 2.91e-01 | 8.03e-02 | 6.33e-01 |
GOBP ACTIN NUCLEATION | 38 | 3.92e-01 | -8.03e-02 | 7.12e-01 |
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 113 | 1.42e-01 | -8.02e-02 | 4.73e-01 |
GOCC SNARE COMPLEX | 36 | 4.05e-01 | 8.02e-02 | 7.22e-01 |
GOBP REGULATION OF SPINDLE ORGANIZATION | 33 | 4.26e-01 | 8.02e-02 | 7.34e-01 |
GOMF HSP90 PROTEIN BINDING | 26 | 4.79e-01 | 8.02e-02 | 7.72e-01 |
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS | 9 | 6.77e-01 | -8.02e-02 | 8.78e-01 |
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION | 45 | 3.53e-01 | 8.02e-02 | 6.83e-01 |
GOCC LEADING EDGE MEMBRANE | 84 | 2.05e-01 | -8.02e-02 | 5.53e-01 |
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND | 18 | 5.56e-01 | -8.02e-02 | 8.14e-01 |
GOBP NEURON PROJECTION ORGANIZATION | 44 | 3.59e-01 | -8.01e-02 | 6.87e-01 |
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE | 63 | 2.73e-01 | -8.00e-02 | 6.17e-01 |
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION | 20 | 5.36e-01 | -8.00e-02 | 8.04e-01 |
GOBP REGULATION OF MUSCLE SYSTEM PROCESS | 88 | 1.96e-01 | -8.00e-02 | 5.43e-01 |
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS | 16 | 5.80e-01 | 7.99e-02 | 8.27e-01 |
GOCC GOLGI TRANS CISTERNA | 8 | 6.96e-01 | -7.99e-02 | 8.87e-01 |
GOBP AMIDE BIOSYNTHETIC PROCESS | 631 | 7.99e-04 | 7.99e-02 | 2.98e-02 |
GOBP RECEPTOR SIGNALING PATHWAY VIA STAT | 80 | 2.18e-01 | -7.98e-02 | 5.71e-01 |
GOBP TYPE I INTERFERON PRODUCTION | 80 | 2.19e-01 | -7.98e-02 | 5.71e-01 |
GOBP ENERGY RESERVE METABOLIC PROCESS | 39 | 3.89e-01 | -7.98e-02 | 7.10e-01 |
GOBP PEROXISOME FISSION | 5 | 7.58e-01 | 7.97e-02 | 9.16e-01 |
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING | 229 | 3.93e-02 | -7.97e-02 | 2.66e-01 |
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS | 11 | 6.48e-01 | 7.96e-02 | 8.63e-01 |
GOBP REGULATION OF EXOCYTOSIS | 95 | 1.81e-01 | -7.96e-02 | 5.28e-01 |
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT | 64 | 2.72e-01 | -7.96e-02 | 6.16e-01 |
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING | 143 | 1.02e-01 | 7.96e-02 | 4.12e-01 |
GOMF CHROMATIN DNA BINDING | 72 | 2.44e-01 | -7.96e-02 | 5.92e-01 |
GOCC PRONUCLEUS | 9 | 6.80e-01 | -7.96e-02 | 8.79e-01 |
GOMF PEPTIDASE ACTIVATOR ACTIVITY | 35 | 4.16e-01 | 7.95e-02 | 7.30e-01 |
GOBP REGULATION OF CELL DEVELOPMENT | 396 | 7.45e-03 | -7.94e-02 | 1.12e-01 |
GOBP REGULATION OF LYMPHOCYTE ACTIVATION | 281 | 2.33e-02 | -7.94e-02 | 2.10e-01 |
GOBP HEART MORPHOGENESIS | 73 | 2.42e-01 | -7.94e-02 | 5.90e-01 |
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 94 | 1.85e-01 | -7.94e-02 | 5.31e-01 |
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS | 40 | 3.86e-01 | 7.94e-02 | 7.07e-01 |
GOBP COLLAGEN FIBRIL ORGANIZATION | 10 | 6.64e-01 | -7.94e-02 | 8.72e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION | 17 | 5.71e-01 | -7.93e-02 | 8.21e-01 |
GOMF U4 SNRNA BINDING | 6 | 7.37e-01 | 7.93e-02 | 9.06e-01 |
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS | 694 | 5.07e-04 | -7.93e-02 | 2.15e-02 |
GOCC PRESYNAPTIC CYTOSOL | 8 | 6.98e-01 | 7.93e-02 | 8.88e-01 |
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 27 | 4.76e-01 | 7.93e-02 | 7.70e-01 |
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS | 17 | 5.72e-01 | -7.92e-02 | 8.21e-01 |
GOBP BODY FLUID SECRETION | 32 | 4.39e-01 | -7.92e-02 | 7.41e-01 |
GOBP ENTRY INTO HOST | 80 | 2.22e-01 | -7.91e-02 | 5.74e-01 |
GOBP GUANINE NUCLEOTIDE TRANSPORT | 5 | 7.59e-01 | 7.91e-02 | 9.16e-01 |
GOBP REVERSE CHOLESTEROL TRANSPORT | 6 | 7.37e-01 | 7.91e-02 | 9.06e-01 |
GOBP DOPAMINE SECRETION | 11 | 6.50e-01 | 7.91e-02 | 8.64e-01 |
GOBP TRANSLATIONAL INITIATION | 104 | 1.65e-01 | 7.91e-02 | 5.04e-01 |
GOBP TUBE FORMATION | 60 | 2.90e-01 | 7.91e-02 | 6.33e-01 |
GOBP EMBRYONIC MORPHOGENESIS | 208 | 5.10e-02 | -7.90e-02 | 2.96e-01 |
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 23 | 5.12e-01 | 7.90e-02 | 7.88e-01 |
GOCC MYELIN SHEATH | 24 | 5.04e-01 | 7.89e-02 | 7.83e-01 |
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY | 6 | 7.38e-01 | 7.89e-02 | 9.06e-01 |
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY | 11 | 6.51e-01 | 7.89e-02 | 8.65e-01 |
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY | 10 | 6.66e-01 | 7.88e-02 | 8.73e-01 |
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT | 185 | 6.62e-02 | -7.88e-02 | 3.38e-01 |
GOBP MAINTENANCE OF SYNAPSE STRUCTURE | 9 | 6.83e-01 | 7.88e-02 | 8.81e-01 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL | 48 | 3.46e-01 | 7.87e-02 | 6.79e-01 |
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY | 8 | 7.00e-01 | -7.87e-02 | 8.90e-01 |
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING | 19 | 5.53e-01 | 7.87e-02 | 8.13e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 783 | 2.69e-04 | -7.87e-02 | 1.36e-02 |
GOBP CELLULAR RESPONSE TO ZINC ION | 8 | 7.00e-01 | 7.86e-02 | 8.90e-01 |
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS | 33 | 4.35e-01 | 7.86e-02 | 7.40e-01 |
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS | 1048 | 3.39e-05 | -7.86e-02 | 2.53e-03 |
GOBP GLUCOSE METABOLIC PROCESS | 103 | 1.70e-01 | -7.85e-02 | 5.11e-01 |
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY | 5 | 7.61e-01 | 7.85e-02 | 9.17e-01 |
GOBP DEVELOPMENTAL MATURATION | 124 | 1.33e-01 | -7.85e-02 | 4.60e-01 |
GOBP HEMOPOIESIS | 523 | 2.55e-03 | -7.85e-02 | 6.27e-02 |
GOBP MELANOSOME ASSEMBLY | 16 | 5.87e-01 | -7.84e-02 | 8.31e-01 |
GOBP T HELPER 1 CELL DIFFERENTIATION | 13 | 6.25e-01 | 7.84e-02 | 8.51e-01 |
GOBP POSITIVE REGULATION OF LOCOMOTION | 242 | 3.72e-02 | -7.84e-02 | 2.60e-01 |
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS | 8 | 7.01e-01 | -7.84e-02 | 8.91e-01 |
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS | 66 | 2.72e-01 | -7.83e-02 | 6.17e-01 |
GOBP RETINA HOMEOSTASIS | 27 | 4.82e-01 | -7.83e-02 | 7.72e-01 |
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 261 | 3.08e-02 | -7.83e-02 | 2.39e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 71 | 2.55e-01 | -7.83e-02 | 5.98e-01 |
GOMF DNA SECONDARY STRUCTURE BINDING | 28 | 4.74e-01 | 7.82e-02 | 7.69e-01 |
GOBP PROTEIN PHOSPHORYLATION | 647 | 9.07e-04 | -7.82e-02 | 3.27e-02 |
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION | 29 | 4.67e-01 | -7.81e-02 | 7.63e-01 |
GOCC CONTRACTILE FIBER | 87 | 2.09e-01 | 7.81e-02 | 5.57e-01 |
GOBP NEGATIVE REGULATION OF GLIOGENESIS | 17 | 5.77e-01 | -7.81e-02 | 8.25e-01 |
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY | 7 | 7.21e-01 | 7.80e-02 | 8.99e-01 |
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN | 14 | 6.13e-01 | 7.80e-02 | 8.46e-01 |
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL | 88 | 2.07e-01 | -7.80e-02 | 5.54e-01 |
GOBP FORMATION OF PRIMARY GERM LAYER | 40 | 3.94e-01 | -7.80e-02 | 7.13e-01 |
GOBP ENDOTHELIAL CELL CHEMOTAXIS | 8 | 7.03e-01 | -7.79e-02 | 8.91e-01 |
GOBP BLASTOCYST FORMATION | 28 | 4.76e-01 | -7.79e-02 | 7.69e-01 |
GOBP REGULATION OF PROTEIN COMPLEX STABILITY | 10 | 6.70e-01 | 7.79e-02 | 8.74e-01 |
GOCC VESICLE TETHERING COMPLEX | 44 | 3.72e-01 | 7.78e-02 | 6.99e-01 |
GOBP POSITIVE REGULATION OF LIPID KINASE ACTIVITY | 8 | 7.03e-01 | -7.78e-02 | 8.92e-01 |
GOBP BLASTOCYST DEVELOPMENT | 69 | 2.65e-01 | 7.78e-02 | 6.09e-01 |
GOBP RESPONSE TO OXIDATIVE STRESS | 226 | 4.56e-02 | 7.78e-02 | 2.83e-01 |
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY | 109 | 1.62e-01 | -7.77e-02 | 5.01e-01 |
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY | 31 | 4.55e-01 | -7.77e-02 | 7.53e-01 |
GOBP OSTEOCLAST DIFFERENTIATION | 50 | 3.43e-01 | -7.76e-02 | 6.78e-01 |
GOBP SYNAPSE ORGANIZATION | 160 | 9.20e-02 | -7.76e-02 | 3.94e-01 |
GOMF NUCLEOSIDE KINASE ACTIVITY | 8 | 7.04e-01 | 7.76e-02 | 8.93e-01 |
GOBP MOTOR NEURON APOPTOTIC PROCESS | 12 | 6.42e-01 | -7.75e-02 | 8.60e-01 |
GOBP REGULATION OF ISOTYPE SWITCHING | 26 | 4.95e-01 | 7.74e-02 | 7.79e-01 |
GOCC POSTSYNAPTIC SPECIALIZATION | 134 | 1.24e-01 | -7.73e-02 | 4.50e-01 |
GOBP EMBRYONIC PATTERN SPECIFICATION | 19 | 5.60e-01 | -7.73e-02 | 8.16e-01 |
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE | 120 | 1.45e-01 | -7.73e-02 | 4.77e-01 |
GOMF RACEMASE AND EPIMERASE ACTIVITY | 7 | 7.23e-01 | 7.72e-02 | 9.00e-01 |
GOCC CALCIUM CHANNEL COMPLEX | 20 | 5.51e-01 | 7.71e-02 | 8.12e-01 |
GOBP RESPONSE TO UV B | 13 | 6.30e-01 | -7.71e-02 | 8.54e-01 |
GOBP MDA 5 SIGNALING PATHWAY | 7 | 7.24e-01 | 7.71e-02 | 9.00e-01 |
GOBP SECONDARY PALATE DEVELOPMENT | 7 | 7.24e-01 | -7.71e-02 | 9.00e-01 |
GOBP TOR SIGNALING | 119 | 1.48e-01 | -7.70e-02 | 4.81e-01 |
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS | 11 | 6.58e-01 | -7.70e-02 | 8.69e-01 |
GOBP REGULATION OF CELL PROJECTION ORGANIZATION | 312 | 2.08e-02 | -7.69e-02 | 1.96e-01 |
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 26 | 4.98e-01 | -7.68e-02 | 7.79e-01 |
GOCC NUCLEAR BODY | 612 | 1.51e-03 | -7.67e-02 | 4.50e-02 |
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY | 17 | 5.84e-01 | -7.67e-02 | 8.30e-01 |
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 87 | 2.18e-01 | 7.66e-02 | 5.71e-01 |
GOCC FLEMMING BODY | 25 | 5.08e-01 | -7.66e-02 | 7.86e-01 |
GOBP IMMUNE RESPONSE TO TUMOR CELL | 10 | 6.75e-01 | 7.65e-02 | 8.78e-01 |
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION | 6 | 7.46e-01 | -7.65e-02 | 9.09e-01 |
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS | 13 | 6.33e-01 | 7.65e-02 | 8.56e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 50 | 3.50e-01 | -7.65e-02 | 6.81e-01 |
GOMF PROTEIN HETERODIMERIZATION ACTIVITY | 146 | 1.12e-01 | -7.65e-02 | 4.30e-01 |
GOBP MITOCHONDRIAL TRANSCRIPTION | 14 | 6.20e-01 | 7.65e-02 | 8.49e-01 |
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST | 8 | 7.08e-01 | 7.65e-02 | 8.94e-01 |
GOBP NEUROTROPHIN SIGNALING PATHWAY | 17 | 5.86e-01 | -7.64e-02 | 8.30e-01 |
GOBP REGULATION OF DOSAGE COMPENSATION BY INACTIVATION OF X CHROMOSOME | 13 | 6.34e-01 | -7.64e-02 | 8.56e-01 |
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION | 23 | 5.27e-01 | -7.64e-02 | 7.98e-01 |
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX | 13 | 6.34e-01 | 7.63e-02 | 8.56e-01 |
GOBP DUMP METABOLIC PROCESS | 5 | 7.68e-01 | 7.63e-02 | 9.21e-01 |
GOBP REGULATION OF PROTEIN FOLDING | 6 | 7.46e-01 | 7.63e-02 | 9.10e-01 |
GOCC CHROMATIN SILENCING COMPLEX | 11 | 6.62e-01 | 7.63e-02 | 8.71e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 6 | 7.46e-01 | 7.62e-02 | 9.10e-01 |
GOCC KINETOCHORE MICROTUBULE | 17 | 5.87e-01 | 7.62e-02 | 8.31e-01 |
GOBP SECRETION | 383 | 1.15e-02 | -7.62e-02 | 1.41e-01 |
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT | 410 | 9.05e-03 | -7.62e-02 | 1.23e-01 |
GOBP RESPONSE TO ENDOGENOUS STIMULUS | 752 | 5.43e-04 | -7.60e-02 | 2.27e-02 |
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS | 294 | 2.64e-02 | -7.60e-02 | 2.25e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE | 331 | 1.87e-02 | 7.60e-02 | 1.85e-01 |
GOMF CARBOXYPEPTIDASE ACTIVITY | 20 | 5.57e-01 | 7.60e-02 | 8.14e-01 |
GOBP REGULATION OF HEMOPOIESIS | 229 | 4.93e-02 | -7.60e-02 | 2.90e-01 |
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 16 | 5.99e-01 | -7.60e-02 | 8.37e-01 |
GOBP POSITIVE REGULATION OF BINDING | 79 | 2.45e-01 | -7.59e-02 | 5.92e-01 |
GOMF LAMIN BINDING | 12 | 6.49e-01 | -7.58e-02 | 8.64e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING | 10 | 6.78e-01 | -7.58e-02 | 8.79e-01 |
GOMF STRUCTURAL MOLECULE ACTIVITY | 289 | 2.81e-02 | 7.58e-02 | 2.30e-01 |
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY | 5 | 7.69e-01 | 7.58e-02 | 9.22e-01 |
GOBP REGULATION OF CYTOKINESIS | 52 | 3.46e-01 | 7.57e-02 | 6.79e-01 |
GOBP SEQUESTERING OF CALCIUM ION | 56 | 3.28e-01 | 7.57e-02 | 6.64e-01 |
GOMF FAD BINDING | 22 | 5.39e-01 | 7.57e-02 | 8.04e-01 |
GOMF DAMAGED DNA BINDING | 55 | 3.33e-01 | 7.56e-02 | 6.68e-01 |
GOBP ORGANELLE DISASSEMBLY | 113 | 1.67e-01 | 7.56e-02 | 5.06e-01 |
GOBP REGULATION OF KINASE ACTIVITY | 286 | 2.94e-02 | -7.56e-02 | 2.35e-01 |
GOBP AMINOGLYCAN CATABOLIC PROCESS | 10 | 6.79e-01 | -7.56e-02 | 8.79e-01 |
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 29 | 4.82e-01 | 7.55e-02 | 7.72e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT | 14 | 6.25e-01 | -7.55e-02 | 8.51e-01 |
GOBP HEART DEVELOPMENT | 225 | 5.30e-02 | -7.54e-02 | 3.00e-01 |
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 88 | 2.23e-01 | -7.54e-02 | 5.74e-01 |
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY | 52 | 3.48e-01 | -7.54e-02 | 6.80e-01 |
GOBP CELLULAR RESPONSE TO ALKALOID | 14 | 6.26e-01 | 7.53e-02 | 8.51e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME | 10 | 6.80e-01 | -7.53e-02 | 8.80e-01 |
GOMF ANNEALING ACTIVITY | 8 | 7.12e-01 | -7.53e-02 | 8.96e-01 |
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY | 177 | 8.60e-02 | 7.52e-02 | 3.83e-01 |
GOBP REGULATION OF SYSTEM PROCESS | 160 | 1.03e-01 | -7.52e-02 | 4.13e-01 |
GOBP MATURE B CELL DIFFERENTIATION | 24 | 5.24e-01 | -7.52e-02 | 7.96e-01 |
GOBP ENDOTHELIAL CELL MIGRATION | 96 | 2.06e-01 | -7.50e-02 | 5.53e-01 |
GOBP REGULATION OF STEM CELL DIVISION | 6 | 7.51e-01 | 7.49e-02 | 9.11e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 410 | 1.03e-02 | -7.48e-02 | 1.34e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 9 | 6.98e-01 | -7.48e-02 | 8.88e-01 |
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION | 16 | 6.05e-01 | -7.48e-02 | 8.41e-01 |
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 902 | 2.25e-04 | -7.47e-02 | 1.18e-02 |
GOBP POSITIVE REGULATION OF DNA BINDING | 21 | 5.54e-01 | -7.47e-02 | 8.14e-01 |
GOCC CENTRIOLE | 90 | 2.23e-01 | -7.45e-02 | 5.74e-01 |
GOBP NON CANONICAL WNT SIGNALING PATHWAY | 27 | 5.03e-01 | -7.45e-02 | 7.82e-01 |
GOBP POSITIVE REGULATION OF EXOCYTOSIS | 42 | 4.04e-01 | 7.45e-02 | 7.21e-01 |
GOBP TISSUE HOMEOSTASIS | 108 | 1.83e-01 | -7.45e-02 | 5.29e-01 |
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING | 10 | 6.84e-01 | 7.44e-02 | 8.81e-01 |
GOBP REGULATION OF VIRAL GENOME REPLICATION | 59 | 3.24e-01 | -7.44e-02 | 6.61e-01 |
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 257 | 4.19e-02 | -7.43e-02 | 2.73e-01 |
GOBP RESPONSE TO PROGESTERONE | 18 | 5.85e-01 | -7.43e-02 | 8.30e-01 |
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 102 | 1.96e-01 | -7.43e-02 | 5.43e-01 |
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION | 7 | 7.34e-01 | 7.43e-02 | 9.04e-01 |
GOBP MAMMARY GLAND DEVELOPMENT | 49 | 3.69e-01 | -7.43e-02 | 6.96e-01 |
GOMF PROTEIN MACROMOLECULE ADAPTOR ACTIVITY | 271 | 3.70e-02 | -7.43e-02 | 2.60e-01 |
GOBP NEGATIVE REGULATION OF SIGNALING | 657 | 1.50e-03 | -7.43e-02 | 4.50e-02 |
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN | 157 | 1.10e-01 | -7.42e-02 | 4.27e-01 |
GOMF SULFOTRANSFERASE ACTIVITY | 10 | 6.85e-01 | 7.42e-02 | 8.81e-01 |
GOBP DEVELOPMENTAL GROWTH | 273 | 3.66e-02 | -7.42e-02 | 2.58e-01 |
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS | 26 | 5.13e-01 | 7.42e-02 | 7.88e-01 |
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY | 7 | 7.35e-01 | -7.40e-02 | 9.05e-01 |
GOCC PROTEIN DNA COMPLEX | 687 | 1.24e-03 | -7.40e-02 | 4.02e-02 |
GOBP INNER EAR MORPHOGENESIS | 18 | 5.87e-01 | -7.40e-02 | 8.31e-01 |
GOMF MUSCLE ALPHA ACTININ BINDING | 6 | 7.54e-01 | -7.39e-02 | 9.14e-01 |
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS | 283 | 3.41e-02 | 7.39e-02 | 2.49e-01 |
GOMF SIGNAL SEQUENCE BINDING | 33 | 4.63e-01 | 7.39e-02 | 7.60e-01 |
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING | 45 | 3.92e-01 | 7.38e-02 | 7.12e-01 |
GOCC BRUSH BORDER | 38 | 4.32e-01 | -7.38e-02 | 7.38e-01 |
GOCC MICROVILLUS | 36 | 4.44e-01 | -7.38e-02 | 7.46e-01 |
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 28 | 5.00e-01 | 7.37e-02 | 7.80e-01 |
GOBP MALE MEIOTIC NUCLEAR DIVISION | 16 | 6.10e-01 | 7.37e-02 | 8.44e-01 |
GOBP POSITIVE REGULATION OF VASOCONSTRICTION | 8 | 7.18e-01 | -7.37e-02 | 8.99e-01 |
GOBP DETECTION OF STIMULUS | 50 | 3.68e-01 | 7.37e-02 | 6.95e-01 |
GOCC AXOLEMMA | 5 | 7.76e-01 | -7.36e-02 | 9.25e-01 |
GOMF UBIQUITINATION LIKE MODIFICATION DEPENDENT PROTEIN BINDING | 18 | 5.89e-01 | -7.36e-02 | 8.32e-01 |
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS | 33 | 4.65e-01 | -7.36e-02 | 7.62e-01 |
GOBP LYMPHOCYTE COSTIMULATION | 23 | 5.42e-01 | -7.35e-02 | 8.05e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 48 | 3.79e-01 | 7.35e-02 | 7.04e-01 |
GOBP REGULATION OF HISTONE METHYLATION | 17 | 6.00e-01 | -7.35e-02 | 8.38e-01 |
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS | 21 | 5.60e-01 | -7.35e-02 | 8.16e-01 |
GOMF CHEMOKINE RECEPTOR BINDING | 10 | 6.88e-01 | -7.35e-02 | 8.83e-01 |
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 162 | 1.09e-01 | -7.34e-02 | 4.24e-01 |
GOMF LYSOPHOSPHOLIPASE ACTIVITY | 10 | 6.88e-01 | -7.34e-02 | 8.83e-01 |
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 31 | 4.80e-01 | -7.34e-02 | 7.72e-01 |
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE | 8 | 7.20e-01 | -7.33e-02 | 8.99e-01 |
GOMF PROTEASOME BINDING | 15 | 6.23e-01 | -7.33e-02 | 8.51e-01 |
GOBP NEGATIVE T CELL SELECTION | 5 | 7.77e-01 | 7.32e-02 | 9.25e-01 |
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 13 | 6.48e-01 | 7.32e-02 | 8.63e-01 |
GOCC SARCOLEMMA | 49 | 3.77e-01 | -7.31e-02 | 7.03e-01 |
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION | 6 | 7.57e-01 | 7.31e-02 | 9.15e-01 |
GOBP SCHWANN CELL PROLIFERATION | 6 | 7.57e-01 | 7.31e-02 | 9.15e-01 |
GOCC TRANS GOLGI NETWORK MEMBRANE | 69 | 2.95e-01 | -7.30e-02 | 6.37e-01 |
GOBP REGULATION OF DENDRITE MORPHOGENESIS | 30 | 4.89e-01 | -7.30e-02 | 7.76e-01 |
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING | 97 | 2.15e-01 | -7.30e-02 | 5.68e-01 |
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX | 948 | 2.30e-04 | 7.30e-02 | 1.20e-02 |
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION | 10 | 6.90e-01 | 7.30e-02 | 8.83e-01 |
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 11 | 6.76e-01 | 7.29e-02 | 8.78e-01 |
GOBP REGULATION OF EMBRYONIC DEVELOPMENT | 49 | 3.78e-01 | -7.29e-02 | 7.03e-01 |
GOBP EPITHELIAL TUBE FORMATION | 57 | 3.42e-01 | 7.29e-02 | 6.77e-01 |
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS | 40 | 4.26e-01 | -7.29e-02 | 7.34e-01 |
GOBP NEGATIVE REGULATION OF DNA REPAIR | 27 | 5.13e-01 | -7.29e-02 | 7.88e-01 |
GOBP AMINE TRANSPORT | 30 | 4.90e-01 | -7.29e-02 | 7.76e-01 |
GOBP NUCLEOSIDE SALVAGE | 7 | 7.39e-01 | 7.28e-02 | 9.06e-01 |
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY | 7 | 7.39e-01 | -7.27e-02 | 9.06e-01 |
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON | 42 | 4.15e-01 | -7.27e-02 | 7.29e-01 |
GOBP TRACHEA FORMATION | 6 | 7.58e-01 | -7.27e-02 | 9.16e-01 |
GOBP TRACHEA MORPHOGENESIS | 6 | 7.58e-01 | -7.27e-02 | 9.16e-01 |
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY | 6 | 7.58e-01 | -7.27e-02 | 9.16e-01 |
GOMF LEUCINE ZIPPER DOMAIN BINDING | 9 | 7.06e-01 | -7.27e-02 | 8.93e-01 |
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX | 22 | 5.56e-01 | -7.26e-02 | 8.14e-01 |
GOBP REGULATION OF NEURON APOPTOTIC PROCESS | 109 | 1.92e-01 | -7.26e-02 | 5.38e-01 |
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 706 | 1.34e-03 | -7.26e-02 | 4.26e-02 |
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN | 31 | 4.85e-01 | -7.26e-02 | 7.74e-01 |
GOBP REGULATION OF MICROTUBULE BASED PROCESS | 132 | 1.52e-01 | -7.25e-02 | 4.87e-01 |
GOMF KINASE REGULATOR ACTIVITY | 146 | 1.32e-01 | -7.25e-02 | 4.60e-01 |
GOMF TRANSCRIPTION COREPRESSOR BINDING | 38 | 4.40e-01 | -7.25e-02 | 7.42e-01 |
GOCC IGM IMMUNOGLOBULIN COMPLEX | 5 | 7.79e-01 | 7.24e-02 | 9.26e-01 |
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM | 57 | 3.45e-01 | 7.24e-02 | 6.79e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 12 | 6.64e-01 | 7.24e-02 | 8.72e-01 |
GOCC TERMINAL BOUTON | 12 | 6.64e-01 | -7.23e-02 | 8.72e-01 |
GOMF SYNTAXIN BINDING | 36 | 4.53e-01 | 7.23e-02 | 7.52e-01 |
GOBP INORGANIC ANION TRANSPORT | 39 | 4.35e-01 | -7.23e-02 | 7.40e-01 |
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION | 6 | 7.59e-01 | -7.22e-02 | 9.16e-01 |
GOBP CYTOKINE PRODUCTION | 375 | 1.77e-02 | -7.22e-02 | 1.79e-01 |
GOMF PROTEIN PHOSPHATASE BINDING | 93 | 2.30e-01 | -7.22e-02 | 5.78e-01 |
GOBP CONNECTIVE TISSUE REPLACEMENT | 8 | 7.24e-01 | -7.22e-02 | 9.00e-01 |
GOBP REGULATION OF NUCLEASE ACTIVITY | 17 | 6.07e-01 | 7.22e-02 | 8.42e-01 |
GOBP CORTICAL CYTOSKELETON ORGANIZATION | 32 | 4.80e-01 | -7.22e-02 | 7.72e-01 |
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX | 14 | 6.41e-01 | 7.21e-02 | 8.59e-01 |
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING | 8 | 7.24e-01 | -7.21e-02 | 9.00e-01 |
GOBP TAXIS | 160 | 1.18e-01 | -7.21e-02 | 4.39e-01 |
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS | 12 | 6.66e-01 | 7.21e-02 | 8.73e-01 |
GOBP NEUROGENESIS | 678 | 1.80e-03 | -7.20e-02 | 5.13e-02 |
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS | 566 | 4.11e-03 | -7.19e-02 | 8.05e-02 |
GOCC CLATHRIN ADAPTOR COMPLEX | 18 | 5.98e-01 | -7.19e-02 | 8.36e-01 |
GOCC CONTRACTILE RING | 9 | 7.09e-01 | 7.18e-02 | 8.95e-01 |
GOBP CELLULAR COMPONENT DISASSEMBLY | 319 | 2.92e-02 | 7.18e-02 | 2.34e-01 |
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 13 | 6.54e-01 | 7.17e-02 | 8.66e-01 |
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS | 58 | 3.46e-01 | 7.17e-02 | 6.79e-01 |
GOBP CELLULAR RESPONSE TO MECHANICAL STIMULUS | 37 | 4.51e-01 | -7.17e-02 | 7.51e-01 |
GOBP REGULATION OF VIRAL PROCESS | 107 | 2.02e-01 | -7.17e-02 | 5.50e-01 |
GOBP XENOBIOTIC METABOLIC PROCESS | 22 | 5.61e-01 | -7.16e-02 | 8.17e-01 |
GOBP REGULATION OF WOUND HEALING | 41 | 4.29e-01 | -7.15e-02 | 7.36e-01 |
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS | 16 | 6.21e-01 | 7.15e-02 | 8.49e-01 |
GOCC SIN3 TYPE COMPLEX | 22 | 5.62e-01 | 7.15e-02 | 8.17e-01 |
GOBP RESPONSE TO HYDROGEN PEROXIDE | 60 | 3.39e-01 | 7.15e-02 | 6.75e-01 |
GOCC ANCHORING JUNCTION | 428 | 1.25e-02 | -7.14e-02 | 1.46e-01 |
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT | 9 | 7.11e-01 | 7.14e-02 | 8.96e-01 |
GOMF IGE BINDING | 5 | 7.82e-01 | 7.14e-02 | 9.26e-01 |
GOCC SPERM MIDPIECE | 18 | 6.01e-01 | 7.13e-02 | 8.38e-01 |
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS | 16 | 6.22e-01 | -7.13e-02 | 8.50e-01 |
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY | 6 | 7.63e-01 | -7.12e-02 | 9.18e-01 |
GOBP NUCLEOTIDE EXCISION REPAIR | 71 | 3.00e-01 | 7.12e-02 | 6.42e-01 |
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 30 | 5.00e-01 | -7.12e-02 | 7.81e-01 |
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 6 | 7.63e-01 | -7.11e-02 | 9.18e-01 |
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS | 28 | 5.16e-01 | -7.11e-02 | 7.90e-01 |
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE | 21 | 5.73e-01 | 7.11e-02 | 8.22e-01 |
GOBP CYCLIC NUCLEOTIDE TRANSPORT | 6 | 7.63e-01 | 7.10e-02 | 9.18e-01 |
GOBP TRANSCRIPTION INITIATION COUPLED CHROMATIN REMODELING | 28 | 5.16e-01 | 7.10e-02 | 7.90e-01 |
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 137 | 1.54e-01 | -7.09e-02 | 4.88e-01 |
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 49 | 3.92e-01 | 7.08e-02 | 7.12e-01 |
GOBP REGULATION OF CELL CYCLE PROCESS | 450 | 1.12e-02 | 7.08e-02 | 1.39e-01 |
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX | 15 | 6.35e-01 | 7.08e-02 | 8.57e-01 |
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE | 6 | 7.64e-01 | 7.08e-02 | 9.19e-01 |
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 47 | 4.02e-01 | -7.07e-02 | 7.20e-01 |
GOBP MAPK CASCADE | 332 | 2.85e-02 | -7.07e-02 | 2.31e-01 |
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY | 196 | 9.00e-02 | 7.07e-02 | 3.90e-01 |
GOBP T CELL MEDIATED CYTOTOXICITY | 25 | 5.41e-01 | 7.07e-02 | 8.05e-01 |
GOBP EXPORT FROM CELL | 370 | 2.12e-02 | -7.07e-02 | 1.99e-01 |
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM | 5 | 7.85e-01 | -7.06e-02 | 9.28e-01 |
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 42 | 4.29e-01 | 7.06e-02 | 7.36e-01 |
GOMF ADENYLYLTRANSFERASE ACTIVITY | 17 | 6.15e-01 | 7.06e-02 | 8.46e-01 |
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 7 | 7.47e-01 | 7.06e-02 | 9.10e-01 |
GOBP MITOTIC SISTER CHROMATID COHESION | 22 | 5.67e-01 | 7.06e-02 | 8.19e-01 |
GOMF DIPHOSPHOTRANSFERASE ACTIVITY | 5 | 7.85e-01 | -7.05e-02 | 9.28e-01 |
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 17 | 6.15e-01 | -7.05e-02 | 8.47e-01 |
GOMF PROMOTER SPECIFIC CHROMATIN BINDING | 45 | 4.14e-01 | 7.04e-02 | 7.28e-01 |
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION | 26 | 5.35e-01 | -7.04e-02 | 8.03e-01 |
GOBP SUCCINYL COA METABOLIC PROCESS | 6 | 7.65e-01 | -7.04e-02 | 9.19e-01 |
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS | 17 | 6.16e-01 | 7.03e-02 | 8.47e-01 |
GOBP AMINO ACID TRANSPORT | 52 | 3.81e-01 | -7.03e-02 | 7.05e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS | 88 | 2.56e-01 | -7.03e-02 | 5.98e-01 |
GOMF DEATH DOMAIN BINDING | 9 | 7.15e-01 | -7.03e-02 | 8.97e-01 |
GOCC POSTSYNAPSE | 250 | 5.79e-02 | -7.02e-02 | 3.15e-01 |
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT | 49 | 3.97e-01 | -7.01e-02 | 7.16e-01 |
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS | 51 | 3.87e-01 | 7.01e-02 | 7.08e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 61 | 3.45e-01 | -7.01e-02 | 6.79e-01 |
GOBP REGULATION OF CILIUM ASSEMBLY | 57 | 3.61e-01 | -7.01e-02 | 6.88e-01 |
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING | 20 | 5.88e-01 | -7.01e-02 | 8.31e-01 |
GOCC SECRETORY GRANULE MEMBRANE | 172 | 1.15e-01 | -7.01e-02 | 4.36e-01 |
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS | 8 | 7.32e-01 | 7.00e-02 | 9.04e-01 |
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY | 10 | 7.02e-01 | 7.00e-02 | 8.91e-01 |
GOBP VACUOLAR ACIDIFICATION | 29 | 5.15e-01 | 6.99e-02 | 7.90e-01 |
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 72 | 3.06e-01 | 6.99e-02 | 6.47e-01 |
GOMF SNARE BINDING | 61 | 3.46e-01 | 6.98e-02 | 6.79e-01 |
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION | 33 | 4.88e-01 | 6.98e-02 | 7.76e-01 |
GOMF PEPTIDE BINDING | 135 | 1.64e-01 | 6.98e-02 | 5.02e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 176 | 1.13e-01 | -6.97e-02 | 4.31e-01 |
GOBP AXO DENDRITIC TRANSPORT | 53 | 3.81e-01 | -6.97e-02 | 7.05e-01 |
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS | 5 | 7.87e-01 | -6.96e-02 | 9.29e-01 |
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND | 402 | 1.81e-02 | -6.96e-02 | 1.82e-01 |
GOBP MACROPINOCYTOSIS | 8 | 7.33e-01 | -6.96e-02 | 9.04e-01 |
GOCC ELONGATOR HOLOENZYME COMPLEX | 6 | 7.68e-01 | 6.95e-02 | 9.22e-01 |
GOCC SIDE OF MEMBRANE | 260 | 5.59e-02 | -6.95e-02 | 3.08e-01 |
GOBP CERAMIDE CATABOLIC PROCESS | 9 | 7.18e-01 | 6.94e-02 | 8.99e-01 |
GOBP REGULATION OF AMYLOID BETA CLEARANCE | 9 | 7.19e-01 | 6.93e-02 | 8.99e-01 |
GOBP REGULATION OF ERBB SIGNALING PATHWAY | 39 | 4.54e-01 | 6.93e-02 | 7.53e-01 |
GOMF FIBROBLAST GROWTH FACTOR BINDING | 7 | 7.51e-01 | -6.93e-02 | 9.11e-01 |
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 36 | 4.73e-01 | 6.93e-02 | 7.68e-01 |
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 39 | 4.55e-01 | 6.92e-02 | 7.53e-01 |
GOMF SODIUM CHANNEL REGULATOR ACTIVITY | 11 | 6.91e-01 | -6.92e-02 | 8.84e-01 |
GOBP MITOTIC SPINDLE ASSEMBLY | 49 | 4.03e-01 | 6.92e-02 | 7.20e-01 |
GOBP REGULATION OF LEUKOCYTE PROLIFERATION | 137 | 1.64e-01 | -6.92e-02 | 5.02e-01 |
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY | 22 | 5.75e-01 | -6.92e-02 | 8.24e-01 |
GOBP UDP GLUCOSE METABOLIC PROCESS | 6 | 7.70e-01 | 6.90e-02 | 9.23e-01 |
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY | 216 | 8.30e-02 | -6.89e-02 | 3.78e-01 |
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 9 | 7.21e-01 | -6.89e-02 | 8.99e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION | 7 | 7.53e-01 | -6.88e-02 | 9.13e-01 |
GOMF SNAP RECEPTOR ACTIVITY | 31 | 5.08e-01 | 6.88e-02 | 7.86e-01 |
GOBP REGULATION OF AXON EXTENSION | 35 | 4.82e-01 | 6.88e-02 | 7.72e-01 |
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY | 18 | 6.14e-01 | -6.87e-02 | 8.46e-01 |
GOBP SECRETORY GRANULE ORGANIZATION | 38 | 4.64e-01 | -6.87e-02 | 7.61e-01 |
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS | 6 | 7.71e-01 | 6.87e-02 | 9.23e-01 |
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION | 8 | 7.37e-01 | 6.87e-02 | 9.06e-01 |
GOBP REGULATION OF DNA DAMAGE CHECKPOINT | 22 | 5.78e-01 | 6.86e-02 | 8.25e-01 |
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 10 | 7.07e-01 | -6.86e-02 | 8.94e-01 |
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS | 81 | 2.87e-01 | 6.86e-02 | 6.29e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION | 195 | 1.01e-01 | -6.85e-02 | 4.10e-01 |
GOBP RHO PROTEIN SIGNAL TRANSDUCTION | 68 | 3.30e-01 | -6.85e-02 | 6.65e-01 |
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS | 7 | 7.54e-01 | -6.85e-02 | 9.14e-01 |
GOBP MYELOID CELL APOPTOTIC PROCESS | 21 | 5.87e-01 | -6.85e-02 | 8.31e-01 |
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 56 | 3.77e-01 | -6.84e-02 | 7.03e-01 |
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL | 6 | 7.72e-01 | -6.84e-02 | 9.24e-01 |
GOBP R LOOP PROCESSING | 6 | 7.72e-01 | -6.84e-02 | 9.24e-01 |
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS | 24 | 5.63e-01 | 6.83e-02 | 8.17e-01 |
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS | 37 | 4.74e-01 | 6.81e-02 | 7.69e-01 |
GOBP POSITIVE REGULATION OF RNA SPLICING | 30 | 5.20e-01 | 6.80e-02 | 7.93e-01 |
GOCC CCR4 NOT CORE COMPLEX | 6 | 7.73e-01 | -6.80e-02 | 9.24e-01 |
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 81 | 2.92e-01 | 6.80e-02 | 6.34e-01 |
GOMF GATED CHANNEL ACTIVITY | 48 | 4.16e-01 | -6.79e-02 | 7.30e-01 |
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION | 49 | 4.11e-01 | -6.79e-02 | 7.27e-01 |
GOBP CELLULAR RESPONSE TO MANGANESE ION | 6 | 7.73e-01 | -6.79e-02 | 9.24e-01 |
GOBP FEAR RESPONSE | 16 | 6.39e-01 | -6.79e-02 | 8.59e-01 |
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 116 | 2.09e-01 | -6.79e-02 | 5.56e-01 |
GOBP REGULATORY NCRNA PROCESSING | 49 | 4.12e-01 | -6.78e-02 | 7.27e-01 |
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 6 | 7.74e-01 | -6.78e-02 | 9.24e-01 |
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 9 | 7.25e-01 | 6.77e-02 | 9.01e-01 |
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 494 | 1.12e-02 | -6.77e-02 | 1.39e-01 |
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 19 | 6.10e-01 | 6.77e-02 | 8.44e-01 |
GOBP IMMUNOGLOBULIN V D J RECOMBINATION | 6 | 7.74e-01 | -6.77e-02 | 9.24e-01 |
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX | 6 | 7.74e-01 | -6.77e-02 | 9.24e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS | 7 | 7.57e-01 | -6.76e-02 | 9.15e-01 |
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS | 11 | 6.98e-01 | -6.76e-02 | 8.88e-01 |
GOMF INSULIN RECEPTOR SUBSTRATE BINDING | 11 | 6.98e-01 | 6.76e-02 | 8.88e-01 |
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY | 11 | 6.98e-01 | -6.75e-02 | 8.88e-01 |
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 28 | 5.37e-01 | -6.75e-02 | 8.04e-01 |
GOCC ARP2 3 PROTEIN COMPLEX | 9 | 7.26e-01 | 6.75e-02 | 9.02e-01 |
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 16 | 6.40e-01 | 6.75e-02 | 8.59e-01 |
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION | 30 | 5.23e-01 | -6.75e-02 | 7.95e-01 |
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY | 219 | 8.77e-02 | -6.75e-02 | 3.86e-01 |
GOBP REGULATION OF MITOCHONDRION ORGANIZATION | 100 | 2.45e-01 | 6.74e-02 | 5.92e-01 |
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE | 106 | 2.32e-01 | -6.74e-02 | 5.78e-01 |
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING | 159 | 1.45e-01 | -6.74e-02 | 4.77e-01 |
GOCC NUCLEOLUS | 726 | 2.60e-03 | 6.73e-02 | 6.31e-02 |
GOBP GENERATION OF NEURONS | 568 | 7.17e-03 | -6.73e-02 | 1.09e-01 |
GOMF DEACETYLASE ACTIVITY | 22 | 5.85e-01 | -6.73e-02 | 8.30e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION | 26 | 5.53e-01 | -6.73e-02 | 8.13e-01 |
GOCC PHAGOPHORE ASSEMBLY SITE | 32 | 5.11e-01 | -6.73e-02 | 7.88e-01 |
GOCC ZONULA ADHERENS | 6 | 7.75e-01 | -6.73e-02 | 9.25e-01 |
GOBP RECEPTOR METABOLIC PROCESS | 52 | 4.03e-01 | -6.72e-02 | 7.20e-01 |
GOBP RESPONSE TO NITRIC OXIDE | 10 | 7.13e-01 | -6.72e-02 | 8.96e-01 |
GOBP COPII COATED VESICLE BUDDING | 40 | 4.64e-01 | 6.71e-02 | 7.61e-01 |
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT | 7 | 7.59e-01 | 6.70e-02 | 9.16e-01 |
GOBP POSITIVE REGULATION OF CELL ACTIVATION | 216 | 9.21e-02 | -6.70e-02 | 3.94e-01 |
GOBP ICOSANOID METABOLIC PROCESS | 41 | 4.59e-01 | -6.70e-02 | 7.56e-01 |
GOCC OMEGASOME | 5 | 7.95e-01 | 6.70e-02 | 9.33e-01 |
GOBP STRIATED MUSCLE CONTRACTION | 53 | 4.00e-01 | 6.70e-02 | 7.19e-01 |
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION | 369 | 2.92e-02 | -6.69e-02 | 2.34e-01 |
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY | 6 | 7.77e-01 | -6.69e-02 | 9.25e-01 |
GOBP RESPONSE TO ACID CHEMICAL | 72 | 3.28e-01 | -6.69e-02 | 6.63e-01 |
GOBP GRANULOCYTE DIFFERENTIATION | 30 | 5.27e-01 | -6.69e-02 | 7.98e-01 |
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION | 49 | 4.19e-01 | -6.68e-02 | 7.31e-01 |
GOMF TRANSMEMBRANE TRANSPORTER BINDING | 66 | 3.49e-01 | 6.68e-02 | 6.81e-01 |
GOCC THO COMPLEX | 6 | 7.77e-01 | 6.68e-02 | 9.25e-01 |
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES | 110 | 2.29e-01 | 6.67e-02 | 5.77e-01 |
GOMF S100 PROTEIN BINDING | 9 | 7.30e-01 | 6.66e-02 | 9.03e-01 |
GOCC GABA ERGIC SYNAPSE | 15 | 6.56e-01 | -6.65e-02 | 8.66e-01 |
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS | 137 | 1.81e-01 | -6.65e-02 | 5.28e-01 |
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 12 | 6.90e-01 | -6.65e-02 | 8.83e-01 |
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING | 14 | 6.67e-01 | -6.65e-02 | 8.73e-01 |
GOCC SARCOPLASM | 39 | 4.73e-01 | 6.65e-02 | 7.68e-01 |
GOBP PHOSPHATE ION TRANSPORT | 12 | 6.90e-01 | -6.65e-02 | 8.83e-01 |
GOBP POSITIVE REGULATION OF WOUND HEALING | 21 | 5.98e-01 | 6.65e-02 | 8.36e-01 |
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 118 | 2.14e-01 | -6.65e-02 | 5.66e-01 |
GOBP GTP METABOLIC PROCESS | 17 | 6.36e-01 | -6.64e-02 | 8.57e-01 |
GOBP ENDOSOME TO LYSOSOME TRANSPORT | 50 | 4.17e-01 | 6.64e-02 | 7.30e-01 |
GOBP ENDODERMAL CELL DIFFERENTIATION | 15 | 6.56e-01 | -6.64e-02 | 8.67e-01 |
GOCC MEIOTIC SPINDLE | 6 | 7.78e-01 | 6.64e-02 | 9.26e-01 |
GOCC GLIAL CELL PROJECTION | 14 | 6.68e-01 | -6.63e-02 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 16 | 6.46e-01 | 6.63e-02 | 8.63e-01 |
GOBP MICROTUBULE BASED MOVEMENT | 169 | 1.39e-01 | -6.63e-02 | 4.69e-01 |
GOBP POSITIVE REGULATION OF HEMOPOIESIS | 113 | 2.25e-01 | -6.63e-02 | 5.75e-01 |
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA | 9 | 7.31e-01 | -6.62e-02 | 9.04e-01 |
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT | 186 | 1.22e-01 | -6.62e-02 | 4.47e-01 |
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE | 136 | 1.85e-01 | -6.62e-02 | 5.30e-01 |
GOCC CCR4 NOT COMPLEX | 13 | 6.80e-01 | -6.62e-02 | 8.79e-01 |
GOBP REGULATION OF DNA RECOMBINATION | 86 | 2.91e-01 | 6.61e-02 | 6.33e-01 |
GOBP PROTEIN K11 LINKED DEUBIQUITINATION | 6 | 7.80e-01 | -6.60e-02 | 9.26e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 13 | 6.81e-01 | 6.60e-02 | 8.80e-01 |
GOMF COA HYDROLASE ACTIVITY | 8 | 7.47e-01 | -6.59e-02 | 9.10e-01 |
GOBP MAMMALIAN OOGENESIS STAGE | 5 | 7.99e-01 | -6.59e-02 | 9.33e-01 |
GOBP GLAND DEVELOPMENT | 167 | 1.44e-01 | -6.59e-02 | 4.76e-01 |
GOBP CELLULAR RESPONSE TO STARVATION | 115 | 2.24e-01 | -6.59e-02 | 5.75e-01 |
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY | 6 | 7.80e-01 | -6.58e-02 | 9.26e-01 |
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 5 | 7.99e-01 | 6.58e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS | 5 | 7.99e-01 | 6.58e-02 | 9.33e-01 |
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY | 25 | 5.69e-01 | -6.58e-02 | 8.20e-01 |
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS | 41 | 4.67e-01 | -6.58e-02 | 7.62e-01 |
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 284 | 5.88e-02 | -6.58e-02 | 3.16e-01 |
GOBP POSITIVE REGULATION OF CELL DIVISION | 38 | 4.84e-01 | 6.58e-02 | 7.74e-01 |
GOBP POSITIVE REGULATION OF SIGNALING | 815 | 1.93e-03 | -6.57e-02 | 5.29e-02 |
GOMF MOLECULAR ADAPTOR ACTIVITY | 372 | 3.16e-02 | -6.57e-02 | 2.42e-01 |
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 6 | 7.81e-01 | 6.57e-02 | 9.26e-01 |
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 230 | 8.88e-02 | 6.56e-02 | 3.87e-01 |
GOBP ESTROGEN METABOLIC PROCESS | 9 | 7.33e-01 | -6.56e-02 | 9.04e-01 |
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX | 691 | 4.12e-03 | 6.56e-02 | 8.05e-02 |
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT | 5 | 8.00e-01 | 6.55e-02 | 9.34e-01 |
GOBP XENOPHAGY | 12 | 6.95e-01 | 6.55e-02 | 8.87e-01 |
GOBP WALKING BEHAVIOR | 17 | 6.41e-01 | -6.53e-02 | 8.59e-01 |
GOCC NUCLEAR ENVELOPE | 328 | 4.44e-02 | 6.53e-02 | 2.82e-01 |
GOMF MISMATCHED DNA BINDING | 13 | 6.84e-01 | 6.53e-02 | 8.81e-01 |
GOBP RECEPTOR LOCALIZATION TO SYNAPSE | 22 | 5.97e-01 | 6.52e-02 | 8.36e-01 |
GOBP REGULATION OF CELL ACTIVATION | 340 | 4.11e-02 | -6.52e-02 | 2.71e-01 |
GOCC ACTIN BASED CELL PROJECTION | 93 | 2.79e-01 | -6.52e-02 | 6.22e-01 |
GOBP REGULATION OF HETEROCHROMATIN ORGANIZATION | 18 | 6.33e-01 | 6.51e-02 | 8.56e-01 |
GOCC SPINDLE MICROTUBULE | 52 | 4.17e-01 | -6.51e-02 | 7.30e-01 |
GOCC TRANS GOLGI NETWORK | 168 | 1.48e-01 | -6.51e-02 | 4.81e-01 |
GOBP RNA LOCALIZATION | 169 | 1.47e-01 | 6.50e-02 | 4.80e-01 |
GOBP LEUKOCYTE MEDIATED IMMUNITY | 214 | 1.04e-01 | -6.50e-02 | 4.15e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION | 11 | 7.09e-01 | 6.50e-02 | 8.95e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE | 6 | 7.83e-01 | -6.49e-02 | 9.27e-01 |
GOBP ADAPTATION OF SIGNALING PATHWAY | 7 | 7.66e-01 | -6.49e-02 | 9.20e-01 |
GOBP PEPTIDYL SERINE MODIFICATION | 179 | 1.37e-01 | -6.49e-02 | 4.65e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 296 | 5.75e-02 | -6.48e-02 | 3.13e-01 |
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION | 153 | 1.69e-01 | -6.48e-02 | 5.10e-01 |
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION | 91 | 2.87e-01 | -6.48e-02 | 6.29e-01 |
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING | 60 | 3.86e-01 | 6.48e-02 | 7.07e-01 |
GOBP CELL FATE SPECIFICATION | 25 | 5.76e-01 | 6.47e-02 | 8.24e-01 |
GOBP KIDNEY EPITHELIUM DEVELOPMENT | 35 | 5.08e-01 | 6.47e-02 | 7.86e-01 |
GOCC NUCLEAR OUTER MEMBRANE | 14 | 6.76e-01 | -6.46e-02 | 8.78e-01 |
GOBP REGULATION OF IMMUNE SYSTEM PROCESS | 781 | 2.80e-03 | -6.46e-02 | 6.62e-02 |
GOBP DENDRITIC CELL CHEMOTAXIS | 10 | 7.24e-01 | -6.46e-02 | 9.00e-01 |
GOBP ACETYL COA METABOLIC PROCESS | 20 | 6.17e-01 | 6.46e-02 | 8.47e-01 |
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION | 121 | 2.22e-01 | -6.46e-02 | 5.74e-01 |
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION | 23 | 5.93e-01 | 6.45e-02 | 8.34e-01 |
GOBP MICROTUBULE ANCHORING | 15 | 6.66e-01 | 6.45e-02 | 8.73e-01 |
GOBP POSITIVE REGULATION OF LIPID TRANSPORT | 27 | 5.63e-01 | 6.44e-02 | 8.17e-01 |
GOBP MITOTIC CELL CYCLE PROCESS | 498 | 1.55e-02 | 6.44e-02 | 1.67e-01 |
GOBP T CELL DIFFERENTIATION IN THYMUS | 47 | 4.46e-01 | -6.44e-02 | 7.47e-01 |
GOBP ENDOCARDIUM DEVELOPMENT | 5 | 8.03e-01 | 6.44e-02 | 9.35e-01 |
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE | 11 | 7.12e-01 | 6.44e-02 | 8.96e-01 |
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 9 | 7.38e-01 | 6.44e-02 | 9.06e-01 |
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 22 | 6.01e-01 | 6.44e-02 | 8.38e-01 |
GOBP CELLULAR RESPONSE TO LIPID | 281 | 6.60e-02 | -6.43e-02 | 3.37e-01 |
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS | 307 | 5.51e-02 | -6.43e-02 | 3.05e-01 |
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS | 6 | 7.85e-01 | 6.43e-02 | 9.28e-01 |
GOBP DENDRITIC TRANSPORT | 9 | 7.39e-01 | 6.43e-02 | 9.06e-01 |
GOBP ALDEHYDE BIOSYNTHETIC PROCESS | 5 | 8.04e-01 | 6.42e-02 | 9.35e-01 |
GOMF TAU PROTEIN BINDING | 33 | 5.24e-01 | -6.42e-02 | 7.96e-01 |
GOBP REGULATION OF METAL ION TRANSPORT | 135 | 2.00e-01 | -6.41e-02 | 5.48e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION | 9 | 7.39e-01 | -6.41e-02 | 9.06e-01 |
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION | 36 | 5.06e-01 | 6.41e-02 | 7.86e-01 |
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST | 9 | 7.39e-01 | -6.41e-02 | 9.06e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL | 5 | 8.04e-01 | -6.40e-02 | 9.36e-01 |
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT | 12 | 7.02e-01 | 6.39e-02 | 8.91e-01 |
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX | 5 | 8.05e-01 | 6.39e-02 | 9.36e-01 |
GOMF CYCLIC NUCLEOTIDE BINDING | 12 | 7.02e-01 | 6.38e-02 | 8.91e-01 |
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC | 86 | 3.08e-01 | 6.37e-02 | 6.48e-01 |
GOBP MEMBRANE LIPID CATABOLIC PROCESS | 14 | 6.80e-01 | -6.37e-02 | 8.79e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION | 85 | 3.12e-01 | -6.37e-02 | 6.49e-01 |
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE | 5 | 8.06e-01 | -6.36e-02 | 9.37e-01 |
GOMF LIPASE INHIBITOR ACTIVITY | 7 | 7.71e-01 | 6.35e-02 | 9.23e-01 |
GOBP MESODERM DEVELOPMENT | 44 | 4.67e-01 | -6.35e-02 | 7.62e-01 |
GOBP CELLULAR RESPONSE TO PEPTIDE | 191 | 1.33e-01 | -6.35e-02 | 4.60e-01 |
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE | 14 | 6.81e-01 | -6.35e-02 | 8.80e-01 |
GOBP RAS PROTEIN SIGNAL TRANSDUCTION | 194 | 1.31e-01 | -6.34e-02 | 4.58e-01 |
GOBP RESPONSE TO PEPTIDE | 248 | 8.84e-02 | -6.33e-02 | 3.86e-01 |
GOBP RETICULOPHAGY | 15 | 6.71e-01 | 6.33e-02 | 8.75e-01 |
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY | 17 | 6.51e-01 | 6.33e-02 | 8.65e-01 |
GOBP POSITIVE REGULATION OF T CELL MIGRATION | 20 | 6.24e-01 | -6.33e-02 | 8.51e-01 |
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER | 29 | 5.56e-01 | -6.32e-02 | 8.14e-01 |
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 28 | 5.63e-01 | -6.32e-02 | 8.17e-01 |
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS | 40 | 4.90e-01 | -6.32e-02 | 7.76e-01 |
GOBP GLYCOPROTEIN CATABOLIC PROCESS | 17 | 6.53e-01 | -6.31e-02 | 8.66e-01 |
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 7.73e-01 | -6.31e-02 | 9.24e-01 |
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS | 17 | 6.54e-01 | 6.29e-02 | 8.66e-01 |
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY | 51 | 4.38e-01 | -6.29e-02 | 7.41e-01 |
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION | 6 | 7.90e-01 | 6.29e-02 | 9.30e-01 |
GOBP HISTAMINE SECRETION | 10 | 7.31e-01 | -6.29e-02 | 9.04e-01 |
GOBP HISTAMINE TRANSPORT | 10 | 7.31e-01 | -6.29e-02 | 9.04e-01 |
GOBP TRANSPOSITION | 10 | 7.31e-01 | 6.28e-02 | 9.04e-01 |
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND | 328 | 5.33e-02 | -6.28e-02 | 3.01e-01 |
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE | 5 | 8.08e-01 | 6.28e-02 | 9.37e-01 |
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY | 5 | 8.08e-01 | 6.28e-02 | 9.37e-01 |
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 144 | 1.96e-01 | 6.27e-02 | 5.43e-01 |
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION | 556 | 1.31e-02 | -6.27e-02 | 1.50e-01 |
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS | 127 | 2.24e-01 | 6.27e-02 | 5.75e-01 |
GOBP VIRAL RNA GENOME REPLICATION | 22 | 6.11e-01 | 6.26e-02 | 8.45e-01 |
GOMF RNA POLYMERASE CORE ENZYME BINDING | 36 | 5.16e-01 | -6.26e-02 | 7.90e-01 |
GOCC PHOTORECEPTOR CONNECTING CILIUM | 17 | 6.55e-01 | -6.26e-02 | 8.66e-01 |
GOBP RESPONSE TO UV | 102 | 2.77e-01 | 6.25e-02 | 6.20e-01 |
GOCC SYNAPSE | 597 | 1.07e-02 | -6.24e-02 | 1.37e-01 |
GOMF DNA BINDING BENDING | 11 | 7.21e-01 | 6.23e-02 | 8.99e-01 |
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 545 | 1.47e-02 | -6.23e-02 | 1.61e-01 |
GOCC APICAL JUNCTION COMPLEX | 53 | 4.34e-01 | -6.23e-02 | 7.39e-01 |
GOBP B CELL DIFFERENTIATION | 97 | 2.91e-01 | -6.22e-02 | 6.33e-01 |
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 172 | 1.62e-01 | -6.22e-02 | 5.00e-01 |
GOBP PEPTIDYL TYROSINE MODIFICATION | 118 | 2.45e-01 | -6.22e-02 | 5.92e-01 |
GOMF GTPASE ACTIVATOR ACTIVITY | 146 | 1.97e-01 | -6.21e-02 | 5.45e-01 |
GOBP MICROTUBULE BASED TRANSPORT | 120 | 2.42e-01 | -6.21e-02 | 5.90e-01 |
GOBP RESPONSE TO AMINE | 18 | 6.49e-01 | -6.21e-02 | 8.63e-01 |
GOBP COPII COATED VESICLE CARGO LOADING | 15 | 6.78e-01 | -6.20e-02 | 8.79e-01 |
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY | 5 | 8.10e-01 | 6.20e-02 | 9.39e-01 |
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 8 | 7.61e-01 | -6.20e-02 | 9.17e-01 |
GOBP REGULATION OF PHOSPHORYLATION | 487 | 2.12e-02 | -6.20e-02 | 1.99e-01 |
GOBP ICOSANOID SECRETION | 10 | 7.35e-01 | 6.20e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE | 59 | 4.11e-01 | 6.19e-02 | 7.27e-01 |
GOBP HEXOSE CATABOLIC PROCESS | 19 | 6.40e-01 | 6.19e-02 | 8.59e-01 |
GOCC INCLUSION BODY | 46 | 4.69e-01 | 6.19e-02 | 7.64e-01 |
GOBP MITOTIC CELL CYCLE | 581 | 1.25e-02 | 6.19e-02 | 1.46e-01 |
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 10 | 7.35e-01 | 6.18e-02 | 9.05e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 36 | 5.22e-01 | 6.17e-02 | 7.94e-01 |
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 21 | 6.25e-01 | -6.16e-02 | 8.51e-01 |
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY | 29 | 5.67e-01 | 6.16e-02 | 8.19e-01 |
GOMF TRANSCRIPTION FACTOR BINDING | 398 | 3.77e-02 | -6.15e-02 | 2.62e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION | 31 | 5.54e-01 | -6.15e-02 | 8.14e-01 |
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION | 6 | 7.94e-01 | 6.14e-02 | 9.33e-01 |
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC | 10 | 7.37e-01 | -6.14e-02 | 9.06e-01 |
GOCC RECYCLING ENDOSOME | 118 | 2.51e-01 | -6.14e-02 | 5.96e-01 |
GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS | 5 | 8.12e-01 | 6.14e-02 | 9.40e-01 |
GOBP NEGATIVE REGULATION OF ERAD PATHWAY | 5 | 8.12e-01 | -6.14e-02 | 9.40e-01 |
GOCC NUCLEAR PERIPHERY | 110 | 2.68e-01 | 6.13e-02 | 6.12e-01 |
GOBP RIG I SIGNALING PATHWAY | 19 | 6.44e-01 | 6.13e-02 | 8.61e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 94 | 3.06e-01 | 6.12e-02 | 6.47e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 478 | 2.42e-02 | -6.12e-02 | 2.14e-01 |
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY | 21 | 6.28e-01 | -6.12e-02 | 8.53e-01 |
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY | 6 | 7.95e-01 | 6.11e-02 | 9.33e-01 |
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 6 | 7.96e-01 | -6.11e-02 | 9.33e-01 |
GOMF ADENYL NUCLEOTIDE BINDING | 934 | 2.20e-03 | 6.11e-02 | 5.69e-02 |
GOBP TORC1 SIGNALING | 77 | 3.55e-01 | -6.11e-02 | 6.86e-01 |
GOBP RIBONUCLEOTIDE CATABOLIC PROCESS | 24 | 6.05e-01 | 6.10e-02 | 8.41e-01 |
GOBP MONOATOMIC ION HOMEOSTASIS | 254 | 9.67e-02 | 6.10e-02 | 4.03e-01 |
GOBP HORMONE METABOLIC PROCESS | 55 | 4.35e-01 | 6.10e-02 | 7.39e-01 |
GOBP RESPONSE TO SALT | 153 | 1.95e-01 | -6.10e-02 | 5.42e-01 |
GOBP RETROGRADE AXONAL TRANSPORT | 12 | 7.15e-01 | -6.10e-02 | 8.97e-01 |
GOCC CAVEOLA | 35 | 5.33e-01 | -6.09e-02 | 8.03e-01 |
GOCC CYTOPLASMIC REGION | 118 | 2.55e-01 | -6.09e-02 | 5.97e-01 |
GOBP PHOSPHORYLATION | 794 | 4.52e-03 | -6.09e-02 | 8.48e-02 |
GOMF S ADENOSYL L METHIONINE BINDING | 12 | 7.16e-01 | 6.07e-02 | 8.98e-01 |
GOMF SULFURIC ESTER HYDROLASE ACTIVITY | 5 | 8.14e-01 | -6.07e-02 | 9.40e-01 |
GOBP REGULATION OF B CELL MEDIATED IMMUNITY | 34 | 5.41e-01 | 6.07e-02 | 8.05e-01 |
GOBP ACTIN FILAMENT DEPOLYMERIZATION | 35 | 5.35e-01 | 6.06e-02 | 8.03e-01 |
GOBP PROTEIN DEACETYLATION | 40 | 5.07e-01 | 6.06e-02 | 7.86e-01 |
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY | 22 | 6.23e-01 | 6.06e-02 | 8.51e-01 |
GOMF METHYLATION DEPENDENT PROTEIN BINDING | 60 | 4.18e-01 | 6.06e-02 | 7.30e-01 |
GOBP MAINTENANCE OF CELL NUMBER | 117 | 2.60e-01 | -6.06e-02 | 6.03e-01 |
GOBP REGULATION OF GLIAL CELL MIGRATION | 12 | 7.17e-01 | 6.06e-02 | 8.98e-01 |
GOBP LIMBIC SYSTEM DEVELOPMENT | 45 | 4.83e-01 | -6.06e-02 | 7.73e-01 |
GOBP REGULATION OF HORMONE LEVELS | 161 | 1.88e-01 | -6.05e-02 | 5.34e-01 |
GOBP REGULATION OF NEUROGENESIS | 155 | 1.96e-01 | -6.05e-02 | 5.43e-01 |
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION | 51 | 4.56e-01 | -6.04e-02 | 7.54e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING | 5 | 8.15e-01 | 6.04e-02 | 9.40e-01 |
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 15 | 6.86e-01 | 6.04e-02 | 8.82e-01 |
GOBP REGULATION OF CELL MORPHOGENESIS | 128 | 2.40e-01 | -6.04e-02 | 5.89e-01 |
GOBP RNA PROCESSING | 747 | 6.30e-03 | 6.02e-02 | 1.01e-01 |
GOBP MEMBRANE FUSION | 102 | 2.95e-01 | 6.02e-02 | 6.37e-01 |
GOBP MULTICELLULAR ORGANISMAL MOVEMENT | 17 | 6.68e-01 | -6.01e-02 | 8.73e-01 |
GOCC ACTIN FILAMENT | 57 | 4.33e-01 | -6.01e-02 | 7.39e-01 |
GOBP HYPOTHALAMUS DEVELOPMENT | 6 | 7.99e-01 | -6.01e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS | 24 | 6.11e-01 | 6.01e-02 | 8.44e-01 |
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 38 | 5.22e-01 | 6.01e-02 | 7.94e-01 |
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL | 15 | 6.88e-01 | -6.00e-02 | 8.83e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 116 | 2.67e-01 | -5.99e-02 | 6.11e-01 |
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS | 11 | 7.31e-01 | 5.98e-02 | 9.04e-01 |
GOBP ADAPTIVE IMMUNE RESPONSE | 255 | 1.03e-01 | -5.98e-02 | 4.13e-01 |
GOBP LINOLEIC ACID METABOLIC PROCESS | 7 | 7.84e-01 | -5.98e-02 | 9.28e-01 |
GOBP PLASMA MEMBRANE ORGANIZATION | 73 | 3.78e-01 | -5.98e-02 | 7.04e-01 |
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS | 118 | 2.65e-01 | 5.96e-02 | 6.09e-01 |
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 80 | 3.58e-01 | -5.96e-02 | 6.87e-01 |
GOCC CILIARY TRANSITION ZONE | 31 | 5.66e-01 | -5.96e-02 | 8.19e-01 |
GOBP REGULATION OF TOLERANCE INDUCTION | 7 | 7.85e-01 | 5.96e-02 | 9.28e-01 |
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY | 60 | 4.26e-01 | -5.96e-02 | 7.34e-01 |
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS | 145 | 2.18e-01 | 5.96e-02 | 5.71e-01 |
GOMF PALMITOYLTRANSFERASE ACTIVITY | 21 | 6.37e-01 | -5.96e-02 | 8.57e-01 |
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY | 6 | 8.01e-01 | -5.95e-02 | 9.34e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY | 11 | 7.33e-01 | 5.95e-02 | 9.04e-01 |
GOBP LYMPHOCYTE CHEMOTAXIS | 18 | 6.62e-01 | -5.95e-02 | 8.71e-01 |
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY | 6 | 8.01e-01 | 5.95e-02 | 9.34e-01 |
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 65 | 4.08e-01 | -5.95e-02 | 7.23e-01 |
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION | 10 | 7.45e-01 | 5.94e-02 | 9.09e-01 |
GOCC NEURON TO NEURON SYNAPSE | 143 | 2.22e-01 | -5.94e-02 | 5.74e-01 |
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 30 | 5.74e-01 | 5.94e-02 | 8.23e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS | 387 | 4.80e-02 | -5.93e-02 | 2.87e-01 |
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS | 56 | 4.44e-01 | 5.93e-02 | 7.46e-01 |
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT | 8 | 7.72e-01 | -5.92e-02 | 9.24e-01 |
GOCC ANAPHASE PROMOTING COMPLEX | 16 | 6.82e-01 | 5.92e-02 | 8.81e-01 |
GOBP RESPONSE TO LIPID | 408 | 4.30e-02 | -5.92e-02 | 2.77e-01 |
GOBP INOSITOL METABOLIC PROCESS | 6 | 8.02e-01 | -5.92e-02 | 9.35e-01 |
GOBP LYSOSOMAL LUMEN ACIDIFICATION | 22 | 6.31e-01 | 5.91e-02 | 8.55e-01 |
GOBP REGULATION OF RESPONSE TO STRESS | 792 | 5.92e-03 | -5.91e-02 | 9.77e-02 |
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 532 | 2.20e-02 | -5.91e-02 | 2.04e-01 |
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS | 88 | 3.39e-01 | 5.91e-02 | 6.75e-01 |
GOCC PRESYNAPSE | 217 | 1.37e-01 | -5.90e-02 | 4.65e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR | 9 | 7.59e-01 | 5.90e-02 | 9.16e-01 |
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION | 44 | 4.99e-01 | -5.90e-02 | 7.80e-01 |
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION | 288 | 8.80e-02 | 5.90e-02 | 3.86e-01 |
GOBP NEURON APOPTOTIC PROCESS | 141 | 2.29e-01 | -5.90e-02 | 5.78e-01 |
GOBP POSITIVE REGULATION OF PROTEIN SECRETION | 57 | 4.43e-01 | -5.89e-02 | 7.45e-01 |
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 89 | 3.39e-01 | -5.88e-02 | 6.75e-01 |
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 37 | 5.36e-01 | -5.88e-02 | 8.04e-01 |
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY | 25 | 6.12e-01 | 5.87e-02 | 8.45e-01 |
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION | 28 | 5.92e-01 | 5.86e-02 | 8.34e-01 |
GOBP SKIN DEVELOPMENT | 85 | 3.52e-01 | -5.85e-02 | 6.83e-01 |
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION | 18 | 6.68e-01 | -5.85e-02 | 8.73e-01 |
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY | 50 | 4.75e-01 | 5.85e-02 | 7.69e-01 |
GOBP PROTEIN EXPORT FROM NUCLEUS | 46 | 4.94e-01 | -5.83e-02 | 7.79e-01 |
GOBP HISTONE METHYLATION | 33 | 5.63e-01 | -5.83e-02 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF AUTOPHAGY | 65 | 4.17e-01 | -5.83e-02 | 7.30e-01 |
GOCC GERM CELL NUCLEUS | 34 | 5.57e-01 | 5.82e-02 | 8.15e-01 |
GOBP IMPORT INTO CELL | 434 | 4.04e-02 | -5.82e-02 | 2.69e-01 |
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS | 50 | 4.78e-01 | 5.81e-02 | 7.71e-01 |
GOBP NOTCH SIGNALING PATHWAY | 70 | 4.02e-01 | -5.81e-02 | 7.20e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 46 | 4.96e-01 | 5.81e-02 | 7.79e-01 |
GOCC DENDRITIC SHAFT | 13 | 7.17e-01 | 5.80e-02 | 8.98e-01 |
GOMF EXOPEPTIDASE ACTIVITY | 52 | 4.70e-01 | 5.80e-02 | 7.66e-01 |
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS | 16 | 6.88e-01 | -5.80e-02 | 8.83e-01 |
GOCC CENTRIOLAR SATELLITE | 72 | 3.96e-01 | -5.79e-02 | 7.16e-01 |
GOBP REGULATION OF MITOTIC CELL CYCLE | 322 | 7.70e-02 | 5.79e-02 | 3.64e-01 |
GOMF ANGIOTENSIN RECEPTOR BINDING | 5 | 8.23e-01 | -5.79e-02 | 9.43e-01 |
GOBP PROTEIN LOCALIZATION TO ORGANELLE | 653 | 1.36e-02 | 5.79e-02 | 1.54e-01 |
GOBP RESPONSE TO CADMIUM ION | 32 | 5.71e-01 | 5.79e-02 | 8.21e-01 |
GOBP CARBOHYDRATE HOMEOSTASIS | 99 | 3.22e-01 | -5.78e-02 | 6.59e-01 |
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY | 62 | 4.32e-01 | -5.78e-02 | 7.39e-01 |
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING | 21 | 6.47e-01 | 5.78e-02 | 8.63e-01 |
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY | 12 | 7.29e-01 | 5.77e-02 | 9.03e-01 |
GOBP CELLULAR RESPONSE TO GAMMA RADIATION | 20 | 6.55e-01 | 5.77e-02 | 8.66e-01 |
GOMF CALCIUM DEPENDENT PROTEIN BINDING | 35 | 5.56e-01 | 5.76e-02 | 8.14e-01 |
GOBP GERMINAL CENTER B CELL DIFFERENTIATION | 6 | 8.07e-01 | -5.76e-02 | 9.37e-01 |
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY | 21 | 6.48e-01 | 5.76e-02 | 8.63e-01 |
GOBP NEURAL TUBE DEVELOPMENT | 74 | 3.93e-01 | 5.76e-02 | 7.12e-01 |
GOBP LIPID EXPORT FROM CELL | 14 | 7.10e-01 | 5.75e-02 | 8.95e-01 |
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE | 11 | 7.41e-01 | -5.75e-02 | 9.07e-01 |
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 198 | 1.66e-01 | -5.75e-02 | 5.05e-01 |
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 124 | 2.71e-01 | -5.75e-02 | 6.16e-01 |
GOBP POST ANAL TAIL MORPHOGENESIS | 6 | 8.08e-01 | -5.74e-02 | 9.37e-01 |
GOBP NEGATIVE REGULATION OF RNA SPLICING | 23 | 6.34e-01 | 5.74e-02 | 8.56e-01 |
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS | 7 | 7.93e-01 | -5.73e-02 | 9.32e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS | 41 | 5.26e-01 | 5.73e-02 | 7.97e-01 |
GOBP GLANDULAR EPITHELIAL CELL MATURATION | 5 | 8.25e-01 | 5.73e-02 | 9.43e-01 |
GOBP 5 PHOSPHORIBOSE 1 DIPHOSPHATE METABOLIC PROCESS | 5 | 8.25e-01 | 5.72e-02 | 9.43e-01 |
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 67 | 4.19e-01 | -5.72e-02 | 7.31e-01 |
GOBP MACROMOLECULE DEACYLATION | 49 | 4.90e-01 | 5.72e-02 | 7.76e-01 |
GOMF KINASE ACTIVITY | 422 | 4.72e-02 | -5.71e-02 | 2.85e-01 |
GOBP REGULATORY T CELL DIFFERENTIATION | 20 | 6.59e-01 | -5.71e-02 | 8.69e-01 |
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS | 185 | 1.83e-01 | -5.71e-02 | 5.29e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 122 | 2.78e-01 | -5.71e-02 | 6.22e-01 |
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE | 14 | 7.12e-01 | 5.71e-02 | 8.96e-01 |
GOBP PROTEIN RNA COMPLEX ORGANIZATION | 177 | 1.93e-01 | 5.70e-02 | 5.40e-01 |
GOBP COCHLEA DEVELOPMENT | 10 | 7.55e-01 | -5.70e-02 | 9.14e-01 |
GOBP MYELOID LEUKOCYTE DIFFERENTIATION | 124 | 2.75e-01 | -5.70e-02 | 6.19e-01 |
GOBP LEUKOCYTE HOMEOSTASIS | 71 | 4.08e-01 | -5.70e-02 | 7.23e-01 |
GOBP LABYRINTHINE LAYER MORPHOGENESIS | 7 | 7.95e-01 | -5.67e-02 | 9.33e-01 |
GOBP SPHINGOLIPID CATABOLIC PROCESS | 13 | 7.23e-01 | -5.67e-02 | 9.00e-01 |
GOBP REGULATION OF GTPASE ACTIVITY | 145 | 2.41e-01 | -5.67e-02 | 5.89e-01 |
GOBP VESICLE TETHERING TO GOLGI | 5 | 8.26e-01 | 5.67e-02 | 9.43e-01 |
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA | 17 | 6.86e-01 | -5.67e-02 | 8.82e-01 |
GOMF PROTEIN PHOSPHATASE 2A BINDING | 20 | 6.61e-01 | -5.67e-02 | 8.70e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 75 | 3.97e-01 | -5.67e-02 | 7.17e-01 |
GOBP CHROMOSOME LOCALIZATION | 79 | 3.85e-01 | 5.66e-02 | 7.06e-01 |
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY | 9 | 7.69e-01 | 5.66e-02 | 9.22e-01 |
GOBP REGULATION OF CYTOSKELETON ORGANIZATION | 264 | 1.17e-01 | -5.65e-02 | 4.39e-01 |
GOMF PHOSPHOLIPASE ACTIVITY | 30 | 5.93e-01 | -5.65e-02 | 8.34e-01 |
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS | 228 | 1.45e-01 | -5.65e-02 | 4.77e-01 |
GOBP ACID SECRETION | 7 | 7.96e-01 | -5.65e-02 | 9.33e-01 |
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS | 5 | 8.27e-01 | -5.65e-02 | 9.43e-01 |
GOBP POST FERTILIZATION EPIGENETIC REGULATION OF GENE EXPRESSION | 9 | 7.70e-01 | 5.64e-02 | 9.23e-01 |
GOBP RESPONSE TO ZINC ION | 16 | 6.96e-01 | -5.64e-02 | 8.88e-01 |
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION | 7 | 7.96e-01 | 5.64e-02 | 9.33e-01 |
GOBP CARDIAC CONDUCTION | 27 | 6.13e-01 | 5.63e-02 | 8.45e-01 |
GOBP DEMETHYLATION | 30 | 5.94e-01 | -5.63e-02 | 8.34e-01 |
GOBP INTERSTRAND CROSS LINK REPAIR | 21 | 6.55e-01 | 5.63e-02 | 8.66e-01 |
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION | 733 | 1.14e-02 | -5.63e-02 | 1.40e-01 |
GOBP PROTEIN LIPID COMPLEX ORGANIZATION | 17 | 6.88e-01 | -5.62e-02 | 8.83e-01 |
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 7 | 7.97e-01 | -5.62e-02 | 9.33e-01 |
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS | 13 | 7.26e-01 | 5.61e-02 | 9.02e-01 |
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY | 10 | 7.59e-01 | -5.61e-02 | 9.16e-01 |
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT | 44 | 5.21e-01 | -5.60e-02 | 7.93e-01 |
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION | 7 | 7.98e-01 | -5.60e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION | 27 | 6.15e-01 | -5.59e-02 | 8.47e-01 |
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY | 63 | 4.45e-01 | 5.58e-02 | 7.46e-01 |
GOBP RESPONSE TO SALT STRESS | 12 | 7.38e-01 | -5.58e-02 | 9.06e-01 |
GOBP RESPONSE TO MUSCLE ACTIVITY | 9 | 7.72e-01 | 5.58e-02 | 9.24e-01 |
GOCC GTPASE ACTIVATOR COMPLEX | 10 | 7.60e-01 | -5.58e-02 | 9.17e-01 |
GOMF PHOSPHOLIPID TRANSFER ACTIVITY | 13 | 7.28e-01 | -5.57e-02 | 9.03e-01 |
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX | 9 | 7.72e-01 | 5.57e-02 | 9.24e-01 |
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION | 5 | 8.29e-01 | 5.57e-02 | 9.43e-01 |
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS | 93 | 3.55e-01 | -5.57e-02 | 6.85e-01 |
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 172 | 2.11e-01 | -5.56e-02 | 5.59e-01 |
GOMF RRNA BINDING | 57 | 4.68e-01 | 5.56e-02 | 7.64e-01 |
GOBP CD40 SIGNALING PATHWAY | 12 | 7.39e-01 | 5.56e-02 | 9.06e-01 |
GOBP REGULATION OF MACROPHAGE ACTIVATION | 25 | 6.31e-01 | -5.56e-02 | 8.54e-01 |
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING | 32 | 5.87e-01 | -5.56e-02 | 8.31e-01 |
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 43 | 5.29e-01 | 5.56e-02 | 8.00e-01 |
GOBP L ALANINE TRANSPORT | 5 | 8.30e-01 | -5.56e-02 | 9.43e-01 |
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION | 15 | 7.10e-01 | -5.56e-02 | 8.95e-01 |
GOCC MHC CLASS II PROTEIN COMPLEX | 14 | 7.19e-01 | -5.55e-02 | 8.99e-01 |
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION | 537 | 3.07e-02 | -5.55e-02 | 2.38e-01 |
GOBP REGULATION OF EXTENT OF CELL GROWTH | 41 | 5.40e-01 | 5.54e-02 | 8.04e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING | 13 | 7.30e-01 | -5.54e-02 | 9.03e-01 |
GOBP CALCIUM ION HOMEOSTASIS | 127 | 2.83e-01 | 5.54e-02 | 6.25e-01 |
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING | 19 | 6.77e-01 | 5.53e-02 | 8.78e-01 |
GOBP PROTEIN NEDDYLATION | 23 | 6.46e-01 | -5.53e-02 | 8.63e-01 |
GOBP INSULIN RECEPTOR SIGNALING PATHWAY | 76 | 4.06e-01 | -5.53e-02 | 7.22e-01 |
GOMF GROWTH FACTOR BINDING | 37 | 5.61e-01 | -5.52e-02 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 10 | 7.62e-01 | -5.52e-02 | 9.18e-01 |
GOBP PROTEIN TO MEMBRANE DOCKING | 5 | 8.31e-01 | -5.52e-02 | 9.43e-01 |
GOBP REGULATION OF REPRODUCTIVE PROCESS | 67 | 4.36e-01 | 5.51e-02 | 7.40e-01 |
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS | 82 | 3.91e-01 | -5.50e-02 | 7.11e-01 |
GOBP EXTRACELLULAR MATRIX ASSEMBLY | 9 | 7.76e-01 | -5.49e-02 | 9.25e-01 |
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT | 43 | 5.34e-01 | 5.48e-02 | 8.03e-01 |
GOBP DETERMINATION OF ADULT LIFESPAN | 18 | 6.87e-01 | -5.48e-02 | 8.83e-01 |
GOBP MHC CLASS II BIOSYNTHETIC PROCESS | 11 | 7.53e-01 | 5.48e-02 | 9.13e-01 |
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION | 50 | 5.04e-01 | 5.47e-02 | 7.84e-01 |
GOBP ENDOCYTOSIS | 373 | 7.34e-02 | -5.47e-02 | 3.58e-01 |
GOBP RNA SECONDARY STRUCTURE UNWINDING | 8 | 7.89e-01 | 5.47e-02 | 9.29e-01 |
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 6.97e-01 | 5.47e-02 | 8.88e-01 |
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY | 10 | 7.65e-01 | 5.46e-02 | 9.19e-01 |
GOCC IMMUNOGLOBULIN COMPLEX | 42 | 5.41e-01 | -5.46e-02 | 8.05e-01 |
GOBP REGULATION OF CELL SUBSTRATE ADHESION | 96 | 3.57e-01 | -5.46e-02 | 6.87e-01 |
GOBP RESPONSE TO OSMOTIC STRESS | 52 | 4.97e-01 | -5.46e-02 | 7.79e-01 |
GOMF ALKALI METAL ION BINDING | 8 | 7.90e-01 | -5.44e-02 | 9.30e-01 |
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS | 27 | 6.25e-01 | 5.44e-02 | 8.51e-01 |
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION | 17 | 6.98e-01 | -5.44e-02 | 8.88e-01 |
GOBP REGULATION OF MUSCLE CONTRACTION | 53 | 4.94e-01 | 5.44e-02 | 7.79e-01 |
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 13 | 7.34e-01 | 5.44e-02 | 9.05e-01 |
GOBP CYTOKINESIS | 117 | 3.12e-01 | 5.43e-02 | 6.50e-01 |
GOBP MICROTUBULE DEPOLYMERIZATION | 20 | 6.75e-01 | 5.43e-02 | 8.78e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 37 | 5.69e-01 | -5.42e-02 | 8.20e-01 |
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY | 5 | 8.34e-01 | -5.41e-02 | 9.46e-01 |
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY | 53 | 4.96e-01 | -5.41e-02 | 7.79e-01 |
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION | 176 | 2.19e-01 | -5.41e-02 | 5.71e-01 |
GOBP REGULATION OF MRNA PROCESSING | 98 | 3.57e-01 | -5.41e-02 | 6.86e-01 |
GOBP CELLULAR RESPONSE TO KETONE | 47 | 5.22e-01 | 5.40e-02 | 7.94e-01 |
GOMF PROTEIN DOMAIN SPECIFIC BINDING | 391 | 7.04e-02 | -5.40e-02 | 3.50e-01 |
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS | 519 | 3.86e-02 | -5.40e-02 | 2.65e-01 |
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS | 20 | 6.76e-01 | -5.40e-02 | 8.78e-01 |
GOBP AMINE METABOLIC PROCESS | 41 | 5.51e-01 | -5.39e-02 | 8.12e-01 |
GOMF ZINC ION BINDING | 427 | 5.97e-02 | -5.39e-02 | 3.20e-01 |
GOMF AMINOACYLTRANSFERASE ACTIVITY | 297 | 1.14e-01 | -5.38e-02 | 4.34e-01 |
GOBP REGULATION OF PROTEOLYSIS | 348 | 8.83e-02 | -5.38e-02 | 3.86e-01 |
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS | 17 | 7.01e-01 | -5.38e-02 | 8.91e-01 |
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 41 | 5.52e-01 | -5.37e-02 | 8.13e-01 |
GOBP PROTEIN COMPLEX OLIGOMERIZATION | 121 | 3.10e-01 | 5.37e-02 | 6.49e-01 |
GOBP SENSORY ORGAN DEVELOPMENT | 163 | 2.40e-01 | -5.36e-02 | 5.89e-01 |
GOBP HINDBRAIN MORPHOGENESIS | 20 | 6.78e-01 | -5.36e-02 | 8.79e-01 |
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 297 | 1.16e-01 | 5.35e-02 | 4.37e-01 |
GOMF NUCLEAR RECEPTOR BINDING | 101 | 3.55e-01 | -5.35e-02 | 6.85e-01 |
GOCC PORE COMPLEX | 16 | 7.12e-01 | 5.34e-02 | 8.96e-01 |
GOBP PEPTIDYL THREONINE MODIFICATION | 63 | 4.65e-01 | -5.33e-02 | 7.62e-01 |
GOBP REGULATION OF PEPTIDASE ACTIVITY | 160 | 2.48e-01 | -5.32e-02 | 5.93e-01 |
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 24 | 6.52e-01 | -5.32e-02 | 8.65e-01 |
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA | 41 | 5.56e-01 | 5.32e-02 | 8.14e-01 |
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION | 14 | 7.31e-01 | -5.31e-02 | 9.04e-01 |
GOMF DEUBIQUITINASE ACTIVITY | 73 | 4.35e-01 | -5.30e-02 | 7.39e-01 |
GOBP EXTRACELLULAR VESICLE BIOGENESIS | 20 | 6.82e-01 | -5.30e-02 | 8.81e-01 |
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 211 | 1.88e-01 | 5.29e-02 | 5.34e-01 |
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS | 14 | 7.32e-01 | 5.29e-02 | 9.04e-01 |
GOBP MRNA PSEUDOURIDINE SYNTHESIS | 6 | 8.23e-01 | 5.28e-02 | 9.43e-01 |
GOBP SELECTIVE AUTOPHAGY | 74 | 4.34e-01 | 5.28e-02 | 7.39e-01 |
GOBP INTESTINAL LIPID ABSORPTION | 6 | 8.23e-01 | 5.28e-02 | 9.43e-01 |
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION | 5 | 8.38e-01 | -5.27e-02 | 9.47e-01 |
GOBP REGULATION OF PROTEIN SUMOYLATION | 15 | 7.24e-01 | -5.26e-02 | 9.00e-01 |
GOBP MUSCLE ORGAN MORPHOGENESIS | 17 | 7.07e-01 | -5.26e-02 | 8.94e-01 |
GOBP POST EMBRYONIC ANIMAL ORGAN MORPHOGENESIS | 5 | 8.39e-01 | 5.26e-02 | 9.47e-01 |
GOBP CARDIAC CHAMBER DEVELOPMENT | 50 | 5.21e-01 | -5.26e-02 | 7.93e-01 |
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK | 679 | 2.27e-02 | 5.25e-02 | 2.08e-01 |
GOBP NEUROTRANSMITTER UPTAKE | 10 | 7.74e-01 | 5.25e-02 | 9.24e-01 |
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 52 | 5.13e-01 | -5.25e-02 | 7.88e-01 |
GOBP POSITIVE REGULATION OF DNA RECOMBINATION | 51 | 5.17e-01 | 5.25e-02 | 7.91e-01 |
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS | 210 | 1.93e-01 | 5.25e-02 | 5.39e-01 |
GOBP REGULATION OF ORGANELLE ASSEMBLY | 160 | 2.55e-01 | -5.25e-02 | 5.97e-01 |
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 51 | 5.18e-01 | 5.24e-02 | 7.91e-01 |
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE | 6 | 8.24e-01 | -5.24e-02 | 9.43e-01 |
GOBP CORPUS CALLOSUM DEVELOPMENT | 13 | 7.44e-01 | -5.24e-02 | 9.08e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL | 11 | 7.64e-01 | -5.23e-02 | 9.19e-01 |
GOBP CELL MIGRATION IN HINDBRAIN | 6 | 8.24e-01 | -5.23e-02 | 9.43e-01 |
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 17 | 7.09e-01 | 5.23e-02 | 8.95e-01 |
GOBP RIBOSOME ASSEMBLY | 52 | 5.15e-01 | 5.23e-02 | 7.90e-01 |
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION | 5 | 8.40e-01 | -5.22e-02 | 9.48e-01 |
GOBP REGULATION OF CELL PROJECTION ASSEMBLY | 126 | 3.13e-01 | -5.22e-02 | 6.51e-01 |
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY | 5 | 8.40e-01 | -5.22e-02 | 9.48e-01 |
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 128 | 3.10e-01 | -5.22e-02 | 6.49e-01 |
GOBP GAMETE GENERATION | 296 | 1.27e-01 | -5.21e-02 | 4.55e-01 |
GOCC TIGHT JUNCTION | 46 | 5.42e-01 | -5.21e-02 | 8.05e-01 |
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 90 | 3.95e-01 | 5.21e-02 | 7.14e-01 |
GOBP PROTEIN ACYLATION | 103 | 3.63e-01 | -5.20e-02 | 6.90e-01 |
GOCC CELL CORTEX REGION | 18 | 7.03e-01 | 5.19e-02 | 8.92e-01 |
GOBP MAINTENANCE OF LOCATION IN CELL | 123 | 3.22e-01 | 5.19e-02 | 6.59e-01 |
GOBP APOPTOTIC MITOCHONDRIAL CHANGES | 73 | 4.45e-01 | 5.19e-02 | 7.46e-01 |
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS | 27 | 6.41e-01 | 5.18e-02 | 8.59e-01 |
GOCC NUCLEOSOME | 30 | 6.24e-01 | 5.18e-02 | 8.51e-01 |
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS | 9 | 7.88e-01 | -5.18e-02 | 9.29e-01 |
GOBP STEM CELL DEVELOPMENT | 25 | 6.54e-01 | -5.18e-02 | 8.66e-01 |
GOBP MRNA MODIFICATION | 25 | 6.54e-01 | -5.18e-02 | 8.66e-01 |
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY | 13 | 7.47e-01 | 5.17e-02 | 9.10e-01 |
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN | 6 | 8.26e-01 | -5.17e-02 | 9.43e-01 |
GOBP REGULATION OF DNA REPAIR | 159 | 2.63e-01 | 5.17e-02 | 6.07e-01 |
GOCC CLATHRIN VESICLE COAT | 24 | 6.61e-01 | -5.17e-02 | 8.71e-01 |
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY | 6 | 8.27e-01 | -5.16e-02 | 9.43e-01 |
GOBP POLYAMINE BIOSYNTHETIC PROCESS | 10 | 7.78e-01 | -5.16e-02 | 9.25e-01 |
GOBP AMINE BIOSYNTHETIC PROCESS | 17 | 7.13e-01 | -5.15e-02 | 8.96e-01 |
GOBP REGULATION OF GOLGI ORGANIZATION | 13 | 7.48e-01 | 5.15e-02 | 9.10e-01 |
GOBP MITOTIC CELL CYCLE PHASE TRANSITION | 302 | 1.28e-01 | 5.15e-02 | 4.56e-01 |
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS | 201 | 2.11e-01 | -5.15e-02 | 5.60e-01 |
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT | 7 | 8.14e-01 | -5.15e-02 | 9.40e-01 |
GOMF GLUTATHIONE TRANSFERASE ACTIVITY | 13 | 7.48e-01 | 5.14e-02 | 9.10e-01 |
GOCC LATERAL PLASMA MEMBRANE | 25 | 6.57e-01 | -5.14e-02 | 8.67e-01 |
GOBP ACTIVATION OF JANUS KINASE ACTIVITY | 6 | 8.27e-01 | -5.14e-02 | 9.43e-01 |
GOBP RESPONSE TO BACTERIUM | 264 | 1.54e-01 | -5.14e-02 | 4.89e-01 |
GOBP ONE CARBON COMPOUND TRANSPORT | 13 | 7.49e-01 | 5.14e-02 | 9.11e-01 |
GOBP EMBRYONIC PLACENTA DEVELOPMENT | 36 | 5.94e-01 | -5.13e-02 | 8.35e-01 |
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 7 | 8.14e-01 | -5.13e-02 | 9.40e-01 |
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY | 6 | 8.28e-01 | -5.13e-02 | 9.43e-01 |
GOBP SUPRAMOLECULAR FIBER ORGANIZATION | 374 | 9.29e-02 | -5.12e-02 | 3.96e-01 |
GOBP T CELL HOMEOSTASIS | 26 | 6.52e-01 | -5.12e-02 | 8.65e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 22 | 6.78e-01 | -5.12e-02 | 8.79e-01 |
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION | 5 | 8.43e-01 | 5.12e-02 | 9.50e-01 |
GOBP CELL RECOGNITION | 40 | 5.76e-01 | -5.12e-02 | 8.24e-01 |
GOCC RETROMER COMPLEX | 12 | 7.59e-01 | 5.12e-02 | 9.16e-01 |
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION | 26 | 6.52e-01 | -5.12e-02 | 8.65e-01 |
GOCC CILIARY PLASM | 43 | 5.63e-01 | -5.11e-02 | 8.17e-01 |
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE | 104 | 3.70e-01 | -5.10e-02 | 6.97e-01 |
GOBP PROTEIN AUTOUBIQUITINATION | 50 | 5.33e-01 | -5.10e-02 | 8.03e-01 |
GOBP CELL MATURATION | 66 | 4.75e-01 | -5.10e-02 | 7.69e-01 |
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT | 213 | 2.04e-01 | -5.08e-02 | 5.52e-01 |
GOBP POSITIVE REGULATION OF P38MAPK CASCADE | 14 | 7.42e-01 | -5.08e-02 | 9.07e-01 |
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX | 24 | 6.67e-01 | 5.08e-02 | 8.73e-01 |
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION | 62 | 4.90e-01 | -5.08e-02 | 7.76e-01 |
GOMF POLY ADP D RIBOSE BINDING | 6 | 8.30e-01 | 5.08e-02 | 9.43e-01 |
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT | 5 | 8.44e-01 | 5.07e-02 | 9.50e-01 |
GOBP REGULATION OF TRANSFERASE ACTIVITY | 364 | 1.01e-01 | -5.07e-02 | 4.10e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 41 | 5.75e-01 | -5.07e-02 | 8.24e-01 |
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE | 5 | 8.44e-01 | 5.07e-02 | 9.50e-01 |
GOCC PHAGOCYTIC VESICLE MEMBRANE | 55 | 5.17e-01 | 5.07e-02 | 7.90e-01 |
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 10 | 7.82e-01 | -5.06e-02 | 9.26e-01 |
GOMF HORMONE RECEPTOR BINDING | 8 | 8.04e-01 | 5.06e-02 | 9.36e-01 |
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 10 | 7.82e-01 | -5.05e-02 | 9.26e-01 |
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 75 | 4.50e-01 | -5.05e-02 | 7.50e-01 |
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT | 12 | 7.62e-01 | -5.05e-02 | 9.18e-01 |
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION | 7 | 8.17e-01 | 5.05e-02 | 9.41e-01 |
GOBP REGULATION OF MACROAUTOPHAGY | 116 | 3.50e-01 | -5.04e-02 | 6.81e-01 |
GOBP MYELOID CELL DIFFERENTIATION | 245 | 1.78e-01 | -5.04e-02 | 5.24e-01 |
GOBP ZYMOGEN INHIBITION | 6 | 8.31e-01 | 5.03e-02 | 9.43e-01 |
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 62 | 4.94e-01 | -5.03e-02 | 7.79e-01 |
GOBP COLLAGEN METABOLIC PROCESS | 26 | 6.57e-01 | -5.03e-02 | 8.68e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE | 228 | 1.94e-01 | 5.03e-02 | 5.40e-01 |
GOCC CYTOSOLIC REGION | 11 | 7.73e-01 | 5.03e-02 | 9.24e-01 |
GOBP CELL CYCLE PHASE TRANSITION | 365 | 1.03e-01 | 5.03e-02 | 4.14e-01 |
GOBP LIPID HOMEOSTASIS | 64 | 4.88e-01 | -5.02e-02 | 7.76e-01 |
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR | 9 | 7.94e-01 | -5.02e-02 | 9.33e-01 |
GOBP CARBOHYDRATE CATABOLIC PROCESS | 89 | 4.15e-01 | -5.02e-02 | 7.28e-01 |
GOBP MOLTING CYCLE PROCESS | 28 | 6.47e-01 | 5.01e-02 | 8.63e-01 |
GOMF CULLIN FAMILY PROTEIN BINDING | 15 | 7.37e-01 | -5.01e-02 | 9.06e-01 |
GOMF DNA POLYMERASE BINDING | 15 | 7.37e-01 | 5.01e-02 | 9.06e-01 |
GOMF N ACETYLTRANSFERASE ACTIVITY | 49 | 5.45e-01 | -5.01e-02 | 8.08e-01 |
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS | 5 | 8.46e-01 | -5.00e-02 | 9.51e-01 |
GOCC ATG12 ATG5 ATG16 COMPLEX | 5 | 8.46e-01 | -5.00e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 9 | 7.95e-01 | 5.00e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 32 | 6.25e-01 | -5.00e-02 | 8.51e-01 |
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 135 | 3.18e-01 | 5.00e-02 | 6.56e-01 |
GOBP CELL CYCLE PROCESS | 781 | 2.08e-02 | 5.00e-02 | 1.97e-01 |
GOBP NERVOUS SYSTEM PROCESS | 297 | 1.43e-01 | -4.99e-02 | 4.74e-01 |
GOBP REGULATION OF B CELL PROLIFERATION | 45 | 5.63e-01 | 4.99e-02 | 8.17e-01 |
GOBP DECIDUALIZATION | 10 | 7.85e-01 | 4.99e-02 | 9.28e-01 |
GOBP COLLAGEN CATABOLIC PROCESS | 12 | 7.65e-01 | -4.99e-02 | 9.19e-01 |
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 211 | 2.15e-01 | 4.99e-02 | 5.67e-01 |
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION | 5 | 8.47e-01 | 4.99e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF MYOBLAST FUSION | 8 | 8.07e-01 | -4.98e-02 | 9.37e-01 |
GOBP REGULATION OF VACUOLE ORGANIZATION | 42 | 5.77e-01 | -4.98e-02 | 8.25e-01 |
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION | 10 | 7.85e-01 | 4.98e-02 | 9.28e-01 |
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS | 5 | 8.47e-01 | 4.98e-02 | 9.51e-01 |
GOBP MULTICELLULAR ORGANISM REPRODUCTION | 342 | 1.18e-01 | -4.98e-02 | 4.39e-01 |
GOMF SIALYLTRANSFERASE ACTIVITY | 10 | 7.86e-01 | 4.97e-02 | 9.28e-01 |
GOBP LYMPHOCYTE HOMEOSTASIS | 52 | 5.37e-01 | -4.96e-02 | 8.04e-01 |
GOBP TRIGLYCERIDE CATABOLIC PROCESS | 7 | 8.21e-01 | -4.95e-02 | 9.42e-01 |
GOBP PROTEIN POLYUBIQUITINATION | 165 | 2.76e-01 | -4.95e-02 | 6.19e-01 |
GOBP REGULATION OF MYOBLAST DIFFERENTIATION | 39 | 5.94e-01 | -4.94e-02 | 8.34e-01 |
GOBP PEPTIDYL LYSINE ACETYLATION | 54 | 5.30e-01 | 4.94e-02 | 8.01e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 10 | 7.87e-01 | 4.94e-02 | 9.28e-01 |
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE | 101 | 3.93e-01 | -4.93e-02 | 7.13e-01 |
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 128 | 3.37e-01 | -4.93e-02 | 6.73e-01 |
GOCC CLEAVAGE FURROW | 33 | 6.24e-01 | -4.93e-02 | 8.51e-01 |
GOBP PHOSPHOLIPID TRANSPORT | 54 | 5.32e-01 | -4.93e-02 | 8.01e-01 |
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION | 24 | 6.77e-01 | -4.92e-02 | 8.78e-01 |
GOBP CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 170 | 2.71e-01 | -4.92e-02 | 6.16e-01 |
GOBP EAR MORPHOGENESIS | 26 | 6.65e-01 | -4.92e-02 | 8.72e-01 |
GOBP NEGATIVE REGULATION OF VIRAL PROCESS | 57 | 5.22e-01 | -4.92e-02 | 7.94e-01 |
GOMF PROTEIN TRANSPORTER ACTIVITY | 29 | 6.47e-01 | 4.91e-02 | 8.63e-01 |
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 21 | 6.97e-01 | 4.91e-02 | 8.88e-01 |
GOBP REGULATION OF SUPEROXIDE ANION GENERATION | 11 | 7.78e-01 | -4.91e-02 | 9.25e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION | 22 | 6.91e-01 | -4.90e-02 | 8.83e-01 |
GOCC AUTOPHAGOSOME | 80 | 4.49e-01 | -4.90e-02 | 7.50e-01 |
GOBP POSITIVE CHEMOTAXIS | 18 | 7.19e-01 | 4.90e-02 | 8.99e-01 |
GOMF I SMAD BINDING | 10 | 7.89e-01 | -4.90e-02 | 9.29e-01 |
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION | 32 | 6.33e-01 | 4.89e-02 | 8.56e-01 |
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY | 55 | 5.32e-01 | -4.88e-02 | 8.02e-01 |
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS | 10 | 7.89e-01 | 4.88e-02 | 9.30e-01 |
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III | 15 | 7.44e-01 | 4.88e-02 | 9.08e-01 |
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS | 127 | 3.45e-01 | -4.87e-02 | 6.79e-01 |
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS | 19 | 7.13e-01 | -4.87e-02 | 8.96e-01 |
GOBP REGULATION OF PROTEIN LIPIDATION | 9 | 8.00e-01 | -4.87e-02 | 9.34e-01 |
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS | 817 | 2.14e-02 | 4.87e-02 | 2.01e-01 |
GOBP PROTEIN HYDROXYLATION | 11 | 7.80e-01 | -4.87e-02 | 9.26e-01 |
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH | 280 | 1.65e-01 | -4.87e-02 | 5.04e-01 |
GOMF GROWTH FACTOR RECEPTOR BINDING | 50 | 5.53e-01 | -4.86e-02 | 8.13e-01 |
GOBP TRANSPORT ALONG MICROTUBULE | 112 | 3.77e-01 | -4.85e-02 | 7.03e-01 |
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS | 16 | 7.37e-01 | -4.85e-02 | 9.06e-01 |
GOMF SNRNA BINDING | 41 | 5.92e-01 | -4.85e-02 | 8.34e-01 |
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION | 6 | 8.37e-01 | -4.85e-02 | 9.47e-01 |
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION | 8 | 8.13e-01 | 4.84e-02 | 9.40e-01 |
GOCC TRANSLOCON COMPLEX | 6 | 8.37e-01 | 4.84e-02 | 9.47e-01 |
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY | 7 | 8.25e-01 | 4.84e-02 | 9.43e-01 |
GOMF TRANSCRIPTION COREGULATOR ACTIVITY | 361 | 1.19e-01 | -4.84e-02 | 4.40e-01 |
GOBP CRD MEDIATED MRNA STABILIZATION | 9 | 8.02e-01 | -4.84e-02 | 9.35e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 73 | 4.76e-01 | -4.83e-02 | 7.70e-01 |
GOBP VESICLE BUDDING FROM MEMBRANE | 72 | 4.80e-01 | 4.83e-02 | 7.72e-01 |
GOBP ENDOCYTIC RECYCLING | 61 | 5.15e-01 | -4.83e-02 | 7.90e-01 |
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION | 55 | 5.37e-01 | 4.83e-02 | 8.04e-01 |
GOCC EXTRINSIC COMPONENT OF MEMBRANE | 101 | 4.03e-01 | -4.83e-02 | 7.21e-01 |
GOBP REGULATION OF RNA SPLICING | 139 | 3.29e-01 | -4.82e-02 | 6.64e-01 |
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION | 7 | 8.25e-01 | 4.82e-02 | 9.43e-01 |
GOCC TRANSPORT VESICLE MEMBRANE | 120 | 3.64e-01 | 4.81e-02 | 6.91e-01 |
GOMF INSULIN RECEPTOR BINDING | 15 | 7.47e-01 | -4.81e-02 | 9.10e-01 |
GOMF TRNA METHYLTRANSFERASE ACTIVITY | 23 | 6.90e-01 | 4.81e-02 | 8.83e-01 |
GOBP NK T CELL PROLIFERATION | 6 | 8.38e-01 | 4.81e-02 | 9.47e-01 |
GOMF CYTIDYLYLTRANSFERASE ACTIVITY | 7 | 8.26e-01 | 4.81e-02 | 9.43e-01 |
GOMF ABC TYPE TRANSPORTER ACTIVITY | 19 | 7.17e-01 | 4.81e-02 | 8.98e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS | 828 | 2.24e-02 | -4.81e-02 | 2.06e-01 |
GOCC CLATHRIN COATED VESICLE | 119 | 3.67e-01 | 4.81e-02 | 6.94e-01 |
GOBP POSITIVE REGULATION OF CHEMOTAXIS | 55 | 5.38e-01 | 4.80e-02 | 8.04e-01 |
GOMF OXIDIZED DNA BINDING | 10 | 7.93e-01 | -4.80e-02 | 9.32e-01 |
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 59 | 5.25e-01 | -4.79e-02 | 7.97e-01 |
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING | 5 | 8.53e-01 | 4.79e-02 | 9.51e-01 |
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION | 94 | 4.24e-01 | -4.79e-02 | 7.34e-01 |
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS | 34 | 6.29e-01 | -4.79e-02 | 8.54e-01 |
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 5 | 8.53e-01 | 4.78e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF TORC1 SIGNALING | 42 | 5.92e-01 | -4.78e-02 | 8.34e-01 |
GOCC DENDRITE CYTOPLASM | 16 | 7.41e-01 | -4.78e-02 | 9.06e-01 |
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE | 30 | 6.51e-01 | -4.78e-02 | 8.65e-01 |
GOBP INTRACELLULAR MRNA LOCALIZATION | 9 | 8.04e-01 | -4.78e-02 | 9.36e-01 |
GOBP REGULATION OF B CELL ACTIVATION | 90 | 4.35e-01 | -4.77e-02 | 7.40e-01 |
GOBP MUSCLE CONTRACTION | 97 | 4.20e-01 | 4.76e-02 | 7.31e-01 |
GOBP SUPEROXIDE ANION GENERATION | 18 | 7.27e-01 | -4.75e-02 | 9.02e-01 |
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE | 18 | 7.27e-01 | 4.75e-02 | 9.02e-01 |
GOBP LYMPHOCYTE MEDIATED IMMUNITY | 162 | 2.99e-01 | -4.75e-02 | 6.41e-01 |
GOBP POSITIVE THYMIC T CELL SELECTION | 7 | 8.28e-01 | -4.75e-02 | 9.43e-01 |
GOBP POSITIVE REGULATION OF NEUROGENESIS | 97 | 4.21e-01 | -4.75e-02 | 7.32e-01 |
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR | 26 | 6.76e-01 | -4.75e-02 | 8.78e-01 |
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY | 203 | 2.47e-01 | -4.74e-02 | 5.93e-01 |
GOBP LIPID MODIFICATION | 98 | 4.19e-01 | 4.74e-02 | 7.31e-01 |
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE | 214 | 2.35e-01 | -4.74e-02 | 5.82e-01 |
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY | 6 | 8.41e-01 | 4.74e-02 | 9.48e-01 |
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 319 | 1.50e-01 | -4.74e-02 | 4.83e-01 |
GOCC HOPS COMPLEX | 6 | 8.41e-01 | 4.73e-02 | 9.48e-01 |
GOBP BLOOD VESSEL REMODELING | 16 | 7.43e-01 | -4.73e-02 | 9.08e-01 |
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX | 83 | 4.58e-01 | 4.73e-02 | 7.55e-01 |
GOBP MITOCHONDRION MORPHOGENESIS | 18 | 7.28e-01 | -4.73e-02 | 9.03e-01 |
GOBP RESPONSE TO IONIZING RADIATION | 98 | 4.20e-01 | 4.73e-02 | 7.32e-01 |
GOBP PROSTANOID BIOSYNTHETIC PROCESS | 17 | 7.36e-01 | 4.72e-02 | 9.06e-01 |
GOBP SPHINGOMYELIN METABOLIC PROCESS | 10 | 7.96e-01 | -4.72e-02 | 9.33e-01 |
GOBP AMINOGLYCAN METABOLIC PROCESS | 45 | 5.84e-01 | -4.72e-02 | 8.30e-01 |
GOBP TRNA CATABOLIC PROCESS | 12 | 7.77e-01 | 4.72e-02 | 9.25e-01 |
GOBP POSITIVE REGULATION OF PHOSPHORYLATION | 291 | 1.70e-01 | -4.72e-02 | 5.11e-01 |
GOBP B CELL ACTIVATION | 182 | 2.77e-01 | -4.70e-02 | 6.20e-01 |
GOBP OLIGODENDROCYTE DIFFERENTIATION | 40 | 6.07e-01 | -4.70e-02 | 8.43e-01 |
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 7.38e-01 | 4.70e-02 | 9.06e-01 |
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS | 5 | 8.56e-01 | -4.68e-02 | 9.53e-01 |
GOBP RESPONSE TO STARVATION | 132 | 3.56e-01 | -4.68e-02 | 6.86e-01 |
GOMF GUANYL NUCLEOTIDE BINDING | 223 | 2.33e-01 | -4.67e-02 | 5.78e-01 |
GOCC BASAL PART OF CELL | 97 | 4.28e-01 | 4.67e-02 | 7.36e-01 |
GOBP DNA DAMAGE RESPONSE | 612 | 5.33e-02 | 4.67e-02 | 3.01e-01 |
GOBP SPERM FLAGELLUM ASSEMBLY | 10 | 7.98e-01 | -4.67e-02 | 9.33e-01 |
GOBP NEURON FATE COMMITMENT | 13 | 7.71e-01 | 4.67e-02 | 9.23e-01 |
GOBP NEUROTRANSMITTER REUPTAKE | 8 | 8.20e-01 | 4.66e-02 | 9.42e-01 |
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 17 | 7.40e-01 | 4.66e-02 | 9.06e-01 |
GOBP INTERLEUKIN 5 PRODUCTION | 7 | 8.31e-01 | 4.66e-02 | 9.43e-01 |
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS | 194 | 2.67e-01 | 4.66e-02 | 6.11e-01 |
GOMF NF KAPPAB BINDING | 25 | 6.88e-01 | 4.65e-02 | 8.83e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 24 | 6.94e-01 | 4.65e-02 | 8.86e-01 |
GOMF MYOSIN V BINDING | 8 | 8.20e-01 | -4.65e-02 | 9.42e-01 |
GOBP INTEGRIN ACTIVATION | 13 | 7.72e-01 | -4.64e-02 | 9.24e-01 |
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS | 21 | 7.13e-01 | 4.64e-02 | 8.96e-01 |
GOBP CELLULAR LIPID METABOLIC PROCESS | 458 | 9.39e-02 | 4.64e-02 | 3.98e-01 |
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 8.20e-01 | -4.64e-02 | 9.42e-01 |
GOBP REGULATION OF CELL SIZE | 86 | 4.59e-01 | -4.64e-02 | 7.56e-01 |
GOBP EXECUTION PHASE OF APOPTOSIS | 43 | 5.99e-01 | 4.64e-02 | 8.37e-01 |
GOBP PROTEIN K11 LINKED UBIQUITINATION | 24 | 6.95e-01 | -4.63e-02 | 8.87e-01 |
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY | 38 | 6.22e-01 | -4.63e-02 | 8.50e-01 |
GOBP 7 METHYLGUANOSINE RNA CAPPING | 7 | 8.32e-01 | -4.63e-02 | 9.44e-01 |
GOBP NEURON CELLULAR HOMEOSTASIS | 32 | 6.51e-01 | -4.63e-02 | 8.65e-01 |
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS | 12 | 7.81e-01 | 4.63e-02 | 9.26e-01 |
GOCC CYTOPLASMIC STRESS GRANULE | 69 | 5.07e-01 | -4.63e-02 | 7.86e-01 |
GOBP RESPONSE TO INSULIN | 145 | 3.39e-01 | -4.63e-02 | 6.75e-01 |
GOBP REGULATION OF CHEMOTAXIS | 77 | 4.84e-01 | 4.62e-02 | 7.74e-01 |
GOBP STEROL HOMEOSTASIS | 35 | 6.37e-01 | -4.62e-02 | 8.57e-01 |
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION | 12 | 7.82e-01 | 4.62e-02 | 9.26e-01 |
GOCC CYTOPLASMIC MICROTUBULE | 39 | 6.18e-01 | -4.62e-02 | 8.48e-01 |
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 197 | 2.67e-01 | -4.61e-02 | 6.11e-01 |
GOBP RNA EXPORT FROM NUCLEUS | 79 | 4.80e-01 | 4.61e-02 | 7.72e-01 |
GOBP SYNAPTIC VESICLE RECYCLING | 46 | 5.90e-01 | -4.60e-02 | 8.32e-01 |
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS | 81 | 4.75e-01 | 4.60e-02 | 7.69e-01 |
GOBP LACTATE METABOLIC PROCESS | 10 | 8.01e-01 | 4.60e-02 | 9.34e-01 |
GOBP RESPONSE TO AXON INJURY | 33 | 6.48e-01 | -4.60e-02 | 8.63e-01 |
GOBP REGULATION OF PROTEIN POLYMERIZATION | 106 | 4.16e-01 | -4.59e-02 | 7.29e-01 |
GOBP EPITHELIUM DEVELOPMENT | 419 | 1.12e-01 | -4.59e-02 | 4.30e-01 |
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE | 8 | 8.22e-01 | 4.59e-02 | 9.43e-01 |
GOBP RESPONSE TO THYROID HORMONE | 17 | 7.44e-01 | -4.59e-02 | 9.08e-01 |
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN | 10 | 8.02e-01 | 4.58e-02 | 9.35e-01 |
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 13 | 7.75e-01 | -4.57e-02 | 9.25e-01 |
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION | 352 | 1.46e-01 | -4.57e-02 | 4.78e-01 |
GOCC GOLGI TRANSPORT COMPLEX | 8 | 8.23e-01 | -4.56e-02 | 9.43e-01 |
GOBP PROTEIN HOMOOLIGOMERIZATION | 83 | 4.74e-01 | 4.56e-02 | 7.69e-01 |
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL | 6 | 8.47e-01 | 4.55e-02 | 9.51e-01 |
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION | 7 | 8.35e-01 | 4.55e-02 | 9.46e-01 |
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY | 17 | 7.45e-01 | -4.55e-02 | 9.09e-01 |
GOBP CILIUM ORGANIZATION | 193 | 2.79e-01 | -4.55e-02 | 6.22e-01 |
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 580 | 6.69e-02 | -4.54e-02 | 3.40e-01 |
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM | 20 | 7.25e-01 | 4.54e-02 | 9.01e-01 |
GOBP FEMALE SEX DIFFERENTIATION | 38 | 6.29e-01 | -4.53e-02 | 8.54e-01 |
GOBP HORMONE BIOSYNTHETIC PROCESS | 16 | 7.54e-01 | -4.53e-02 | 9.14e-01 |
GOBP REGULATION OF CYCLASE ACTIVITY | 11 | 7.95e-01 | -4.53e-02 | 9.33e-01 |
GOMF HEXOSYLTRANSFERASE ACTIVITY | 82 | 4.80e-01 | 4.52e-02 | 7.72e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 16 | 7.54e-01 | -4.52e-02 | 9.14e-01 |
GOBP CELLULAR RESPONSE TO UNFOLDED PROTEIN | 70 | 5.14e-01 | -4.52e-02 | 7.89e-01 |
GOCC M BAND | 7 | 8.36e-01 | -4.52e-02 | 9.46e-01 |
GOBP RESPONSE TO VITAMIN | 32 | 6.59e-01 | 4.51e-02 | 8.69e-01 |
GOBP GOLGI VESICLE TRANSPORT | 241 | 2.32e-01 | 4.50e-02 | 5.78e-01 |
GOBP ANTEROGRADE AXONAL TRANSPORT | 33 | 6.55e-01 | -4.49e-02 | 8.66e-01 |
GOCC METHYLTRANSFERASE COMPLEX | 80 | 4.89e-01 | 4.49e-02 | 7.76e-01 |
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION | 5 | 8.62e-01 | -4.49e-02 | 9.56e-01 |
GOBP RESPONSE TO CORTICOSTEROID | 52 | 5.77e-01 | -4.48e-02 | 8.25e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS | 144 | 3.56e-01 | 4.48e-02 | 6.86e-01 |
GOCC NONHOMOLOGOUS END JOINING COMPLEX | 7 | 8.38e-01 | 4.47e-02 | 9.47e-01 |
GOMF UBIQUITIN LIKE PROTEIN BINDING | 100 | 4.41e-01 | -4.47e-02 | 7.43e-01 |
GOBP RELAXATION OF MUSCLE | 15 | 7.64e-01 | 4.47e-02 | 9.19e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION | 5 | 8.63e-01 | -4.47e-02 | 9.56e-01 |
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 72 | 5.13e-01 | 4.47e-02 | 7.88e-01 |
GOMF HISTONE BINDING | 183 | 3.00e-01 | 4.47e-02 | 6.42e-01 |
GOCC ENDOSOME LUMEN | 16 | 7.57e-01 | -4.46e-02 | 9.16e-01 |
GOCC RIBBON SYNAPSE | 6 | 8.50e-01 | 4.46e-02 | 9.51e-01 |
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE | 14 | 7.73e-01 | 4.46e-02 | 9.24e-01 |
GOCC CELL DIVISION SITE | 43 | 6.13e-01 | -4.46e-02 | 8.46e-01 |
GOCC PERINUCLEAR REGION OF CYTOPLASM | 410 | 1.27e-01 | -4.46e-02 | 4.55e-01 |
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY | 186 | 2.98e-01 | -4.45e-02 | 6.40e-01 |
GOCC BETA CATENIN DESTRUCTION COMPLEX | 9 | 8.17e-01 | 4.45e-02 | 9.41e-01 |
GOMF SYMPORTER ACTIVITY | 36 | 6.45e-01 | 4.45e-02 | 8.62e-01 |
GOBP MACROPHAGE CYTOKINE PRODUCTION | 19 | 7.38e-01 | -4.44e-02 | 9.06e-01 |
GOBP SPINDLE LOCALIZATION | 36 | 6.45e-01 | -4.44e-02 | 8.62e-01 |
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS | 313 | 1.82e-01 | 4.44e-02 | 5.28e-01 |
GOMF PROFILIN BINDING | 6 | 8.51e-01 | -4.44e-02 | 9.51e-01 |
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION | 83 | 4.86e-01 | -4.44e-02 | 7.76e-01 |
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH | 29 | 6.80e-01 | -4.43e-02 | 8.79e-01 |
GOCC LAMELLIPODIUM MEMBRANE | 10 | 8.08e-01 | 4.43e-02 | 9.37e-01 |
GOBP CELLULAR CATABOLIC PROCESS | 926 | 2.71e-02 | 4.43e-02 | 2.27e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE | 185 | 3.03e-01 | 4.42e-02 | 6.44e-01 |
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX | 8 | 8.29e-01 | -4.41e-02 | 9.43e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY | 59 | 5.59e-01 | -4.40e-02 | 8.16e-01 |
GOBP REGULATION OF COAGULATION | 19 | 7.41e-01 | 4.39e-02 | 9.06e-01 |
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 8 | 8.30e-01 | -4.39e-02 | 9.43e-01 |
GOBP RESPONSE TO PEPTIDE HORMONE | 211 | 2.75e-01 | -4.39e-02 | 6.19e-01 |
GOBP TRANSLATIONAL ELONGATION | 49 | 5.96e-01 | 4.39e-02 | 8.35e-01 |
GOMF TRANSITION METAL ION BINDING | 528 | 9.04e-02 | -4.39e-02 | 3.91e-01 |
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING | 6 | 8.53e-01 | -4.38e-02 | 9.51e-01 |
GOBP REGULATION OF PLASMA MEMBRANE REPAIR | 6 | 8.53e-01 | -4.38e-02 | 9.51e-01 |
GOCC CLATHRIN COATED PIT | 46 | 6.08e-01 | -4.37e-02 | 8.43e-01 |
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY | 5 | 8.66e-01 | 4.37e-02 | 9.57e-01 |
GOMF CYCLASE REGULATOR ACTIVITY | 5 | 8.66e-01 | 4.37e-02 | 9.57e-01 |
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION | 135 | 3.83e-01 | -4.37e-02 | 7.06e-01 |
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS | 24 | 7.12e-01 | 4.36e-02 | 8.96e-01 |
GOCC RECYCLING ENDOSOME MEMBRANE | 68 | 5.35e-01 | -4.36e-02 | 8.03e-01 |
GOBP MAINTENANCE OF ORGANELLE LOCATION | 8 | 8.31e-01 | 4.36e-02 | 9.43e-01 |
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS | 47 | 6.06e-01 | -4.35e-02 | 8.42e-01 |
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT | 6 | 8.54e-01 | -4.34e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 32 | 6.72e-01 | 4.33e-02 | 8.75e-01 |
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS | 445 | 1.23e-01 | -4.33e-02 | 4.49e-01 |
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 26 | 7.03e-01 | -4.33e-02 | 8.91e-01 |
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 16 | 7.64e-01 | 4.33e-02 | 9.19e-01 |
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 6 | 8.54e-01 | 4.33e-02 | 9.52e-01 |
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY | 19 | 7.44e-01 | 4.32e-02 | 9.08e-01 |
GOBP POSITIVE REGULATION OF ENDOCYTOSIS | 78 | 5.11e-01 | 4.32e-02 | 7.88e-01 |
GOBP METHYLATION | 190 | 3.09e-01 | 4.31e-02 | 6.48e-01 |
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE | 8 | 8.33e-01 | -4.31e-02 | 9.45e-01 |
GOBP REGULATION OF PH | 52 | 5.93e-01 | -4.30e-02 | 8.34e-01 |
GOCC DENDRITIC TREE | 238 | 2.57e-01 | -4.30e-02 | 6.00e-01 |
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 73 | 5.27e-01 | -4.29e-02 | 7.98e-01 |
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE | 115 | 4.29e-01 | -4.29e-02 | 7.36e-01 |
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY | 5 | 8.68e-01 | -4.28e-02 | 9.59e-01 |
GOBP INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION | 8 | 8.34e-01 | 4.27e-02 | 9.46e-01 |
GOBP OVULATION CYCLE | 18 | 7.54e-01 | -4.27e-02 | 9.14e-01 |
GOBP CELLULAR RESPONSE TO RADIATION | 106 | 4.49e-01 | 4.27e-02 | 7.49e-01 |
GOBP REGULATION OF NEURON DIFFERENTIATION | 68 | 5.44e-01 | -4.27e-02 | 8.07e-01 |
GOBP HETEROCYCLE CATABOLIC PROCESS | 304 | 2.06e-01 | 4.27e-02 | 5.53e-01 |
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY | 7 | 8.45e-01 | -4.27e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS | 133 | 3.99e-01 | -4.25e-02 | 7.18e-01 |
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 341 | 1.82e-01 | 4.25e-02 | 5.28e-01 |
GOCC CILIARY BASAL BODY | 76 | 5.23e-01 | -4.25e-02 | 7.95e-01 |
GOCC IMMUNOLOGICAL SYNAPSE | 30 | 6.87e-01 | -4.25e-02 | 8.83e-01 |
GOMF SNRNP BINDING | 9 | 8.25e-01 | 4.25e-02 | 9.43e-01 |
GOBP NEUTRAL AMINO ACID TRANSPORT | 22 | 7.30e-01 | -4.25e-02 | 9.04e-01 |
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT | 6 | 8.57e-01 | 4.24e-02 | 9.53e-01 |
GOBP HOMEOSTASIS OF NUMBER OF CELLS | 200 | 3.05e-01 | -4.24e-02 | 6.46e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING | 17 | 7.63e-01 | 4.23e-02 | 9.18e-01 |
GOMF PEPTIDE HORMONE BINDING | 12 | 8.00e-01 | 4.23e-02 | 9.34e-01 |
GOCC SYNAPTONEMAL STRUCTURE | 10 | 8.17e-01 | 4.23e-02 | 9.41e-01 |
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 26 | 7.09e-01 | -4.23e-02 | 8.95e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE | 7 | 8.47e-01 | 4.22e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT | 30 | 6.89e-01 | 4.22e-02 | 8.83e-01 |
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 31 | 6.85e-01 | 4.22e-02 | 8.81e-01 |
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS | 362 | 1.73e-01 | -4.22e-02 | 5.16e-01 |
GOCC GLUTAMATERGIC SYNAPSE | 169 | 3.47e-01 | -4.22e-02 | 6.79e-01 |
GOBP ATRIAL SEPTUM DEVELOPMENT | 9 | 8.27e-01 | -4.22e-02 | 9.43e-01 |
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS | 12 | 8.01e-01 | 4.21e-02 | 9.34e-01 |
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 15 | 7.78e-01 | 4.21e-02 | 9.25e-01 |
GOBP GOLGI VESICLE BUDDING | 10 | 8.18e-01 | 4.21e-02 | 9.41e-01 |
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY | 32 | 6.81e-01 | -4.20e-02 | 8.80e-01 |
GOBP ACTIN FILAMENT BASED MOVEMENT | 44 | 6.30e-01 | 4.20e-02 | 8.54e-01 |
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION | 7 | 8.47e-01 | 4.20e-02 | 9.51e-01 |
GOBP REGULATION OF NK T CELL ACTIVATION | 6 | 8.59e-01 | 4.20e-02 | 9.54e-01 |
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY | 23 | 7.28e-01 | -4.20e-02 | 9.02e-01 |
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY | 5 | 8.71e-01 | -4.19e-02 | 9.59e-01 |
GOMF HORMONE BINDING | 26 | 7.12e-01 | 4.19e-02 | 8.96e-01 |
GOBP REGULATION OF TELOMERE MAINTENANCE | 89 | 4.96e-01 | 4.18e-02 | 7.79e-01 |
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT | 7 | 8.48e-01 | -4.18e-02 | 9.51e-01 |
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION | 14 | 7.87e-01 | -4.17e-02 | 9.28e-01 |
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER | 9 | 8.28e-01 | 4.17e-02 | 9.43e-01 |
GOBP MITOTIC CYTOKINESIS | 60 | 5.77e-01 | 4.17e-02 | 8.25e-01 |
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY | 11 | 8.11e-01 | -4.17e-02 | 9.39e-01 |
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION | 8 | 8.39e-01 | 4.16e-02 | 9.47e-01 |
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY | 27 | 7.09e-01 | -4.16e-02 | 8.95e-01 |
GOBP PEPTIDYL PROLINE HYDROXYLATION | 7 | 8.49e-01 | -4.15e-02 | 9.51e-01 |
GOCC PHAGOCYTIC VESICLE | 102 | 4.70e-01 | -4.15e-02 | 7.66e-01 |
GOCC BLOOD MICROPARTICLE | 49 | 6.16e-01 | -4.15e-02 | 8.47e-01 |
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS | 97 | 4.81e-01 | 4.15e-02 | 7.72e-01 |
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE | 34 | 6.76e-01 | 4.15e-02 | 8.78e-01 |
GOBP VESICLE LOCALIZATION | 146 | 3.89e-01 | 4.15e-02 | 7.10e-01 |
GOBP L AMINO ACID TRANSPORT | 37 | 6.63e-01 | -4.15e-02 | 8.72e-01 |
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS | 9 | 8.30e-01 | -4.14e-02 | 9.43e-01 |
GOCC PERICENTRIOLAR MATERIAL | 14 | 7.89e-01 | 4.14e-02 | 9.29e-01 |
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION | 22 | 7.37e-01 | 4.14e-02 | 9.06e-01 |
GOBP MITOPHAGY | 31 | 6.90e-01 | -4.14e-02 | 8.83e-01 |
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS | 43 | 6.39e-01 | -4.14e-02 | 8.59e-01 |
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS | 66 | 5.62e-01 | 4.13e-02 | 8.17e-01 |
GOMF RNA STEM LOOP BINDING | 13 | 7.97e-01 | -4.13e-02 | 9.33e-01 |
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS | 13 | 7.97e-01 | -4.13e-02 | 9.33e-01 |
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION | 18 | 7.62e-01 | 4.13e-02 | 9.17e-01 |
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND | 807 | 5.28e-02 | -4.13e-02 | 2.99e-01 |
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS | 170 | 3.56e-01 | -4.13e-02 | 6.86e-01 |
GOBP MACROMOLECULE DEPALMITOYLATION | 9 | 8.31e-01 | 4.12e-02 | 9.43e-01 |
GOMF PALMITOYL HYDROLASE ACTIVITY | 9 | 8.31e-01 | 4.12e-02 | 9.43e-01 |
GOBP PURINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS | 11 | 8.13e-01 | -4.12e-02 | 9.40e-01 |
GOBP GOLGI LUMEN ACIDIFICATION | 13 | 7.97e-01 | 4.11e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 27 | 7.12e-01 | -4.11e-02 | 8.96e-01 |
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 30 | 6.98e-01 | -4.10e-02 | 8.88e-01 |
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY | 16 | 7.77e-01 | 4.09e-02 | 9.25e-01 |
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 86 | 5.13e-01 | -4.09e-02 | 7.88e-01 |
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 39 | 6.59e-01 | -4.09e-02 | 8.69e-01 |
GOBP HOMOTYPIC CELL CELL ADHESION | 48 | 6.25e-01 | -4.09e-02 | 8.51e-01 |
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 9 | 8.32e-01 | -4.09e-02 | 9.44e-01 |
GOBP RESPONSE TO INTERLEUKIN 9 | 6 | 8.63e-01 | 4.08e-02 | 9.56e-01 |
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS | 87 | 5.13e-01 | 4.07e-02 | 7.88e-01 |
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY | 112 | 4.59e-01 | -4.07e-02 | 7.56e-01 |
GOBP OVARIAN FOLLICLE DEVELOPMENT | 19 | 7.59e-01 | -4.07e-02 | 9.16e-01 |
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION | 12 | 8.07e-01 | 4.07e-02 | 9.37e-01 |
GOBP POSITIVE REGULATION OF MAPK CASCADE | 174 | 3.58e-01 | -4.07e-02 | 6.87e-01 |
GOCC CELL SUBSTRATE JUNCTION | 273 | 2.53e-01 | -4.06e-02 | 5.96e-01 |
GOBP POSITIVE REGULATION OF DNA REPAIR | 98 | 4.89e-01 | 4.06e-02 | 7.76e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT | 39 | 6.62e-01 | -4.05e-02 | 8.71e-01 |
GOBP BIOGENIC AMINE METABOLIC PROCESS | 37 | 6.70e-01 | -4.05e-02 | 8.75e-01 |
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 163 | 3.76e-01 | -4.04e-02 | 7.01e-01 |
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS | 162 | 3.77e-01 | -4.04e-02 | 7.03e-01 |
GOMF DOUBLE STRANDED RNA BINDING | 57 | 5.98e-01 | 4.04e-02 | 8.36e-01 |
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 46 | 6.36e-01 | 4.04e-02 | 8.57e-01 |
GOMF CALCIUM ION BINDING | 191 | 3.39e-01 | -4.04e-02 | 6.75e-01 |
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 10 | 8.25e-01 | -4.04e-02 | 9.43e-01 |
GOBP NATURAL KILLER CELL DEGRANULATION | 10 | 8.25e-01 | -4.04e-02 | 9.43e-01 |
GOBP POSITIVE REGULATION OF HISTONE METHYLATION | 14 | 7.94e-01 | -4.03e-02 | 9.33e-01 |
GOMF TBP CLASS PROTEIN BINDING | 21 | 7.49e-01 | -4.03e-02 | 9.11e-01 |
GOCC VACUOLAR LUMEN | 96 | 4.97e-01 | 4.02e-02 | 7.79e-01 |
GOBP PURINE CONTAINING COMPOUND SALVAGE | 11 | 8.18e-01 | 4.02e-02 | 9.41e-01 |
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 105 | 4.79e-01 | -4.02e-02 | 7.72e-01 |
GOBP NATURAL KILLER CELL DIFFERENTIATION | 17 | 7.75e-01 | -4.01e-02 | 9.24e-01 |
GOBP RESPONSE TO WOUNDING | 228 | 3.00e-01 | -4.01e-02 | 6.42e-01 |
GOBP CYTOKINETIC PROCESS | 30 | 7.04e-01 | 4.01e-02 | 8.93e-01 |
GOCC EXOCYTIC VESICLE | 104 | 4.81e-01 | -4.01e-02 | 7.72e-01 |
GOBP REGULATION OF B CELL DIFFERENTIATION | 21 | 7.51e-01 | -4.01e-02 | 9.11e-01 |
GOMF PEPTIDASE ACTIVITY | 252 | 2.77e-01 | 4.01e-02 | 6.20e-01 |
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS | 69 | 5.67e-01 | -4.00e-02 | 8.19e-01 |
GOBP LYTIC VACUOLE ORGANIZATION | 72 | 5.59e-01 | -3.99e-02 | 8.16e-01 |
GOBP HYALURONAN METABOLIC PROCESS | 11 | 8.19e-01 | -3.99e-02 | 9.41e-01 |
GOBP GDP METABOLIC PROCESS | 8 | 8.45e-01 | -3.99e-02 | 9.51e-01 |
GOCC SPECIFIC GRANULE | 93 | 5.07e-01 | -3.99e-02 | 7.86e-01 |
GOBP STEROL METABOLIC PROCESS | 64 | 5.82e-01 | -3.99e-02 | 8.28e-01 |
GOBP REGULATION OF CENTROSOME CYCLE | 39 | 6.67e-01 | -3.99e-02 | 8.73e-01 |
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 6 | 8.66e-01 | 3.98e-02 | 9.57e-01 |
GOBP SECRETORY GRANULE LOCALIZATION | 6 | 8.66e-01 | 3.98e-02 | 9.57e-01 |
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT | 124 | 4.47e-01 | -3.97e-02 | 7.48e-01 |
GOCC VACUOLAR MEMBRANE | 313 | 2.32e-01 | -3.97e-02 | 5.78e-01 |
GOMF GUANYLATE KINASE ACTIVITY | 7 | 8.56e-01 | 3.97e-02 | 9.53e-01 |
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY | 31 | 7.02e-01 | -3.97e-02 | 8.91e-01 |
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX | 6 | 8.66e-01 | -3.97e-02 | 9.58e-01 |
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 139 | 4.22e-01 | 3.96e-02 | 7.33e-01 |
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING | 243 | 2.92e-01 | -3.96e-02 | 6.34e-01 |
GOCC SOMATODENDRITIC COMPARTMENT | 311 | 2.35e-01 | -3.95e-02 | 5.82e-01 |
GOBP RESPONSE TO INACTIVITY | 5 | 8.79e-01 | -3.95e-02 | 9.63e-01 |
GOBP INTERLEUKIN 17 PRODUCTION | 19 | 7.66e-01 | -3.94e-02 | 9.20e-01 |
GOBP B CELL MEDIATED IMMUNITY | 85 | 5.31e-01 | -3.94e-02 | 8.01e-01 |
GOMF LIPID TRANSPORTER ACTIVITY | 72 | 5.64e-01 | -3.94e-02 | 8.17e-01 |
GOBP ACTIN FILAMENT BASED PROCESS | 353 | 2.10e-01 | -3.93e-02 | 5.58e-01 |
GOCC ORGANELLE MEMBRANE CONTACT SITE | 38 | 6.75e-01 | -3.93e-02 | 8.78e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS | 425 | 1.72e-01 | -3.92e-02 | 5.13e-01 |
GOBP REGULATION OF AUTOPHAGY | 243 | 2.97e-01 | -3.92e-02 | 6.38e-01 |
GOBP MONOATOMIC CATION TRANSPORT | 368 | 2.03e-01 | 3.91e-02 | 5.51e-01 |
GOBP NEUROMUSCULAR PROCESS | 48 | 6.40e-01 | -3.91e-02 | 8.59e-01 |
GOBP MATERNAL PLACENTA DEVELOPMENT | 16 | 7.87e-01 | 3.90e-02 | 9.28e-01 |
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY | 29 | 7.17e-01 | 3.90e-02 | 8.98e-01 |
GOMF LIPID BINDING | 381 | 1.97e-01 | -3.90e-02 | 5.45e-01 |
GOBP REGULATION OF MONOATOMIC ION TRANSPORT | 170 | 3.84e-01 | -3.90e-02 | 7.06e-01 |
GOMF IRON ION BINDING | 53 | 6.25e-01 | 3.89e-02 | 8.51e-01 |
GOCC CELL PROJECTION MEMBRANE | 131 | 4.44e-01 | -3.89e-02 | 7.46e-01 |
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 16 | 7.88e-01 | 3.89e-02 | 9.29e-01 |
GOBP MEMBRANE RAFT ASSEMBLY | 6 | 8.69e-01 | 3.88e-02 | 9.59e-01 |
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION | 5 | 8.81e-01 | -3.87e-02 | 9.63e-01 |
GOBP CELL DIFFERENTIATION IN HINDBRAIN | 8 | 8.50e-01 | 3.87e-02 | 9.51e-01 |
GOBP REGULATION OF VASCULAR PERMEABILITY | 10 | 8.32e-01 | 3.87e-02 | 9.44e-01 |
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 201 | 3.49e-01 | 3.86e-02 | 6.81e-01 |
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION | 129 | 4.52e-01 | -3.86e-02 | 7.51e-01 |
GOBP DETECTION OF MECHANICAL STIMULUS | 14 | 8.03e-01 | -3.85e-02 | 9.35e-01 |
GOCC MICROTUBULE PLUS END | 14 | 8.03e-01 | 3.85e-02 | 9.35e-01 |
GOMF MRNA 5 PHOSPHATASE ACTIVITY | 8 | 8.51e-01 | 3.85e-02 | 9.51e-01 |
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS | 278 | 2.74e-01 | 3.85e-02 | 6.19e-01 |
GOBP REGULATION OF MRNA METABOLIC PROCESS | 217 | 3.32e-01 | -3.85e-02 | 6.68e-01 |
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS | 63 | 5.98e-01 | -3.85e-02 | 8.36e-01 |
GOBP SODIUM ION TRANSPORT | 66 | 5.90e-01 | -3.84e-02 | 8.33e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY | 76 | 5.64e-01 | 3.84e-02 | 8.17e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING | 20 | 7.67e-01 | -3.83e-02 | 9.20e-01 |
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION | 7 | 8.61e-01 | -3.83e-02 | 9.55e-01 |
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 107 | 4.95e-01 | -3.83e-02 | 7.79e-01 |
GOCC SWI SNF COMPLEX | 25 | 7.41e-01 | 3.83e-02 | 9.06e-01 |
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS | 106 | 4.98e-01 | 3.82e-02 | 7.79e-01 |
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION | 135 | 4.45e-01 | -3.82e-02 | 7.47e-01 |
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 14 | 8.05e-01 | 3.82e-02 | 9.36e-01 |
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY | 253 | 3.00e-01 | -3.81e-02 | 6.42e-01 |
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY | 121 | 4.71e-01 | 3.81e-02 | 7.66e-01 |
GOBP CYTOSOLIC RIBOSOME ASSEMBLY | 5 | 8.83e-01 | -3.81e-02 | 9.63e-01 |
GOBP PROTEIN DNA COMPLEX ASSEMBLY | 121 | 4.72e-01 | 3.80e-02 | 7.67e-01 |
GOMF INTEGRIN BINDING | 51 | 6.39e-01 | 3.80e-02 | 8.59e-01 |
GOBP MOTILE CILIUM ASSEMBLY | 18 | 7.80e-01 | -3.80e-02 | 9.26e-01 |
GOBP SKIN EPIDERMIS DEVELOPMENT | 36 | 6.94e-01 | 3.80e-02 | 8.86e-01 |
GOBP REGULATION OF SPINDLE ASSEMBLY | 25 | 7.43e-01 | 3.80e-02 | 9.07e-01 |
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI | 77 | 5.65e-01 | 3.80e-02 | 8.18e-01 |
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY | 43 | 6.67e-01 | -3.80e-02 | 8.73e-01 |
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 115 | 4.84e-01 | -3.79e-02 | 7.74e-01 |
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 116 | 4.82e-01 | -3.79e-02 | 7.72e-01 |
GOCC FILOPODIUM MEMBRANE | 7 | 8.62e-01 | 3.79e-02 | 9.56e-01 |
GOBP REGULATION OF CELLULAR COMPONENT SIZE | 179 | 3.84e-01 | -3.79e-02 | 7.06e-01 |
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION | 8 | 8.53e-01 | -3.79e-02 | 9.51e-01 |
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION | 8 | 8.53e-01 | -3.79e-02 | 9.51e-01 |
GOCC LYSOSOMAL LUMEN | 44 | 6.65e-01 | -3.78e-02 | 8.72e-01 |
GOCC CLATHRIN COATED VESICLE MEMBRANE | 74 | 5.75e-01 | 3.78e-02 | 8.24e-01 |
GOBP PLASMA MEMBRANE RAFT ORGANIZATION | 5 | 8.84e-01 | -3.78e-02 | 9.63e-01 |
GOMF BASAL TRANSCRIPTION MACHINERY BINDING | 53 | 6.35e-01 | -3.77e-02 | 8.57e-01 |
GOCC BASOLATERAL PLASMA MEMBRANE | 84 | 5.51e-01 | 3.77e-02 | 8.13e-01 |
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 98 | 5.20e-01 | 3.77e-02 | 7.93e-01 |
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE | 8 | 8.54e-01 | 3.77e-02 | 9.51e-01 |
GOCC FILOPODIUM | 51 | 6.42e-01 | -3.77e-02 | 8.60e-01 |
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE | 10 | 8.37e-01 | -3.76e-02 | 9.46e-01 |
GOBP OLIGODENDROCYTE DEVELOPMENT | 17 | 7.88e-01 | -3.76e-02 | 9.29e-01 |
GOCC SYNAPTIC MEMBRANE | 90 | 5.39e-01 | -3.75e-02 | 8.04e-01 |
GOBP SPINDLE ORGANIZATION | 134 | 4.55e-01 | 3.75e-02 | 7.54e-01 |
GOCC FILAMENTOUS ACTIN | 11 | 8.29e-01 | -3.75e-02 | 9.43e-01 |
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION | 5 | 8.85e-01 | 3.75e-02 | 9.63e-01 |
GOBP RESPONSE TO ACTINOMYCIN D | 5 | 8.85e-01 | 3.75e-02 | 9.63e-01 |
GOBP ERK1 AND ERK2 CASCADE | 114 | 4.91e-01 | -3.75e-02 | 7.77e-01 |
GOCC MEDIATOR COMPLEX | 30 | 7.23e-01 | 3.74e-02 | 9.00e-01 |
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS | 51 | 6.45e-01 | -3.74e-02 | 8.62e-01 |
GOCC TRANSPORT VESICLE | 226 | 3.37e-01 | 3.73e-02 | 6.74e-01 |
GOBP MOTOR BEHAVIOR | 13 | 8.16e-01 | -3.73e-02 | 9.41e-01 |
GOBP T HELPER 2 CELL DIFFERENTIATION | 8 | 8.55e-01 | -3.72e-02 | 9.52e-01 |
GOBP ACROSOME ASSEMBLY | 12 | 8.24e-01 | -3.72e-02 | 9.43e-01 |
GOCC GOLGI APPARATUS SUBCOMPARTMENT | 235 | 3.30e-01 | -3.72e-02 | 6.65e-01 |
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 169 | 4.08e-01 | 3.71e-02 | 7.23e-01 |
GOMF CARGO RECEPTOR ACTIVITY | 18 | 7.86e-01 | 3.71e-02 | 9.28e-01 |
GOBP CELL FATE COMMITMENT | 82 | 5.63e-01 | -3.70e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY | 30 | 7.26e-01 | 3.70e-02 | 9.02e-01 |
GOBP INTERMEDIATE FILAMENT BASED PROCESS | 21 | 7.69e-01 | -3.70e-02 | 9.22e-01 |
GOBP HEPARIN BIOSYNTHETIC PROCESS | 5 | 8.86e-01 | -3.70e-02 | 9.64e-01 |
GOBP IMMUNE SYSTEM DEVELOPMENT | 111 | 5.03e-01 | 3.70e-02 | 7.82e-01 |
GOBP INTRACELLULAR TRANSPORT | 1107 | 4.65e-02 | 3.69e-02 | 2.83e-01 |
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING | 19 | 7.81e-01 | -3.68e-02 | 9.26e-01 |
GOBP ALANINE TRANSPORT | 9 | 8.49e-01 | 3.68e-02 | 9.51e-01 |
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY | 9 | 8.49e-01 | 3.67e-02 | 9.51e-01 |
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE | 13 | 8.19e-01 | -3.67e-02 | 9.41e-01 |
GOBP DICARBOXYLIC ACID TRANSPORT | 34 | 7.11e-01 | -3.67e-02 | 8.96e-01 |
GOBP RESPONSE TO NITROGEN COMPOUND | 558 | 1.47e-01 | -3.66e-02 | 4.79e-01 |
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS | 556 | 1.47e-01 | -3.66e-02 | 4.80e-01 |
GOBP MACROMOLECULE METHYLATION | 152 | 4.39e-01 | 3.66e-02 | 7.42e-01 |
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER | 78 | 5.78e-01 | 3.65e-02 | 8.25e-01 |
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 7.47e-01 | -3.65e-02 | 9.10e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION | 5 | 8.88e-01 | 3.64e-02 | 9.65e-01 |
GOBP REGULATION OF ICOSANOID SECRETION | 6 | 8.77e-01 | 3.64e-02 | 9.63e-01 |
GOMF PURINE NUCLEOTIDE BINDING | 1127 | 4.79e-02 | 3.64e-02 | 2.87e-01 |
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING | 8 | 8.59e-01 | -3.62e-02 | 9.54e-01 |
GOMF U1 SNRNA BINDING | 8 | 8.59e-01 | 3.62e-02 | 9.54e-01 |
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS | 11 | 8.35e-01 | 3.62e-02 | 9.46e-01 |
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY | 6 | 8.78e-01 | -3.62e-02 | 9.63e-01 |
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 55 | 6.43e-01 | -3.62e-02 | 8.60e-01 |
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY | 24 | 7.59e-01 | 3.62e-02 | 9.16e-01 |
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS | 20 | 7.80e-01 | -3.62e-02 | 9.26e-01 |
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT | 7 | 8.69e-01 | 3.61e-02 | 9.59e-01 |
GOBP REGULATION OF HYDROLASE ACTIVITY | 383 | 2.31e-01 | -3.61e-02 | 5.78e-01 |
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS | 14 | 8.15e-01 | -3.61e-02 | 9.40e-01 |
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY | 14 | 8.15e-01 | -3.61e-02 | 9.40e-01 |
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING | 9 | 8.51e-01 | -3.61e-02 | 9.51e-01 |
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION | 10 | 8.44e-01 | -3.60e-02 | 9.50e-01 |
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE | 101 | 5.33e-01 | -3.60e-02 | 8.03e-01 |
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 100 | 5.36e-01 | -3.60e-02 | 8.03e-01 |
GOBP PEXOPHAGY | 5 | 8.89e-01 | 3.60e-02 | 9.66e-01 |
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION | 7 | 8.69e-01 | -3.59e-02 | 9.59e-01 |
GOBP RECEPTOR INTERNALIZATION | 68 | 6.09e-01 | -3.59e-02 | 8.44e-01 |
GOBP IMMATURE B CELL DIFFERENTIATION | 9 | 8.52e-01 | 3.59e-02 | 9.51e-01 |
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING | 21 | 7.76e-01 | -3.59e-02 | 9.25e-01 |
GOBP ODONTOBLAST DIFFERENTIATION | 6 | 8.79e-01 | -3.59e-02 | 9.63e-01 |
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET | 24 | 7.61e-01 | 3.59e-02 | 9.17e-01 |
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 77 | 5.87e-01 | -3.59e-02 | 8.31e-01 |
GOCC MAIN AXON | 19 | 7.87e-01 | -3.58e-02 | 9.28e-01 |
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 20 | 7.82e-01 | 3.58e-02 | 9.26e-01 |
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY | 21 | 7.77e-01 | -3.57e-02 | 9.25e-01 |
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED EIF2 ALPHA PHOSPHORYLATION | 5 | 8.90e-01 | -3.57e-02 | 9.66e-01 |
GOBP PROTEIN LINEAR POLYUBIQUITINATION | 5 | 8.90e-01 | 3.57e-02 | 9.66e-01 |
GOBP ERYTHROCYTE HOMEOSTASIS | 99 | 5.41e-01 | 3.57e-02 | 8.05e-01 |
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 6 | 8.80e-01 | -3.56e-02 | 9.63e-01 |
GOMF INTERLEUKIN 6 RECEPTOR BINDING | 5 | 8.91e-01 | -3.55e-02 | 9.66e-01 |
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 25 | 7.60e-01 | 3.54e-02 | 9.16e-01 |
GOBP ANIMAL ORGAN REGENERATION | 27 | 7.51e-01 | -3.53e-02 | 9.11e-01 |
GOBP REGULATION OF DNA STRAND ELONGATION | 16 | 8.07e-01 | 3.53e-02 | 9.37e-01 |
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX | 13 | 8.26e-01 | -3.53e-02 | 9.43e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE | 49 | 6.70e-01 | 3.53e-02 | 8.74e-01 |
GOBP REGULATION OF TRANSLATIONAL INITIATION | 70 | 6.12e-01 | 3.52e-02 | 8.45e-01 |
GOBP PROTEIN ACETYLATION | 78 | 5.93e-01 | -3.51e-02 | 8.34e-01 |
GOBP RENAL SYSTEM DEVELOPMENT | 106 | 5.34e-01 | -3.50e-02 | 8.03e-01 |
GOCC FIBRILLAR CENTER | 106 | 5.35e-01 | 3.50e-02 | 8.03e-01 |
GOBP PROTEIN TARGETING TO PEROXISOME | 15 | 8.15e-01 | -3.49e-02 | 9.40e-01 |
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION | 14 | 8.21e-01 | 3.49e-02 | 9.42e-01 |
GOBP PROTEIN DESTABILIZATION | 34 | 7.25e-01 | -3.49e-02 | 9.01e-01 |
GOBP UBIQUITIN RECYCLING | 11 | 8.41e-01 | -3.49e-02 | 9.49e-01 |
GOBP REGULATION OF LIPID TRANSPORT | 52 | 6.64e-01 | 3.49e-02 | 8.72e-01 |
GOMF PHOSPHATIDYLCHOLINE BINDING | 19 | 7.93e-01 | -3.48e-02 | 9.32e-01 |
GOBP CARDIAC CHAMBER MORPHOGENESIS | 29 | 7.46e-01 | -3.48e-02 | 9.10e-01 |
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS | 11 | 8.42e-01 | -3.47e-02 | 9.49e-01 |
GOBP SYNAPTIC VESICLE TRANSPORT | 29 | 7.46e-01 | -3.47e-02 | 9.10e-01 |
GOBP DIAPEDESIS | 6 | 8.83e-01 | -3.47e-02 | 9.63e-01 |
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 18 | 7.99e-01 | -3.47e-02 | 9.33e-01 |
GOBP HORMONE MEDIATED SIGNALING PATHWAY | 103 | 5.44e-01 | -3.47e-02 | 8.07e-01 |
GOBP VACUOLE ORGANIZATION | 163 | 4.47e-01 | -3.47e-02 | 7.49e-01 |
GOBP REGULATION OF MAST CELL ACTIVATION | 26 | 7.60e-01 | -3.47e-02 | 9.16e-01 |
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION | 13 | 8.29e-01 | -3.46e-02 | 9.43e-01 |
GOMF CYTOSKELETAL PROTEIN BINDING | 492 | 1.96e-01 | -3.46e-02 | 5.43e-01 |
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION | 5 | 8.93e-01 | 3.46e-02 | 9.67e-01 |
GOBP LYSOSOMAL TRANSPORT | 95 | 5.61e-01 | -3.46e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION | 10 | 8.50e-01 | 3.46e-02 | 9.51e-01 |
GOBP PROTEIN DEGLYCOSYLATION | 13 | 8.29e-01 | 3.46e-02 | 9.43e-01 |
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES | 6 | 8.84e-01 | 3.46e-02 | 9.63e-01 |
GOBP REGULATION OF CATALYTIC ACTIVITY | 745 | 1.18e-01 | -3.45e-02 | 4.39e-01 |
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 309 | 3.02e-01 | 3.45e-02 | 6.43e-01 |
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION | 124 | 5.09e-01 | -3.45e-02 | 7.87e-01 |
GOBP REGULATION OF GLUTAMATE SECRETION | 8 | 8.66e-01 | 3.44e-02 | 9.57e-01 |
GOCC AXONAL GROWTH CONE | 14 | 8.24e-01 | -3.44e-02 | 9.43e-01 |
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR | 56 | 6.58e-01 | -3.42e-02 | 8.69e-01 |
GOBP EPITHELIAL TUBE MORPHOGENESIS | 111 | 5.36e-01 | -3.42e-02 | 8.03e-01 |
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS | 155 | 4.65e-01 | -3.41e-02 | 7.62e-01 |
GOBP REGULATION OF PROTEIN STABILITY | 222 | 3.84e-01 | 3.41e-02 | 7.06e-01 |
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION | 22 | 7.82e-01 | 3.41e-02 | 9.26e-01 |
GOCC PODOSOME | 21 | 7.87e-01 | -3.41e-02 | 9.28e-01 |
GOCC SET1C COMPASS COMPLEX | 11 | 8.45e-01 | 3.41e-02 | 9.51e-01 |
GOBP AUTOPHAGY OF MITOCHONDRION | 74 | 6.13e-01 | 3.41e-02 | 8.46e-01 |
GOBP MONOATOMIC ION TRANSPORT | 421 | 2.38e-01 | 3.40e-02 | 5.85e-01 |
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS | 10 | 8.52e-01 | -3.40e-02 | 9.51e-01 |
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS | 20 | 7.92e-01 | -3.40e-02 | 9.32e-01 |
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY | 16 | 8.14e-01 | -3.40e-02 | 9.40e-01 |
GOBP RESPONSE TO LITHIUM ION | 5 | 8.95e-01 | 3.40e-02 | 9.68e-01 |
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT | 24 | 7.73e-01 | -3.40e-02 | 9.24e-01 |
GOBP REGULATION OF CENTRIOLE REPLICATION | 17 | 8.09e-01 | 3.40e-02 | 9.37e-01 |
GOBP REGULATION OF LIPASE ACTIVITY | 29 | 7.52e-01 | -3.39e-02 | 9.12e-01 |
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION | 7 | 8.77e-01 | 3.39e-02 | 9.62e-01 |
GOBP RESPONSE TO HORMONE | 403 | 2.50e-01 | -3.39e-02 | 5.96e-01 |
GOMF CARD DOMAIN BINDING | 10 | 8.53e-01 | -3.38e-02 | 9.51e-01 |
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS | 57 | 6.59e-01 | -3.38e-02 | 8.69e-01 |
GOBP RESPONSE TO ESTROGEN | 30 | 7.49e-01 | -3.37e-02 | 9.11e-01 |
GOBP GLUCOSE CATABOLIC PROCESS | 13 | 8.33e-01 | 3.37e-02 | 9.45e-01 |
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS | 166 | 4.56e-01 | -3.37e-02 | 7.54e-01 |
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION | 12 | 8.40e-01 | -3.37e-02 | 9.48e-01 |
GOBP PROTEIN PROCESSING | 117 | 5.31e-01 | 3.36e-02 | 8.01e-01 |
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 8.78e-01 | -3.36e-02 | 9.63e-01 |
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY | 37 | 7.24e-01 | -3.36e-02 | 9.00e-01 |
GOBP REGULATION OF CHROMATIN ORGANIZATION | 42 | 7.07e-01 | -3.36e-02 | 8.93e-01 |
GOBP REGULATION OF STEM CELL DIFFERENTIATION | 46 | 6.95e-01 | 3.35e-02 | 8.87e-01 |
GOBP PROTEIN LIPID COMPLEX ASSEMBLY | 14 | 8.29e-01 | -3.34e-02 | 9.43e-01 |
GOMF HISTONE DEACETYLASE BINDING | 74 | 6.20e-01 | -3.34e-02 | 8.49e-01 |
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT | 133 | 5.08e-01 | -3.34e-02 | 7.86e-01 |
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY | 8 | 8.70e-01 | 3.33e-02 | 9.59e-01 |
GOMF MYOSIN PHOSPHATASE ACTIVITY | 48 | 6.90e-01 | -3.33e-02 | 8.83e-01 |
GOCC MITOTIC SPINDLE | 115 | 5.39e-01 | 3.33e-02 | 8.04e-01 |
GOBP T HELPER 1 TYPE IMMUNE RESPONSE | 22 | 7.87e-01 | -3.33e-02 | 9.28e-01 |
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY | 36 | 7.30e-01 | 3.33e-02 | 9.04e-01 |
GOBP DEPHOSPHORYLATION | 179 | 4.46e-01 | -3.33e-02 | 7.47e-01 |
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS | 81 | 6.07e-01 | 3.32e-02 | 8.42e-01 |
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY | 7 | 8.79e-01 | -3.32e-02 | 9.63e-01 |
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING | 5 | 8.98e-01 | -3.32e-02 | 9.69e-01 |
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING | 38 | 7.24e-01 | 3.31e-02 | 9.00e-01 |
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX | 33 | 7.42e-01 | 3.31e-02 | 9.07e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II | 26 | 7.70e-01 | -3.31e-02 | 9.23e-01 |
GOBP POSITIVE REGULATION OF GENE EXPRESSION | 580 | 1.82e-01 | -3.31e-02 | 5.28e-01 |
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 23 | 7.84e-01 | -3.31e-02 | 9.28e-01 |
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 118 | 5.37e-01 | -3.31e-02 | 8.04e-01 |
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY | 12 | 8.43e-01 | 3.31e-02 | 9.50e-01 |
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 19 | 8.03e-01 | 3.30e-02 | 9.35e-01 |
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY | 6 | 8.89e-01 | -3.30e-02 | 9.65e-01 |
GOBP CIRCULATORY SYSTEM PROCESS | 176 | 4.54e-01 | -3.29e-02 | 7.53e-01 |
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 9 | 8.64e-01 | -3.29e-02 | 9.57e-01 |
GOBP CAMP CATABOLIC PROCESS | 5 | 8.99e-01 | -3.29e-02 | 9.70e-01 |
GOBP REGULATION OF BODY FLUID LEVELS | 142 | 5.02e-01 | -3.28e-02 | 7.82e-01 |
GOBP ORGANELLE ASSEMBLY | 568 | 1.90e-01 | -3.28e-02 | 5.37e-01 |
GOBP REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II | 73 | 6.30e-01 | 3.27e-02 | 8.54e-01 |
GOBP INTRACELLULAR PROTEIN TRANSPORT | 616 | 1.75e-01 | 3.27e-02 | 5.18e-01 |
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY | 8 | 8.73e-01 | -3.27e-02 | 9.60e-01 |
GOCC ENDOSOME | 613 | 1.76e-01 | -3.27e-02 | 5.20e-01 |
GOBP CELLULAR RESPONSE TO IONIZING RADIATION | 49 | 6.93e-01 | 3.26e-02 | 8.86e-01 |
GOBP NCRNA CATABOLIC PROCESS | 41 | 7.18e-01 | -3.26e-02 | 8.99e-01 |
GOMF GLYCOSAMINOGLYCAN BINDING | 48 | 6.96e-01 | 3.26e-02 | 8.88e-01 |
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS | 6 | 8.90e-01 | 3.26e-02 | 9.66e-01 |
GOCC AP 2 ADAPTOR COMPLEX | 6 | 8.90e-01 | -3.26e-02 | 9.66e-01 |
GOMF SIGNALING RECEPTOR BINDING | 488 | 2.27e-01 | -3.25e-02 | 5.76e-01 |
GOBP FATTY ACID BIOSYNTHETIC PROCESS | 75 | 6.28e-01 | -3.24e-02 | 8.53e-01 |
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY | 125 | 5.34e-01 | -3.23e-02 | 8.03e-01 |
GOMF NADPLUS BINDING | 13 | 8.40e-01 | 3.23e-02 | 9.48e-01 |
GOMF MONOOXYGENASE ACTIVITY | 18 | 8.13e-01 | 3.22e-02 | 9.40e-01 |
GOBP CORTICOSTEROID RECEPTOR SIGNALING PATHWAY | 11 | 8.54e-01 | -3.21e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 6 | 8.92e-01 | -3.21e-02 | 9.67e-01 |
GOBP STEROID BIOSYNTHETIC PROCESS | 74 | 6.34e-01 | -3.21e-02 | 8.56e-01 |
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY | 18 | 8.14e-01 | -3.20e-02 | 9.40e-01 |
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY | 5 | 9.01e-01 | 3.20e-02 | 9.71e-01 |
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 94 | 5.93e-01 | 3.20e-02 | 8.34e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN | 36 | 7.40e-01 | 3.20e-02 | 9.06e-01 |
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS | 51 | 6.95e-01 | 3.18e-02 | 8.87e-01 |
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 125 | 5.41e-01 | -3.18e-02 | 8.05e-01 |
GOCC LIPID DROPLET | 53 | 6.90e-01 | 3.18e-02 | 8.83e-01 |
GOBP PROTEIN LOCALIZATION TO CELL CORTEX | 8 | 8.76e-01 | 3.18e-02 | 9.62e-01 |
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY | 69 | 6.49e-01 | -3.18e-02 | 8.63e-01 |
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS | 151 | 5.03e-01 | 3.18e-02 | 7.82e-01 |
GOBP POSITIVE REGULATION OF PROTEIN MATURATION | 12 | 8.49e-01 | -3.18e-02 | 9.51e-01 |
GOBP SEX DIFFERENTIATION | 98 | 5.88e-01 | 3.17e-02 | 8.32e-01 |
GOBP LIPOPROTEIN METABOLIC PROCESS | 83 | 6.18e-01 | -3.17e-02 | 8.48e-01 |
GOBP REGULATION OF EXIT FROM MITOSIS | 12 | 8.49e-01 | -3.17e-02 | 9.51e-01 |
GOBP REGULATION OF CALCIUM ION IMPORT | 8 | 8.77e-01 | -3.17e-02 | 9.62e-01 |
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY | 32 | 7.57e-01 | 3.17e-02 | 9.15e-01 |
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION | 42 | 7.23e-01 | 3.16e-02 | 9.00e-01 |
GOMF LIPASE ACTIVITY | 36 | 7.43e-01 | -3.16e-02 | 9.08e-01 |
GOBP REGULATION OF LIPID LOCALIZATION | 64 | 6.63e-01 | 3.16e-02 | 8.72e-01 |
GOBP NEUROBLAST PROLIFERATION | 28 | 7.73e-01 | -3.15e-02 | 9.24e-01 |
GOBP STRESS FIBER ASSEMBLY | 52 | 6.95e-01 | -3.15e-02 | 8.87e-01 |
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT | 11 | 8.57e-01 | -3.14e-02 | 9.53e-01 |
GOCC CORVET COMPLEX | 5 | 9.03e-01 | 3.14e-02 | 9.71e-01 |
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 115 | 5.62e-01 | 3.14e-02 | 8.17e-01 |
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY | 18 | 8.18e-01 | 3.14e-02 | 9.41e-01 |
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 292 | 3.62e-01 | -3.13e-02 | 6.89e-01 |
GOBP MIDBRAIN DEVELOPMENT | 43 | 7.23e-01 | 3.13e-02 | 9.00e-01 |
GOMF UBIQUITIN BINDING | 85 | 6.19e-01 | -3.13e-02 | 8.49e-01 |
GOBP SKELETAL MUSCLE ADAPTATION | 6 | 8.95e-01 | -3.13e-02 | 9.68e-01 |
GOBP IMPORT INTO NUCLEUS | 114 | 5.66e-01 | -3.12e-02 | 8.19e-01 |
GOBP ACTIN FILAMENT ORGANIZATION | 226 | 4.23e-01 | -3.12e-02 | 7.33e-01 |
GOBP REGULATION OF PHOSPHATASE ACTIVITY | 40 | 7.33e-01 | -3.12e-02 | 9.04e-01 |
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND | 24 | 7.92e-01 | 3.12e-02 | 9.31e-01 |
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION | 107 | 5.79e-01 | 3.12e-02 | 8.26e-01 |
GOBP REGULATION OF BLOOD CIRCULATION | 68 | 6.58e-01 | -3.11e-02 | 8.68e-01 |
GOMF CYTOKINE ACTIVITY | 32 | 7.61e-01 | 3.11e-02 | 9.17e-01 |
GOBP LYSOSOMAL MEMBRANE ORGANIZATION | 12 | 8.52e-01 | 3.11e-02 | 9.51e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES | 38 | 7.41e-01 | 3.11e-02 | 9.06e-01 |
GOCC CHROMOSOME TELOMERIC REPEAT REGION | 11 | 8.59e-01 | -3.10e-02 | 9.54e-01 |
GOBP AUTOPHAGOSOME ORGANIZATION | 90 | 6.12e-01 | -3.10e-02 | 8.45e-01 |
GOBP CELLULAR HYPOTONIC RESPONSE | 5 | 9.05e-01 | -3.10e-02 | 9.72e-01 |
GOBP HYPOTONIC RESPONSE | 5 | 9.05e-01 | -3.10e-02 | 9.72e-01 |
GOCC ROUGH ENDOPLASMIC RETICULUM | 41 | 7.32e-01 | 3.09e-02 | 9.04e-01 |
GOCC COP9 SIGNALOSOME | 12 | 8.53e-01 | 3.09e-02 | 9.51e-01 |
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS | 14 | 8.42e-01 | -3.09e-02 | 9.49e-01 |
GOCC ORGANELLE SUBCOMPARTMENT | 861 | 1.37e-01 | 3.08e-02 | 4.65e-01 |
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX | 8 | 8.80e-01 | 3.08e-02 | 9.63e-01 |
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE | 57 | 6.88e-01 | 3.08e-02 | 8.83e-01 |
GOCC TRANSFERASE COMPLEX | 626 | 1.99e-01 | 3.07e-02 | 5.46e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT | 21 | 8.08e-01 | 3.07e-02 | 9.37e-01 |
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY | 6 | 8.97e-01 | 3.06e-02 | 9.68e-01 |
GOBP REGULATION OF ACTIN FILAMENT LENGTH | 79 | 6.39e-01 | 3.06e-02 | 8.59e-01 |
GOBP GOLGI ORGANIZATION | 112 | 5.78e-01 | 3.06e-02 | 8.25e-01 |
GOMF TETRAPYRROLE BINDING | 45 | 7.23e-01 | -3.05e-02 | 9.00e-01 |
GOBP C4 DICARBOXYLATE TRANSPORT | 12 | 8.55e-01 | -3.05e-02 | 9.52e-01 |
GOBP POLYSACCHARIDE CATABOLIC PROCESS | 9 | 8.74e-01 | -3.05e-02 | 9.62e-01 |
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX | 15 | 8.38e-01 | 3.05e-02 | 9.47e-01 |
GOBP MESODERM MORPHOGENESIS | 22 | 8.05e-01 | -3.05e-02 | 9.36e-01 |
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS | 9 | 8.74e-01 | -3.05e-02 | 9.62e-01 |
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY | 9 | 8.74e-01 | 3.05e-02 | 9.62e-01 |
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION | 5 | 9.07e-01 | -3.03e-02 | 9.72e-01 |
GOBP AXON DEVELOPMENT | 164 | 5.06e-01 | -3.02e-02 | 7.86e-01 |
GOCC NUCLEAR MEMBRANE | 205 | 4.60e-01 | 3.01e-02 | 7.57e-01 |
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 26 | 7.90e-01 | -3.01e-02 | 9.30e-01 |
GOBP PLACENTA DEVELOPMENT | 63 | 6.80e-01 | -3.01e-02 | 8.79e-01 |
GOBP INTRACILIARY TRANSPORT | 26 | 7.91e-01 | 3.01e-02 | 9.30e-01 |
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION | 10 | 8.69e-01 | -3.01e-02 | 9.59e-01 |
GOBP T CELL MEDIATED IMMUNITY | 56 | 6.97e-01 | 3.01e-02 | 8.88e-01 |
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 24 | 7.99e-01 | 3.00e-02 | 9.33e-01 |
GOBP REGULATION OF TRANSPORTER ACTIVITY | 78 | 6.48e-01 | -3.00e-02 | 8.63e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS | 5 | 9.08e-01 | 3.00e-02 | 9.73e-01 |
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY | 5 | 9.08e-01 | -3.00e-02 | 9.73e-01 |
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 209 | 4.59e-01 | 2.99e-02 | 7.56e-01 |
GOBP PROTEIN LOCALIZATION TO CILIUM | 36 | 7.57e-01 | 2.99e-02 | 9.15e-01 |
GOBP RESPONSE TO KETONE | 86 | 6.33e-01 | -2.99e-02 | 8.56e-01 |
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING | 35 | 7.60e-01 | -2.98e-02 | 9.17e-01 |
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX | 18 | 8.27e-01 | 2.98e-02 | 9.43e-01 |
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE | 6 | 8.99e-01 | 2.98e-02 | 9.70e-01 |
GOBP AMYLOID BETA METABOLIC PROCESS | 37 | 7.54e-01 | -2.98e-02 | 9.14e-01 |
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY | 5 | 9.08e-01 | -2.98e-02 | 9.73e-01 |
GOBP MYOFIBROBLAST DIFFERENTIATION | 8 | 8.84e-01 | -2.98e-02 | 9.63e-01 |
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 12 | 8.59e-01 | 2.97e-02 | 9.54e-01 |
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS | 31 | 7.75e-01 | 2.97e-02 | 9.25e-01 |
GOBP TISSUE MORPHOGENESIS | 200 | 4.72e-01 | -2.97e-02 | 7.68e-01 |
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE | 27 | 7.90e-01 | 2.96e-02 | 9.30e-01 |
GOCC CELL TRAILING EDGE | 9 | 8.78e-01 | -2.96e-02 | 9.63e-01 |
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION | 7 | 8.92e-01 | -2.96e-02 | 9.67e-01 |
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION | 21 | 8.15e-01 | 2.95e-02 | 9.40e-01 |
GOMF NEDD8 TRANSFERASE ACTIVITY | 6 | 9.00e-01 | 2.95e-02 | 9.70e-01 |
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 534 | 2.52e-01 | -2.95e-02 | 5.96e-01 |
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY | 6 | 9.01e-01 | -2.95e-02 | 9.70e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION | 6 | 9.01e-01 | 2.95e-02 | 9.70e-01 |
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION | 22 | 8.11e-01 | 2.95e-02 | 9.40e-01 |
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 40 | 7.48e-01 | -2.94e-02 | 9.10e-01 |
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 72 | 6.67e-01 | 2.94e-02 | 8.73e-01 |
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 25 | 8.00e-01 | 2.94e-02 | 9.34e-01 |
GOCC LATE ENDOSOME MEMBRANE | 117 | 5.85e-01 | 2.94e-02 | 8.30e-01 |
GOBP NEGATIVE REGULATION OF GENE EXPRESSION | 611 | 2.25e-01 | -2.93e-02 | 5.75e-01 |
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS | 9 | 8.79e-01 | 2.93e-02 | 9.63e-01 |
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX | 8 | 8.86e-01 | 2.93e-02 | 9.64e-01 |
GOMF PROTEIN TYROSINE KINASE ACTIVITY | 65 | 6.84e-01 | -2.93e-02 | 8.81e-01 |
GOMF EXOGENOUS PROTEIN BINDING | 35 | 7.65e-01 | -2.93e-02 | 9.19e-01 |
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 53 | 7.14e-01 | 2.92e-02 | 8.96e-01 |
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT | 54 | 7.11e-01 | 2.92e-02 | 8.96e-01 |
GOBP MORPHOGENESIS OF AN EPITHELIUM | 171 | 5.13e-01 | -2.91e-02 | 7.88e-01 |
GOBP NEURONAL ACTION POTENTIAL | 7 | 8.94e-01 | 2.91e-02 | 9.67e-01 |
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL | 5 | 9.10e-01 | -2.91e-02 | 9.73e-01 |
GOCC UNIPLEX COMPLEX | 6 | 9.02e-01 | 2.91e-02 | 9.71e-01 |
GOCC CANONICAL INFLAMMASOME COMPLEX | 10 | 8.74e-01 | -2.91e-02 | 9.61e-01 |
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 17 | 8.36e-01 | 2.91e-02 | 9.46e-01 |
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION | 5 | 9.11e-01 | 2.90e-02 | 9.73e-01 |
GOBP POSITIVE REGULATION OF HEART GROWTH | 9 | 8.81e-01 | -2.89e-02 | 9.63e-01 |
GOMF 1 PHOSPHATIDYLINOSITOL BINDING | 9 | 8.81e-01 | -2.89e-02 | 9.63e-01 |
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION | 54 | 7.14e-01 | 2.88e-02 | 8.97e-01 |
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 78 | 6.61e-01 | 2.88e-02 | 8.70e-01 |
GOBP REPLICATIVE SENESCENCE | 12 | 8.63e-01 | 2.88e-02 | 9.56e-01 |
GOBP FERTILIZATION | 51 | 7.22e-01 | -2.88e-02 | 9.00e-01 |
GOBP SPINDLE ASSEMBLY | 92 | 6.34e-01 | 2.88e-02 | 8.56e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY | 206 | 4.79e-01 | -2.88e-02 | 7.72e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION | 120 | 5.88e-01 | 2.87e-02 | 8.32e-01 |
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION | 7 | 8.95e-01 | -2.87e-02 | 9.68e-01 |
GOBP CELLULAR HOMEOSTASIS | 362 | 3.55e-01 | 2.87e-02 | 6.85e-01 |
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY | 8 | 8.88e-01 | 2.87e-02 | 9.65e-01 |
GOCC CELL SURFACE | 268 | 4.24e-01 | -2.87e-02 | 7.34e-01 |
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 236 | 4.52e-01 | -2.87e-02 | 7.51e-01 |
GOBP KINETOCHORE ASSEMBLY | 15 | 8.48e-01 | 2.86e-02 | 9.51e-01 |
GOBP RESPONSE TO FUNGICIDE | 5 | 9.12e-01 | 2.86e-02 | 9.74e-01 |
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY | 10 | 8.76e-01 | -2.86e-02 | 9.62e-01 |
GOBP ESCRT COMPLEX DISASSEMBLY | 10 | 8.76e-01 | 2.86e-02 | 9.62e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS | 365 | 3.55e-01 | 2.86e-02 | 6.85e-01 |
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER | 9 | 8.82e-01 | -2.85e-02 | 9.63e-01 |
GOBP RESPONSE TO STEROID HORMONE | 155 | 5.43e-01 | -2.84e-02 | 8.07e-01 |
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION | 33 | 7.80e-01 | 2.81e-02 | 9.26e-01 |
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION | 9 | 8.84e-01 | -2.80e-02 | 9.63e-01 |
GOMF DYSTROGLYCAN BINDING | 5 | 9.14e-01 | -2.80e-02 | 9.74e-01 |
GOMF HISTONE METHYLTRANSFERASE BINDING | 13 | 8.61e-01 | -2.80e-02 | 9.56e-01 |
GOBP REGULATION OF CELL MATRIX ADHESION | 56 | 7.18e-01 | -2.79e-02 | 8.99e-01 |
GOBP REGULATION OF CYTOPLASMIC TRANSLATION | 26 | 8.05e-01 | 2.79e-02 | 9.36e-01 |
GOBP AXIS SPECIFICATION | 23 | 8.17e-01 | -2.79e-02 | 9.41e-01 |
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY | 78 | 6.71e-01 | 2.79e-02 | 8.75e-01 |
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS | 13 | 8.62e-01 | -2.78e-02 | 9.56e-01 |
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING | 29 | 7.96e-01 | 2.78e-02 | 9.33e-01 |
GOBP CELL CYCLE | 1091 | 1.37e-01 | 2.77e-02 | 4.66e-01 |
GOCC PSEUDOPODIUM | 10 | 8.79e-01 | 2.77e-02 | 9.63e-01 |
GOCC AZUROPHIL GRANULE | 110 | 6.17e-01 | -2.77e-02 | 8.47e-01 |
GOBP REGULATION OF DNA DEMETHYLATION | 6 | 9.07e-01 | -2.77e-02 | 9.72e-01 |
GOCC CILIARY MEMBRANE | 20 | 8.31e-01 | -2.77e-02 | 9.43e-01 |
GOBP RESPONSE TO TEMPERATURE STIMULUS | 85 | 6.61e-01 | 2.76e-02 | 8.70e-01 |
GOBP SPHINGOLIPID METABOLIC PROCESS | 86 | 6.59e-01 | -2.76e-02 | 8.69e-01 |
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE | 24 | 8.15e-01 | 2.76e-02 | 9.40e-01 |
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS | 12 | 8.69e-01 | -2.76e-02 | 9.59e-01 |
GOMF N METHYLTRANSFERASE ACTIVITY | 61 | 7.10e-01 | 2.76e-02 | 8.95e-01 |
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS | 15 | 8.54e-01 | 2.75e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF TISSUE REMODELING | 5 | 9.15e-01 | -2.75e-02 | 9.74e-01 |
GOBP STEROID METABOLIC PROCESS | 115 | 6.12e-01 | -2.75e-02 | 8.45e-01 |
GOBP MOLTING CYCLE | 34 | 7.82e-01 | -2.74e-02 | 9.26e-01 |
GOBP REGULATION OF PROGRAMMED CELL DEATH | 785 | 2.03e-01 | -2.74e-02 | 5.51e-01 |
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION | 16 | 8.49e-01 | 2.74e-02 | 9.51e-01 |
GOBP MYELOID CELL DEVELOPMENT | 57 | 7.21e-01 | -2.74e-02 | 8.99e-01 |
GOBP NECROPTOTIC PROCESS | 28 | 8.02e-01 | 2.74e-02 | 9.35e-01 |
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY | 5 | 9.16e-01 | -2.73e-02 | 9.74e-01 |
GOCC MYOSIN II COMPLEX | 8 | 8.94e-01 | 2.73e-02 | 9.67e-01 |
GOBP PHOTORECEPTOR CELL MAINTENANCE | 12 | 8.70e-01 | -2.73e-02 | 9.59e-01 |
GOBP APOPTOTIC PROCESS | 1020 | 1.56e-01 | -2.73e-02 | 4.91e-01 |
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS | 6 | 9.08e-01 | 2.72e-02 | 9.73e-01 |
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS | 75 | 6.85e-01 | 2.72e-02 | 8.81e-01 |
GOBP NERVE DEVELOPMENT | 23 | 8.22e-01 | 2.72e-02 | 9.42e-01 |
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS | 14 | 8.60e-01 | 2.72e-02 | 9.55e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING | 5 | 9.16e-01 | 2.72e-02 | 9.74e-01 |
GOBP RESPONSE TO INTERFERON BETA | 24 | 8.18e-01 | 2.72e-02 | 9.41e-01 |
GOBP NEURON PROJECTION EXTENSION | 74 | 6.87e-01 | -2.72e-02 | 8.83e-01 |
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS | 35 | 7.81e-01 | -2.72e-02 | 9.26e-01 |
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY | 6 | 9.08e-01 | -2.71e-02 | 9.73e-01 |
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION | 10 | 8.82e-01 | -2.71e-02 | 9.63e-01 |
GOBP REGULATION OF RECEPTOR INTERNALIZATION | 34 | 7.85e-01 | 2.71e-02 | 9.28e-01 |
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE | 16 | 8.52e-01 | 2.70e-02 | 9.51e-01 |
GOBP SINGLE FERTILIZATION | 38 | 7.74e-01 | -2.70e-02 | 9.24e-01 |
GOBP HEMOSTASIS | 97 | 6.48e-01 | 2.69e-02 | 8.63e-01 |
GOBP REGULATION OF CATABOLIC PROCESS | 678 | 2.43e-01 | -2.69e-02 | 5.91e-01 |
GOMF ACETYLTRANSFERASE ACTIVITY | 66 | 7.07e-01 | 2.69e-02 | 8.93e-01 |
GOCC STEREOCILIUM BUNDLE | 17 | 8.48e-01 | 2.68e-02 | 9.51e-01 |
GOCC UNCONVENTIONAL MYOSIN COMPLEX | 5 | 9.17e-01 | 2.68e-02 | 9.74e-01 |
GOBP PROTEIN TARGETING TO MEMBRANE | 76 | 6.87e-01 | 2.68e-02 | 8.83e-01 |
GOMF U1 SNRNP BINDING | 6 | 9.10e-01 | 2.68e-02 | 9.73e-01 |
GOBP PRIMITIVE HEMOPOIESIS | 8 | 8.96e-01 | -2.68e-02 | 9.68e-01 |
GOMF AMINO ACID BINDING | 15 | 8.58e-01 | 2.67e-02 | 9.54e-01 |
GOMF PRE MRNA 3 SPLICE SITE BINDING | 5 | 9.18e-01 | 2.67e-02 | 9.74e-01 |
GOBP GLYCEROLIPID METABOLIC PROCESS | 193 | 5.25e-01 | -2.67e-02 | 7.97e-01 |
GOBP REGULATION OF PROTEIN TARGETING | 55 | 7.32e-01 | -2.67e-02 | 9.04e-01 |
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS | 28 | 8.07e-01 | 2.67e-02 | 9.37e-01 |
GOBP POSITIVE REGULATION OF AMINE TRANSPORT | 15 | 8.58e-01 | 2.66e-02 | 9.54e-01 |
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT | 5 | 9.18e-01 | -2.66e-02 | 9.74e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT | 63 | 7.15e-01 | -2.66e-02 | 8.97e-01 |
GOBP PROTEIN CATABOLIC PROCESS | 670 | 2.51e-01 | 2.66e-02 | 5.96e-01 |
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION | 81 | 6.80e-01 | 2.66e-02 | 8.79e-01 |
GOBP MULTICELLULAR ORGANISM GROWTH | 70 | 7.01e-01 | -2.66e-02 | 8.91e-01 |
GOMF CENTROMERIC DNA BINDING | 5 | 9.18e-01 | -2.65e-02 | 9.74e-01 |
GOBP GLYCOPROTEIN METABOLIC PROCESS | 184 | 5.38e-01 | 2.65e-02 | 8.04e-01 |
GOMF ACTIN BINDING | 200 | 5.22e-01 | -2.65e-02 | 7.94e-01 |
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 9 | 8.91e-01 | 2.64e-02 | 9.66e-01 |
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE | 12 | 8.75e-01 | 2.63e-02 | 9.62e-01 |
GOBP ARACHIDONIC ACID METABOLIC PROCESS | 13 | 8.70e-01 | 2.63e-02 | 9.59e-01 |
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION | 24 | 8.24e-01 | -2.63e-02 | 9.43e-01 |
GOBP LOCALIZATION WITHIN MEMBRANE | 409 | 3.69e-01 | 2.63e-02 | 6.96e-01 |
GOBP CYTOSKELETON ORGANIZATION | 709 | 2.46e-01 | -2.62e-02 | 5.92e-01 |
GOBP PROTEOGLYCAN CATABOLIC PROCESS | 6 | 9.12e-01 | -2.60e-02 | 9.74e-01 |
GOBP REGULATION OF CELLULAR RESPIRATION | 27 | 8.15e-01 | 2.60e-02 | 9.40e-01 |
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 100 | 6.55e-01 | -2.60e-02 | 8.66e-01 |
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY | 8 | 8.99e-01 | -2.59e-02 | 9.70e-01 |
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING | 7 | 9.05e-01 | -2.59e-02 | 9.72e-01 |
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS | 185 | 5.45e-01 | 2.59e-02 | 8.08e-01 |
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL | 29 | 8.09e-01 | -2.59e-02 | 9.38e-01 |
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 77 | 6.95e-01 | 2.59e-02 | 8.87e-01 |
GOBP TRANSFORMING GROWTH FACTOR BETA ACTIVATION | 5 | 9.20e-01 | -2.59e-02 | 9.75e-01 |
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY | 6 | 9.13e-01 | 2.59e-02 | 9.74e-01 |
GOBP POSITIVE REGULATION OF SECRETION | 125 | 6.19e-01 | -2.58e-02 | 8.49e-01 |
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE | 7 | 9.06e-01 | -2.58e-02 | 9.72e-01 |
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION | 6 | 9.13e-01 | -2.57e-02 | 9.74e-01 |
GOMF THIOL OXIDASE ACTIVITY | 6 | 9.13e-01 | -2.57e-02 | 9.74e-01 |
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM | 157 | 5.80e-01 | 2.57e-02 | 8.27e-01 |
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 14 | 8.68e-01 | -2.57e-02 | 9.59e-01 |
GOBP SNRNA MODIFICATION | 7 | 9.06e-01 | 2.57e-02 | 9.72e-01 |
GOBP AMYLOID FIBRIL FORMATION | 28 | 8.14e-01 | 2.57e-02 | 9.40e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS | 28 | 8.15e-01 | -2.56e-02 | 9.40e-01 |
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY | 19 | 8.47e-01 | -2.55e-02 | 9.51e-01 |
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY | 182 | 5.55e-01 | -2.55e-02 | 8.14e-01 |
GOBP REGULATION OF DEPHOSPHORYLATION | 73 | 7.07e-01 | 2.55e-02 | 8.93e-01 |
GOBP REGULATION OF EXOSOMAL SECRETION | 14 | 8.69e-01 | 2.55e-02 | 9.59e-01 |
GOBP ESTROUS CYCLE | 7 | 9.07e-01 | 2.54e-02 | 9.72e-01 |
GOBP MEMBRANE PROTEIN PROTEOLYSIS | 40 | 7.81e-01 | 2.54e-02 | 9.26e-01 |
GOMF CADHERIN BINDING | 228 | 5.11e-01 | 2.54e-02 | 7.88e-01 |
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS | 28 | 8.16e-01 | -2.54e-02 | 9.41e-01 |
GOMF PROTEIN KINASE B BINDING | 9 | 8.95e-01 | 2.54e-02 | 9.68e-01 |
GOBP RESPONSE TO ABIOTIC STIMULUS | 539 | 3.24e-01 | -2.53e-02 | 6.61e-01 |
GOBP TRANSEPITHELIAL TRANSPORT | 9 | 8.96e-01 | -2.52e-02 | 9.68e-01 |
GOBP MONOAMINE TRANSPORT | 20 | 8.45e-01 | -2.52e-02 | 9.51e-01 |
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION | 105 | 6.57e-01 | -2.52e-02 | 8.67e-01 |
GOBP REGULATION OF MRNA CATABOLIC PROCESS | 135 | 6.15e-01 | -2.52e-02 | 8.47e-01 |
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS | 54 | 7.50e-01 | -2.51e-02 | 9.11e-01 |
GOBP PYRUVATE METABOLIC PROCESS | 66 | 7.25e-01 | -2.51e-02 | 9.01e-01 |
GOBP RESPONSE TO MAGNESIUM ION | 5 | 9.23e-01 | 2.51e-02 | 9.76e-01 |
GOMF PROTEIN PHOSPHATASE 1 BINDING | 14 | 8.71e-01 | -2.50e-02 | 9.60e-01 |
GOBP RESPONSE TO GAMMA RADIATION | 36 | 7.95e-01 | 2.50e-02 | 9.33e-01 |
GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY | 129 | 6.25e-01 | -2.50e-02 | 8.51e-01 |
GOCC EARLY ENDOSOME MEMBRANE | 115 | 6.46e-01 | -2.49e-02 | 8.62e-01 |
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT | 281 | 4.77e-01 | -2.49e-02 | 7.70e-01 |
GOBP PSEUDOURIDINE SYNTHESIS | 13 | 8.77e-01 | 2.48e-02 | 9.62e-01 |
GOBP RESPONSE TO HYPEROXIA | 10 | 8.92e-01 | -2.48e-02 | 9.67e-01 |
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE | 63 | 7.34e-01 | -2.48e-02 | 9.04e-01 |
GOBP INSULIN METABOLIC PROCESS | 8 | 9.04e-01 | -2.47e-02 | 9.71e-01 |
GOMF RECEPTOR SERINE THREONINE KINASE BINDING | 5 | 9.24e-01 | 2.47e-02 | 9.76e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 59 | 7.44e-01 | 2.47e-02 | 9.08e-01 |
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION | 15 | 8.69e-01 | -2.46e-02 | 9.59e-01 |
GOBP MONOSACCHARIDE METABOLIC PROCESS | 140 | 6.17e-01 | -2.46e-02 | 8.47e-01 |
GOMF CARBONYL REDUCTASE NADPH ACTIVITY | 6 | 9.17e-01 | -2.46e-02 | 9.74e-01 |
GOCC HISTONE METHYLTRANSFERASE COMPLEX | 53 | 7.58e-01 | -2.46e-02 | 9.16e-01 |
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM | 30 | 8.16e-01 | 2.45e-02 | 9.41e-01 |
GOBP POSTSYNAPSE ORGANIZATION | 80 | 7.05e-01 | 2.45e-02 | 8.93e-01 |
GOBP REGULATION OF HEART CONTRACTION | 51 | 7.62e-01 | -2.45e-02 | 9.18e-01 |
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT | 130 | 6.31e-01 | -2.45e-02 | 8.55e-01 |
GOCC EARLY ENDOSOME | 256 | 5.04e-01 | -2.45e-02 | 7.83e-01 |
GOBP VIRAL TRANSLATION | 20 | 8.50e-01 | 2.45e-02 | 9.51e-01 |
GOBP SYNAPTIC VESICLE LOCALIZATION | 33 | 8.08e-01 | -2.44e-02 | 9.37e-01 |
GOBP TRANSMEMBRANE TRANSPORT | 554 | 3.35e-01 | 2.44e-02 | 6.71e-01 |
GOBP EMBRYO DEVELOPMENT | 465 | 3.76e-01 | -2.44e-02 | 7.01e-01 |
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY | 205 | 5.52e-01 | 2.43e-02 | 8.13e-01 |
GOBP REGULATION OF CATION CHANNEL ACTIVITY | 32 | 8.13e-01 | -2.42e-02 | 9.40e-01 |
GOMF PROTEIN DIMERIZATION ACTIVITY | 513 | 3.57e-01 | -2.42e-02 | 6.87e-01 |
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 42 | 7.87e-01 | -2.42e-02 | 9.28e-01 |
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT | 21 | 8.48e-01 | -2.41e-02 | 9.51e-01 |
GOCC AMPHISOME | 12 | 8.85e-01 | 2.41e-02 | 9.64e-01 |
GOBP RESPONSE TO INTERLEUKIN 2 | 7 | 9.12e-01 | -2.41e-02 | 9.74e-01 |
GOBP ERBB SIGNALING PATHWAY | 64 | 7.40e-01 | 2.40e-02 | 9.06e-01 |
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 26 | 8.32e-01 | 2.40e-02 | 9.44e-01 |
GOBP SPERMATID DIFFERENTIATION | 65 | 7.38e-01 | -2.40e-02 | 9.06e-01 |
GOBP PLATELET ACTIVATION | 66 | 7.36e-01 | 2.40e-02 | 9.06e-01 |
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM | 6 | 9.19e-01 | -2.40e-02 | 9.75e-01 |
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS | 10 | 8.95e-01 | -2.40e-02 | 9.68e-01 |
GOMF ACTIN FILAMENT BINDING | 102 | 6.77e-01 | 2.40e-02 | 8.78e-01 |
GOMF MANNOSE BINDING | 7 | 9.13e-01 | 2.39e-02 | 9.74e-01 |
GOBP RESPONSE TO ALDOSTERONE | 9 | 9.01e-01 | -2.39e-02 | 9.71e-01 |
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 9 | 9.01e-01 | -2.39e-02 | 9.71e-01 |
GOBP IMMUNOLOGICAL MEMORY PROCESS | 9 | 9.02e-01 | -2.38e-02 | 9.71e-01 |
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION | 29 | 8.25e-01 | -2.37e-02 | 9.43e-01 |
GOMF TPR DOMAIN BINDING | 6 | 9.20e-01 | 2.37e-02 | 9.75e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS | 9 | 9.02e-01 | 2.37e-02 | 9.71e-01 |
GOMF DIOXYGENASE ACTIVITY | 51 | 7.71e-01 | -2.36e-02 | 9.23e-01 |
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 537 | 3.59e-01 | 2.36e-02 | 6.87e-01 |
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC | 29 | 8.27e-01 | -2.35e-02 | 9.43e-01 |
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 100 | 6.86e-01 | -2.35e-02 | 8.82e-01 |
GOBP PULMONARY VALVE DEVELOPMENT | 7 | 9.14e-01 | -2.35e-02 | 9.74e-01 |
GOBP MESENCHYMAL CELL DIFFERENTIATION | 88 | 7.05e-01 | -2.34e-02 | 8.93e-01 |
GOBP SYNAPTIC VESICLE MATURATION | 16 | 8.72e-01 | 2.33e-02 | 9.60e-01 |
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT | 32 | 8.20e-01 | -2.33e-02 | 9.42e-01 |
GOMF BETA TUBULIN BINDING | 26 | 8.37e-01 | -2.33e-02 | 9.47e-01 |
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 35 | 8.12e-01 | 2.33e-02 | 9.40e-01 |
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY | 10 | 8.99e-01 | 2.32e-02 | 9.70e-01 |
GOBP ERYTHROCYTE MATURATION | 14 | 8.81e-01 | -2.32e-02 | 9.63e-01 |
GOBP CO TRANSCRIPTIONAL MRNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY | 5 | 9.29e-01 | 2.31e-02 | 9.77e-01 |
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH | 464 | 4.01e-01 | -2.31e-02 | 7.20e-01 |
GOCC GOLGI STACK | 84 | 7.15e-01 | 2.31e-02 | 8.97e-01 |
GOBP DNA METHYLATION | 35 | 8.14e-01 | -2.30e-02 | 9.40e-01 |
GOBP PIGMENTATION | 59 | 7.60e-01 | -2.30e-02 | 9.16e-01 |
GOBP CEREBELLAR CORTEX FORMATION | 10 | 9.00e-01 | -2.30e-02 | 9.70e-01 |
GOMF MRNA BINDING | 236 | 5.47e-01 | 2.30e-02 | 8.10e-01 |
GOBP PROTEIN O LINKED GLYCOSYLATION | 45 | 7.90e-01 | -2.29e-02 | 9.30e-01 |
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS | 13 | 8.87e-01 | -2.29e-02 | 9.64e-01 |
GOBP REGULATION OF CELL CYCLE | 676 | 3.22e-01 | 2.29e-02 | 6.59e-01 |
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 94 | 7.04e-01 | 2.27e-02 | 8.93e-01 |
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 577 | 3.63e-01 | -2.26e-02 | 6.89e-01 |
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION | 40 | 8.06e-01 | 2.25e-02 | 9.37e-01 |
GOBP RESPONSE TO X RAY | 21 | 8.59e-01 | 2.25e-02 | 9.54e-01 |
GOBP REGULATION OF LEUKOCYTE MIGRATION | 97 | 7.04e-01 | -2.24e-02 | 8.93e-01 |
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY | 36 | 8.17e-01 | 2.24e-02 | 9.41e-01 |
GOMF SH2 DOMAIN BINDING | 28 | 8.38e-01 | 2.24e-02 | 9.47e-01 |
GOBP OSTEOBLAST DIFFERENTIATION | 96 | 7.06e-01 | -2.23e-02 | 8.93e-01 |
GOMF HISTONE METHYLTRANSFERASE ACTIVITY | 45 | 7.96e-01 | 2.23e-02 | 9.33e-01 |
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 86 | 7.23e-01 | -2.22e-02 | 9.00e-01 |
GOBP THYMIC T CELL SELECTION | 10 | 9.04e-01 | -2.21e-02 | 9.71e-01 |
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY | 10 | 9.04e-01 | -2.21e-02 | 9.71e-01 |
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY | 11 | 8.99e-01 | -2.20e-02 | 9.70e-01 |
GOBP VACUOLAR TRANSPORT | 124 | 6.73e-01 | -2.20e-02 | 8.77e-01 |
GOBP REGULATION OF MEMBRANE PERMEABILITY | 46 | 7.96e-01 | -2.20e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF AXONOGENESIS | 32 | 8.30e-01 | -2.20e-02 | 9.43e-01 |
GOMF CARBOHYDRATE BINDING | 95 | 7.12e-01 | -2.20e-02 | 8.96e-01 |
GOMF ENZYME ACTIVATOR ACTIVITY | 330 | 4.98e-01 | -2.19e-02 | 7.79e-01 |
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT | 12 | 8.95e-01 | -2.19e-02 | 9.68e-01 |
GOBP REGULATION OF HORMONE METABOLIC PROCESS | 12 | 8.95e-01 | -2.19e-02 | 9.68e-01 |
GOBP ANDROGEN METABOLIC PROCESS | 8 | 9.15e-01 | 2.19e-02 | 9.74e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION | 39 | 8.14e-01 | -2.19e-02 | 9.40e-01 |
GOCC SCAR COMPLEX | 9 | 9.10e-01 | 2.19e-02 | 9.73e-01 |
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 23 | 8.56e-01 | -2.19e-02 | 9.53e-01 |
GOBP DNA DEALKYLATION | 23 | 8.56e-01 | -2.18e-02 | 9.53e-01 |
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 16 | 8.80e-01 | -2.18e-02 | 9.63e-01 |
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS | 10 | 9.05e-01 | 2.18e-02 | 9.72e-01 |
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION | 26 | 8.48e-01 | -2.18e-02 | 9.51e-01 |
GOBP PROTEIN LOCALIZATION TO VACUOLE | 63 | 7.66e-01 | 2.18e-02 | 9.19e-01 |
GOMF LIPID PHOSPHATASE ACTIVITY | 6 | 9.27e-01 | 2.18e-02 | 9.77e-01 |
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING | 13 | 8.92e-01 | 2.17e-02 | 9.67e-01 |
GOCC CLATHRIN COATED ENDOCYTIC VESICLE | 40 | 8.12e-01 | 2.17e-02 | 9.40e-01 |
GOCC SEC61 TRANSLOCON COMPLEX | 5 | 9.33e-01 | -2.17e-02 | 9.79e-01 |
GOBP POSITIVE REGULATION OF ORGAN GROWTH | 14 | 8.88e-01 | -2.17e-02 | 9.65e-01 |
GOBP ALCOHOL BIOSYNTHETIC PROCESS | 64 | 7.65e-01 | -2.17e-02 | 9.19e-01 |
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 724 | 3.34e-01 | -2.16e-02 | 6.70e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 35 | 8.25e-01 | -2.16e-02 | 9.43e-01 |
GOBP SEXUAL REPRODUCTION | 398 | 4.66e-01 | -2.16e-02 | 7.62e-01 |
GOBP INTERFERON MEDIATED SIGNALING PATHWAY | 58 | 7.77e-01 | -2.15e-02 | 9.25e-01 |
GOBP PROTEIN TARGETING TO VACUOLE | 38 | 8.19e-01 | 2.15e-02 | 9.41e-01 |
GOBP RESPONSE TO FATTY ACID | 21 | 8.65e-01 | -2.14e-02 | 9.57e-01 |
GOBP SCHWANN CELL DEVELOPMENT | 17 | 8.79e-01 | -2.14e-02 | 9.63e-01 |
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 47 | 8.00e-01 | -2.14e-02 | 9.34e-01 |
GOMF ANTIPORTER ACTIVITY | 60 | 7.75e-01 | 2.14e-02 | 9.25e-01 |
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS | 19 | 8.72e-01 | 2.13e-02 | 9.60e-01 |
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 46 | 8.03e-01 | 2.13e-02 | 9.35e-01 |
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION | 5 | 9.34e-01 | -2.13e-02 | 9.80e-01 |
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION | 38 | 8.21e-01 | -2.12e-02 | 9.42e-01 |
GOBP CALCIUM ION REGULATED EXOCYTOSIS | 17 | 8.80e-01 | -2.12e-02 | 9.63e-01 |
GOBP ERYTHROCYTE DEVELOPMENT | 27 | 8.49e-01 | -2.12e-02 | 9.51e-01 |
GOBP INTERLEUKIN 10 PRODUCTION | 28 | 8.47e-01 | -2.11e-02 | 9.51e-01 |
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 295 | 5.37e-01 | 2.11e-02 | 8.04e-01 |
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 77 | 7.49e-01 | -2.11e-02 | 9.11e-01 |
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS | 15 | 8.88e-01 | 2.11e-02 | 9.65e-01 |
GOMF CYTOKINE RECEPTOR ACTIVITY | 24 | 8.59e-01 | -2.10e-02 | 9.54e-01 |
GOBP CARDIAC ATRIUM DEVELOPMENT | 12 | 9.00e-01 | -2.10e-02 | 9.70e-01 |
GOBP ENDOTHELIAL CELL PROLIFERATION | 59 | 7.81e-01 | 2.10e-02 | 9.26e-01 |
GOBP PHAGOLYSOSOME ASSEMBLY | 8 | 9.18e-01 | 2.10e-02 | 9.74e-01 |
GOBP REGULATION OF TRANSPORT | 758 | 3.39e-01 | -2.10e-02 | 6.75e-01 |
GOBP REGULATION OF AMIDE METABOLIC PROCESS | 345 | 5.10e-01 | 2.09e-02 | 7.87e-01 |
GOCC SYNAPTIC VESICLE MEMBRANE | 50 | 7.99e-01 | -2.09e-02 | 9.33e-01 |
GOCC RIBONUCLEOPROTEIN GRANULE | 184 | 6.27e-01 | -2.09e-02 | 8.53e-01 |
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY | 7 | 9.24e-01 | 2.09e-02 | 9.76e-01 |
GOCC MRNA CAP BINDING COMPLEX | 11 | 9.05e-01 | 2.08e-02 | 9.72e-01 |
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT | 19 | 8.76e-01 | -2.07e-02 | 9.62e-01 |
GOBP SNRNA METABOLIC PROCESS | 46 | 8.08e-01 | 2.07e-02 | 9.37e-01 |
GOCC MLL1 2 COMPLEX | 27 | 8.52e-01 | -2.07e-02 | 9.51e-01 |
GOCC SUPRAMOLECULAR COMPLEX | 636 | 3.84e-01 | 2.07e-02 | 7.06e-01 |
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION | 373 | 5.00e-01 | -2.06e-02 | 7.80e-01 |
GOCC CORTICAL ACTIN CYTOSKELETON | 38 | 8.26e-01 | 2.06e-02 | 9.43e-01 |
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 30 | 8.45e-01 | -2.06e-02 | 9.51e-01 |
GOCC CELL CORTEX | 161 | 6.54e-01 | 2.06e-02 | 8.66e-01 |
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION | 13 | 8.98e-01 | 2.05e-02 | 9.69e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS | 7 | 9.25e-01 | -2.05e-02 | 9.76e-01 |
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 56 | 7.91e-01 | -2.05e-02 | 9.31e-01 |
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY | 42 | 8.18e-01 | -2.05e-02 | 9.41e-01 |
GOBP MACROMOLECULE CATABOLIC PROCESS | 919 | 3.08e-01 | 2.05e-02 | 6.48e-01 |
GOMF QUATERNARY AMMONIUM GROUP BINDING | 24 | 8.63e-01 | -2.04e-02 | 9.56e-01 |
GOBP CALCIUM MEDIATED SIGNALING | 75 | 7.61e-01 | 2.04e-02 | 9.17e-01 |
GOBP RESPONSE TO METAL ION | 164 | 6.54e-01 | -2.04e-02 | 8.66e-01 |
GOBP SULFUR COMPOUND TRANSPORT | 17 | 8.85e-01 | -2.04e-02 | 9.63e-01 |
GOBP NK T CELL ACTIVATION | 8 | 9.21e-01 | 2.03e-02 | 9.75e-01 |
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS | 380 | 5.02e-01 | 2.03e-02 | 7.82e-01 |
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 105 | 7.20e-01 | -2.03e-02 | 8.99e-01 |
GOCC CORE MEDIATOR COMPLEX | 21 | 8.72e-01 | -2.03e-02 | 9.60e-01 |
GOBP REGULATION OF ENDOCYTOSIS | 156 | 6.64e-01 | -2.03e-02 | 8.72e-01 |
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS | 39 | 8.27e-01 | 2.02e-02 | 9.43e-01 |
GOCC MYOSIN COMPLEX | 18 | 8.82e-01 | 2.02e-02 | 9.63e-01 |
GOBP POSITIVE REGULATION OF CYTOKINESIS | 23 | 8.67e-01 | -2.02e-02 | 9.58e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION | 64 | 7.80e-01 | 2.02e-02 | 9.26e-01 |
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 9 | 9.17e-01 | 2.02e-02 | 9.74e-01 |
GOMF PHOSPHATIDYLSERINE BINDING | 20 | 8.76e-01 | 2.02e-02 | 9.62e-01 |
GOBP POSITIVE REGULATION OF PROTEOLYSIS | 214 | 6.14e-01 | 2.02e-02 | 8.46e-01 |
GOBP CATECHOLAMINE SECRETION | 14 | 8.96e-01 | 2.01e-02 | 9.68e-01 |
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION | 7 | 9.27e-01 | 2.00e-02 | 9.77e-01 |
GOBP PROTEIN HEXAMERIZATION | 8 | 9.22e-01 | 2.00e-02 | 9.75e-01 |
GOCC TRNA SPLICING LIGASE COMPLEX | 8 | 9.22e-01 | -2.00e-02 | 9.75e-01 |
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 181 | 6.45e-01 | -2.00e-02 | 8.62e-01 |
GOBP GAMMA DELTA T CELL DIFFERENTIATION | 9 | 9.17e-01 | -2.00e-02 | 9.74e-01 |
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY | 14 | 8.97e-01 | -1.99e-02 | 9.69e-01 |
GOBP REGULATION OF PLATELET ACTIVATION | 23 | 8.69e-01 | 1.99e-02 | 9.59e-01 |
GOBP MESENCHYME DEVELOPMENT | 103 | 7.28e-01 | -1.99e-02 | 9.03e-01 |
GOMF PROTEIN CONTAINING COMPLEX BINDING | 1005 | 3.04e-01 | 1.98e-02 | 6.45e-01 |
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT | 5 | 9.39e-01 | -1.98e-02 | 9.82e-01 |
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY | 5 | 9.39e-01 | -1.98e-02 | 9.82e-01 |
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING | 5 | 9.39e-01 | -1.98e-02 | 9.82e-01 |
GOCC VACUOLE | 517 | 4.49e-01 | -1.98e-02 | 7.49e-01 |
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY | 23 | 8.70e-01 | 1.98e-02 | 9.59e-01 |
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER | 9 | 9.18e-01 | 1.98e-02 | 9.74e-01 |
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT | 11 | 9.10e-01 | -1.97e-02 | 9.73e-01 |
GOMF ANTIGEN BINDING | 72 | 7.73e-01 | 1.97e-02 | 9.24e-01 |
GOCC MICROTUBULE ORGANIZING CENTER | 503 | 4.57e-01 | -1.97e-02 | 7.55e-01 |
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS | 5 | 9.39e-01 | 1.97e-02 | 9.82e-01 |
GOBP EOSINOPHIL ACTIVATION | 7 | 9.28e-01 | 1.97e-02 | 9.77e-01 |
GOBP CELLULAR RESPONSE TO HEAT | 42 | 8.26e-01 | 1.96e-02 | 9.43e-01 |
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS | 236 | 6.07e-01 | 1.96e-02 | 8.43e-01 |
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC | 13 | 9.03e-01 | -1.95e-02 | 9.71e-01 |
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE | 24 | 8.69e-01 | 1.95e-02 | 9.59e-01 |
GOBP MEGAKARYOCYTE DEVELOPMENT | 15 | 8.96e-01 | -1.95e-02 | 9.68e-01 |
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION | 104 | 7.33e-01 | 1.95e-02 | 9.04e-01 |
GOMF ADRENERGIC RECEPTOR BINDING | 8 | 9.24e-01 | -1.95e-02 | 9.76e-01 |
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS | 22 | 8.75e-01 | 1.94e-02 | 9.62e-01 |
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE | 7 | 9.29e-01 | 1.94e-02 | 9.78e-01 |
GOBP CYTOPLASMIC SEQUESTERING OF NF KAPPAB | 6 | 9.35e-01 | -1.93e-02 | 9.80e-01 |
GOBP POSITIVE REGULATION OF VIRAL PROCESS | 46 | 8.21e-01 | -1.93e-02 | 9.42e-01 |
GOBP GLUCAN BIOSYNTHETIC PROCESS | 24 | 8.70e-01 | -1.93e-02 | 9.59e-01 |
GOCC MULTIVESICULAR BODY | 35 | 8.44e-01 | 1.93e-02 | 9.50e-01 |
GOBP SYNAPTIC TRANSMISSION GABAERGIC | 17 | 8.91e-01 | 1.92e-02 | 9.66e-01 |
GOBP MONOATOMIC ANION TRANSPORT | 45 | 8.25e-01 | -1.91e-02 | 9.43e-01 |
GOCC POSTSYNAPTIC MEMBRANE | 48 | 8.19e-01 | -1.91e-02 | 9.42e-01 |
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 155 | 6.83e-01 | -1.91e-02 | 8.81e-01 |
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 61 | 7.97e-01 | 1.91e-02 | 9.33e-01 |
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 10 | 9.17e-01 | -1.90e-02 | 9.74e-01 |
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY | 17 | 8.92e-01 | 1.90e-02 | 9.67e-01 |
GOBP VESICLE TRANSPORT ALONG MICROTUBULE | 33 | 8.51e-01 | -1.89e-02 | 9.51e-01 |
GOBP DETECTION OF BIOTIC STIMULUS | 13 | 9.06e-01 | -1.89e-02 | 9.72e-01 |
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 27 | 8.65e-01 | -1.89e-02 | 9.57e-01 |
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON | 41 | 8.35e-01 | 1.89e-02 | 9.46e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE | 76 | 7.80e-01 | 1.86e-02 | 9.26e-01 |
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY | 8 | 9.27e-01 | 1.86e-02 | 9.77e-01 |
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE | 40 | 8.39e-01 | 1.85e-02 | 9.48e-01 |
GOBP VIRAL PROCESS | 287 | 5.93e-01 | -1.85e-02 | 8.34e-01 |
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES | 455 | 5.05e-01 | 1.85e-02 | 7.85e-01 |
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION | 67 | 7.94e-01 | -1.85e-02 | 9.33e-01 |
GOBP CELLULAR PIGMENTATION | 42 | 8.37e-01 | 1.84e-02 | 9.46e-01 |
GOBP NEPHRON DEVELOPMENT | 42 | 8.37e-01 | 1.84e-02 | 9.46e-01 |
GOBP ORGANIC ACID TRANSPORT | 112 | 7.38e-01 | 1.84e-02 | 9.06e-01 |
GOBP PRE MIRNA PROCESSING | 11 | 9.16e-01 | 1.84e-02 | 9.74e-01 |
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE | 6 | 9.38e-01 | 1.84e-02 | 9.82e-01 |
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY | 21 | 8.84e-01 | 1.84e-02 | 9.63e-01 |
GOBP PROGRAMMED NECROTIC CELL DEATH | 35 | 8.51e-01 | 1.84e-02 | 9.51e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE | 12 | 9.12e-01 | -1.84e-02 | 9.74e-01 |
GOBP FOREBRAIN NEURON DIFFERENTIATION | 11 | 9.16e-01 | 1.84e-02 | 9.74e-01 |
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE | 5 | 9.43e-01 | -1.83e-02 | 9.83e-01 |
GOBP MICROTUBULE BUNDLE FORMATION | 27 | 8.70e-01 | 1.82e-02 | 9.59e-01 |
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION | 19 | 8.91e-01 | -1.82e-02 | 9.66e-01 |
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 69 | 7.94e-01 | 1.82e-02 | 9.33e-01 |
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS | 15 | 9.03e-01 | 1.82e-02 | 9.71e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS | 106 | 7.49e-01 | 1.81e-02 | 9.11e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 5 | 9.44e-01 | 1.81e-02 | 9.83e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS | 5 | 9.44e-01 | 1.81e-02 | 9.83e-01 |
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY | 20 | 8.89e-01 | 1.80e-02 | 9.66e-01 |
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 9 | 9.25e-01 | 1.80e-02 | 9.76e-01 |
GOBP CELL CYCLE G2 M PHASE TRANSITION | 103 | 7.53e-01 | 1.80e-02 | 9.13e-01 |
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS | 21 | 8.87e-01 | 1.80e-02 | 9.64e-01 |
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX | 9 | 9.26e-01 | -1.80e-02 | 9.76e-01 |
GOBP REGULATION OF TELOMERASE ACTIVITY | 34 | 8.57e-01 | -1.79e-02 | 9.53e-01 |
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS | 251 | 6.28e-01 | 1.79e-02 | 8.53e-01 |
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY | 10 | 9.22e-01 | -1.79e-02 | 9.75e-01 |
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY | 8 | 9.30e-01 | -1.78e-02 | 9.78e-01 |
GOBP ZYMOGEN ACTIVATION | 22 | 8.85e-01 | -1.78e-02 | 9.64e-01 |
GOBP MEMBRANE DEPOLARIZATION | 24 | 8.80e-01 | -1.78e-02 | 9.63e-01 |
GOBP REGULATION OF ORGANELLE ORGANIZATION | 714 | 4.31e-01 | 1.77e-02 | 7.37e-01 |
GOMF TRANSLATION ACTIVATOR ACTIVITY | 6 | 9.40e-01 | -1.77e-02 | 9.82e-01 |
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY | 100 | 7.60e-01 | 1.77e-02 | 9.17e-01 |
GOMF ENZYME REGULATOR ACTIVITY | 683 | 4.41e-01 | -1.77e-02 | 7.43e-01 |
GOBP MAINTENANCE OF LOCATION | 180 | 6.85e-01 | 1.76e-02 | 8.82e-01 |
GOBP PEPTIDYL LYSINE DIMETHYLATION | 9 | 9.27e-01 | -1.75e-02 | 9.77e-01 |
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING | 51 | 8.29e-01 | 1.75e-02 | 9.43e-01 |
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 11 | 9.20e-01 | 1.75e-02 | 9.75e-01 |
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY | 24 | 8.82e-01 | -1.75e-02 | 9.63e-01 |
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES | 10 | 9.24e-01 | 1.75e-02 | 9.76e-01 |
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE | 14 | 9.11e-01 | 1.73e-02 | 9.73e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN | 68 | 8.06e-01 | -1.72e-02 | 9.37e-01 |
GOBP HEART PROCESS | 74 | 7.99e-01 | -1.72e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY | 34 | 8.63e-01 | -1.72e-02 | 9.56e-01 |
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY | 26 | 8.80e-01 | -1.71e-02 | 9.63e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM | 5 | 9.47e-01 | 1.71e-02 | 9.84e-01 |
GOCC SPINDLE POLE | 118 | 7.50e-01 | -1.71e-02 | 9.11e-01 |
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 9 | 9.30e-01 | -1.70e-02 | 9.78e-01 |
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION | 5 | 9.48e-01 | 1.70e-02 | 9.84e-01 |
GOCC CALCINEURIN COMPLEX | 5 | 9.48e-01 | -1.70e-02 | 9.84e-01 |
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY | 29 | 8.75e-01 | 1.69e-02 | 9.62e-01 |
GOMF DEAD H BOX RNA HELICASE BINDING | 7 | 9.39e-01 | -1.68e-02 | 9.82e-01 |
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 66 | 8.14e-01 | -1.68e-02 | 9.40e-01 |
GOBP GANGLIOSIDE CATABOLIC PROCESS | 5 | 9.48e-01 | 1.68e-02 | 9.84e-01 |
GOCC SCHMIDT LANTERMAN INCISURE | 5 | 9.48e-01 | -1.68e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL | 9 | 9.31e-01 | -1.68e-02 | 9.78e-01 |
GOBP MRNA EXPORT FROM NUCLEUS | 61 | 8.22e-01 | 1.67e-02 | 9.42e-01 |
GOBP NUCLEAR PORE LOCALIZATION | 5 | 9.48e-01 | 1.67e-02 | 9.84e-01 |
GOMF ACYLTRANSFERASE ACTIVITY | 431 | 5.59e-01 | -1.67e-02 | 8.16e-01 |
GOBP PROTEIN DEPHOSPHORYLATION | 134 | 7.41e-01 | -1.66e-02 | 9.07e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE | 27 | 8.82e-01 | -1.66e-02 | 9.63e-01 |
GOCC FICOLIN 1 RICH GRANULE | 139 | 7.37e-01 | 1.66e-02 | 9.06e-01 |
GOBP MUSCLE SYSTEM PROCESS | 142 | 7.34e-01 | -1.66e-02 | 9.05e-01 |
GOBP CELLULAR SENESCENCE | 63 | 8.21e-01 | -1.66e-02 | 9.42e-01 |
GOBP TYPE II INTERFERON PRODUCTION | 44 | 8.50e-01 | -1.65e-02 | 9.51e-01 |
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS | 9 | 9.32e-01 | 1.65e-02 | 9.78e-01 |
GOBP PROTEIN POLYMERIZATION | 160 | 7.22e-01 | 1.64e-02 | 9.00e-01 |
GOBP SPERM MOTILITY | 25 | 8.88e-01 | 1.64e-02 | 9.65e-01 |
GOBP BONE REMODELING | 34 | 8.69e-01 | 1.63e-02 | 9.59e-01 |
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT | 68 | 8.17e-01 | 1.63e-02 | 9.41e-01 |
GOBP EAR DEVELOPMENT | 55 | 8.35e-01 | 1.62e-02 | 9.46e-01 |
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS | 11 | 9.26e-01 | -1.62e-02 | 9.76e-01 |
GOBP CHEMICAL HOMEOSTASIS | 416 | 5.76e-01 | 1.62e-02 | 8.24e-01 |
GOBP RESPONSE TO ANGIOTENSIN | 16 | 9.11e-01 | -1.62e-02 | 9.73e-01 |
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT | 64 | 8.24e-01 | -1.61e-02 | 9.43e-01 |
GOMF OPSONIN BINDING | 6 | 9.46e-01 | -1.61e-02 | 9.84e-01 |
GOBP EXIT FROM MITOSIS | 25 | 8.89e-01 | 1.61e-02 | 9.66e-01 |
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS | 96 | 7.86e-01 | 1.61e-02 | 9.28e-01 |
GOCC POLYMERIC CYTOSKELETAL FIBER | 299 | 6.37e-01 | -1.60e-02 | 8.58e-01 |
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS | 39 | 8.63e-01 | 1.60e-02 | 9.56e-01 |
GOBP REGULATION OF SODIUM ION TRANSPORT | 30 | 8.80e-01 | -1.59e-02 | 9.63e-01 |
GOCC MONOATOMIC ION CHANNEL COMPLEX | 50 | 8.46e-01 | -1.59e-02 | 9.51e-01 |
GOBP MITOCHONDRIAL GENOME MAINTENANCE | 24 | 8.93e-01 | 1.59e-02 | 9.67e-01 |
GOBP B CELL PROLIFERATION | 57 | 8.36e-01 | 1.59e-02 | 9.46e-01 |
GOBP CYTOSOLIC TRANSPORT | 139 | 7.48e-01 | 1.59e-02 | 9.10e-01 |
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 29 | 8.83e-01 | 1.58e-02 | 9.63e-01 |
GOBP MESENCHYME MORPHOGENESIS | 16 | 9.13e-01 | 1.58e-02 | 9.74e-01 |
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY | 10 | 9.31e-01 | -1.58e-02 | 9.78e-01 |
GOBP RESPONSE TO INTERLEUKIN 4 | 24 | 8.94e-01 | -1.58e-02 | 9.67e-01 |
GOBP NEGATIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 14 | 9.19e-01 | 1.58e-02 | 9.75e-01 |
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR | 66 | 8.25e-01 | 1.57e-02 | 9.43e-01 |
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION | 12 | 9.25e-01 | 1.57e-02 | 9.76e-01 |
GOCC NUCLEAR STRESS GRANULE | 5 | 9.52e-01 | 1.57e-02 | 9.84e-01 |
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY | 7 | 9.43e-01 | 1.57e-02 | 9.83e-01 |
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 41 | 8.62e-01 | 1.57e-02 | 9.56e-01 |
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION | 5 | 9.52e-01 | -1.56e-02 | 9.84e-01 |
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS | 8 | 9.39e-01 | -1.56e-02 | 9.82e-01 |
GOBP MALE SEX DIFFERENTIATION | 68 | 8.24e-01 | 1.56e-02 | 9.43e-01 |
GOBP REGULATION OF MONOATOMIC CATION TRANSMEMBRANE TRANSPORT | 109 | 7.79e-01 | -1.56e-02 | 9.26e-01 |
GOBP HAIR CELL DIFFERENTIATION | 10 | 9.32e-01 | -1.56e-02 | 9.78e-01 |
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT | 14 | 9.20e-01 | 1.55e-02 | 9.75e-01 |
GOCC LAMELLIPODIUM | 113 | 7.77e-01 | 1.55e-02 | 9.25e-01 |
GOBP INTESTINAL ABSORPTION | 13 | 9.23e-01 | -1.55e-02 | 9.76e-01 |
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY | 6 | 9.48e-01 | -1.55e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION | 30 | 8.84e-01 | 1.55e-02 | 9.63e-01 |
GOBP AMYLOID BETA CLEARANCE | 22 | 9.00e-01 | -1.54e-02 | 9.70e-01 |
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS | 35 | 8.75e-01 | -1.54e-02 | 9.62e-01 |
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION | 7 | 9.44e-01 | 1.54e-02 | 9.83e-01 |
GOBP ICOSANOID BIOSYNTHETIC PROCESS | 28 | 8.88e-01 | -1.54e-02 | 9.65e-01 |
GOBP POSITIVE REGULATION OF NEURON MIGRATION | 9 | 9.37e-01 | 1.53e-02 | 9.81e-01 |
GOCC AXON | 253 | 6.79e-01 | 1.52e-02 | 8.79e-01 |
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 51 | 8.51e-01 | -1.52e-02 | 9.51e-01 |
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS | 39 | 8.70e-01 | 1.52e-02 | 9.59e-01 |
GOBP POSITIVE REGULATION OF B CELL ACTIVATION | 57 | 8.43e-01 | 1.52e-02 | 9.50e-01 |
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION | 17 | 9.14e-01 | 1.52e-02 | 9.74e-01 |
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE | 15 | 9.19e-01 | -1.52e-02 | 9.75e-01 |
GOBP GANGLIOSIDE METABOLIC PROCESS | 17 | 9.14e-01 | 1.52e-02 | 9.74e-01 |
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS | 19 | 9.09e-01 | -1.51e-02 | 9.73e-01 |
GOBP CELLULAR RESPONSE TO STRESS | 1213 | 3.97e-01 | 1.51e-02 | 7.17e-01 |
GOBP HOMEOSTATIC PROCESS | 771 | 4.88e-01 | -1.51e-02 | 7.76e-01 |
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS | 166 | 7.40e-01 | -1.50e-02 | 9.06e-01 |
GOBP MACROAUTOPHAGY | 255 | 6.83e-01 | 1.50e-02 | 8.81e-01 |
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY | 43 | 8.65e-01 | -1.50e-02 | 9.57e-01 |
GOBP PROTEIN METHYLATION | 56 | 8.47e-01 | 1.50e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS | 8 | 9.42e-01 | -1.50e-02 | 9.83e-01 |
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 56 | 8.47e-01 | 1.49e-02 | 9.51e-01 |
GOMF POLY PYRIMIDINE TRACT BINDING | 21 | 9.06e-01 | 1.49e-02 | 9.72e-01 |
GOBP MONOCYTE DIFFERENTIATION | 17 | 9.16e-01 | 1.49e-02 | 9.74e-01 |
GOBP SENSORY PERCEPTION OF PAIN | 15 | 9.21e-01 | -1.48e-02 | 9.75e-01 |
GOBP TEMPERATURE HOMEOSTASIS | 83 | 8.16e-01 | -1.48e-02 | 9.40e-01 |
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS | 9 | 9.39e-01 | 1.48e-02 | 9.82e-01 |
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 14 | 9.24e-01 | 1.48e-02 | 9.76e-01 |
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION | 14 | 9.24e-01 | 1.48e-02 | 9.76e-01 |
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS | 6 | 9.50e-01 | 1.48e-02 | 9.84e-01 |
GOBP STEROL TRANSPORT | 58 | 8.46e-01 | 1.48e-02 | 9.51e-01 |
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE | 66 | 8.36e-01 | 1.48e-02 | 9.46e-01 |
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT | 102 | 7.98e-01 | 1.47e-02 | 9.33e-01 |
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY | 5 | 9.55e-01 | -1.47e-02 | 9.85e-01 |
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT | 14 | 9.25e-01 | 1.46e-02 | 9.76e-01 |
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 79 | 8.24e-01 | 1.45e-02 | 9.43e-01 |
GOMF METHYL CPG BINDING | 16 | 9.20e-01 | -1.45e-02 | 9.75e-01 |
GOBP HISTONE H4 ACETYLATION | 12 | 9.31e-01 | -1.45e-02 | 9.78e-01 |
GOBP REGULATION OF FIBROBLAST PROLIFERATION | 48 | 8.63e-01 | 1.44e-02 | 9.56e-01 |
GOCC LATE ENDOSOME | 202 | 7.26e-01 | 1.44e-02 | 9.02e-01 |
GOBP ENDOSOMAL TRANSPORT | 185 | 7.38e-01 | 1.44e-02 | 9.06e-01 |
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX | 122 | 7.85e-01 | 1.43e-02 | 9.28e-01 |
GOBP RECEPTOR MEDIATED ENDOCYTOSIS | 133 | 7.77e-01 | 1.43e-02 | 9.25e-01 |
GOCC ENDOPLASMIC RETICULUM EXIT SITE | 24 | 9.04e-01 | 1.43e-02 | 9.71e-01 |
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY | 85 | 8.21e-01 | -1.43e-02 | 9.42e-01 |
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION | 57 | 8.53e-01 | 1.43e-02 | 9.51e-01 |
GOBP ORGANOPHOSPHATE ESTER TRANSPORT | 82 | 8.24e-01 | 1.42e-02 | 9.43e-01 |
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY | 18 | 9.17e-01 | -1.42e-02 | 9.74e-01 |
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION | 23 | 9.06e-01 | 1.42e-02 | 9.72e-01 |
GOBP PROSTANOID METABOLIC PROCESS | 25 | 9.03e-01 | 1.41e-02 | 9.71e-01 |
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION | 7 | 9.48e-01 | 1.41e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 15 | 9.25e-01 | -1.41e-02 | 9.76e-01 |
GOBP HIPPOCAMPUS DEVELOPMENT | 39 | 8.80e-01 | -1.40e-02 | 9.63e-01 |
GOBP HISTONE MODIFICATION | 97 | 8.12e-01 | 1.40e-02 | 9.40e-01 |
GOBP RESPONSE TO L GLUTAMATE | 9 | 9.42e-01 | -1.40e-02 | 9.83e-01 |
GOBP REGULATION OF FATTY ACID TRANSPORT | 13 | 9.31e-01 | 1.40e-02 | 9.78e-01 |
GOBP MITOCHONDRIAL DEPOLARIZATION | 12 | 9.34e-01 | 1.38e-02 | 9.79e-01 |
GOBP DEFENSE RESPONSE TO SYMBIONT | 182 | 7.49e-01 | -1.38e-02 | 9.11e-01 |
GOBP FIBROBLAST PROLIFERATION | 57 | 8.57e-01 | 1.38e-02 | 9.53e-01 |
GOBP EMBRYO IMPLANTATION | 22 | 9.11e-01 | 1.38e-02 | 9.73e-01 |
GOBP KERATAN SULFATE METABOLIC PROCESS | 10 | 9.40e-01 | 1.38e-02 | 9.82e-01 |
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING | 21 | 9.13e-01 | 1.38e-02 | 9.74e-01 |
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY | 81 | 8.31e-01 | 1.37e-02 | 9.43e-01 |
GOBP PEPTIDYL LYSINE METHYLATION | 37 | 8.85e-01 | -1.37e-02 | 9.64e-01 |
GOBP NEGATIVE REGULATION OF AXONOGENESIS | 21 | 9.13e-01 | -1.37e-02 | 9.74e-01 |
GOBP HETEROCHROMATIN ORGANIZATION | 70 | 8.43e-01 | 1.37e-02 | 9.50e-01 |
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 136 | 7.84e-01 | 1.37e-02 | 9.28e-01 |
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES | 6 | 9.54e-01 | 1.36e-02 | 9.85e-01 |
GOCC VESICLE MEMBRANE | 659 | 5.59e-01 | -1.36e-02 | 8.16e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA | 8 | 9.47e-01 | 1.36e-02 | 9.84e-01 |
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION | 76 | 8.38e-01 | -1.36e-02 | 9.47e-01 |
GOBP B CELL HOMEOSTASIS | 29 | 9.00e-01 | 1.36e-02 | 9.70e-01 |
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION | 9 | 9.44e-01 | -1.35e-02 | 9.83e-01 |
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS | 107 | 8.10e-01 | 1.35e-02 | 9.38e-01 |
GOBP RESPONSE TO INTERLEUKIN 15 | 9 | 9.44e-01 | -1.35e-02 | 9.83e-01 |
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 122 | 7.98e-01 | 1.35e-02 | 9.33e-01 |
GOBP CELL CYCLE G1 S PHASE TRANSITION | 166 | 7.66e-01 | 1.35e-02 | 9.20e-01 |
GOBP RESPONSE TO TYPE I INTERFERON | 49 | 8.71e-01 | 1.35e-02 | 9.59e-01 |
GOMF PROTEIN LIPID COMPLEX BINDING | 9 | 9.44e-01 | 1.34e-02 | 9.83e-01 |
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY | 15 | 9.28e-01 | 1.34e-02 | 9.77e-01 |
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS | 7 | 9.51e-01 | -1.34e-02 | 9.84e-01 |
GOBP VESICLE ORGANIZATION | 252 | 7.19e-01 | 1.33e-02 | 8.99e-01 |
GOCC HISTONE DEACETYLASE COMPLEX | 71 | 8.48e-01 | -1.32e-02 | 9.51e-01 |
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY | 8 | 9.49e-01 | 1.32e-02 | 9.84e-01 |
GOBP RNA DESTABILIZATION | 84 | 8.35e-01 | -1.32e-02 | 9.46e-01 |
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY | 7 | 9.52e-01 | -1.32e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION | 272 | 7.13e-01 | -1.31e-02 | 8.96e-01 |
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION | 16 | 9.28e-01 | -1.31e-02 | 9.77e-01 |
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 80 | 8.41e-01 | -1.30e-02 | 9.48e-01 |
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT | 7 | 9.52e-01 | -1.30e-02 | 9.84e-01 |
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE | 7 | 9.53e-01 | 1.30e-02 | 9.84e-01 |
GOCC AXON CYTOPLASM | 43 | 8.84e-01 | -1.29e-02 | 9.63e-01 |
GOCC B CELL RECEPTOR COMPLEX | 5 | 9.60e-01 | -1.29e-02 | 9.87e-01 |
GOBP CELL JUNCTION MAINTENANCE | 13 | 9.36e-01 | 1.29e-02 | 9.81e-01 |
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT | 15 | 9.31e-01 | -1.29e-02 | 9.78e-01 |
GOBP POSITIVE REGULATION OF LIPID STORAGE | 10 | 9.44e-01 | -1.28e-02 | 9.83e-01 |
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 99 | 8.27e-01 | -1.28e-02 | 9.43e-01 |
GOBP AXON GUIDANCE | 48 | 8.79e-01 | 1.28e-02 | 9.63e-01 |
GOBP MEMBRANE DOCKING | 62 | 8.62e-01 | 1.28e-02 | 9.56e-01 |
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX | 20 | 9.22e-01 | 1.27e-02 | 9.75e-01 |
GOBP RESPONSE TO ESTRADIOL | 48 | 8.80e-01 | 1.26e-02 | 9.63e-01 |
GOBP PEPTIDYL LYSINE MONOMETHYLATION | 6 | 9.58e-01 | -1.25e-02 | 9.87e-01 |
GOBP LIPID BIOSYNTHETIC PROCESS | 350 | 6.94e-01 | -1.24e-02 | 8.86e-01 |
GOBP T CELL CYTOKINE PRODUCTION | 16 | 9.32e-01 | -1.24e-02 | 9.78e-01 |
GOMF SPECTRIN BINDING | 9 | 9.49e-01 | 1.24e-02 | 9.84e-01 |
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS | 20 | 9.24e-01 | 1.23e-02 | 9.76e-01 |
GOBP SUPEROXIDE METABOLIC PROCESS | 31 | 9.05e-01 | 1.23e-02 | 9.72e-01 |
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 79 | 8.51e-01 | 1.23e-02 | 9.51e-01 |
GOBP WOUND HEALING | 183 | 7.76e-01 | -1.23e-02 | 9.25e-01 |
GOBP VESICLE CYTOSKELETAL TRAFFICKING | 45 | 8.87e-01 | 1.22e-02 | 9.65e-01 |
GOMF MODIFICATION DEPENDENT PROTEIN BINDING | 141 | 8.03e-01 | -1.22e-02 | 9.35e-01 |
GOBP SPHINGOSINE BIOSYNTHETIC PROCESS | 6 | 9.59e-01 | 1.22e-02 | 9.87e-01 |
GOBP NUCLEAR EXPORT | 137 | 8.07e-01 | -1.22e-02 | 9.37e-01 |
GOBP TUBULIN DEACETYLATION | 16 | 9.33e-01 | 1.21e-02 | 9.79e-01 |
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 71 | 8.60e-01 | 1.21e-02 | 9.55e-01 |
GOMF RAGE RECEPTOR BINDING | 5 | 9.63e-01 | 1.21e-02 | 9.88e-01 |
GOCC PLASMA MEMBRANE REGION | 422 | 6.75e-01 | -1.21e-02 | 8.78e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 107 | 8.30e-01 | -1.21e-02 | 9.43e-01 |
GOBP BEHAVIORAL RESPONSE TO PAIN | 7 | 9.56e-01 | 1.21e-02 | 9.85e-01 |
GOBP BONE RESORPTION | 29 | 9.11e-01 | -1.20e-02 | 9.73e-01 |
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 8 | 9.53e-01 | -1.20e-02 | 9.85e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION | 174 | 7.86e-01 | -1.20e-02 | 9.28e-01 |
GOBP NEPHRON EPITHELIUM DEVELOPMENT | 27 | 9.14e-01 | 1.20e-02 | 9.74e-01 |
GOBP RESPONSE TO ISOQUINOLINE ALKALOID | 5 | 9.63e-01 | -1.19e-02 | 9.88e-01 |
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS | 12 | 9.43e-01 | -1.19e-02 | 9.83e-01 |
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION | 10 | 9.48e-01 | 1.19e-02 | 9.84e-01 |
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 31 | 9.09e-01 | -1.18e-02 | 9.73e-01 |
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION | 105 | 8.36e-01 | -1.17e-02 | 9.46e-01 |
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION | 14 | 9.39e-01 | -1.17e-02 | 9.82e-01 |
GOMF CHROMATIN BINDING | 381 | 6.98e-01 | 1.17e-02 | 8.88e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING | 28 | 9.15e-01 | 1.17e-02 | 9.74e-01 |
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS | 12 | 9.44e-01 | 1.17e-02 | 9.83e-01 |
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING | 95 | 8.44e-01 | -1.17e-02 | 9.50e-01 |
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY | 9 | 9.52e-01 | -1.16e-02 | 9.84e-01 |
GOBP RNA SPLICING | 370 | 7.06e-01 | 1.16e-02 | 8.93e-01 |
GOMF CELL ADHESION MOLECULE BINDING | 290 | 7.39e-01 | 1.15e-02 | 9.06e-01 |
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION | 21 | 9.28e-01 | 1.15e-02 | 9.77e-01 |
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS | 162 | 8.02e-01 | 1.15e-02 | 9.35e-01 |
GOCC GRANULAR COMPONENT | 6 | 9.61e-01 | 1.14e-02 | 9.88e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY | 78 | 8.62e-01 | 1.14e-02 | 9.56e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS | 10 | 9.50e-01 | 1.13e-02 | 9.84e-01 |
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS | 10 | 9.50e-01 | 1.13e-02 | 9.84e-01 |
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS | 21 | 9.28e-01 | 1.13e-02 | 9.77e-01 |
GOBP RESPONSE TO EXTRACELLULAR STIMULUS | 256 | 7.58e-01 | -1.13e-02 | 9.16e-01 |
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION | 1062 | 5.55e-01 | 1.11e-02 | 8.14e-01 |
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA | 10 | 9.51e-01 | -1.11e-02 | 9.84e-01 |
GOMF PHOSPHATIDIC ACID BINDING | 11 | 9.49e-01 | 1.11e-02 | 9.84e-01 |
GOBP PLATELET AGGREGATION | 41 | 9.03e-01 | 1.11e-02 | 9.71e-01 |
GOBP MONOSACCHARIDE CATABOLIC PROCESS | 23 | 9.27e-01 | 1.10e-02 | 9.77e-01 |
GOBP RNA CATABOLIC PROCESS | 221 | 7.79e-01 | -1.10e-02 | 9.26e-01 |
GOCC GBAF COMPLEX | 12 | 9.47e-01 | 1.10e-02 | 9.84e-01 |
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS | 12 | 9.47e-01 | -1.10e-02 | 9.84e-01 |
GOBP RECEPTOR CATABOLIC PROCESS | 23 | 9.28e-01 | 1.09e-02 | 9.77e-01 |
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION | 25 | 9.25e-01 | -1.09e-02 | 9.76e-01 |
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION | 7 | 9.60e-01 | -1.09e-02 | 9.87e-01 |
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 86 | 8.62e-01 | 1.09e-02 | 9.56e-01 |
GOBP LIPID LOCALIZATION | 198 | 7.94e-01 | 1.08e-02 | 9.33e-01 |
GOBP PHAGOSOME LYSOSOME FUSION | 6 | 9.64e-01 | -1.08e-02 | 9.89e-01 |
GOBP MRNA PROCESSING | 387 | 7.20e-01 | 1.08e-02 | 8.99e-01 |
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY | 62 | 8.84e-01 | -1.07e-02 | 9.63e-01 |
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT | 9 | 9.56e-01 | 1.07e-02 | 9.85e-01 |
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE | 53 | 8.93e-01 | -1.07e-02 | 9.67e-01 |
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION | 12 | 9.49e-01 | 1.06e-02 | 9.84e-01 |
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY | 35 | 9.14e-01 | 1.06e-02 | 9.74e-01 |
GOMF PHOSPHATIDYLINOSITOL BINDING | 157 | 8.20e-01 | -1.06e-02 | 9.42e-01 |
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS | 62 | 8.86e-01 | 1.06e-02 | 9.64e-01 |
GOMF RNA POLYMERASE BINDING | 51 | 8.96e-01 | -1.05e-02 | 9.68e-01 |
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY | 263 | 7.71e-01 | -1.05e-02 | 9.23e-01 |
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT | 112 | 8.49e-01 | 1.05e-02 | 9.51e-01 |
GOCC EXTERNAL ENCAPSULATING STRUCTURE | 97 | 8.59e-01 | 1.05e-02 | 9.54e-01 |
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT | 42 | 9.07e-01 | 1.05e-02 | 9.72e-01 |
GOMF ACTININ BINDING | 12 | 9.50e-01 | 1.04e-02 | 9.84e-01 |
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION | 312 | 7.54e-01 | -1.04e-02 | 9.14e-01 |
GOMF PHOSPHATASE ACTIVITY | 149 | 8.28e-01 | -1.03e-02 | 9.43e-01 |
GOBP AXON EXTENSION | 49 | 9.01e-01 | 1.03e-02 | 9.70e-01 |
GOBP PROTEIN LOCALIZATION TO NUCLEUS | 218 | 7.94e-01 | 1.03e-02 | 9.33e-01 |
GOCC MICROTUBULE | 225 | 7.91e-01 | 1.03e-02 | 9.31e-01 |
GOMF G PROTEIN BETA SUBUNIT BINDING | 7 | 9.63e-01 | 1.02e-02 | 9.88e-01 |
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION | 76 | 8.78e-01 | -1.02e-02 | 9.63e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN BINDING | 42 | 9.09e-01 | 1.02e-02 | 9.73e-01 |
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS | 23 | 9.32e-01 | 1.02e-02 | 9.79e-01 |
GOMF HISTONE ACETYLTRANSFERASE BINDING | 18 | 9.40e-01 | -1.02e-02 | 9.82e-01 |
GOBP CELLULAR RESPONSE TO UV | 58 | 8.93e-01 | 1.02e-02 | 9.67e-01 |
GOBP LONG CHAIN FATTY ACID TRANSPORT | 24 | 9.31e-01 | 1.02e-02 | 9.78e-01 |
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION | 19 | 9.39e-01 | -1.02e-02 | 9.82e-01 |
GOMF STRUCTURAL CONSTITUENT OF MUSCLE | 11 | 9.54e-01 | 1.01e-02 | 9.85e-01 |
GOBP MUSCLE CELL APOPTOTIC PROCESS | 37 | 9.15e-01 | 1.01e-02 | 9.74e-01 |
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM | 79 | 8.77e-01 | 1.01e-02 | 9.63e-01 |
GOBP OLIGOSACCHARIDE METABOLIC PROCESS | 29 | 9.25e-01 | -1.01e-02 | 9.76e-01 |
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS | 67 | 8.87e-01 | 1.00e-02 | 9.65e-01 |
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY | 19 | 9.40e-01 | -1.00e-02 | 9.82e-01 |
GOMF AMYLOID BETA BINDING | 34 | 9.20e-01 | -1.00e-02 | 9.75e-01 |
GOMF GROWTH FACTOR ACTIVITY | 30 | 9.24e-01 | 1.00e-02 | 9.76e-01 |
GOCC SUPRAMOLECULAR POLYMER | 376 | 7.42e-01 | -1.00e-02 | 9.07e-01 |
GOCC TRANSLATION PREINITIATION COMPLEX | 17 | 9.43e-01 | 9.97e-03 | 9.83e-01 |
GOBP P BODY ASSEMBLY | 19 | 9.41e-01 | 9.89e-03 | 9.82e-01 |
GOCC CLATHRIN COAT | 34 | 9.21e-01 | -9.87e-03 | 9.75e-01 |
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION | 26 | 9.31e-01 | 9.86e-03 | 9.78e-01 |
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH | 23 | 9.35e-01 | 9.86e-03 | 9.80e-01 |
GOBP MICROTUBULE BASED PROCESS | 468 | 7.19e-01 | -9.86e-03 | 8.99e-01 |
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY | 23 | 9.35e-01 | -9.85e-03 | 9.80e-01 |
GOBP RESPONSE TO ANTIBIOTIC | 25 | 9.32e-01 | 9.85e-03 | 9.78e-01 |
GOBP REPRODUCTION | 539 | 7.01e-01 | -9.83e-03 | 8.91e-01 |
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION | 24 | 9.34e-01 | -9.83e-03 | 9.79e-01 |
GOBP IN UTERO EMBRYONIC DEVELOPMENT | 199 | 8.12e-01 | 9.83e-03 | 9.40e-01 |
GOBP PROTEIN AUTOPROCESSING | 13 | 9.51e-01 | 9.82e-03 | 9.84e-01 |
GOBP REGULATION OF MONOOXYGENASE ACTIVITY | 17 | 9.44e-01 | -9.79e-03 | 9.83e-01 |
GOCC ACROSOMAL VESICLE | 39 | 9.16e-01 | 9.76e-03 | 9.74e-01 |
GOCC GOLGI CISTERNA MEMBRANE | 44 | 9.11e-01 | -9.75e-03 | 9.73e-01 |
GOCC ENDOCYTIC VESICLE | 183 | 8.22e-01 | -9.73e-03 | 9.42e-01 |
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY | 8 | 9.62e-01 | -9.68e-03 | 9.88e-01 |
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY | 47 | 9.09e-01 | -9.63e-03 | 9.73e-01 |
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 136 | 8.47e-01 | 9.61e-03 | 9.51e-01 |
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING | 52 | 9.05e-01 | -9.55e-03 | 9.72e-01 |
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS | 8 | 9.63e-01 | -9.55e-03 | 9.88e-01 |
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX | 42 | 9.15e-01 | -9.51e-03 | 9.74e-01 |
GOBP PEPTIDYL AMINO ACID MODIFICATION | 519 | 7.16e-01 | -9.49e-03 | 8.98e-01 |
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION | 12 | 9.55e-01 | -9.35e-03 | 9.85e-01 |
GOBP PEPTIDYL LYSINE MODIFICATION | 147 | 8.46e-01 | 9.34e-03 | 9.51e-01 |
GOCC NEURON SPINE | 68 | 8.94e-01 | -9.34e-03 | 9.68e-01 |
GOBP KIDNEY MORPHOGENESIS | 22 | 9.40e-01 | 9.33e-03 | 9.82e-01 |
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY | 20 | 9.43e-01 | 9.28e-03 | 9.83e-01 |
GOBP REGULATION OF INTRACELLULAR TRANSPORT | 225 | 8.12e-01 | -9.26e-03 | 9.40e-01 |
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 26 | 9.35e-01 | 9.26e-03 | 9.80e-01 |
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY | 9 | 9.62e-01 | 9.25e-03 | 9.88e-01 |
GOBP PROTEIN DENEDDYLATION | 9 | 9.62e-01 | 9.20e-03 | 9.88e-01 |
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE | 7 | 9.67e-01 | 9.16e-03 | 9.90e-01 |
GOBP INTRACELLULAR PH REDUCTION | 39 | 9.22e-01 | -9.13e-03 | 9.75e-01 |
GOCC GOLGI MEMBRANE | 404 | 7.56e-01 | 9.12e-03 | 9.15e-01 |
GOBP FOREBRAIN GENERATION OF NEURONS | 16 | 9.50e-01 | 9.07e-03 | 9.84e-01 |
GOMF ACID THIOL LIGASE ACTIVITY | 16 | 9.50e-01 | 9.05e-03 | 9.84e-01 |
GOBP PHOSPHOLIPID METABOLIC PROCESS | 196 | 8.29e-01 | -9.02e-03 | 9.43e-01 |
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE | 53 | 9.10e-01 | 8.98e-03 | 9.73e-01 |
GOCC CILIUM | 251 | 8.08e-01 | -8.96e-03 | 9.37e-01 |
GOBP CARBOHYDRATE METABOLIC PROCESS | 279 | 7.99e-01 | -8.95e-03 | 9.33e-01 |
GOBP PEROXISOMAL TRANSPORT | 17 | 9.49e-01 | -8.94e-03 | 9.84e-01 |
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS | 5 | 9.72e-01 | -8.92e-03 | 9.91e-01 |
GOBP REGULATION OF RECEPTOR RECYCLING | 15 | 9.53e-01 | 8.86e-03 | 9.84e-01 |
GOMF C2H2 ZINC FINGER DOMAIN BINDING | 12 | 9.58e-01 | -8.85e-03 | 9.87e-01 |
GOBP RESPONSE TO PAIN | 8 | 9.66e-01 | -8.80e-03 | 9.90e-01 |
GOCC XY BODY | 8 | 9.66e-01 | 8.80e-03 | 9.90e-01 |
GOCC SECRETORY GRANULE | 442 | 7.55e-01 | 8.79e-03 | 9.14e-01 |
GOCC ENDOSOME MEMBRANE | 348 | 7.81e-01 | -8.79e-03 | 9.26e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE | 98 | 8.81e-01 | 8.76e-03 | 9.63e-01 |
GOBP MEMBRANE ORGANIZATION | 506 | 7.41e-01 | 8.75e-03 | 9.06e-01 |
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 51 | 9.14e-01 | -8.71e-03 | 9.74e-01 |
GOBP EPIDERMIS DEVELOPMENT | 99 | 8.82e-01 | 8.67e-03 | 9.63e-01 |
GOBP GERMINAL CENTER FORMATION | 10 | 9.62e-01 | -8.62e-03 | 9.88e-01 |
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION | 8 | 9.66e-01 | 8.60e-03 | 9.90e-01 |
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS | 9 | 9.65e-01 | -8.56e-03 | 9.89e-01 |
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY | 34 | 9.31e-01 | -8.55e-03 | 9.78e-01 |
GOBP SPINDLE ELONGATION | 5 | 9.74e-01 | 8.52e-03 | 9.91e-01 |
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION | 24 | 9.43e-01 | -8.51e-03 | 9.83e-01 |
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY | 29 | 9.37e-01 | 8.44e-03 | 9.82e-01 |
GOBP SPHINGOID METABOLIC PROCESS | 10 | 9.63e-01 | -8.42e-03 | 9.88e-01 |
GOBP MELANIN METABOLIC PROCESS | 7 | 9.69e-01 | 8.37e-03 | 9.90e-01 |
GOMF RNA METHYLTRANSFERASE ACTIVITY | 48 | 9.21e-01 | 8.33e-03 | 9.75e-01 |
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 19 | 9.50e-01 | 8.29e-03 | 9.84e-01 |
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY | 11 | 9.62e-01 | 8.28e-03 | 9.88e-01 |
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS | 7 | 9.70e-01 | 8.28e-03 | 9.90e-01 |
GOBP MYELOID CELL HOMEOSTASIS | 119 | 8.77e-01 | 8.27e-03 | 9.62e-01 |
GOMF POLYSACCHARIDE BINDING | 5 | 9.75e-01 | -8.26e-03 | 9.91e-01 |
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT | 13 | 9.59e-01 | -8.25e-03 | 9.87e-01 |
GOCC CHROMOSOME | 1037 | 6.65e-01 | 8.25e-03 | 8.72e-01 |
GOCC NADPH OXIDASE COMPLEX | 7 | 9.70e-01 | -8.21e-03 | 9.90e-01 |
GOBP STRIATED MUSCLE CELL PROLIFERATION | 29 | 9.39e-01 | 8.19e-03 | 9.82e-01 |
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST | 19 | 9.51e-01 | -8.17e-03 | 9.84e-01 |
GOCC MITOTIC SPINDLE POLE | 29 | 9.39e-01 | 8.16e-03 | 9.82e-01 |
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 382 | 7.87e-01 | 8.16e-03 | 9.28e-01 |
GOBP TISSUE REMODELING | 63 | 9.11e-01 | -8.15e-03 | 9.73e-01 |
GOBP POSITIVE REGULATION OF KINASE ACTIVITY | 158 | 8.61e-01 | 8.14e-03 | 9.55e-01 |
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT | 14 | 9.58e-01 | 8.12e-03 | 9.87e-01 |
GOBP REGULATION OF PHAGOCYTOSIS | 47 | 9.24e-01 | 8.10e-03 | 9.76e-01 |
GOMF PROTEIN HOMODIMERIZATION ACTIVITY | 382 | 7.89e-01 | -8.08e-03 | 9.29e-01 |
GOMF PROTEASE BINDING | 77 | 9.03e-01 | 8.07e-03 | 9.71e-01 |
GOCC CELL LEADING EDGE | 224 | 8.36e-01 | -8.07e-03 | 9.46e-01 |
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI | 8 | 9.69e-01 | -8.05e-03 | 9.90e-01 |
GOCC CENTROSOME | 406 | 7.84e-01 | -8.04e-03 | 9.28e-01 |
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY | 40 | 9.30e-01 | 8.03e-03 | 9.78e-01 |
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS | 7 | 9.71e-01 | 7.96e-03 | 9.90e-01 |
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS | 157 | 8.64e-01 | -7.95e-03 | 9.57e-01 |
GOBP RRNA TRANSPORT | 5 | 9.75e-01 | 7.94e-03 | 9.92e-01 |
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS | 14 | 9.59e-01 | -7.85e-03 | 9.87e-01 |
GOMF LRR DOMAIN BINDING | 13 | 9.61e-01 | -7.76e-03 | 9.88e-01 |
GOBP GERM CELL DEVELOPMENT | 126 | 8.81e-01 | 7.76e-03 | 9.63e-01 |
GOBP REGULATION OF MEMBRANE INVAGINATION | 10 | 9.66e-01 | 7.71e-03 | 9.90e-01 |
GOCC CD40 RECEPTOR COMPLEX | 9 | 9.68e-01 | 7.67e-03 | 9.90e-01 |
GOBP REGULATION OF PROTEIN DEACETYLATION | 23 | 9.49e-01 | -7.66e-03 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 52 | 9.24e-01 | 7.65e-03 | 9.76e-01 |
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY | 33 | 9.40e-01 | -7.58e-03 | 9.82e-01 |
GOCC GOLGI APPARATUS | 878 | 7.12e-01 | 7.56e-03 | 8.96e-01 |
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 78 | 9.09e-01 | -7.52e-03 | 9.73e-01 |
GOMF PROTEIN KINASE C BINDING | 26 | 9.48e-01 | 7.45e-03 | 9.84e-01 |
GOCC APICAL PART OF CELL | 143 | 8.78e-01 | 7.44e-03 | 9.63e-01 |
GOMF CYTOKINE RECEPTOR BINDING | 79 | 9.09e-01 | -7.44e-03 | 9.73e-01 |
GOBP RESPONSE TO LIGHT STIMULUS | 159 | 8.72e-01 | -7.43e-03 | 9.60e-01 |
GOBP RESPONSE TO VITAMIN D | 11 | 9.66e-01 | 7.43e-03 | 9.90e-01 |
GOMF SOLUTE PROTON SYMPORTER ACTIVITY | 9 | 9.69e-01 | 7.43e-03 | 9.90e-01 |
GOBP CERAMIDE BIOSYNTHETIC PROCESS | 36 | 9.39e-01 | -7.34e-03 | 9.82e-01 |
GOMF CHEMOKINE BINDING | 10 | 9.68e-01 | 7.33e-03 | 9.90e-01 |
GOCC OUTER MEMBRANE | 166 | 8.72e-01 | 7.26e-03 | 9.60e-01 |
GOBP REGULATION OF METAPHASE PLATE CONGRESSION | 9 | 9.70e-01 | 7.25e-03 | 9.90e-01 |
GOCC MICROTUBULE CYTOSKELETON | 774 | 7.39e-01 | 7.24e-03 | 9.06e-01 |
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM | 6 | 9.76e-01 | -7.21e-03 | 9.92e-01 |
GOCC DISTAL AXON | 110 | 8.97e-01 | -7.14e-03 | 9.69e-01 |
GOBP APOPTOTIC SIGNALING PATHWAY | 368 | 8.17e-01 | 7.13e-03 | 9.41e-01 |
GOBP I KAPPAB PHOSPHORYLATION | 7 | 9.74e-01 | 7.10e-03 | 9.91e-01 |
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY | 6 | 9.76e-01 | 6.99e-03 | 9.92e-01 |
GOBP TELOMERE CAPPING | 30 | 9.47e-01 | 6.97e-03 | 9.84e-01 |
GOCC TERTIARY GRANULE LUMEN | 28 | 9.50e-01 | 6.87e-03 | 9.84e-01 |
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION | 32 | 9.47e-01 | -6.86e-03 | 9.84e-01 |
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING | 42 | 9.39e-01 | -6.83e-03 | 9.82e-01 |
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX | 35 | 9.45e-01 | -6.71e-03 | 9.84e-01 |
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY | 9 | 9.72e-01 | -6.71e-03 | 9.91e-01 |
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 64 | 9.27e-01 | 6.66e-03 | 9.77e-01 |
GOBP POSITIVE REGULATION OF TRANSPORT | 409 | 8.20e-01 | -6.65e-03 | 9.42e-01 |
GOCC SHELTERIN COMPLEX | 5 | 9.80e-01 | 6.61e-03 | 9.92e-01 |
GOBP ENDOSOME ORGANIZATION | 74 | 9.22e-01 | 6.60e-03 | 9.75e-01 |
GOCC NEURON PROJECTION | 485 | 8.08e-01 | -6.56e-03 | 9.37e-01 |
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM | 24 | 9.56e-01 | 6.53e-03 | 9.85e-01 |
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS | 22 | 9.58e-01 | -6.47e-03 | 9.87e-01 |
GOCC DNA REPAIR COMPLEX | 19 | 9.61e-01 | -6.46e-03 | 9.88e-01 |
GOCC NON MOTILE CILIUM | 48 | 9.38e-01 | -6.46e-03 | 9.82e-01 |
GOBP VIRAL GENOME REPLICATION | 92 | 9.16e-01 | 6.40e-03 | 9.74e-01 |
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION | 36 | 9.47e-01 | -6.37e-03 | 9.84e-01 |
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN | 5 | 9.81e-01 | 6.30e-03 | 9.93e-01 |
GOBP CRANIAL NERVE DEVELOPMENT | 11 | 9.72e-01 | 6.22e-03 | 9.90e-01 |
GOBP RESPONSE TO OXYGEN LEVELS | 165 | 8.93e-01 | -6.09e-03 | 9.67e-01 |
GOBP REGULATION OF GASTRULATION | 6 | 9.80e-01 | -6.03e-03 | 9.92e-01 |
GOBP REGULATION OF HISTONE MODIFICATION | 33 | 9.53e-01 | 5.98e-03 | 9.84e-01 |
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE | 14 | 9.69e-01 | 5.95e-03 | 9.90e-01 |
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION | 14 | 9.69e-01 | 5.93e-03 | 9.90e-01 |
GOBP THYMUS DEVELOPMENT | 26 | 9.58e-01 | 5.91e-03 | 9.87e-01 |
GOBP LYMPH NODE DEVELOPMENT | 7 | 9.78e-01 | 5.90e-03 | 9.92e-01 |
GOMF S ACYLTRANSFERASE ACTIVITY | 17 | 9.67e-01 | 5.87e-03 | 9.90e-01 |
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY | 42 | 9.48e-01 | -5.87e-03 | 9.84e-01 |
GOBP HISTONE MRNA METABOLIC PROCESS | 20 | 9.64e-01 | 5.85e-03 | 9.89e-01 |
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS | 96 | 9.22e-01 | 5.81e-03 | 9.75e-01 |
GOBP PROTEOLYSIS | 910 | 7.75e-01 | 5.76e-03 | 9.25e-01 |
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY | 31 | 9.56e-01 | -5.75e-03 | 9.85e-01 |
GOBP NEGATIVE REGULATION OF COAGULATION | 9 | 9.76e-01 | -5.75e-03 | 9.92e-01 |
GOBP MRNA TRANSCRIPTION | 37 | 9.52e-01 | -5.71e-03 | 9.84e-01 |
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY | 33 | 9.55e-01 | 5.67e-03 | 9.85e-01 |
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY | 9 | 9.77e-01 | -5.65e-03 | 9.92e-01 |
GOMF PHOSPHOLIPID BINDING | 241 | 8.82e-01 | -5.58e-03 | 9.63e-01 |
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY | 43 | 9.50e-01 | 5.57e-03 | 9.84e-01 |
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION | 9 | 9.77e-01 | 5.50e-03 | 9.92e-01 |
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION | 9 | 9.77e-01 | 5.50e-03 | 9.92e-01 |
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX | 10 | 9.76e-01 | -5.48e-03 | 9.92e-01 |
GOCC GOLGI CISTERNA | 61 | 9.42e-01 | -5.44e-03 | 9.83e-01 |
GOBP POTASSIUM ION TRANSPORT | 57 | 9.44e-01 | -5.42e-03 | 9.83e-01 |
GOCC U2AF COMPLEX | 5 | 9.83e-01 | 5.42e-03 | 9.93e-01 |
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY | 30 | 9.59e-01 | -5.38e-03 | 9.87e-01 |
GOBP CHROMATIN REMODELING | 422 | 8.52e-01 | 5.37e-03 | 9.51e-01 |
GOCC PCG PROTEIN COMPLEX | 29 | 9.60e-01 | 5.34e-03 | 9.88e-01 |
GOBP ESTABLISHMENT OF RNA LOCALIZATION | 136 | 9.15e-01 | 5.33e-03 | 9.74e-01 |
GOBP REGULATION OF T CELL MEDIATED IMMUNITY | 40 | 9.54e-01 | -5.32e-03 | 9.85e-01 |
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR | 97 | 9.28e-01 | 5.31e-03 | 9.77e-01 |
GOBP ISG15 PROTEIN CONJUGATION | 5 | 9.84e-01 | 5.28e-03 | 9.93e-01 |
GOMF GLYCOSYLTRANSFERASE ACTIVITY | 128 | 9.18e-01 | -5.28e-03 | 9.74e-01 |
GOBP RESPONSE TO ALKALOID | 38 | 9.55e-01 | 5.25e-03 | 9.85e-01 |
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY | 279 | 8.82e-01 | -5.22e-03 | 9.63e-01 |
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING | 12 | 9.76e-01 | -5.11e-03 | 9.92e-01 |
GOBP RESPONSE TO TESTOSTERONE | 23 | 9.67e-01 | 5.00e-03 | 9.90e-01 |
GOBP RESPONSE TO VIRUS | 243 | 8.94e-01 | -5.00e-03 | 9.68e-01 |
GOMF GTPASE BINDING | 210 | 9.02e-01 | -4.97e-03 | 9.71e-01 |
GOBP REGULATION OF CELLULAR LOCALIZATION | 550 | 8.46e-01 | -4.93e-03 | 9.51e-01 |
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY | 19 | 9.71e-01 | -4.89e-03 | 9.90e-01 |
GOBP POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT | 8 | 9.81e-01 | -4.88e-03 | 9.93e-01 |
GOBP CALCINEURIN MEDIATED SIGNALING | 24 | 9.68e-01 | 4.71e-03 | 9.90e-01 |
GOBP REGULATION OF RUFFLE ASSEMBLY | 21 | 9.70e-01 | -4.70e-03 | 9.90e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 23 | 9.69e-01 | 4.69e-03 | 9.90e-01 |
GOBP MRNA METABOLIC PROCESS | 560 | 8.53e-01 | 4.68e-03 | 9.51e-01 |
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS | 33 | 9.63e-01 | 4.66e-03 | 9.88e-01 |
GOMF GLYCOLIPID BINDING | 16 | 9.74e-01 | 4.65e-03 | 9.91e-01 |
GOCC ENDOLYSOSOME MEMBRANE | 12 | 9.78e-01 | -4.55e-03 | 9.92e-01 |
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY | 9 | 9.81e-01 | -4.54e-03 | 9.93e-01 |
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION | 7 | 9.84e-01 | 4.50e-03 | 9.93e-01 |
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR | 8 | 9.83e-01 | 4.41e-03 | 9.93e-01 |
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY | 12 | 9.79e-01 | 4.40e-03 | 9.92e-01 |
GOMF SYNTAXIN 1 BINDING | 10 | 9.81e-01 | -4.37e-03 | 9.93e-01 |
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX | 26 | 9.69e-01 | 4.35e-03 | 9.90e-01 |
GOMF R SMAD BINDING | 16 | 9.76e-01 | -4.35e-03 | 9.92e-01 |
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION | 8 | 9.83e-01 | 4.30e-03 | 9.93e-01 |
GOMF PHOSPHOPROTEIN BINDING | 61 | 9.54e-01 | -4.30e-03 | 9.85e-01 |
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS | 15 | 9.78e-01 | -4.12e-03 | 9.92e-01 |
GOBP ORGANIC ANION TRANSPORT | 147 | 9.33e-01 | 4.06e-03 | 9.79e-01 |
GOBP HISTONE MRNA CATABOLIC PROCESS | 14 | 9.79e-01 | -3.98e-03 | 9.92e-01 |
GOMF SINGLE STRANDED RNA BINDING | 59 | 9.59e-01 | 3.90e-03 | 9.87e-01 |
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY | 8 | 9.85e-01 | -3.86e-03 | 9.94e-01 |
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE | 17 | 9.78e-01 | -3.86e-03 | 9.92e-01 |
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION | 12 | 9.82e-01 | -3.79e-03 | 9.93e-01 |
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE | 7 | 9.86e-01 | -3.77e-03 | 9.95e-01 |
GOBP ADAPTIVE THERMOGENESIS | 81 | 9.54e-01 | 3.75e-03 | 9.85e-01 |
GOBP AXONEME ASSEMBLY | 14 | 9.81e-01 | 3.73e-03 | 9.93e-01 |
GOBP MULTI MULTICELLULAR ORGANISM PROCESS | 74 | 9.56e-01 | 3.71e-03 | 9.85e-01 |
GOCC CELL BODY | 198 | 9.29e-01 | -3.71e-03 | 9.77e-01 |
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE | 38 | 9.69e-01 | 3.70e-03 | 9.90e-01 |
GOCC SPINDLE | 280 | 9.16e-01 | 3.70e-03 | 9.74e-01 |
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION | 7 | 9.87e-01 | 3.68e-03 | 9.95e-01 |
GOBP PROTEIN DNA COMPLEX ORGANIZATION | 584 | 8.82e-01 | -3.68e-03 | 9.63e-01 |
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS | 17 | 9.79e-01 | 3.65e-03 | 9.92e-01 |
GOMF TELOMERIC DNA BINDING | 33 | 9.71e-01 | 3.61e-03 | 9.90e-01 |
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY | 21 | 9.78e-01 | 3.56e-03 | 9.92e-01 |
GOCC MIDBODY | 153 | 9.40e-01 | -3.54e-03 | 9.82e-01 |
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION | 31 | 9.73e-01 | 3.53e-03 | 9.91e-01 |
GOBP MEMBRANE LIPID METABOLIC PROCESS | 109 | 9.50e-01 | -3.50e-03 | 9.84e-01 |
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING | 45 | 9.68e-01 | 3.50e-03 | 9.90e-01 |
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING | 10 | 9.85e-01 | -3.46e-03 | 9.94e-01 |
GOBP REGULATION OF MEIOTIC CELL CYCLE | 28 | 9.75e-01 | 3.45e-03 | 9.91e-01 |
GOBP TRIGLYCERIDE METABOLIC PROCESS | 37 | 9.71e-01 | 3.43e-03 | 9.90e-01 |
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 136 | 9.45e-01 | -3.41e-03 | 9.84e-01 |
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS | 6 | 9.88e-01 | -3.40e-03 | 9.96e-01 |
GOBP NUCLEAR TRANSPORT | 247 | 9.28e-01 | -3.39e-03 | 9.77e-01 |
GOBP REGULATION OF LYSOSOMAL LUMEN PH | 26 | 9.77e-01 | 3.30e-03 | 9.92e-01 |
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION | 6 | 9.89e-01 | -3.29e-03 | 9.96e-01 |
GOBP MICROTUBULE POLYMERIZATION | 61 | 9.65e-01 | 3.25e-03 | 9.90e-01 |
GOMF MICROTUBULE MINUS END BINDING | 10 | 9.86e-01 | 3.24e-03 | 9.95e-01 |
GOBP SUCKLING BEHAVIOR | 7 | 9.88e-01 | 3.23e-03 | 9.96e-01 |
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION | 64 | 9.65e-01 | 3.15e-03 | 9.90e-01 |
GOCC ENDOCYTIC VESICLE MEMBRANE | 100 | 9.57e-01 | 3.11e-03 | 9.86e-01 |
GOBP MRNA TRANSPORT | 108 | 9.56e-01 | 3.10e-03 | 9.85e-01 |
GOBP ORGANELLE LOCALIZATION | 394 | 9.18e-01 | -3.07e-03 | 9.74e-01 |
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS | 51 | 9.70e-01 | 3.04e-03 | 9.90e-01 |
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION | 12 | 9.85e-01 | 3.04e-03 | 9.95e-01 |
GOBP PROTEIN STABILIZATION | 146 | 9.50e-01 | 3.01e-03 | 9.84e-01 |
GOBP RESPONSE TO EPINEPHRINE | 8 | 9.88e-01 | -3.00e-03 | 9.96e-01 |
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 52 | 9.70e-01 | -2.99e-03 | 9.90e-01 |
GOBP FAT CELL PROLIFERATION | 7 | 9.89e-01 | 2.98e-03 | 9.96e-01 |
GOMF CYTOKINE BINDING | 42 | 9.74e-01 | -2.96e-03 | 9.91e-01 |
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 129 | 9.54e-01 | 2.95e-03 | 9.85e-01 |
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM | 412 | 9.20e-01 | 2.94e-03 | 9.75e-01 |
GOBP ENDOPLASMIC RETICULUM ORGANIZATION | 73 | 9.66e-01 | -2.92e-03 | 9.90e-01 |
GOCC PHOTORECEPTOR INNER SEGMENT | 18 | 9.83e-01 | -2.91e-03 | 9.93e-01 |
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE | 59 | 9.69e-01 | -2.91e-03 | 9.90e-01 |
GOCC ACTIN CYTOSKELETON | 238 | 9.40e-01 | -2.86e-03 | 9.82e-01 |
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY | 471 | 9.18e-01 | 2.82e-03 | 9.74e-01 |
GOBP CYTOSOLIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 86 | 9.65e-01 | 2.78e-03 | 9.89e-01 |
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION | 5 | 9.91e-01 | -2.75e-03 | 9.97e-01 |
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS | 79 | 9.66e-01 | 2.75e-03 | 9.90e-01 |
GOBP RESPONSE TO INORGANIC SUBSTANCE | 249 | 9.41e-01 | -2.74e-03 | 9.82e-01 |
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY | 101 | 9.62e-01 | -2.73e-03 | 9.88e-01 |
GOBP RESPONSE TO AMINO ACID STARVATION | 41 | 9.76e-01 | -2.69e-03 | 9.92e-01 |
GOBP POLYAMINE METABOLIC PROCESS | 11 | 9.88e-01 | 2.64e-03 | 9.96e-01 |
GOBP POSITIVE REGULATION OF BONE RESORPTION | 8 | 9.90e-01 | -2.64e-03 | 9.96e-01 |
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS | 178 | 9.52e-01 | -2.62e-03 | 9.84e-01 |
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 41 | 9.77e-01 | -2.57e-03 | 9.92e-01 |
GOBP RUFFLE ORGANIZATION | 37 | 9.78e-01 | -2.56e-03 | 9.92e-01 |
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION | 12 | 9.88e-01 | 2.55e-03 | 9.96e-01 |
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN | 31 | 9.80e-01 | 2.54e-03 | 9.93e-01 |
GOMF N ACYLTRANSFERASE ACTIVITY | 60 | 9.73e-01 | 2.53e-03 | 9.91e-01 |
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION | 10 | 9.89e-01 | -2.53e-03 | 9.96e-01 |
GOBP REGULATION OF STEROL TRANSPORT | 23 | 9.83e-01 | 2.50e-03 | 9.93e-01 |
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY | 72 | 9.73e-01 | -2.34e-03 | 9.91e-01 |
GOBP REGULATION OF NERVOUS SYSTEM PROCESS | 34 | 9.81e-01 | -2.33e-03 | 9.93e-01 |
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION | 64 | 9.75e-01 | -2.30e-03 | 9.91e-01 |
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION | 6 | 9.92e-01 | 2.29e-03 | 9.97e-01 |
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN | 89 | 9.70e-01 | -2.29e-03 | 9.90e-01 |
GOBP PROTEIN MONOUBIQUITINATION | 33 | 9.82e-01 | -2.25e-03 | 9.93e-01 |
GOBP NUCLEUS ORGANIZATION | 107 | 9.69e-01 | 2.18e-03 | 9.90e-01 |
GOBP BRADYKININ CATABOLIC PROCESS | 5 | 9.93e-01 | 2.17e-03 | 9.98e-01 |
GOCC PTW PP1 PHOSPHATASE COMPLEX | 7 | 9.92e-01 | -2.16e-03 | 9.97e-01 |
GOBP NEURAL NUCLEUS DEVELOPMENT | 34 | 9.83e-01 | 2.15e-03 | 9.93e-01 |
GOBP TRABECULA MORPHOGENESIS | 13 | 9.89e-01 | -2.12e-03 | 9.96e-01 |
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST | 115 | 9.69e-01 | -2.10e-03 | 9.90e-01 |
GOMF MONOATOMIC CATION CHANNEL ACTIVITY | 66 | 9.77e-01 | -2.10e-03 | 9.92e-01 |
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY | 224 | 9.57e-01 | -2.09e-03 | 9.86e-01 |
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY | 138 | 9.67e-01 | -2.05e-03 | 9.90e-01 |
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS | 38 | 9.83e-01 | 2.03e-03 | 9.93e-01 |
GOBP REGULATION OF ER ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 8 | 9.92e-01 | 2.03e-03 | 9.97e-01 |
GOBP PYROPTOSIS | 21 | 9.87e-01 | -2.01e-03 | 9.95e-01 |
GOBP DENDRITIC CELL CYTOKINE PRODUCTION | 9 | 9.92e-01 | 1.97e-03 | 9.97e-01 |
GOCC SITE OF POLARIZED GROWTH | 88 | 9.75e-01 | -1.95e-03 | 9.91e-01 |
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 25 | 9.87e-01 | 1.93e-03 | 9.95e-01 |
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS | 120 | 9.71e-01 | -1.90e-03 | 9.90e-01 |
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX | 11 | 9.92e-01 | 1.82e-03 | 9.97e-01 |
GOCC CAJAL BODY | 44 | 9.84e-01 | -1.78e-03 | 9.93e-01 |
GOBP FUCOSE METABOLIC PROCESS | 5 | 9.95e-01 | 1.78e-03 | 9.98e-01 |
GOMF TRANSLATION INITIATION FACTOR BINDING | 24 | 9.88e-01 | 1.72e-03 | 9.96e-01 |
GOBP PLATELET DENSE GRANULE ORGANIZATION | 20 | 9.89e-01 | 1.72e-03 | 9.96e-01 |
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY | 427 | 9.54e-01 | -1.66e-03 | 9.85e-01 |
GOMF N6 METHYLADENOSINE CONTAINING RNA BINDING | 9 | 9.93e-01 | 1.65e-03 | 9.98e-01 |
GOMF NOTCH BINDING | 9 | 9.93e-01 | -1.60e-03 | 9.98e-01 |
GOCC CHITOSOME | 7 | 9.94e-01 | -1.55e-03 | 9.98e-01 |
GOBP SENSORY PERCEPTION | 116 | 9.77e-01 | 1.53e-03 | 9.92e-01 |
GOMF MYOSIN BINDING | 29 | 9.89e-01 | -1.51e-03 | 9.96e-01 |
GOMF HISTONE MODIFYING ACTIVITY | 150 | 9.75e-01 | -1.51e-03 | 9.91e-01 |
GOCC PLASMA MEMBRANE PROTEIN COMPLEX | 191 | 9.72e-01 | -1.47e-03 | 9.91e-01 |
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK | 22 | 9.91e-01 | 1.45e-03 | 9.97e-01 |
GOBP MRNA SPLICE SITE RECOGNITION | 25 | 9.90e-01 | 1.42e-03 | 9.96e-01 |
GOBP VIRAL LIFE CYCLE | 198 | 9.73e-01 | -1.41e-03 | 9.91e-01 |
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION | 338 | 9.66e-01 | -1.36e-03 | 9.90e-01 |
GOBP RESPONSE TO RADIATION | 230 | 9.72e-01 | 1.35e-03 | 9.91e-01 |
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY | 7 | 9.95e-01 | 1.33e-03 | 9.98e-01 |
GOBP REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY | 52 | 9.87e-01 | 1.32e-03 | 9.95e-01 |
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY | 15 | 9.93e-01 | 1.32e-03 | 9.98e-01 |
GOMF MHC CLASS II RECEPTOR ACTIVITY | 8 | 9.95e-01 | 1.22e-03 | 9.98e-01 |
GOBP MOTOR NEURON AXON GUIDANCE | 6 | 9.96e-01 | 1.15e-03 | 9.99e-01 |
GOCC UBIQUITIN LIGASE COMPLEX | 231 | 9.76e-01 | 1.14e-03 | 9.92e-01 |
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION | 11 | 9.95e-01 | 1.13e-03 | 9.98e-01 |
GOMF ARMADILLO REPEAT DOMAIN BINDING | 8 | 9.96e-01 | -1.08e-03 | 9.98e-01 |
GOBP VESICLE MEDIATED TRANSPORT | 899 | 9.58e-01 | -1.06e-03 | 9.87e-01 |
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS | 14 | 9.95e-01 | -1.05e-03 | 9.98e-01 |
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION | 379 | 9.73e-01 | -1.04e-03 | 9.91e-01 |
GOBP CELLULAR KETONE METABOLIC PROCESS | 94 | 9.86e-01 | 1.03e-03 | 9.95e-01 |
GOBP PENTOSE METABOLIC PROCESS | 7 | 9.96e-01 | 1.01e-03 | 9.99e-01 |
GOBP MRNA CATABOLIC PROCESS | 178 | 9.82e-01 | -1.01e-03 | 9.93e-01 |
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION | 158 | 9.86e-01 | -8.40e-04 | 9.95e-01 |
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS | 10 | 9.96e-01 | 8.22e-04 | 9.99e-01 |
GOBP PIGMENT GRANULE ORGANIZATION | 31 | 9.94e-01 | 7.90e-04 | 9.98e-01 |
GOCC 9PLUS0 NON MOTILE CILIUM | 38 | 9.93e-01 | 7.85e-04 | 9.98e-01 |
GOCC SECRETORY VESICLE | 509 | 9.78e-01 | -7.42e-04 | 9.92e-01 |
GOBP NEGATIVE REGULATION OF TRANSPORT | 207 | 9.86e-01 | -7.01e-04 | 9.95e-01 |
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION | 52 | 9.94e-01 | -6.35e-04 | 9.98e-01 |
GOBP TELOMERE LOCALIZATION | 6 | 9.98e-01 | 6.29e-04 | 1.00e+00 |
GOBP SECOND MESSENGER MEDIATED SIGNALING | 101 | 9.91e-01 | 6.26e-04 | 9.97e-01 |
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY | 25 | 9.96e-01 | 6.14e-04 | 9.98e-01 |
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION | 640 | 9.79e-01 | 6.09e-04 | 9.92e-01 |
GOCC ACETYLTRANSFERASE COMPLEX | 82 | 9.94e-01 | -5.10e-04 | 9.98e-01 |
GOBP LONG TERM SYNAPTIC DEPRESSION | 6 | 9.98e-01 | 4.81e-04 | 1.00e+00 |
GOBP POSITIVE REGULATION OF VESICLE FUSION | 6 | 9.98e-01 | -4.81e-04 | 1.00e+00 |
GOBP LIPID METABOLIC PROCESS | 600 | 9.85e-01 | -4.73e-04 | 9.94e-01 |
GOBP LABYRINTHINE LAYER DEVELOPMENT | 18 | 9.97e-01 | -4.69e-04 | 9.99e-01 |
GOCC GOLGI CIS CISTERNA | 8 | 9.98e-01 | 4.16e-04 | 1.00e+00 |
GOBP LIPOSACCHARIDE METABOLIC PROCESS | 56 | 9.96e-01 | -4.11e-04 | 9.98e-01 |
GOMF ATP DEPENDENT PROTEIN BINDING | 5 | 9.99e-01 | 3.99e-04 | 1.00e+00 |
GOBP PHOSPHOLIPID CATABOLIC PROCESS | 17 | 9.98e-01 | -3.53e-04 | 1.00e+00 |
GOBP CERAMIDE METABOLIC PROCESS | 55 | 9.97e-01 | 2.96e-04 | 9.99e-01 |
GOBP CALCIUM ION IMPORT | 13 | 9.99e-01 | 2.22e-04 | 1.00e+00 |
GOBP NADPH REGENERATION | 16 | 1.00e+00 | 8.33e-05 | 1.00e+00 |
GOBP MODULATION BY HOST OF VIRAL PROCESS | 30 | 9.99e-01 | 8.16e-05 | 1.00e+00 |
GOBP DNA MODIFICATION | 68 | 9.99e-01 | -7.56e-05 | 1.00e+00 |
GOBP SYNAPSE MATURATION | 9 | 1.00e+00 | 2.47e-05 | 1.00e+00 |
GOBP ICOSANOID TRANSPORT | 12 | 1.00e+00 | -1.85e-05 | 1.00e+00 |
GOBP MICROTUBULE NUCLEATION | 36 | 1.00e+00 | 1.24e-05 | 1.00e+00 |
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS | 6 | 1.00e+00 | 0.00e+00 | 1.00e+00 |
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE
Top enriched genes
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION
Top enriched genes
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH
Top enriched genes
GOCC BRCA1 C COMPLEX
Top enriched genes
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX
Top enriched genes
GOBP FAT PAD DEVELOPMENT
Top enriched genes
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY
Top enriched genes
GOCC CMG COMPLEX
Top enriched genes
GOBP REGULATION OF NEUTROPHIL DEGRANULATION
Top enriched genes
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS
Top enriched genes
GOBP REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY
Top enriched genes
GOBP DETOXIFICATION OF INORGANIC COMPOUND
Top enriched genes
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE
Top enriched genes
GOMF COPPER CHAPERONE ACTIVITY
Top enriched genes
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX
Top enriched genes
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY
Top enriched genes
GOMF MAP KINASE PHOSPHATASE ACTIVITY
Top enriched genes
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY
Top enriched genes
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY
Top enriched genes
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING
Top enriched genes
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING
Top enriched genes
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE
Top enriched genes
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION
Top enriched genes
GOBP PROXIMAL DISTAL PATTERN FORMATION
Top enriched genes
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX
Top enriched genes
GOBP TETRAPYRROLE CATABOLIC PROCESS
Top enriched genes
GOMF THIOESTERASE BINDING
Top enriched genes
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION
Top enriched genes
GOBP RESPONSE TO WATER
Top enriched genes
GOBP NEURON FATE SPECIFICATION
Top enriched genes
GOCC DNA REPLICATION PREINITIATION COMPLEX
Top enriched genes
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY
Top enriched genes
GOBP STARTLE RESPONSE
Top enriched genes
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION
Top enriched genes
GOMF DNA REPLICATION ORIGIN BINDING
Top enriched genes
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION
Top enriched genes
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE
Top enriched genes
GOCC MCM COMPLEX
Top enriched genes
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION
Top enriched genes
GOCC U4 SNRNP
Top enriched genes
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS
Top enriched genes
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY
Top enriched genes
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT
Top enriched genes
GOCC KNL1 SPC105 COMPLEX
Top enriched genes
GOCC ORIGIN RECOGNITION COMPLEX
Top enriched genes
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION
Top enriched genes
GOBP RESPONSE TO HYDROSTATIC PRESSURE
Top enriched genes
GOMF INTERLEUKIN 1 RECEPTOR BINDING
Top enriched genes
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX
Top enriched genes
GOBP MEIOTIC CHROMOSOME CONDENSATION
Top enriched genes
Here is the session info with all the versions of packages used.
sessionInfo()
## R version 4.3.3 (2024-02-29)
## Platform: x86_64-pc-linux-gnu (64-bit)
## Running under: Ubuntu 22.04.4 LTS
##
## Matrix products: default
## BLAS: /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
##
## locale:
## [1] LC_CTYPE=en_US.UTF-8 LC_NUMERIC=C
## [3] LC_TIME=en_US.UTF-8 LC_COLLATE=en_US.UTF-8
## [5] LC_MONETARY=en_US.UTF-8 LC_MESSAGES=en_US.UTF-8
## [7] LC_PAPER=en_US.UTF-8 LC_NAME=C
## [9] LC_ADDRESS=C LC_TELEPHONE=C
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C
##
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
##
## attached base packages:
## [1] parallel stats4 stats graphics grDevices utils datasets
## [8] methods base
##
## other attached packages:
## [1] pkgload_1.3.4 GGally_2.2.1
## [3] ggplot2_3.5.0 reshape2_1.4.4
## [5] gtools_3.9.5 tibble_3.2.1
## [7] dplyr_1.1.4 echarts4r_0.4.5
## [9] gplots_3.1.3.1 kableExtra_1.4.0
## [11] limma_3.58.1 mitch_1.15.0
## [13] DESeq2_1.42.0 muscat_1.16.0
## [15] beeswarm_0.4.0 stringi_1.8.3
## [17] SingleCellExperiment_1.24.0 SummarizedExperiment_1.32.0
## [19] Biobase_2.62.0 GenomicRanges_1.54.1
## [21] GenomeInfoDb_1.38.6 IRanges_2.36.0
## [23] S4Vectors_0.40.2 BiocGenerics_0.48.1
## [25] MatrixGenerics_1.14.0 matrixStats_1.2.0
## [27] hdf5r_1.3.9 Seurat_5.0.1
## [29] SeuratObject_5.0.1 sp_2.1-3
## [31] plyr_1.8.9
##
## loaded via a namespace (and not attached):
## [1] spatstat.sparse_3.0-3 bitops_1.0-7
## [3] httr_1.4.7 RColorBrewer_1.1-3
## [5] doParallel_1.0.17 numDeriv_2016.8-1.1
## [7] backports_1.4.1 tools_4.3.3
## [9] sctransform_0.4.1 utf8_1.2.4
## [11] R6_2.5.1 lazyeval_0.2.2
## [13] uwot_0.1.16 mgcv_1.9-1
## [15] GetoptLong_1.0.5 withr_3.0.0
## [17] prettyunits_1.2.0 gridExtra_2.3
## [19] progressr_0.14.0 cli_3.6.2
## [21] spatstat.explore_3.2-6 fastDummies_1.7.3
## [23] labeling_0.4.3 sass_0.4.8
## [25] mvtnorm_1.2-4 spatstat.data_3.0-4
## [27] blme_1.0-5 ggridges_0.5.6
## [29] pbapply_1.7-2 systemfonts_1.0.5
## [31] svglite_2.1.3 scater_1.30.1
## [33] parallelly_1.37.0 rstudioapi_0.15.0
## [35] generics_0.1.3 shape_1.4.6
## [37] ica_1.0-3 spatstat.random_3.2-2
## [39] Matrix_1.6-5 ggbeeswarm_0.7.2
## [41] fansi_1.0.6 abind_1.4-5
## [43] lifecycle_1.0.4 yaml_2.3.8
## [45] edgeR_4.0.15 SparseArray_1.2.4
## [47] Rtsne_0.17 grid_4.3.3
## [49] promises_1.2.1 crayon_1.5.2
## [51] miniUI_0.1.1.1 lattice_0.22-5
## [53] beachmat_2.18.1 cowplot_1.1.3
## [55] pillar_1.9.0 knitr_1.45
## [57] ComplexHeatmap_2.18.0 rjson_0.2.21
## [59] boot_1.3-28.1 corpcor_1.6.10
## [61] future.apply_1.11.1 codetools_0.2-19
## [63] leiden_0.4.3.1 glue_1.7.0
## [65] data.table_1.15.2 vctrs_0.6.5
## [67] png_0.1-8 spam_2.10-0
## [69] Rdpack_2.6 gtable_0.3.4
## [71] cachem_1.0.8 xfun_0.42
## [73] rbibutils_2.2.16 S4Arrays_1.2.0
## [75] mime_0.12 survival_3.5-8
## [77] iterators_1.0.14 statmod_1.5.0
## [79] ellipsis_0.3.2 fitdistrplus_1.1-11
## [81] ROCR_1.0-11 nlme_3.1-164
## [83] pbkrtest_0.5.2 bit64_4.0.5
## [85] EnvStats_2.8.1 progress_1.2.3
## [87] RcppAnnoy_0.0.22 bslib_0.6.1
## [89] TMB_1.9.10 irlba_2.3.5.1
## [91] vipor_0.4.7 KernSmooth_2.23-22
## [93] colorspace_2.1-0 ggrastr_1.0.2
## [95] tidyselect_1.2.0 bit_4.0.5
## [97] compiler_4.3.3 BiocNeighbors_1.20.2
## [99] xml2_1.3.6 DelayedArray_0.28.0
## [101] plotly_4.10.4 scales_1.3.0
## [103] caTools_1.18.2 remaCor_0.0.18
## [105] lmtest_0.9-40 stringr_1.5.1
## [107] digest_0.6.34 goftest_1.2-3
## [109] spatstat.utils_3.0-4 minqa_1.2.6
## [111] variancePartition_1.32.5 rmarkdown_2.25
## [113] aod_1.3.3 XVector_0.42.0
## [115] RhpcBLASctl_0.23-42 htmltools_0.5.7
## [117] pkgconfig_2.0.3 lme4_1.1-35.1
## [119] sparseMatrixStats_1.14.0 highr_0.10
## [121] fastmap_1.1.1 rlang_1.1.3
## [123] GlobalOptions_0.1.2 htmlwidgets_1.6.4
## [125] shiny_1.8.0 DelayedMatrixStats_1.24.0
## [127] farver_2.1.1 jquerylib_0.1.4
## [129] zoo_1.8-12 jsonlite_1.8.8
## [131] BiocParallel_1.36.0 BiocSingular_1.18.0
## [133] RCurl_1.98-1.14 magrittr_2.0.3
## [135] scuttle_1.12.0 GenomeInfoDbData_1.2.11
## [137] dotCall64_1.1-1 patchwork_1.2.0
## [139] munsell_0.5.0 Rcpp_1.0.12
## [141] viridis_0.6.5 reticulate_1.35.0
## [143] zlibbioc_1.48.0 MASS_7.3-60.0.1
## [145] ggstats_0.5.1 listenv_0.9.1
## [147] ggrepel_0.9.5 deldir_2.0-2
## [149] splines_4.3.3 tensor_1.5
## [151] hms_1.1.3 circlize_0.4.15
## [153] locfit_1.5-9.8 igraph_2.0.2
## [155] spatstat.geom_3.2-8 RcppHNSW_0.6.0
## [157] ScaledMatrix_1.10.0 evaluate_0.23
## [159] nloptr_2.0.3 foreach_1.5.2
## [161] httpuv_1.6.14 RANN_2.6.1
## [163] tidyr_1.3.1 purrr_1.0.2
## [165] polyclip_1.10-6 future_1.33.1
## [167] clue_0.3-65 scattermore_1.2
## [169] rsvd_1.0.5 broom_1.0.5
## [171] xtable_1.8-4 fANCOVA_0.6-1
## [173] RSpectra_0.16-1 later_1.3.2
## [175] viridisLite_0.4.2 lmerTest_3.1-3
## [177] glmmTMB_1.1.9 cluster_2.1.6
## [179] globals_0.16.2
END of report